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Palavras-chave Artroplastia, osseointegrac¸a˜o, implante ortope´dico, implante
instrumentado ativo, estimulac¸a˜o da regenerac¸a˜o o´ssea, estimulador
capacitivo, gerac¸a˜o de energia.
Resumo A artroplastia total da anca (THR) e´ um dos procedimentos ciru´rgicos
mais realizados a` escala global. Milho˜es de THRs sa˜o realizadas
todos os anos em todo o mundo. Atualmente, as taxas de revisa˜o
destas artroplastias podem ser superiores a 10%. O nu´mero de
THRs prima´rias e de revisa˜o teˆm aumentado e estima-se que cresc¸am
acentuadamente nos pro´ximos anos, principalmente em pacientes com
idades inferiores a 65 anos (incluindo aqueles com menos de 45
anos). Tambe´m se tem verificado uma tendeˆncia generalizada para
o uso de fixac¸o˜es na˜o cimentadas, incideˆncia principalmente causada
pelo aumento significativo de pacientes mais jovens e/ou activos.
Embora se tenham realizado avanc¸os cient´ıficos no projeto de implantes
na˜o cimentados, teˆm-se verificado o seu insucesso a longo-prazo.
Encontram-se evideˆncias da inefica´cia dos modelos de implantes que
teˆm sido desenvolvidos para evitar procedimentos de revisa˜o. O
desempenho dos implantes sera´ otimizado se estes foram projetados
para controlarem eficazmente o processo de osseointegrac¸a˜o. Para
se alcanc¸ar este objetivo, teˆm sido propostas a melhoria das
te´cnicas ciru´rgicas e dos protocolos de reabilitac¸a˜o, a inovac¸a˜o dos
revestimentos (onde se incluem os revestimentos ativos projetados para
a libertac¸a˜o controlada de fa´rmacos e/ou outros bio-agentes) e os
conceitos de Implante Instrumentado Passivo e Implante Instrumentado
Ativo. Contudo, na˜o existem demonstrac¸o˜es conclusivas da efica´cia
de tais metodologias. O principal objetivo desta tese e´ propor um
novo modelo de conceito para implantes instrumentados para se
otimizar a integrac¸a˜o osso-implante: o implante instrumentado ativo,
energeticamente auto-suficiente, com capacidade de aplicar est´ımulos
biof´ısicos em tecidos-alvo de forma controlada e personalizada. A
necessidade de um novo modelo e´ demonstrada atrave´s da realizac¸a˜o de
ana´lises de otimalidade ao desempenho dos implantes instrumentados
e na˜o-instrumentados. Foram encontrados resultados promissores para
o controlo otimizado da osseointegrac¸a˜o usando este novo modelo,
atrave´s da atuac¸a˜o terapeˆutica baseada na estimulac¸a˜o capacitiva com
arquitetura em co-superf´ıcie, assim como para fornecer energia ele´trica
de forma auto´noma por mecanismos de transduc¸a˜o baseados em
induc¸a˜o eletromagne´tica usando configurac¸o˜es baseadas na levitac¸a˜o
magne´tica.

Keywords Arthroplasty, osseointegration, orthopaedic implant, instrumented
active implant, bone remodeling stimulation, capacitive stimulator,
energy harvesting.
Abstract Total hip replacement (THR) is one of the most performed surgical
procedures around the world. Millions of THR are carried out worldwide
each year. Currently, THR revision rates can be higher than 10%. A
significant increase of the number of primary and revision THRs, mainly
among patients less than 65 years old (including those under 45 years
old) has been predicted for the forthcoming years. A worldwide increase
in the use of uncemented fixation has also been reported, incidence
caused mainly by the significant increase of more active and/or younger
patients. Besides the significant breakthroughs for uncemented
fixations, they have not been able to ensure long-term implant survival.
Up to date, current implant models have shown evidences of their
inability to avoid revision procedures. The performance of implants
will be optimized if they are designed to perform an effective control
over the osseointegration process. To pursue this goal, improved
surgical techniques and rehabilitation protocols, innovative bioactive
coatings (including those for controlled delivery of drugs and/or other
bio-agents in the bone-implant interface), the concepts of Passive
Instrumented Implant and Active Instrumented Implant have been
proposed. However, there are no conclusive demonstrations of the
effectiveness of such methodologies. The main goal of this thesis
is to propose a new concept model for instrumented implants to
optimize the bone-implant integration: the self-powered instrumented
active implant with ability to deliver controlled and personalized
biophysical stimuli to target tissue areas. The need of such a new
model is demonstrated by optimality analyses conducted to study
the performance of instrumented and non-instrumented orthopaedic
implants. Promising results on the potential of a therapeutic actuation
driven by cosurface-based capacitive stimulation were achieved, as
well as for self-powering instrumented active implants by magnetic
levitation-based electromagnetic energy harvesting.
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Chapter 1
Introduction
1.1 Scope
More than 20% of the global disability burden is due to musculoskeletal (MSK)
disorders, and increasing trends of these disorders have been observed in developed and
developing countries over the last 20 years [1]. Osteoarthritis is a MSK disorder with
a global prevalence around 4% and the most common indication for both total hip
replacement (THR) and total knee replacement (TKR) [1]. They are among the most
performed surgical procedures around the world: millions of THRs and TKRs are carried
out worldwide each year [2–4]. Surgical revisions are usually more complex and significantly
invasive [5]. By consequence, the burden on individuals, health and social care systems
is huge [1]. The incidence of primary and revision THRs and TKRs have been increasing
and are predicted to increase even more in the forthcoming years, mainly among patients
under 65 years old (including those under the age of 45 years) [6–8], mainly due to the
considerable increases in the aged, sedentary and obese population [2, 3]. The need of hip
revision procedures is currently about 6% after 5 years and 12% after 10 years following
primary THR [9], although 10-year revision rates in the 5-20% range were already estimated
regardless of patients’ age [10]. The probability to undergo a second revision is five
to six-fold higher after the first revision (similar values for THR and TKR) [11], with
increasing risks for patients over 70 years old using uncemented implants [12]. According
to several recognized national registers, current THR revision rates can be higher than
10%, incidences slightly higher than those being observed for TKR revisions [6, 13–16].
Besides, 90-days mortality after THR increases with age, which has achieved rates around
0.5% for patients younger than 65 years old [13, 17, 18]. Another worldwide phenomenon
is the increasing use of uncemented implants in the last decade, upsurge also observed in
the oldest age groups, which has been mainly explained by the increasing number of more
active and/or younger patients, significant breakthroughs for uncemented fixations, as
well as country-related individual surgical cultures and even oriented marketing strategies
[6, 13–15, 19–22]. Recent orthopaedic registers indicate nation-dependent rates varying
between 15% (Sweden) and 82% (Canada) [20].
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1.2 Problem
Besides the significant increasing use of uncemented fixations, mainly among younger
patients, various studies conclude that cemented implants have presented higher survival
rates when compared to uncemented ones, mainly for patients older than 65 years
[19, 20, 22]. Troelsen et al. [20] call ”the uncemented paradox” to this worldwide
phenomenon, highlighting the lack of consensus about which fixation method is able to
achieve best performances [20, 23]. On the one hand, poorer performances of uncemented
fixations seems to be related to the higher risks of revision of uncemented cups due
to aseptic loosening [19]. While stress-shielding also occurs with cemented implants,
uncemented fixations are more prone to induced bone loss due to this mechanical
phenomena [24], although the prevalence of loosening has been reduced as solutions based
on bioactive coatings have been increasingly used [6, 13, 15, 23] (e.g. the CORAIL R©
Hip System, a hydroxyapatite (HA) coated cementless implant). The initial mechanical
stability of uncemented implants usually is a focus of more concerns [24]. Some reports
also refer that fractures occur more often on uncemented stems, which increase risks of
trauma during the first postoperative year, although they are also attributed to fissures
produced during stem insertion [19]. Moreover, antibiotic-impregnated bone cements (e.g.
the PALACOS R© cement that release Gentamicin) are clinically being used to reduce
infection risks [6,13,15,25], but uncemented implants are currently unable to deliver drugs
to the bone-implant interface, as the development of bioactive coatings for such purpose
are still in preclinical testing stages [26]. It should be also noted that better mobility
and reduced post-operative pain seem to be achieved by cementing implants [27]. On
the other hand, better performances of uncemented stems have been reported [19, 20, 23].
This success depends upon various factors, among which must be emphasized the use of
improved bioactive coatings for uncemented stems, the increased failure risk of cemented
stems (mainly of smaller sizes) and the noticed minor training of clinicians to perform
optimized cementing procedures [19, 20, 23]. While good stabilities can be achieved by
cemented fixations at short-term following arthroplasty, the mid and long-term fixation
of cemented implants can deteriorate the cement-stem and/or cement-bone interfaces,
increasing the risk of aseptic loosening [24]. Albeit no significant differences in surgical
complications are usually found between cemented or uncemented THRs [27], there are
significantly higher mortality risks following cemented THRs [28, 29]. Another important
observation is that similar risks of revision due to infection between cemented (using
antibiotic-impregnated bone cements) and uncemented THA have been reported [4, 19].
Still, there is an increased risk of bacterial colonization and consequent biofilm formation
due to porosity of uncemented coatings [30]. Consequently, the controversy about the
higher potential of uncemented fixations for optimizing the implants’ survival is not
surprising [19, 24, 31]. Current therapies have shown evidences of their inability for
revision-free joint replacements. This analysis strongly motivates to emphasize the need
of innovative solutions for avoiding THR and TKR revisions. The increasing societal and
personal burdens associated to revision procedures mainly performed in younger and/or
active patients highlight the importance of developing implants to exceed 50 years survival.
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The scope of this thesis is the optimization of bone-implant fixation for uncemented
THRs. Osseointegration is an essential process to establish an asymptomatic and
stable long-term fixation [24, 32]. An accurate control of the factors modulating the
osseointegration process is mandatory for optimizing the implants’ performance [32–35].
However, such purpose requires a biointegration accomplished at the micrometer and
nanometer scale levels [36, 37]. As adverse bone remodeling intensifies, mainly due
to wear debris and stress-shielding, the relative motion between the implant and bone
increases, which can result in aseptic loosening [24, 32]. Revision rates related to
stress-shielding-induced bone loss can exceed 50%, incidences confirming the implant
loosening among the most common causes indicated for THR [2, 6, 13, 15]. The
periprosthetic infection is also a major consequence of implant insertion [4,38–40]. Analyses
using nationwide sampling have shown that THR revisions rates due to infection are around
15% [6,13,15,41]. This epidemiology also suggests the huge projection that can be achieved
in the development of novel concept models that can ensure successful bonding of implants
to the host skeleton.
Besides surgical techniques and rehabilitation protocols have been quite improved,
the common methodologies aiming to improve the performance of hip implants have
been focused on the optimization of their design and materials [24, 32, 36, 37]. Recent
technology is already able to implement implants with custom-made geometries [42] and
nanometer-scale textured surfaces [37]. Advanced biomaterials have been also proposed
to maximize the bone-implant adhesion [43, 44]. Although these approaches are quite
valuable and further research efforts can improve their long-term outcomes [45–47], they
only allow to design passive implants. Implants can only be categorized as active if
they comprise resources to perform therapeutic actuations to optimize the bone-implant
fixation. The potential of actuation systems based on innovative bioactive biomaterials
for coating uncemented implants has been exhaustively researched [26, 48]. Coating
the implants’ surface with HA has been widely used to promote osseointegration (Fig.
1a) [26]. Although their ability to enhance new bone formation, prevent formation of
fibrous tissue and seal the interface from wear particles and macrophages, some recent
reports have shown no improved clinical outcomes when such coatings are used [26,49,50].
Many other materials have been developed for enhancing bioactivity, osteoconductivity,
osteoinductivity, non-cytotoxicity and non-genotoxicity of modern implant systems, such
as bioactive glasses and glass-ceramics [51,52]. The potential of active implants embedding
local delivery systems has been also quite researched [26, 53, 54] (the mechanism used to
perform such operation is here called ’therapeutic delivery’ or ’therapeutic actuation’).
This is a very relevant approach that consists in developing coating incorporating drugs
(e.g. Gentamicin, tobramycin and vancomycin) and/or biomolecules (e.g. growth factors,
collagen and proteins) [26,53,55,56]. For example, HA coatings incorporated with collagen,
recombinant human bone morphogenetic protein (rhBMP-2) and RGD peptides, HA
coatings augmented with osteogenic protein-1 (OP-1), and biodegradable PDLLA coating
incorporating gentamicin were already proposed to improve the bone-implant bonding
and prevent peri-operative infections [57–59]. Among the delivery methods [60], the
stimuli-controlled release must be highlighted as the release rate can be controlled by
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endogenous and/or exogenous stimuli, such as temperature, pH, ionic strength, ultrasound
and electric or magnetic fields [53, 61–64]. Included are the drug-eluting implants that
use nanocarriers (liposomes, micelles, among others) to encapsulate drugs [54, 62, 64–67].
However, these coatings-based targeted local delivery systems are still being analysed and
have not been translated to clinic usage and, consequently, their clinical effectiveness is
still unknown[26,53,54]. To my best knowledge, no cementless implants incorporating local
delivery of drugs and/or biomolecules were already tested in human patients. The concept
of Multifunctional Coating was recently proposed to produce clinically-useful systems
[26]: cost-effective coatings with ability to deliver optimal temporal and dosing release
without local and systemic toxicity and improve the bone-implant fixation. Although
these mechanisms now opens very attractive opportunities for controlling the bone-implant
bonding, they also present significant drawbacks, namely:
(a) Their design can be extremely complex, increasing as their multifunctional ability
increases;
(b) Their controllability is rather reduced because: their delivery dynamics does not
consider the peri-implant biochemical and biomechanical states; their behavior
cannot be changed after implant insertion (their actuation is pre-established a priori);
their ability to perform personalized release of drugs, biomolecules or biophysical
stimuli is quite limited, as their long-term clinical effectiveness will most likely be
unknown after arthroplasty;
(c) Their long-term controllable release of bioactive substances will most likely be quite
hard to implement;
(d) Their ability to deliver different stimulations to different and nearby tissue areas will
most likely be quite difficult to attain;
(e) Their temporal and dosing release can be significantly hard to monitor.
Hence, the ability of these methods to ensure long-term implant survival must be
inquired. Furthermore, one must question if uncemented implants coated with local
delivery systems as those above described, regardless their functionality levels, are able
to achieve optimal performances.
The concept of Instrumented Implant is another approach that aims to optimize the
performance of implants. Besides the inherent function of implants in replacing bone
and performing load bearing functions, the main idea is to engineer a new type of
implant composed by inner structures to perform monitoring operations and therapeutic
actuations. Rydell (1966) [68] was the first researcher to design instrumented implants
to measure forces and moments in vivo over the implants’ neck. He collected data
during several daily activities of two patients using percutaneous connections. These
findings were the basis for further technological advances aiming optimize the measurement
systems, measure an increasing number of quantities (forces, moments, deformations and
temperatures) and communicate them wirelessly to extracorporeal systems (Fig. 1b)
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[69–75]. The newest two architectures for instrumented hip implants were developed
by Bergmann and co-workers [75, 76] in the last five years. However, the main goal of
their technological solutions has not been the stimulation of the host tissue biointegration.
Biophysical osteogenic stimulation has been studied as a potential non-drug strategy to
develop therapeutic actuators for active instrumented implants, mainly based on delivery
of mechanical and electromagnetic stimuli. Intracorporeal piezoelectric-based mechanical
stimulation was proposed to enhance peri-implant bone formation in sheep femur and tibia
[77]. Positive osteogenic effects of static magnetic fields were observed by using magnetized
metals of negligible cytotoxicity (SmCo, SmFeN, stainless steel, etc.) intracorporeally
(around specific animal bones) [78–81]. The peri-implant bone volume also increased by
delivering static magnetic fields using permanent magnets embedded into intramedullary
femoral implants [82]. The use of attractive forces between permanent magnets is another
innovative fixation method currently being researched to reduce interfacial micromotions
[83]. Finally, electromagnetic-stimulating implant systems (Fig. 1c) have been proposed
as a groundbreaking approach to deliver controllable electric field stimulation to bone
tissues [84–90]. By attaching stimulators’ electrodes to implants’ surfaces and embedding
secondary coil(s) into the implant system, electric fields can be delivered around the implant
when a primary coil, placed outside the patients’ body (e.g. around the hip), provides a
magnetic field to the secondary coil. Although this method has been proposed for various
orthopaedic implants, only stimulative screw systems have been tested in vivo (e.g. the
Magnetodyn R© screw has been used in human patients to avoid necrosis of the femur head
[85]). All these achievements must be highlighted and significant advances can be attained
if these approaches are further explored. The main strengths of implanting instrumented
orthopaedic implants can be enumerated as follows:
(i) They have been implanted to acquire data in vivo: to calibrate models defining the
biomechanical and thermodynamic properties of implants; to optimize the design and
materials of implants; to perform preclinical tests; and to track the healing process
following THR [91–94];
(ii) They can be designed to monitor osseointegration, including the detection of implant
failure states [95–99];
(iii) They can operate as stimuli delivery systems, based on the release of biomolecules,
drugs and/or biophysical stimuli, to control the host tissue biointegration [90,100];
(iv) Their operations, including therapeutic delivery, can be controlled by extracorporeal
systems using wireless communication systems [75,101–103];
(v) They can be composed by processing systems to optimize/manage their operations
and analyze the monitored data [74,75,104].
Although instrumented implants capable of accurately control the peri-implant bone
volume are highly desirable, various constraints must be addressed to develop them. Those
most significant are enumerated as follows:
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(a) The design of non-biological measuring systems to monitor the osseointegration
process is complex (no effective solutions have been found for such purpose [95–98]);
(b) Complex implant designs may be required if drug and/or non-drug delivery systems,
controlled by extracorporeal systems, were embedded into instrumented implants;
(c) The optimized/personalized stimuli delivery for highly controllable osseointegration
may be complex to identify;
(d) The delivery of different stimulations to different and nearby tissue areas may be
hard to achieve (such aim was never accomplished);
(e) Electric powering systems based on batteries or inductive links troubles the activities
of patients and cannot be used for long-term operation [76,94];
(f) Long-term electric self-powering of these implants is hard to develop [102,105,106];
(g) Their hollowed architectures increase fracture risks and, consequently, cytotoxic and
genotoxic risks.
More optimized osseointegration control will be achieved as highest the ability of the
stimulation system deliver different stimuli (amplitude, frequency, periodicity, exposure
time, etc) to different and nearby tissue areas. No instrumented implants with ability
to release drugs and/or other bio-agents in the bone-implant interface were implemented
so far. This methodology could enhance controlled bone remodeling around implants
and avoid adverse tissue responses to infection and foreign bodies, but controlling the
temporal and dosing release to target tissue areas would most likely be a quite difficult
accomplishment, mainly if fibrous tissues are formed due to other causes, such as
micromovements of implants. Although it can ensure controllable dosing release (using
telemetric systems [100, 107]), a highly complex implant design may be required (inner
reservoirs are required, as well as mechanisms to control the delivery vehicles and routes,
etc.). Besides, the functional integrity of biomolecules inside the instrumented implants
does not allow long-term operability. Controlled delivery systems for personalized medicine
can also be implemented by non-drug strategies. Biophysical stimulation is quite attractive
for inducing a direct osteogenic effect or triggering drug releases. Electromagnetic,
mechanical, ultrasound or light stimulations can promote bone adaptation [81, 108–111].
Besides, their long-term operability will most likely be easier to accomplish as there are
no storage requirements, the therapeutic delivery can be controlled by clinicians (using
wireless communication between the implant and extracorporeal systems) and miniaturized
stimulators can be located nearby tissue areas requiring stimulation (even though they
must be embedded into implants). To my best knowledge, no instrumented implants
were designed to deliver mechanical, ultrasound or light stimuli. The potential of using
mechanical stimulators located in the implants’ surface [77] is compromised by the increased
risk of weakening the interfacial bonding. Therewithal, generating mechanical stimuli
inside implants to apply on target tissue areas is currently unfeasible. Mechanisms for
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delivering ultrasound waves may require high complex implant designs and demand a
hollowed structure that can endanger the mechanical integrity of implants. Interestingly,
positive results were observed using this type of stimulus to control the release and routing
of drugs and/or biomolecules [60,110], but such ability was never tested using or involving
instrumented implants. Stimulation by static magnetic fields does not allow controllable
and personalized therapies, although a positional control of the permanent magnets inside
implants can be implemented. Regarding the delivery of electromagnetic stimuli generated
by coils inside active implants, a controllable actuation can be provided, but it was
never tested and certainly involves complex implant designs. The electrical stimulation
obtained by extracorporeally-induced magnetic fields will most likely result in the inability
to provide highly controllable stimuli to multiple tissue areas, since the complexity to design
extracorporeal sources of magnetic field increases as the number of electrodes increases.
Further, technological solutions based on attaching stimulators to the implants’ surfaces
are unable to deliver stimuli to target tissue areas. In any case, their application troubles
the routine activities of the patients if optimized patient-specific clinical therapies must be
administrated. Therefore, more research efforts must be conducted to design instrumented
implants capable of effective long-term implant survival.
1.3 Main goals
Two main goals were defined for this thesis: to answer how to design implants for
permanent bone-implant fixation and to propose an innovative therapeutic delivery system,
as well as supporting systems, potentially more effective than those proposed so far. The
following tasks were conducted to accomplished these goals:
1. Study the ability of both passive and active orthopaedic implants to optimize their
performance. This study intend to answer if methodologies that have been used to
develop implants are able to ensure effective long-term survival or, instead, different
concept models for orthopaedic implants must be developed;
2. Identify the requirements that implants must fulfil to ensure implant performance
optimality;
3. Carry out detailed literature reviews to identify the architectures, therapeutic
actuators and supporting technologies already developed for hip implants with higher
potential to control the osseintegration process1;
4. Conduct a literature review focused on therapeutic delivery systems: (i) effective
inducing positive osteogenic responses to the different stages of bone remodeling; (ii)
not yet used in the design of active orthopaedic implants; (iii) with high potential to
deliver different actuations to different and nearby tissue areas;
1I also collaborated in a similar study for knee implants (Supplement 1)
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5. Develop and test in vitro an innovative delivery system, as well as potential
supporting systems, to enhance the ability of implants to perform personalized control
of the osseointegration process.
Fig. 1: Several approaches used to design THRs: a. HA coated cementless THR (Corail R© Hip
System, DePuy Synthes); b. Instrumented passive THR (Hip II, Orthoload database); c. Prototype of an
electrostimulative THR (reproduced with permission from Zimmermann et al. [90]).
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1.4 Outline
This thesis is divided into seven chapters. Chapters 2 to 5 are composed by a collection
of papers already published or submitted manuscripts. A theoretical study to evaluate the
performance optimality of orthopaedic implants is presented in chapter 2. Chapter 3 is
composed by three literatures reviews that were conducted to evaluate how the implant
performances could be improved, considering the conclusions obtained from the optimality
analysis. An innovative therapeutic delivery system (concept, modulation, manufacturing
and preliminary experimental results) with higher potential to ensure long-term implant
survival is proposed in chapter 4. The various findings to develop auxiliary systems
supporting the therapeutic actuation are the subject of chapter 5. A detailed discussion on
the proposed methodology to design future implants with superior performance is found
in chapter 6. Finally, the 7th chapter reports the list of findings and a viewpoint on how
this field will most likely evolve in the forthcoming years. Besides, supplementary material
is provided to support the innovations here proposed.
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Chapter 2
Optimality Analysis of Orthopaedic
Implants
The most promising trends towards the design of orthopaedic implants capable of
optimizing the osseointegration control are not obvious to identify. The observed results
achieved by the methodologies already proposed are not enough to infer their potential for
such purpose. Besides, the ability of each methodology to ensure long-term implant survival
seems not considered. There are not conclusive demonstrations of the ineffectiveness of
passive implants. There is also no strong evidences suggesting that optimal performances
of implants cannot be attained only by optimizing their design and materials. Much more
research has been nevertheless conducted in order to coat passive implants with bioactive
materials than to design instrumented implants, either passive or active. Considering
the amount of published research, the development of coatings capable of releasing
drugs and/or other bio-agents to control the peri-implant biochemical and biomechanical
environments seem to be considered the most reasonable solution to minimize implant
failures. Nevertheless, no reasons have been exposed to clarify why no research has
been carried out to implement instrumented implants with such ability, since a higher
controllability of the delivery system could be reached. Besides, the potential of organic
adaptation to biophysical pathways must not be discarded without detailed studies. Hence,
the performance optimality of instrumented and non-instrumented orthopaedic implants
firstly must be analysed. This study was conducted in the scope of this thesis and is
entitled ”Active orthopaedic implants: towards optimality”. It is published in the Journal
of the Franklin Institute (volume 352, issue 3, pp. 813-834)1. This study intends to answer
if current methodologies used for implant designing are able to perform effective long-term
operability or a different concept model for orthopaedic implants must be developed. It also
proposes a formulation of the architecture and operation of orthopaedic implants, which
emphasizes what research lines must be primarily pursued to optimize their performance.
1As the content of this study is already published, the formatting rules established by the Journal of
the Franklin Institute are used.
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Abstract
Although everlasting life span is a primary requirement for orthopaedic implants, their current rate
of failure is relatively high. The fundamental problem of implementing optimal implants remains a top
research topic. No methodology to ensure everlasting life span of orthopaedic implants has ever been
proved. Joint prostheses are only being designed to operate passively, only restoring joint function.
Instrumented implants have not been designed as full interactive mechanisms with the surrounding
physiological environment. The purpose of this paper is twofold: (1) to prove that non-instrumented passive
implants and instrumented passive implants are not able to optimize the minimization of the failures
throughout the lifetime of the implants, whatever the optimization level of the implants, rehabilitation
protocols or surgical procedures; and (2) to prove that active implants ensure performance optimality
preventing failures. Research in the design of active implants is thus proposed as an effective methodology
to characterize failures and to perform therapeutic actuations in real-time, ensuring optimal trajectories from
states of failure to states of without-failure.
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1. Introduction
1.1. Demand for joint replacements
The number of arthroplasties has increased and it is estimated to increase even more in the
coming years [1,2]. Kurtz et al. [2] estimated that the demand for total hip replacement (THR)
will grow 174% to 572 000 per year by 2030 in the United States. The need of hip revision
procedures is currently about 6% after 5 years and 12% after 10 years following arthroplasty [3].
The demand for joint replacements among patients less than 65 years old is also increasing,
which is related with the increasing use of uncemented implants in primary replacements [4,5].
Some projections indicate that 50% of the primary THR and 35% of the revision THR will be
performed in patients less than 65 years old between 2010 and 2030 [6]. The probability to
undergo re-revision is five to six times higher after the first revision [7]. Complications following
arthroplasty remain harmful for the durability of the implant [8]. Moreover, demographic
changes and breakthroughs in medical technology have preceded the rising in the number of
patients living longer than the lifetime of the implant.
1.2. Classes of orthopaedic implants
Classes of implants can be categorized according to its instrumentation and actuation features
preventing failures. Currently, passive implants are the only class being considered for mass
implantation in the human being. Non-instrumented passive implants are the class of implants
comprising architectures without instrumentation and active components. They do not comprise
resources: (a) to monitor their own state and the physiological states of the tissues surrounding
the implants; (b) to perform therapeutic actuations in order to prevent failures, i.e., to perform
optimal trajectories from failure states to without-failure states; (c) to communicate with external
systems, namely with medical staff. The composite hip femoral prosthesis, proposed by Simões
and Marques [9], is an example of passive hip implant. The instrumentation of prostheses has
begun in the 60s, when force measurements from total hip implants were first recorded [10].
Over the last 50 years, instrumented prostheses have only been designed to collect data in vivo,
mainly from: (1) contact forces and moments in the joint [11–14]; (2) temperature distribution
along the implant [15,16]; (3) misalignments [17]; (4) articular motions [18]; and (5) aseptic hip
loosening [19,20]. In order to study the risk of thermally induced bone necrosis, Bergmann et al.
[21] proposed the latest instrumented hip implants: an instrumented hip endoprostheses to
measure the implant temperatures in vivo.
Up to date, only instrumented passive implants have been designed [22]: implants only
comprising telemetry and electric power supply systems (Fig. 1). They have been only implanted
for research issues [23–26], namely to optimize their design and preclinical testing [27], and to
improve rehabilitation protocols [28,29].
No active implants have been designed so far [30]. Smart surface coating modifications can be
used to implement non-instrumented active implants [31]. They are not composed by actuation,
monitoring and power supply systems based on mechanical structures. The use of self-protective
surfaces with the ability to monitor and act against infecting organisms [32–34] was recently
proposed as a methodology to design non-instrumented active implants. Only one methodology
to develop instrumented active implants has been proposed: the use of mechanical actuation
systems to control bone formation surrounding the implant. The prototype of an active hip
prosthesis, with the ability to prevent failures by aseptic loosening, is being designed in order to
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demonstrate the concept. Several modules were already developed, namely: (1) two modules for
the electric supply of the implant: motion-driven power generators and an energy conditioning
system [35–39]; (2) two modules for the communication between the implant and external
mechanisms: a dual-link telemetry system and an activation circuit [40]; (3) a module for the
detection of aseptic loosening of prosthetic stem and cup [41]; and (4) a module for the active
therapeutic actuation against loosening: a mechanical stimulator of bone cells, based on six
polyvinylidene fluoride actuators, to induce bone formation surrounding the implant [42].
Instrumented active implants must comprise: (1) monitoring systems to measure in real-time
the physiological states of the tissues surrounding the implant; (2) processing systems to identify
the failures' characteristics in real-time; (3) actuators to operate therapeutic actuations when
failures are detected; (4) communication systems to send/receive data to/from external systems;
and (5) electrical supply systems to power monitoring, processing, actuation and transmission
systems. Instrumented active implants must characterize failures in real-time and perform
therapeutic actuations (also in real-time) to minimize them throughout time [43].
2. Structure of the active implants
2.1. Overall methodological design
The architecture of the active implants comprises two main structures, as shows Fig. 2(a): a
Master-based Active Structure (MBA) outside the human body (OHB), and a Slave-based Active
Structure (SBA) inside the human body (IHB). Passive implants do not comprise neither active
therapeutic systems nor therapeutic command modes, as illustrated by Fig. 2(b). OHB
mechanisms can interact with the instrumented passive implants, but these do not have command
structures: master–slave architectures are only possible for active implants.
2.2. Formulation of the implants' operation
2.2.1. Mechanical features of the in situ implants' structure
Design and properties: Let α and ω be respectively a domain and a codomain. Let αBtbi be the
subsets-domain (sDs) of mathematical models which formulate the design and operation state of
Fig. 1. Instrumented passive hip implant proposed by Bergmann et al. [21] (reproduced with permission from the authors).
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the in situ implant's structure at time t. They must model the dimensions, geometry, type of
materials and life span of all its parts, as well as: (1) the operation state of the solid structure; (2)
the amount, location and operation state of its actuators, sensors, communication subsystems and
harvesters; (3) and the location, amount and availability of the stored resources. Let ωBtbj be the
subsets-codomain (sCs) of mathematical formulations which model the mechanical properties of
the in situ implant's structure at time t, such as the fatigue and wear resistance, Young's modulus,
tensile strength, toxicity, bioactivity and biodegradability. Let αBt be the set-domain (SD) of sDs
αBtbi , and let
ωBt be the set-codomain (SC) of sCs ωBtbj
αωBt ¼ αBt ; ωBt ¼ αBtbio; ωBtbjoonnn ð1Þ
Let F be a vector space of applications. Let ψ tB be the set of applications F-F at time t:
ψ tB ¼ αBtbi-ωBtbj : bir
αBt ; bjr ωBt n o ð2Þ
Operators defined on αB and ωB: Let ⋁ and ⋀ be respectively union and intersection
operators. Let ⋁
Bt
and ⋀
Bt
be the sets of operators which define the operations on αB and ωB at
time t:
⋁
Bt
¼ ⋁
αBbiδ biφ
; ⋁
ωBbjδ bjφ
8<
:
9=
;
t; bi; bj; biδ ; biφ ; bjδ ; bjφAN : biδabiφ ; bjδabjφ ;
Fig. 2. Architecture of: (a) non-instrumented and instrumented active implants; (b) non-instrumented and instrumented
passive implants.
M.P. Soares dos Santos et al. / Journal of the Franklin Institute 352 (2015) 813–834816
1rbiδ ; biφr
αBt ; 1rbjδ ; bjφr ωBt  ð3Þ
⋀
Bt
¼ ⋀
αBbiδ biφ
; ⋀
ωBbjδ bjφ
8<
:
9=
;
t; bi; bj; biδ ; biφ ; bjδ ; bjφAN : biδabiφ ; bjδabjφ ;
1rbiδ ; biφr
αBt ; 1rbjδ ; bjφr ωBt  ð4Þ
Applications between αB and ωB: Let ψ tB be the set of applications F-F between
αBt and
ωBt at time t:
ψ tB ¼ ⋀
αBbiδ biφ
⋁
αBbiδ biφ
αBbi
1
A- ⋀
ωBbjδ bjφ
⋁
ωBbjδ bjφ
ωBbj
0
@
1
A
9=
;
t
0
@
8<
: ð5Þ
Definition of the algebra of B: Let Bt be the algebra of the mechanical features of the in situ
implant's structure at time t:
Bt ¼ ψ tB;⋁
Bt
;⋀
Bt
* +
ð6Þ
2.2.2. Supply of the in situ implants' structure
Acquisition of resources and related changes: Let αEtei be the sDs of mathematical
formulations which model the acquisition of resources by the in situ implant's structure at time t,
required to power its actuation, measurement and communication subsystems. They comprise
models to predict the acquisition of resources; the type, amount and periodicity of resources
required for all subsystems; amount and location of the mechanisms which perform the
acquisition, and their life span; the periodicity of acquisition and the acquired amount of
resources. Let ωEtej be the sCs of mathematical formulations which model the effects, at time t,
due to the operations to acquire resources, such as the biochemical and biomechanical changes in
the patient's body; changes in the mechanical, electrical, chemical and communication
subsystems of the in situ implant's structure. Let αEt be the SD of sDs αEtei , and let
ωEt be
the SC of sCs ωEtej . Let ψ
t
E and ψ
t
E be sets of applications and ⋁
Et
and ⋀
Et
be sets of operators
defined as described in Section 2.2.1, but using αEtei ,
ωEtej ,
αEeiδ eiφ
and ωEejδ ejφ .
Definition of the algebra of E: Let Et be the algebra of the supply operations performed by the
in situ implant's structure at time t:
Et ¼ ψ tE;⋁
Et
;⋀
Et
* +
ð7Þ
2.2.3. Measurement operations performed by the implant
Measurement and related changes: Let αMtmi be the sDs of mathematical models which
formulate the measurement of the states of the implant and the physiological states of the tissues
at time t. They must model the quantities to monitor; the sensors' operation; supply and life span
requirements, the amount of sensors required and their location; the measurement output values;
M.P. Soares dos Santos et al. / Journal of the Franklin Institute 352 (2015) 813–834 817
and periodicity and period of measurement. Let ωMtmj be the sCs of mathematical formulations
which model the effects, at time t, due to the measurement operations, such as the biochemical
and biomechanical changes in the patient's body; and changes in the mechanical, electrical,
chemical and communication subsystems of the in situ implant's structure. Let αMt be the SD of
sDs αMtmi , and let
ωMt be the SC of sCs ωMtmj . Let ψ
t
M and ψ
t
M be sets of applications and⋁
Mt
and
⋀
Mt
be sets of operators defined as described in Section 2.2.1, but using αMtmi ,
ωMtmj ,
αMmiδmiφ
and
ωMmjδmjφ
.
Definition of the algebra of M: Let Mt be the algebra of the measurement operations at time t:
Mt ¼ ψ tM;⋁
Mt
;⋀
Mt
* +
ð8Þ
2.2.4. Physiological states of the patient
Physiological states of tissues: Let αStsi be the sDs of biochemical and biomechanical models
of the patient's body at time t. Let ωStsj be the sCs of mathematical formulations which model the
physiological states of the tissues surrounding the in situ implant's structure. Let αSt be the SD of
sDs αStsi , and let
ωSt be the SC of sCs ωStsj . Let ψ
t
S, ψ
t
S be sets of applications and ⋁
St
and ⋀
St
be
sets of operators defined as described in Section 2.2.1, but using αStsi ,
ωStsj ,
αSsiδ siφ
and ωSsjδ sjφ .
Definition of the algebra of S: Let St be the algebra of the physiological states of the patient at
time t:
St ¼ ψ tS;⋁
St
;⋀
St
* +
ð9Þ
2.2.5. Failures of the in situ implants' structure
Failures and related changes: Let αLtli be the sDs of mathematical models which formulate the
effects, at time t, due to failures, such as the modulation of biochemical and biomechanical changes
on the patient's body; and changes in the mechanical, electrical, chemical and communication
subsystems of the in situ implant's structure. Let ωLtlj be the sCs of mathematical formulations which
model the failures' characteristics of the implant at time t, such as the amount, type, state and regions
of failures. Let us consider that the mechanical features of the structures outside the human body do
not cause failures on the in situ implant's structure, and vice versa. Let αLt be the SD of sDs αLtli ,
and let ωLt be the SC of sCs ωLtlj . Let ψ
t
L and ψ
t
L be sets of applications and⋁
Lt
and ⋀
Lt
be sets of
operators defined as described in Section 2.2.1, but using αLtli ,
ωLtlj ,
αLliδ liφ and
ωLljδ ljφ .
Definition of the algebra of L: Let Lt be the algebra of the failures of the in situ implant's
structure at time t:
Lt ¼ ψ tL;⋁
Lt
;⋀
Lt
* +
ð10Þ
M.P. Soares dos Santos et al. / Journal of the Franklin Institute 352 (2015) 813–834818
2.2.6. Therapeutic prescriptions performed by the in situ implants' structure
Therapies and related changes: Let αTtτi be the sDs of mathematical models which formulate the
active therapeutic actuations required to be performed by the in situ implant's structure to avoid failures.
They must model the failures to eliminate and active therapies to administrate; quantities to control; the
actuators' operation; supply and life span requirements, as well as the amount of required actuators and
their location; active therapeutic actuation values; periodicity and period of actuation. Let ωTtτj be the
sCs of mathematical formulations which model the effects, at time t, due to the active therapeutic
actuations performed by the in situ implant's structure, such as the biochemical and biomechanical
changes in the patient's body; and changes in the mechanical, electrical, chemical and communication
subsystems of the in situ implant's structure. Let αTt be the SD of sDs αTtτi , and let
ωTt be the SC of
sCs ωTtτj . Let ψ
t
T and ψ
t
T be sets of applications and⋁
Tt
and⋀
Tt
be sets of operators defined as described
in Section 2.2.1, but using αTtτi ,
ωTtτj ,
αT τiδ τiφ and
ωTτjδ τjφ .
Definition of the algebra of T: Let Tt be the algebra of the therapeutic actuations performed by
the in situ implant's structure at time t:
Tt ¼ ψ tT;⋁
Tt
;⋀
Tt
* +
ð11Þ
2.2.7. Communication operations performed by the implant
Communication between structures and related changes: Let αWtwi be the sDs of mathematical
models which formulate the communication of the implant (for active implants, between SBA the
MBA structures; for passive implants, between the IHB and the OHB structures) at time t. They must
model the quantities to transfer from the in situ structure's subsystems; rate transfer requirements;
telemetric subsystems' operation; energy and life span requirements, as well as the amount and location
of telemetry subsystems; quantities possible to be transferred; maximum rate transfer and periodicity of
communication of such quantities. Let ωWtwj be the sCs of mathematical formulations which model the
effects, at time t, due to the communication processes, such as the biochemical and biomechanical
changes in the patient's body, changes in the mechanical, electrical subsystems and therapeutic
functions of the in situ implant's structure. Let αWt be the SD of sDs αWtwi , and let
ωWt be the SC of
sCs ωWtwj . Let ψ
t
W and ψ
t
W be sets of applications and ⋁
Wt
and ⋀
Wt
be sets of operators defined as
described in Section 2.2.1, but using αWtwi ,
ωWtwj ,
αWwiδwiφ and
ωWwjδwjφ .
Definition of the algebra of W: Let Wt be the algebra of the communication operations
performed by the implant at time t:
Wt ¼ ψ tW;⋁
Wt
;⋀
Wt
* +
ð12Þ
2.2.8. Therapeutic commands performed by the implant
Generation of medical prescriptions: Let αCtci be the sDs of mathematical models which
predict the state of the implant, physiological state of tissues surrounding the in situ implant's
structure and therapy results of previous therapeutic commands at time t. Let ωCcj be the sCs of
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mathematical formulations which model the generation of therapeutic commands at time t, in
order to be performed by the in situ implant's structure. They must model the therapies to
administrate and therapies possible to be administrated by the in situ implant's structure;
actuation prescriptions to produce the required therapies, which include changes in the
configuration of the in situ implant's structure; periodicity and period of actuation; and therapy
goals. Let αCt be the SD of sDs αCtci , and let
ωCt be the SC of sCs ωCtcj . Let ψ
t
C and ψ
t
C be sets
of applications and⋁
Ct
and⋀
Ct
be sets of operators defined as described in Section 2.2.1, but using
αCtci ,
ωCcj ,
αCciδ ciφ
and ωCcjδ cjφ .
Definition of the algebra of C: Let Ct be the algebra of the therapeutic commands performed
by the implant at time t:
Ct ¼ ψ tC;⋁
Ct
;⋀
Ct
* +
ð13Þ
2.2.9. Operation of the orthopaedic implants
Operation of the instrumented active implants: Let Dt be the algebra of the operation of the
instrumented active implants at time t:
Dt ¼ Bt;St;Lt;Tt;Mt;Et;Wt;Ct ;⋁Dt ;⋀Dt
* +
ð14Þ
in which:
⋁
Dt
¼ f⋁
B E
; ⋁
B M
; ⋁
B T
; ⋁
B W
; ⋁
E W
; ⋁
E T
; ⋁
E M
; ⋁
T M
; ⋁
T L
; ⋁
T W
; ⋁
M L
; ⋁
M S
; ⋁
M W
; ⋁
L S
; ⋁
L W
;
⋁
S W
; ⋁
C W
; ⋁
C M
; ⋁
C L
; ⋁
C S
; ⋁
C T
; ⋁
C E
; ⋁
C N
t ð15Þ
⋀
Dt
¼ ⋀
B E
; ⋀
B M
; ⋀
B T
; ⋀
B W
; ⋀
E W
; ⋀
E T
; ⋀
E M
; ⋀
T M
; ⋀
T L
; ⋀
T W
; ⋀
M L
; ⋀
M S
; ⋀
M W
; ⋀
L S
; ⋀
L W
;

⋀
S W
; ⋀
C W
; ⋀
C M
; ⋀
C L
; ⋀
C S
; ⋀
C T
; ⋀
C E
; ⋀
C N
t ð16Þ
Operation of the non-instrumented active implants: Let Nt be the algebra of the operation of
the non-instrumented active implants at time t:
Nt ¼ Bt;St;Lt;Tt;Mt;Et;Ct ;⋁Nt ;⋀Nt
* +
ð17Þ
in which:
⋁
Nt
¼ ⋁
B E
; ⋁
B M
; ⋁
B T
; ⋁
E T
; ⋁
E M
; ⋁
T M
; ⋁
T L
; ⋁
M L
; ⋁
M S
; ⋁
L S
; ⋁
C M
; ⋁
C L
; ⋁
C S
; ⋁
C T
; ⋁
C E
; ⋁
C N
 t ð18Þ
⋀
Nt
¼ ⋀
B E
; ⋀
B M
; ⋀
B T
; ⋀
E T
; ⋀
E M
; ⋀
T M
; ⋀
T L
; ⋀
M L
; ⋀
M S
; ⋀
L S
; ⋀
C M
; ⋀
C L
; ⋀
C S
; ⋀
C T
; ⋀
C E
; ⋀
C N
 t ð19Þ
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Operation of the instrumented passive implants: Let It be the algebra of the operation of the
instrumented passive implants at time t:
It ¼ Bt;St;Lt;Mt;Et;Wt ;⋁It ;⋀It
* +
ð20Þ
in which:
⋁
It
¼ ⋁
B E
; ⋁
B M
; ⋁
B W
; ⋁
E W
; ⋁
E M
; ⋁
M S
; ⋁
M L
; ⋁
M W
; ⋁
L S
; ⋁
L W
; ⋁
S W
 t ð21Þ
⋀
It
¼ ⋀
B E
; ⋀
B M
; ⋀
B W
; ⋀
E W
; ⋀
E M
; ⋀
M S
; ⋀
M L
; ⋀
M W
; ⋀
L S
; ⋀
L W
; ⋀
S W
 t ð22Þ
Operation of the non-instrumented passive implants: Let Pt be the algebra of the operation of
the non-instrumented passive implants at time t:
Pt ¼ Bt ð23Þ
3. Optimality analysis of the implants
3.1. Outcomes from implants
3.1.1. Instrumented active implants
Implant outcomes: Let ξ and γ be respectively a domain and a codomain. Let γDt be the sCs of
measurements of the instrumented active implant outcomes at time t following implantation,
such as the life span of the implant, utility-cost rate and self-assessment scores (levels of pain;
ability to perform activities of daily living, among others).
ξγDt ¼ ψ tB;ψ tS;ψ tL;ψ tT;ψ tM;ψ tE;ψ tW;ψ tC; γDt
  ð24Þ
ψ tD ¼ ψ tL- γDtyg : yr
γDt n on ð25Þ
Applications defined on ξD: Let ΣtD be the set of applications F-F defined on ξD at time t:
ΣtD ¼ ⋀
ξDpδ
ξDpφ
⋁
ξDpδ
ξDpφ
ξDp
1
A
0
@
9=
;
t; p; pδ; pφAN : pδapφ; 1rpδ; pφr8
8<
: ð26Þ
Applications between ξD and γD: Let f be a real function of the implant outcomes and let ΘtD
be the set of applications F-F between ξD
t
and f at time t:
φtD ¼
n
ΣtD-ψ
t
L :
ξDpφ ;
ξDpδaψ
t
L
o
ð27Þ
ΘtD ¼ φtD-f
  ð28Þ
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3.1.2. Non-instrumented active implants
Implant outcomes: Let γNt be the sCs of measurements of the non-instrumented active implant
outcomes at time t following implantation:
ξγNt ¼ ψ tB;ψ tS;ψ tL;ψ tT;ψ tM;ψ tE;ψ tC; γNt
  ð29Þ
ψ tN ¼ ψ tL- γNtyg : yr
γNt n on ð30Þ
Applications defined on ξN: Let ΣtN be the set of applications F-F defined on ξN at time t:
ΣtN ¼ ⋀
ξNpδ
ξNpφ
⋁
ξNpδ
ξNpφ
ξNp
1
A
0
@
9=
;
t; p; pδ; pφAN : pδapφ; 1rpδ; pφr7
8<
: ð31Þ
Applications between ξN and γN: Let f be a real function of the implant outcomes and let ΘtN
be the set of applications F-F between ξN
t
and f at time t:
φtN ¼ ΣtN-ψ tL : ξNpφ ;
ξNpδaψ
t
Lg
n
ð32Þ
ΘtN ¼ φtN-f
  ð33Þ
3.1.3. Instrumented passive implants
Implant outcomes: Let γIt be the sCs of measurements of the instrumented passive implant
outcomes at time t following implantation:
ξγIt ¼ ψ tB;ψ tS;ψ tL;ψ tM;ψ tE;ψ tW; γIt
  ð34Þ
ψ tI ¼ ψ tL- γItyg : yr
γIt n on ð35Þ
Applications defined on ξI: Let ΣtI be the set of applications F-F defined on ξI at time t:
ΣtI ¼ ⋀
ξIpδ
ξIpφ
⋁
ξIpδ
ξIpφ
ξIp
1
A
9=
;
t; p; pδ; pφAN : pδapφ; 1rpδ; pφr6
0
@
8<
: ð36Þ
Applications between ξI and γI: Let f be a real function of the implant outcomes and let ΘtI be
the set of applications F-F between ξI
t
and f at time t:
φtI ¼ ΣtI-ψ tL : ξIpφ ;
ξIpδaψ
t
L
on
ð37Þ
ΘtI ¼ φtI-f
  ð38Þ
3.1.4. Non-instrumented passive implants
Implant outcomes: Let γPt be the sCs of measurements of the non-instrumented passive
implant outcomes following implantation at time t:
ξγPt ¼ ψ tB; γPt
  ð39Þ
ψ tP ¼ ψ tL- γPty
o
: yr
γPt n on ð40Þ
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Applications between ξP and γP: Let ΘtP be the set of applications F-F between ξP
t
and f at
time t:
φtP ¼ ψ tB-ψ tL
  ð41Þ
ΘtP ¼ φtP-f
  ð42Þ
3.2. Hypothesis
The following equation formulates the hypothesis that the operation outcomes from the active
implants are maximized in relation with passive implants for all t:
f φtD
 
4f φtI
  
⋀
0 1
f φtD
 
4f φtP
  
⋀
0 1
f φtN
 
4f φtI
  
⋀
0 1
f φtN
 
4f φtP
  ¼ 1; 8 t ð43Þ
in which:
ϱ¼ 0; 1f g;⋁
0 1
;⋀
0 1
	 

ð44Þ
3.3. Configurations
3.3.1. Instrumented active implants
The autonomy of the SBA structure lays down two main groups of configurations: non-
autonomous and autonomous command structures.
Non-autonomous SBA structure: Only the MBA structure is able to generate therapeutic
commands. Fig. 3 shows four possible configurations to interconnect the different operations
described in Section 2, namely:
Dt ¼ MBAt;SBAt ;⋁Dt ;⋀Dt
* +
ð45Þ
in which:
Fig. 3(a): SBA¼ B;S;L;T;M;E;Wf g, MBA¼ M;Cf g
Fig. 3(b): SBA¼ B;S;T;M;E;Wf g, MBA¼ L;M;Cf g
Fig. 3(c): SBA¼ B;T;M;E;Wf g, MBA¼ S;L;M;Cf g
Fig. 3(d): SBA¼ B;L;T;M;E;Wf g, MBA¼ S;M;Cf g
The main differences among configurations are the location where S and L are performed. M,
S and L operations can be performed both on the MBA or SBA structure; however, E, B, T and
W operations have to be performed on the SBA structure. Considering the volume restrictions of
the implant, lower processing requirements are demanded on the SBA structure if S and L are
performed on the MBA structure. The flow direction between operations come from the
operations' algebras. Other configurations are possible, such as implementing S and/or B
operations both on the SBA and MBA structures. They have not been introduced because they
proceed from the stated configurations and also to make the analysis easier.
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Autonomous command structure: Both MBA and SBA structures are able to generate
therapeutic commands. However, the generation of commands by the SBA structure must be
carried out under the supervision of the MBA structure's operations. Commands from MBA
structure must keep high priority over the commands generated by the SBA structure. Fig. 4
presents four possible configurations to implement a distributed implant with distributed
command structure, in which:
Fig. 4(a): SBA¼ B; S;L;T;M;E;W;Cf g, MBA¼ M;Cf g
Fig. 4(b): SBA¼ B; S;T;M;E;W;Cf g, MBA¼ L;M;Cf g
Fig. 3. Configuration 1 (a), 2 (b), 3 (c) and 4 (d) of the instrumented active implants – non-autonomous SBA structure.
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Fig. 4(c): SBA¼ B;L;T;M;E;W;Cf g, MBA¼ S;M;Cf g
Fig. 4(d): SBA¼ B;T;M;E;W;Cf g, MBA¼ S;L;M;Cf g
3.3.2. Non-instrumented active implants
The SBA structure of this class of implant is fully autonomous. Because they do not comprise
any MBA structure, only the SBA structure is able to generate therapeutic commands. Fig. 5
shows its only possible configuration.
Nt ¼ SBAt ;⋁Nt ;⋀Nt
* +
ð46Þ
in which SBA¼ B;S;L;T;M;E;Cf g
Fig. 4. Configuration 1 (a), 2 (b), 3 (c) and 4 (d) of the instrumented active implants – autonomous SBA structure.
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3.3.3. Instrumented passive implants
Fig. 6 presents four main configurations to implement instrumented passive implants (empty
squares mean “no operation”). They do not comprise neither the active therapeutic operation
mode nor the therapeutic command operation mode. Although mechanisms outside the human
body can interact with the instrumented passive implants, they do not comprise any master
structure.
3.4. Performance analysis
The hypothesis is true if both non-instrumented and instrumented passive implants do
not satisfy the necessary conditions for optimality, while active implants satisfy necessary and
sufficient conditions.
3.4.1. Optimality of implants' performance
The fundamental problem of implementing an implant can be stated as an optimality problem,
in which one has to look into the existence of optimal trajectories between states. The
performance of the implants will be optimal only if ψB;ψS;ψL
 
follows optimal trajectories. If
sufficient conditions are satisfied, then the optimality of ψB;ψS;ψL
 
is possible to be
implemented. Let us define: the plants of the SBA structures of the instrumented active implants
as ψ tB;ψ
t
S;ψ
t
L
 
D
; the plants of the SBA structures of the non-instrumented active implants as
ψ tB;ψ
t
S;ψ
t
L
 
N ; the plants of the instrumented passive implants as ψ
t
B;ψ
t
S;ψ
t
L
 
I ; and the plants
of the non-instrumented passive implants as ψ tB
 
P
. Let μtS :
ωT-αS and μtB :
ωT-αB be
respectively ψSadmissible models and ψBadmissible models formulating the interconnec-
tion between ψT and ψS and between ψT and ψB. If we consider K as the set of all applications
between two spaces and ðt þ 1Þ as the next time step, and taken into account that the implant is a
system given by Eq. (47), then the problem of implementing an implant which is able to achieve
optimality is formulated as the problem of ensuring that the set of all points ψ tB;ψ
t
S;ψ
t
L
 
is not
empty, such that there exists a trajectory that goes from ψ tB;ψ
t
S;ψ
t
L
 
to the target
ψ ðtþ1ÞB ;ψ
ðtþ1Þ
S ;ψ
ðtþ1Þ
L
 
ψB;ψS;ψL
 0 ¼ g ψB;ψS;ψL ; μS; μB   ð47Þ
Fig. 5. Configuration of the non-instrumented active implants.
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where:
g : K αB; ωB
  K αS; ωD  K αL; ωL   K αS; ωT  K αB; ωT   
- K αB; ωB
  K αS; ωS  K αL; ωL  
3.4.2. Diagrams of the implants' operation
The different configurations for each class of implants do not conduct to different algebras.
Whatever the configuration, the diagram and optimality problem remain unchanged. The
diagrams for each class of implant are introduced in Fig. 7 (empty squares mean “no operation”).
They show that ψS;ψL
 
P
, μS; μB
 
I
and μS; μB
 
P
do not exist.
Fig. 6. Configuration 1 (a), 2 (b), 3 (c) and 4 (d) of the instrumented passive implants.
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3.4.3. Necessary conditions for optimality
An optimality problem O is formally given by the following sixfold form [44]:
O¼ ψB;ψS;ψL
 
; μS; μB
 
; g;G;Λ;ϕ
  ð48Þ
where G is the Lagrangian function (it has the same domain and co-domain as g), Λ is a target,
and ϕ is a function used to define the cost to achieve optimal trajectories. Because ψS;ψL
 
P,
μS; μB
 
I and μS; μB
 
P do not exist, OI and OP are ill-defined, which proves that it is impossible
to achieve Λ both by instrumented passive and non-instrumented passive implants. This fact can
be verified based on the analysis of the Pontryagin Maximum Principle [45]: in order to
implement an optimal trajectory it is necessary that there exists a t-extremal presynthesis, which
demands:
(1) a family Γ ¼ χ ψ tB;ψ tS ;ψ tLð Þ; η ψ tB;ψ tS ;ψ tLð Þ
 n o
of admissible pairs such that the trajectory
χ ψ tB ;ψ tS;ψ tLð Þ, for a control η ψ tB ;ψ tS;ψ tLð Þ,starts at ψ
t
B;ψ
t
S;ψ
t
L
 
and ends at the target;
(2) a normal minimized Hamiltonian H, which is given by Eq. (49) (λ is an adjoint variable):
H vS; vBð Þ; ψ tB;ψ tS;ψ tL
 
; λt
 
rH μtS; μtB
 
; ψ tB;ψ
t
S;ψ
t
L
 
; λt
  ð49Þ
(3) a solution V such that the Hamilton–Jacobi–Bellman equation is satisfied, i.e.,
H ∇V ψ ðtþ1ÞB ;ψ
ðtþ1Þ
S ;ψ
ðtþ1Þ
L
  
; ψ ðtþ1ÞB ;ψ
ðtþ1Þ
S ;ψ
ðtþ1Þ
L
  
¼ 0;
8 ψ tB;ψ tS;ψ tL
 
AΛ ð50Þ
Regarding the existence of optimal trajectories χtB; χ
t
S; χ
t
L
 
opt
, one can verify that if
χtB; χ
t
S; χ
t
L
 
D
and χtB; χ
t
S; χ
t
L
 
N
are optimal, then:
ψ tB; χ
t
S; χ
t
L
 
opt  χtB; χtS; χtL
 
D ð51Þ
ψ tB; χ
t
S; χ
t
L
 
opt  χtB; χtS; χtL
 
N ð52Þ
Using a similar reasoning, one can observe that if χtB; χ
t
S; χ
t
L
 
I and χ
t
B
 
P are optimal, then
χtB; χ
t
S; χ
t
L
 
opt
 χtB; χtS; χtL
 
I
ð53Þ
χtB; χ
t
S; χ
t
L
 
opt  χtB
 
P; ψ
t
S
 
opt; ψ
t
L
 
opt
 
ð54Þ
From Eq. (54), it is deduced that non-instrumented passive implants cannot implement
Fig. 7. Diagram of: (a) non-instrumented passive implants; (b) instrumented passive implants; (c) instrumented and non-
instrumented active implants.
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trajectories that go from χtB; χ
t
S; χ
t
L
 
to the target χðtþ1ÞB ; χ
ðtþ1Þ
S ; χ
ðtþ1Þ
L
 
because
χtB; χ
t
S; χ
t
L
 
Pa χ
t
B; χ
t
S; χ
t
L
 
opt ) ∄V ψ
ðtþ1Þ
B ;ψ
ðtþ1Þ
S ;ψ
ðtþ1Þ
L
  
: H ¼ 0
) ∄Γ χ ψ tB ;ψ tS;ψ tLð Þ; η ψ tB ;ψ tS;ψ tLð Þ
 
P
) ∄ ψ tB; χtS; χtL
 
opt
ð55Þ
Regarding the existence of optimal controls ηtS; η
t
B
 
opt, one can state that if η
t
S; η
t
B
 
D, η
t
S; η
t
B
 
N ,
ηtS; η
t
B
 
I and η
t
S; η
t
B
 
P are optimal, then
ηtS; η
t
B
 
opt
¼ ηtS; ηtB
 
D
ð56Þ
ηtS; η
t
B
 
opt
¼ ηtS; ηtB
 
N
ð57Þ
ηtS; η
t
B
 
opt ¼ ηtS
 
opt; η
t
B
 
opt
 
I
ð58Þ
ηtS; η
t
B
 
opt ¼ ηtS
 
opt; η
t
B
 
opt
 
P
ð59Þ
which means that neither instrumented passive nor non-instrumented passive implants can
implement optimal controls to perform χtB; χ
t
S; χ
t
L
 
opt, because:
ηtS; η
t
B
 
Ia η
t
S; η
t
B
 
opt ) ∄ χtB; χtS; χtL
 
I ð60Þ
ηtS; η
t
B
 
Pa η
t
S; η
t
B
 
opt ) ∄ χtB; χtS; χtL
 
P ð61Þ
These results prove that it is impossible to ensure optimal trajectories for instrumented and non-
instrumented passive implants. However, these analyses cannot confirm the hypothesis (Eq.
(43)). Instead, active implants Dt and Nt comprise architectures which are able to satisfy the
necessary conditions to perform optimal performances, i.e., they are able to find solutions VΓ
such that VΓ  V and
VΓð ÞD ¼
Z
G χtB; χ
t
S; χ
t
L
 
D; η
t
S; η
t
B
 
D
 
dt þ ϕ χðtþ1ÞB ; χðtþ1ÞS ; χðtþ1ÞL
 
D
 
ð62Þ
VΓð ÞN ¼
Z
G χtB; χ
t
S; χ
t
L
 
N ; η
t
S; η
t
B
 
N
 
dt þ ϕ χðtþ1ÞB ; χðtþ1ÞS ; χðtþ1ÞL
 
N
 
ð63Þ
The demonstration of both VΓð ÞD  V and VΓð ÞN  V are included in the demonstration that
these implants satisfy the sufficient conditions to implement optimal trajectories between states
(Section 3.4.4).
3.4.4. Sufficient conditions for optimality
According to Sussmann [44] (see Theorem 3.1), Γ is optimal if four sufficient conditions are
satisfied:
(1) Γ be a total (i.e., the largest possible) t-extremal presynthesis for OD and ON ;
(2) the value function VΓ satisfies all the weak continuity conditions for OD and ON ;
(3) VΓð ÞDrV and VΓð ÞNrV on Λ;
(4) Γ is (g,G)-differentiable at all ψB;ψS;ψL
 
in the complement of a thin subset of
K αB; ωB
  K αS; ωS  K αL; ωL  .
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Let us call ΓDψ tT and
ΓNψ tT the sets of applications in which instrumented and non-
instrumented active implants implement respectively Γ. Because one only has to consider the set
of therapies which starts at ψ tB;ψ
t
S;ψ
t
L
 
and ends at the target at time ðt þ 1Þ, it follows
necessarily that
⋀
ΓDTt
D⋀
Tt
 !
⋀
0 1
⋀
ΓNTt
D⋀
Tt
 !
¼ 1 ð64Þ
⋁
ΓDTt
D⋁
Tt
 !
⋀
0 1
⋁
ΓNTt
D⋁
Tt
 !
¼ 1 ð65Þ
ΓDψ tTDψ
t
T
 
⋀
0 1
ΓNψ tTDψ
t
T
 ¼ 1 ð66Þ
If there exists a therapy which implements only t-extremal presynthesis, such that VΓð ÞD  V and
VΓð ÞN  V and Eqs. (62) and (63) are satisfied, then:
⋀
ΓDð1ÞTt
D ⋀
ΓDTt
 !
⋀
0 1
⋀
ΓNð1ÞTt
D ⋀
ΓNTt
 !
¼ 1 ð67Þ
⋁
ΓDð1ÞTt
D ⋁
ΓDTt
 !
⋀
0 1
⋁
ΓNð1ÞTt
D ⋁
ΓNTt
 !
¼ 1 ð68Þ
ΓDð1Þψ tTD
ΓDψ tT
 
⋀
0 1
ΓNð1Þψ tTD
ΓNψ tT
 ¼ 1 ð69Þ
where ð1Þ in Eqs. (67)– (69) refers to condition (1) applied to Γ. The same statements are true for
the other three conditions:
⋀
ΓDðnÞTt
D ⋀
ΓDTt
 !
⋀
0 1
⋀
ΓNðnÞTt
D ⋀
ΓNTt
 !
¼ 1; n¼ 1; 2; 3; 4 ð70Þ
⋁
ΓDðnÞTt
D ⋁
ΓDTt
 !
⋀
0 1
⋁
ΓNðnÞTt
D ⋁
ΓNTt
 !
¼ 1; n¼ 1; 2; 3; 4 ð71Þ
ΓDðnÞψ tTD
ΓDψ tT
 
⋀
0 1
ΓNðnÞψ tTD
ΓNψ tT
 ¼ 1; n¼ 1; 2; 3; 4 ð72Þ
The desired therapies optψ tT , performed by both instrumented and non-instrumented active
implants, which satisfy the sufficient conditions for optimality, can be deterministically stated as
follows:
optψ tT ¼ ⋀
ΓDðnÞTt
⋁
ΓDðnÞTt
ΓDðnÞψ tT
 !
ð73Þ
optψ tT ¼ ⋀
ΓNðnÞTt
⋁
ΓNðnÞTt
ΓNðnÞψ tT
 !
ð74Þ
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which proves that if there are optimal trajectories optψ tTa∅
 
(one cannot disregard that failures
may become so serious that only surgical procedures are able to minimize the problem), then
instrumented and non-instrumented active implants are able to implement them. From this, it
follows that active implants satisfy the sufficient conditions to perform optimal performances, i.
e., if optimal trajectories between states of failure and states of without-failure exist, then non-
instrumented active implants and instrumented active implants comprise suitable architectures to
implement them. The proof is thus complete.
4. Discussion and conclusion
The concept of Instrumented Implant was first purposed as an accurate method to overcome
the inaccuracy of numerical and analytical models of biomechanical quantities acting on
orthopaedic implants, such as forces, moments and temperatures. Important breakthroughs have
been carried out over the last decades in the optimization of such method, but neither the concept
of Instrumented Implant was fully implemented nor it has evolved as a method to achieve
performance optimality overcoming failures. In vivo data acquisition from instrumented passive
implants has been used to validate biomechanical models, but no study was found about the use
of such implants to validate biochemical models of the tissues surrounding the in situ structure.
Moreover, no valuable data about the interaction between the biochemical properties of the
tissues and the biomechanical properties of the implant was provided by instrumented passive
implants, although their architectures allow the implementation of prediction mechanisms of
failures, including those caused by its own mechanical structure. Thus, more research efforts
must be conducted to implement fully operative instrumented passive implants (see Sections
2.2.9 and 3.1.3).
This study proves that active methodologies can be used to implement optimal implants. For
such purpose, implants' architectures must comprise active therapeutic actuation mechanisms.
Otherwise, instrumented and non-instrumented passive implants will never ensure optimal
trajectories between states of failure and states of without-failure, whatever the optimization of
the implants' design and materials, rehabilitation protocols or surgical procedures.
If multiple networks of different actuators were embedded into the implant, then it would be
possible to implement a multi-agent actuation mode of operation. Prescott et al. [46] designed a
microchip device comprising hundreds of arrays of discrete reservoirs, which is able to control
the release of therapeutic drug doses over several months in biological environments. This study
is an appropriate basis for the research of new designs of instrumented active implants
implementing controlled biological therapies, such as antimicrobial therapy and suppressive
antibiotic therapy. Important advances can also be achieved if research is conducted to design
active implants with the ability to diagnose failures through the detection of failure-specific
molecular markers, such as the detection of serum chromium levels, nitric oxide synthase,
regulators of apoptosis and regulators of macrophase activity [47,48].
According to the possible configurations of the instrumented active implants, it is possible to
diagnose failures and identify the physiological state of the patient outside the human body
(through laboratory analysis of fluids and tissues, imaging evaluation techniques, and/or other
methods), and then use the MBA structure to send these data to the SBA structure.
The definition of optimal trajectories also comprise the state of the mechanical features of the
implant, i.e., therapeutic actuations are performed by the active implants taking into account the
optimal state of its mechanical features as a target. The greater the number of available therapies
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and diagnosis methods, the greater the number of trajectories which ensure that a desired
physiological state target is achievable from a current state of failure.
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Chapter 3
Literature review
The conclusions retrieved from the optimality analysis (section 2) state that, regardless
the methodology, four requirements must be fulfilled to ensure that implants will perform
actuation trajectories from states of failure to states of without-failure:
1. Implants must monitor the osseointegration process, either by using biological or
non-biological mechanisms;
2. Implants must be composed by (biological and/or non-biological) therapeutic
actuators to control the peri-implant bone structure and the bone-implant bonding;
3. Therapeutic actuator(s) must be highly controllable, i.e., their ability to deliver
different actuations must be maximized;
4. Therapeutic actuator(s) must be able to deliver different therapeutic actuations to
different and nearby tissue areas, as required for tracking an optimality actuation
trajectory.
These results are quite useful as they allow to define which are the potentially
most suitable methodologies to design implants capable of minimizing the uncontrolled
osseointegration. Only active implants, either instrumented or non-instrumented, can
optimize osseointegration. Hence, using non-organic control systems, instrumented
active implants may be designed to control the bioactivity on the bone-implant
interface by releasing of bio-agents and/or by delivering exogenous biophysical stimuli.
Non-instrumented implants may be also designed as complex delivering systems (which
may be also established to release bio-agents and/or biophysical stimuli), but they perform
feedback control only using cellular pathways. However, higher controllability of the
therapeutic actuation may be achieved using instrumented implants since:
(a) These implants may comprise non-cellular and/or cellular actuators (e.g. bioactive
coatings and biophysical stimulators), increasing the actuation range;
(b) Non-cellular actuators (such as biophysical stimulators) may be used to control the
behavior of bioactive coatings;
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(c) Biophysical stimulators can be controlled extracorporeally using wireless-based
communication systems, which permit time-dependent therapeutic actuations after
implant’s body insertion;
(d) The human knowledge (from clinicians) can be used to establish long-term
personalized therapies.
Due to the inherent ability of instrumented active implants to perform highly controlled
and personalized therapeutic actuations at nano- to macro-scale levels [using (nano-)
miniaturized biophysical stimulators], the optimization of these implants must be firstly
pursued. This thesis is then focused on enhancing the ability of instrumented implants to
perform personalized control of the osseointegration process.
3.1 Instrumented implants - overview
A detailed state-of-the-art was required to identify the therapeutic actuators and
supporting systems already developed for instrumented THRs, femoral replacements
and femoral fracture stabilizers1. In a first stage, overall comparative analyses were
carried out focusing on their actuation, power supply, measurement, communication and
processing systems. The tests conducted by each research team to evaluate the performance
and safety of their instrumented implants were also evaluated. This state-of-the-art is
entitled ”Instrumented hip joint replacements, femoral replacements and femoral fracture
stabilizers”. It is published in the Expert Review of Medical Devices (volume 11, issue 6, pp.
617-635)2. This study intends to analyse the controllability level of current instrumented
implants and their ability to deliver different therapeutic actuations to different and nearby
tissue areas.
1I also collaborated in a similar study for knee implants (Supplement 1).
2As the content of this study is already published, the formatting rules established by the journal
Expert Review of Medical Devices are used.
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Need of instrumented implants
The number of primary total hip replacements
(THR) has been increasing, as reported by the
latest reports of several national arthroplasty
registers [1–4]. By 2030, the demand for primary
THR is estimated to increase by 174% (to
572,000) per year in the USA and 137% for
revision THR [5,6]. Most studies report survival
rates close to 100% 1 year after primary
THR [1]. Although considerable research efforts
have been conducted to optimize implants’
design and materials, recent hip revision rates
are: 14.5% in 2009, as reported by the Norwe-
gian Arthroplasty Register (NAR) [2]; 13.6% in
2011, according to the Swedish Orthopedic
Register (SOR) [3]; 12% in 2012, as reported by
the National Joint Registry for England, Wales
and Northern Ireland (REWI) [4]; 11.5% in
2008, as published by the Joint Replacement
Registry for USA (RUS) [6]. Most of these regis-
ters have registered increases in hip revi-
sions [2,3,6]. Labek et al. [7] reported revision rates
of about 6% after 5 years and 12% after
10 years, using data from worldwide joint regis-
ters; and Ong et al. [8] found 95.9% for 5-year
survival probabilities, by analyzing the Medicare
database. The risk of subsequent revisions is
reported to be five- to six-times higher after the
first revision [8]. The number of primary THR
at younger ages (less than 65 years old) is
increasing as well [9]. In the USA, younger
patients underwent 44.7% of primary THR
and 38.5% of revision procedures from 2001 to
2008 [6]. Recent projections indicate that young
patients will demand 50% of primary THR and
35% of revisions between 2010 and 2030 [10].
Aseptic loosening and infection are among
the most common causes for THR. The
following aseptic loosening rates were recently
registered: NAR [2]: approximately 50% in
2009; SOR [3]: 58.1% in 2011; REWI [4]: 40%
in 2012; RUS [6]: 28.3% in 2008. However,
THR outcomes are influenced by patient-
related and device factors, as well as
by surgeons’ expertise, health systems and
demographic factors [11]. Aseptic loosening rates
seem to be gradually decreasing [2–4]. Revision
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rates due to infection are: NAR [2]: approximately 17% in 2009;
SOR [3]: 13.1% in 2011; REWI [4]: 12% in 2012; RUS [6]:
19.6% in 2008. Revision risks due to infection have been increas-
ing [2,3,12,13]. SOR also reported that 61% of reoperations without
implant replacement are due to infections [3].
The use of cement in primary and revision THR has been
decreasing. NAR has been reporting this trend since 2003. In
2009, they used about 50% of uncemented and hybrid hip
implants in primary THR, of which 80% were implanted in
younger patients [2]. Such a long-term trend was also observed
by SOR [3], which also found higher risks for revision due to
loosening with cemented cups and due to infection with
cemented stems.
Different methods must be considered to optimize the perfor-
mance of implants. Rydell [14] was the first researcher to design
instrumented hip implants to monitor biomechanical quantities
in vivo. He acquired orthogonal compressive forces and moments
in vivo over the neck of Austin Moore endoprostheses during sev-
eral daily activities of two patients. Data were communicated by
using percutaneous connections to external data acquisition sys-
tems. Many other researchers succeeded Rydell in this research
line. They have designed instrumented implants in order to col-
lect data having the following applications [15–20]:
• Calibration of models defining the implants’ biomechanical
and thermal environment;
• Optimization of mechanical design and materials’ behavior
of implants;
• Preclinical testing;
• Tracking of the healing evolution and improvement of reha-
bilitation processes after arthroplasty.
Considering current revision rates, the growing need of long-
term survival of implants (which is also related with demo-
graphic changes) and the advances in electronic systems, instru-
mented implants may maximize outcomes following THR, if
they are designed to control their biochemical environment.
The epidemiology of revision THR suggests that instrumented
hip implants must be first implemented to prevent aseptic loos-
ening and infection in the bone–implant interface.
Femoral bone loss is one of the most complex problems that
may occur after THR. Mechanical loosening, osteolysis second-
ary to particle debris and stress-shielding with adaptive bone
remodeling are some mechanisms influencing the maintenance
of femoral bone mass after THR [21,22]. Femoral replacements
and femoral fracture fixation implants are being recommended
for sedentary patients with severe bone loss [22]. Then,
adjustable-based instrumented femoral replacements and instru-
mented femoral fracture stabilizers, comprising ability to con-
trol bone growth, may be designed to minimize the risk of
complex revision surgeries due to bone loss.
Review structure
Literature search strategy
Relevant publications were selected in order to identify the
design features, architectures, functions, achievements and
future breakthroughs in instrumented hip joint replacements,
instrumented femoral replacements and instrumented femoral
fracture stabilizers. No time period restriction was introduced
in the search parameters, because there is no previously pub-
lished in-depth review about this subject. The collection was
completed in December 2013.
Selection criteria
The selection of studies was based on the following criteria:
• Literature reporting instrumented hip joint replacements,
instrumented femoral replacements and instrumented femoral
fracture stabilizers that were already implanted, that is,
implants experimentally validated in vivo. In vitro studies
were only considered if later in vivo studies, using the same
instrumented implants, were published;
• Literature focusing on instrumented implants without percu-
taneous wired connections (the use of percutaneous wiring is
considered unacceptable for clinical applications);
• Literature reporting recent advances for future instrumented
implants.
Data extraction & analyses
The key mechanical modifications to standard implants are
described in this document. Tests that were conducted to
evaluate their performance and safety for implantation in
human patients were identified. Their power supply, mea-
surement, communication, data processing and therapeutic
operations were comparatively analyzed. Knowledge obtained
from in vivo operation of these implants was considered out-
side the scope of this work (see the review of Ledet et al. [18]
for such subject).
Instrumented hip joint replacements
Overview
Five research groups have designed a total of 12 architectures
for total hip joint replacements, arranged as follows according
to generations of technological breakthroughs:
• Mann et al. [23–38] proposed three architectures for instru-
mented endoprostheses: [23–27,30] for the first generation,
[28–32,36–38] for the second generation and [32–35] for the third
generation;
• Goodman et al. [39–41] developed an architecture for instru-
mented hip implants;
• Puers et al. [42] developed an architecture for instrumented
hip implants;
• Davy et al. [43–47] reported four architectures for total hip
prostheses: [44] for the first generation, [44] for the second
generation, [43–45] for the third generation and [44–47] for the
fourth generation;
• Bergmann et al. [11,48–66] designed three architectures for
instrumented implants (total hip prostheses and
endoprostheses): [11,48–50,55–63,65] for the first generation,
[11,51,52,61–65] for the second generation and [53,54,66] for the
third generation.
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These authors implemented instrumented hip implants based
on two types of architectures [12]: instrumentation was housed
both in cavities inside and outside the implant; instrumentation
was totally sealed as a one-piece implant. Hereafter, they will
be referred to as ‘HIO’ and ‘HI’, respectively. These architec-
tures comprise measurement, communication and electric
power supply systems. Electronic circuitries have been housed
in hollow regions machined into the implants, mainly inside
the neck and head.
Implants designed by Mann et al. [23–38] are based on an HI
architecture. They were designed for spatial and temporal mea-
surement of pressures over the cartilage surface in human hip
joint. They modified Austin-Moore endoprostheses by spheri-
cally hollowing the hemisphere and cylindrically hollowing the
stem tip. They developed the instrumented hip joint replace-
ments with the largest number of transducers. They conducted
fatigue and calibration tests on the three generations of implants.
Novelties of their research include the development of the first
hip implant comprising a telemetric system, the first implant to
measure spatial pressures over human acetabula and the first
implant electrically supplied by an inductive power link.
An HIO architecture for hip prostheses was designed by
Goodman et al. [39–41] to measure axial forces over the prosthetic
neck. They modified an English prosthesis by designing the
head as a removable piston and cylindrically hollowing the neck
and stem. They conducted calibration tests on the load measure-
ment system. Their research resulted in the following novelties:
acquisition of the first data from loads acting in vivo on human
hip joints using telemetric systems (these results were published
before those published by Mann et al. [23–38]); design of the first
battery supplied instrumented implant; design of the first instru-
mented implant with an externally activated power switch, in
order to minimize the electric power consumption; the first use
of the ‘piston in cylinder’ component (head is designed as a
removable piston, which in turn is fitted into a cylindrically hol-
lowed neck) for implants’ structures without percutaneous con-
nections; design of an instrumented implant based on an HIO
structure. However, all electronic circuits were housed in the tis-
sues surrounding the implant and cables were used to connect
transducers to the transmitter system. This method is liable to
fatigue and sealing problems, significantly increasing the risk of
biological problems. Instrumentation remains disabled if the
activation system fails.
Bergmann et al. have been contributing intensively to the
technological breakthroughs of instrumented implants [11,48–66].
They implanted the first instrumented implants in sheep and
dogs using percutaneous wired connections [67,68]. Since then,
they have implanted three HI generations of instrumented hip
implants in human patients. First, they modified total hip pros-
theses (Uni-hip, Mecron) as follows: the head was cone-shaped
hollowed and it was designed to be removable; the top of
the stem was cylindrically hollowed and the neck was oversized
and cylindrically hollowed. They conducted fatigue, load
calibration, sealing, corrosion, heating, acceleration and bio-
compatibility tests on implants, and finally they implanted
them in three sheep over 3 years before the implantation in
human patients. The second generation was designed using
modified CENOS endoprostheses (ARTOS, Berlin) and
ceramic heads (CERASIV GmbH, Plochingen, Germany): the
head was hollowed in cone shape and was designed to be
removable; the neck was oversized and cylindrically hollowed
and the stem was hollowed lengthwise, according to its own
geometry. Heating, sealing, mechanical shocks, load and tem-
perature calibration tests were carried out on implants before
implantation. ‘Cementless Tapered Wedge’ total hip prostheses
(Merete Medical GmbH, Berlin), with ceramic head, were cus-
tomized by modifying the head (it was hollowed in cone shape
and designed to be removable) and neck (it was oversized and
cylindrically hollowed). This third generation was approved to
be implanted in human patients after sealing, endurance,
fatigue and calibration tests. The number of sensors and bio-
mechanical quantities under tracking were different among
architectures. Considerable amount of biomechanical and ther-
modynamic data (forces, moments and temperatures) have
been acquired in vivo, which can be downloaded from the
OrthoLoad database [69]. These data have been widely used in
orthopedic and biomedical engineering research. This research
team was the first to: propose the ‘MATRIX’ method for 3D
force measurement using only three single strain gauges [50,67];
develop the ‘current difference’ method for low power con-
sumption using strain gauges [50]; acquire data from loads act-
ing in vivo on animal hip joints, using instrumented prostheses;
compare hip joint forces in man, sheep and dogs; miniaturize
telemetric systems (4, 8 and 9 channels) for instrumented
implants; use a telemetric system inside implants comprising
different induction power link and data link and measure tem-
peratures along the entire length of implants.
Davy et al. [43–47] have designed four generations of instru-
mented implants based on HI architecture. The first and the
second are modified T-28 total hip prostheses; the third and
fourth are modified DF-80 (Zimmer) total hip prostheses. All
architectures were implemented to measure three orthogonal
forces on the neck; the third and fourth architectures also mon-
itor rectified supply voltage and temperature inside the neck.
Their necks were cylindrically hollowed; heads were cylindri-
cally and spherically hollowed, and they were designed to be
removable; only the neck of the first generation was not over-
sized. Load calibration tests were conducted on all architectures.
Pacemaker-type batteries were used to power implants based on
the third generation. Magnetic reed switches were replaced by
momentary reed switches and additional circuitry was intro-
duced to power implants for an adjustable period of time.
Davy et al. were the first to use miniaturized pacemaker-type
batteries inside hip joint replacements. The instrumentation of
their implants is disabled if the activation system fails.
Puers et al. [42] modified cemented hip prosthesis (the head
and top of the neck were hollowed) in order to design an HI
architecture with the ability to detect loosening. Prediction is
obtained by analyzing head accelerations when external mechani-
cal vibrations are applied at the distal end of the femoral bone.
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They have found a relation between loosening and distortion rate
of head’s accelerations. Later research concluded that this method
is only reliable when the size of failures is more than one-third of
the stem length, although detection of failures located at the stem
central portion is likely to fail [70]. Nevertheless, they were the
first to propose hip prostheses comprising internal mechanisms
to measure some failure states.
Measurement features
TABLE 1 lists measurement features of the 12 architectures experi-
mentally validated in vivo. Strain gauges (based on resistive
methods) have been used in most implants (only
Puers et al. [42] applied a capacitive method). Most of them
have been housed in the inner walls of the neck. Loads and
moments over hip implants, as well as temperatures inside
implants, have been the main monitored quantities. Head’s
acceleration and rectified supply voltage (inside implants) were
also under tracking. Architectures designed by Mann
et al. [23–38], and the second architecture designed by Bergmann
et al. [11,51,52,61–65], housed the highest number of transducers
inside instrumented implants (14, 13 and 12, respectively).
Bergmann et al. [11,48–52,55–65] achieved load errors lower than
1% and temperature errors lower than 0.1˚C. Data acquisition
was sampled up to 4.2 kHz. Mann et al. [32–35] simultaneously
monitored 13 quantities up to 500 Hz and Bergmann
et al. [11,48–52,55–65] monitored 12 signals up to 250 Hz.
Data storage inside implants has not been reported. Process-
ing of data acquired in vivo has not been reported, namely one
cannot find characteristics of failures determined by implants
(such as extension, type, state and regions of failures), as well as
physiological states of tissues surrounding implants’ structures.
Communication features
TABLE 2 introduces a comparative basis between the communication
features of instrumented implants. All architectures use radiofre-
quency (RF) transmission circuitry and antenna(s). Mann et al.
[23–38] designed the transmitter with the highest number of chan-
nels (16). Bergmann et al. [11,51,52,61–65] decided to use two trans-
mitters, each of them with eight channels. The authors housed
them in different locations, namely in the head, neck and shaft,
and even outside the implants. Transmitters embedded outside
implants may dislocate from its initial position, as reported by
Goodman et al. [41]. Inside implants, antennas were located in
upper regions, namely at the end of the stem, head and upper
neck region. Bergmann et al. [11,48–66] and Puers et al. [42] magnet-
ically and mechanically shielded the circuitry, using metallic pro-
tective hollowed cylinders. Data monitored in vivo have been
transmitted to instrumentation located outside the patients’ body:
the main goal has been to use these data for research proj-
ects [13,14,26,62]. Data acquisition was not performed throughout
the daily living of patients, but only in research laboratories.
Therapeutic features
No architecture comprising therapeutic actuation systems was
reported. Although new designs and materials for orthopedic
implants have been researched, implants have not been designed
to perform real-time therapy in vivo. They do not comprise actu-
ation mechanisms to prevent failures in real-time, that is, to
ensure controlled trajectories between states of failure and states
of without-failure, whatever the failures’ characteristics.
Supply features
TABLE 3 presents a comparative analysis between the supply fea-
tures that allow the implants’ operation. Implants have been
supplied only by electric energy. No other acquisition of
resources (e.g., chemicals) has been managed. Data monitored
in vivo have not been considered as resources required by
implants to operate successfully, that is, the current operation
of implants is not function of previously monitored data.
Only inductive power links and batteries have been used as
electrical power supply systems to operate in vivo. No pub-
lished studies reporting failures of power supply systems were
found. Inductive powering requires circuitry outside the
patients’ body, namely primary coil(s), power oscillator(s),
antenna(s) and processing circuitries. Oscillation frequencies
between 3 and 750 kHz were used. Secondary power coils and
power regulation systems were housed inside the patients’
body: power coils were housed in different regions, namely at
the top of the stem, shaft and neck; regulation systems were
located in head, neck and shaft. Battery-based power systems
were designed to power the instrumentation inside implants
when reed switches were activated (inside the patients’ body)
by magnets (outside the patients’ body). In order to maximize
the power to supply electronics embedded inside implants,
Bergmann et al. [11,51–54,61–66] used microcontrollers (outside the
patients’ body) controlling the oscillator frequency to compen-
sate for effects of relative displacement between primary and
secondary coils. Power consumption of instrumentation has
been minimized: the first architecture designed by Mann
et al. [23–27,30] required 500 mW to operate; the second archi-
tecture developed by Bergmann et al. [11,51,52,61–65] only needed
10 mW (although it comprises three strain gauges, nine ther-
mistors and two transmitter systems requiring power supply).
However, power needs are related with the number of compo-
nents and, consequently, with the number of operations possi-
ble to be carried out by implants.
Methods that were used to power implants constrain their
operation. By using inductive power systems:
• the period between data monitoring operations increases,
because they disturb daily activities of patients after hip
replacement;
• high power consumption is demanded due to their poor effi-
ciency, which can be dangerous if human tissues are exposed
to high levels of RF electromagnetic fields [71].
By using battery-based power systems:
• autonomy for long-term operation of implants is not
ensured;
• the number of systems requiring electric power is fully
related with the lifespan of batteries.
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Power needs have not been high because database storage,
prediction algorithms and therapeutic actuation systems were
not implemented inside implants. These approaches are suit-
able for research purposes focused on studying the dynamics
of biomechanical quantities, and, in an extended scope, for
research requiring data that can be monitored in a laboratory
or in very limited extent during activities of daily living
of patients.
Each power supply system was customized to power the
respective instrumented implant. However, over the past decades,
there were significant technological breakthroughs in monitoring,
processing and communication systems composing such
Table 1. Instrumented hip joint replacements – measurement features†.
Features Mann et al. [23–38] Goodman et al.
[39–41]
Bergmann et al. [11,48–66] Davy et al.
[43–47]
Puers et al.
[42]
Measuring
method
(1, 2, 3) Resistive
(wheatstone bridges)
Resistive
(wheatstone
bridges)
(1, 2, 3) Resistive (wheatstone
bridges)
(1, 2, 3)
Resistive
(wheatstone
bridges)
Capacitive
Components
of
measurement
systems
(1, 2) 14 pressure
transducers‡; (3)
13 pressure
transducers‡;
temperature
transducer (thermistor)
4 sets of strain
gauges
(1) 3 strain gauges, temperature
transducer (thermistor NTC); (2)
3 strain gauges, 9 NTC
transducers; (3) 6 strain gauges;
NTC transducer
(1, 2, 3, 4)
3 sets of strain
gauges; (3, 4)
temperature
transducer
(model: N/D)
Accelerometer
Locations of
components
(1, 2, 3) Inside the
hemisphere
Inside the neck (1) Inside the neck; (2) strain
gauges: inside the neck;
NTCs: 2 inside the neck and
6 inside the stem; (3) inside the
neck
(1, 2) in the
cap; (3, 4)
inside the neck
Inside a
titanium
container, in
the head
Measured
quantities
(1) 14 CSP; (2)
10 CSP; (3) 12 CSP;
temperature inside the
hemisphere
Mean axial load on
the neck
(1) 3 spatial orthogonal forces
on the neck; temperature in the
neck; (2) 3 spatial orthogonal
forces on the neck;
8 temperatures along neck and
shaft; 2 temperatures in circuitry
boards; rectified supply voltage;
(3) 3 spatial orthogonal forces
and 3 moments on the neck;
temperature inside the neck;
rectified supply voltage;
synchronization signal
(1, 2, 3, 4)
3 spatial
orthogonal
forces on the
neck; (3, 4)
rectified supply
voltage and
temperature
inside the neck
Head
acceleration§
Transmitted
quantities{
All measured
quantities were
transmitted
The measured
quantity was
transmitted
All measured quantities were
transmitted
All measured
quantities were
transmitted
The measured
quantity was
transmitted
Sampling
period
(1, 2) 253 Hz; (3)
500 Hz
1 kHz (1, 2) 250 Hz; (3) 120 Hz (1, 2, 3, 4) N/D 4.2 kHz
Errors (1, 2) Maximum offset
error: 0.7 MPa; (3)
maximum noise
level: 0.2 MPa
Maximum
calibration
error: 7%;
maximum accuracy
error (load): 10%
(1) Maximum accuracy error
(load): 3%; maximum accuracy
error (temperature): 0.1ºC;
maximum calibration error (load):
1.5%; (2) maximum calibration
error (load): 1%; maximum
accuracy error (temperature):
0.1ºC; (3) maximum calibration
error (load): 1.9%; maximum
calibration error (moments): 1.5%
(1, 2) N/D; (3, 4)
maximum
calibration error
(load): 2.5%
N/D
†Terminology: (n) – implant of the nth generation.
‡They were designed as cantilever beams with strain gauges.
§They are used to monitor loosening by vibration analysis.
{They were transmitted to signal acquisition systems outside the patients’ body.
CSP: Cartilage surface pressures; N/D: Information not reported; NTC: Negative temperature coefficient.
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implants, which imposed the development of more complex
power supply systems. No published studies reporting compari-
sons between power supply systems for a given implant
were found, thus one cannot conclude about their relative
performance. Even so, Bergmann et al. implemented the
most complex power systems. They also seem to be the most reli-
able and safe because they conducted the highest number of tests
on implants before their implantation in human patients, accord-
ing to literature. However, one must emphasize that inductive
power links and/or batteries are not suitable for instrumented
implants operating throughout the daily living of patients.
In vivo operation details
Implants designed by Mann et al. [23–38] operate when they are
powered by an inductive link. Their first architecture was tested
with six human acetabular components, taken directly from the
autopsy room to a hip simulator. Their second architecture was
implanted into a human patient, allowing in vivo data acquisi-
tion throughout 2 weeks [37], 1 year [28], 3 years [29] and
5 years [32,36,38] postoperatively. Their third architecture was
also implanted into a human patient and the data acquisition
was carried out throughout 1 year [32], 2.5 years [33,34] and
3 years [35] following THR.
Goodman et al. [39–41] implanted its instrumented English
prosthesis into a human patient and, then, they acquired
in vivo data throughout the first 40 days postoperatively. This
architecture of instrumented implant can only operate while
batteries provide energy and when switches enable supply.
Implants designed by Bergmann et al. [11,48–66] are able to
operate if they are powered by inductive link. Four sheep and
Table 2. Instrumented hip joint replacements – communication features†.
Features Mann et al.
[23–38]
Goodman et al.
[39–41]
Bergmann et al. [11,48–66] Davy et al.
[43–47]
Puers et al.
[42]
Method of
communication
(1, 2, 3)
Telemetric (radio
transmission of
inductive link):
radio transmission
of data from
implants to a
receiver
Telemetric: radio
transmission of data
from the implant to a
receiver
(1, 3) Telemetric (radio
transmission of inductive link):
radio transmission of data from
implants to a receiver. (2)
Telemetric (radio transmission of
inductive link): radio transmission
of data from the implant to a
twin receiver
(1, 2, 3, 4)
Telemetric:
radio
transmission of
data from
implants to a
receiver
Telemetric
(radio
transmission of
inductive link):
radio
transmission of
data from the
implant to a
receiver
Components of
communication
systems
(1, 2, 3)
16-channel
100 MHz PAM/
FM transmitter;
antenna (the
secondary coil)
Single channel
102.3 MHz FM
transmitter; antenna;
antenna cable
(1) 4-channel 150 MHz RF
transmitter; antenna; (2) 2
8-channel 130–150 MHz PIM
Coder transmitter; 2 antennas;
(3) 9-channel 150 MHz PIM
transmitter; antenna
(1, 2, 4)
76–90 MHz FM
transmitter
(number of
channels: N/D);
(3) 4-channel
76–90 MHz FM
transmitter;
(1, 2, 3, 4)
antenna
10–11.5 MHz
RF transmitter
(number of
channels: N/D);
antenna
Locations of
components
(1, 2, 3)
Circuitry: inside
the hemisphere;
antenna: end of
the stem
Outside the implant
(inside the transmitter
system housing)
(1) Circuitry: inside a metallic
cylinder‡ in the neck;
antenna: inside the head; (2)
circuitry: 1 transmitter inside a
metallic cylinder in the neck,
1 transmitter inside a metallic
cylinder in the shaft;
2 antennas: inside the head; (3)
circuitry: inside a metallic
cylinder in the neck;
antenna: inside the head
(1, 2, 3, 4)
Circuitry: inside
the head, in the
upper neck
region
Inside a
titanium
container, in
the head
Acquisition
mode§
(1, 2, 3) During
tests{
During tests{ (1, 2, 3) During tests{ (1, 2, 3, 4)
During tests{
During tests{
Resolution (1, 2, 3) 16 bits N/D (1, 2, 3) 12 bits (1, 2, 3, 4) N/D 8 bits
†Terminology: (n) – implant of the nth generation.
‡The metallic cylinder was designed in order to shield magnetically and mechanically the circuitry, as well as to improve power transfer between primary and
secondary coils.
§Period between data monitoring operations.
{Communication with implants was only carried out in the research laboratory.
FM: Frequency modulation; N/D: Information not reported; PAM: Pulse-amplitude modulation; PIM: Pulse interval modulation; RF: Radiofrequency.
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Table 3. Instrumented hip joint replacements – supply features†.
Features Mann et al.
[23–38]
Goodman et al.
[39–41]
Bergmann et al.
[11,48–66]
Davy et al. [43–47] Puers et al.
[42]
Type of supply (1, 2, 3) Electric
energy
Electric energy (1, 2, 3) Electric energy (1, 2, 3, 4) Electric energy Electric energy
Method for
power supply
(1, 2, 3) Inductive
powering, using a
100 kHz
modulation
Powered by
batteries
(1, 2, 3) Inductive
powering using a
3–5 kHz modulator
(1, 2, 3, 4) Powered by a
battery
Inductive
powering,
using a
750 kHz
modulation
Components of
supply systems
inside the
patient’s body
(1, 2, 3) Coil on a
ferrite core;
regulation systems
3 batteries (1.35 V,
mercury); 2 reed
switches
(1, 2, 3) (Secondary)
power coil; regulation
systems
(1, 2) Battery; (3, 4)
pacemaker-type battery
(3.6 V lithium); (2, 3)
magnetic reed switch; (4)
momentary reed switch;
(1, 2, 3, 4) regulation
systems, power coil
(Secondary)
power coil;
regulation
systems
Locations of
components
inside the
patients’ body
(1, 2, 3) Power
induction link: end
of the stem;
circuitry: inside the
hemisphere
Outside the implant
(inside the
transmitter system
embedded around
the implant)
(1) Power coil: top of
the stem, inside a
metallic cylinder;
circuitry: in the neck,
inside a metallic
cylinder; (2) in the shaft,
inside a metallic
cylinder; (3) power coil:
in the neck; circuitry:
inside a metallic cylinder
in the neck
(1, 2) Battery, circuitry:
inside the head, in the
upper neck region; (3, 4)
battery: inside the neck;
(1, 2) power coil: N/D; (3,
4) power coil: base of the
prosthesis ball; (1, 2, 3, 4)
circuitry: inside the head,
in the upper neck region;
(2, 3, 4) switch: inside the
head, in the upper neck
region
Power coil:
inside the neck;
circuitry: inside
a titanium
container, in
the head
Components of
supply systems
outside the
patients’ body
(1, 2, 3) 100 kHz
power oscillator;
(primary or driver)
coil (around the
thigh)
Magnet (to latch
reed switches)
(1) 4 kHz power
oscillator; (primary) coil
(around thigh); (2)
3.5–4.5 kHz power
oscillator; (3) 3–5 kHz
power oscillator; (2, 3)
(primary) coil (around
thigh); antenna, RF
receiver and controllers
(1, 2, 3, 4) Magnet (to
latch reed switches)
750 kHz power
oscillator;
(primary) coil
(around thigh)
Power
regulation
circuitries
(1, 2, 3) Inside the
implant: circuitry to
regulate output
voltage; outside the
implant: N/D
Inside the implant:
N/D; outside the
implant: N/D
(1, 2, 3) Inside the
implant: circuitry to
regulate output voltage;
(2, 3) outside the
implant: control of
oscillator frequency to
compensate
displacements of coils
(1, 2, 3, 4) Inside the
implant: circuitry to
regulate output voltage;
outside the implant: N/D
Inside the
implant:
circuitry for
power control;
outside the
implant: N/D
Power
generation
(1, 2) 500 mW; (3)
30 mW
N/D (1) 7 mW; (2) 10 mW;
(3) N/D (5 mW for
communication
operations)
(1, 2, 3, 4) N/D 22.5 mW
Lifespan (1, 2, 3) N/D 70 h (1, 2, 3) N/D (1, 2, 3, 4) N/D N/D
Efficiency (1, 2, 3) 10% N/D (1) 0.06%; (2) N/D; (3)
between 0.03% and
0.09%
(1, 2, 3, 4) N/D 0.25%
†Terminology: (n) – implant of the nth generation.
N/D: Information not reported; RF: Radiofrequency.
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three human patients underwent the implantation of the first
architecture and acquisition of data took place over
11 months [61,62], 22 months [59], 30 months [55], 33 months [58],
58 months [63], 5 years [57] and 9 years [65] postoperatively.
Their second architecture was implanted into four patients,
which allowed in vivo monitoring over 11 months [61],
14 months [61], 22 months [63], 36 months [64] and 6 years [65]
after THR. Their last architecture was implanted into
10 patients (see database OrthoLoad [69]) and data were moni-
tored throughout 12 months postoperatively [66].
Hip prostheses designed by Davy et al. [43–47] require
battery-based supply. Each of the last three architectures was
implanted into a human patient. They monitored data in vivo
up to 58 days postoperatively. Puers et al. [42] implanted their
instrumented hip prosthesis into a human patient, but they
have not reported how long it already operated in vivo.
Bergmann et al. [11,48–66] have acquired the largest amount of
in vivo data (9 years of measurements). Although 24 patients
underwent the implantation of instrumented hip joint replace-
ments, no side effects were reported in literature.
Breakthroughs in instrumented hip joint implants have
increased their complexity. Those developed by Bergmann
et al. are the most complex implants ever implemented and
tested in vivo. Their implants seem to be the most reliable,
taken into account that: they operated successfully during the
longest time period; they withstood the highest number of tests
before their implantation in human patients; they were
implanted in the highest number of patients without side
effects and they presented the lowest measurement errors.
However, no performance comparisons between instrumented
hip joint implants have been found in literature. Instrumented
hip joint implants were designed for different purposes. No
studies reporting comparisons between relative performances of
instrumented implants were published. Besides, each instru-
mented implant was not implanted in a number of patients
that allows significant statistical analyses. By consequence, one
cannot conclude about the best implant design.
Instrumented femoral replacements & fracture
stabilizers
Overview
Only Taylor et al. [15,72–77] designed instrumentation for femo-
ral replacements. They proposed two architectures for instru-
mented (proximal and distal) femoral replacements: [15,72,74,75]
for the first generation (proximal); [15,73,76,77] for the second
generation (distal). Two research groups have designed two
architectures for femoral fixation implants: Brown et al. [44,78]
developed an architecture for instrumented nail plate implants;
Schneider et al. [79–81] designed an architecture for instrumented
intramedullary nails.
These authors implemented HI architectures: their measure-
ment, communication and electric power supply systems were
housed in hollow regions machined inside implants.
Only Brown et al. [44,78] designed instrumentation for nail
plates. They have designed an HI architecture to measure forces
and moments in the nail plate junction. They modified nail
plate implants as follows: the plate and nail were hollowed; the
plate was machined with four screw holes and non-uniform
hollow regions between screws; a cover was designed to enclose
the hollowed plate sections; an heavier side plate was used and
a hollowed square section was designed in the nail closest to
the plate junction. They conducted fatigue, calibration, bio-
compatibility and signal attenuation tests on implants before
their implantation in human patients. They were the first
authors to: acquire in vivo data from an instrumented femoral
fracture stabilizer; use miniaturized batteries inside instru-
mented implants and propose an instrumented femoral fracture
stabilizer using activation systems.
Only Schneider et al. [79–81] proposed an HI architecture to
instrument intramedullary nails. They modified an AO/ASIF
universal femoral nail by sectioning lengthwise the curved tube
and hollowing five circular cavities around the mid-diaphyseal
cross-section. The distal end and the proximal end were
designed to be removed, as well. They conducted fatigue tests
on the instrumented nail. They acquired a large database of
3-axis orthogonal forces and moments acting in vivo in the
mid-diaphyseal cross-section, providing valuable information
for accurate estimations of long bone forces during healing
processes.
Breakthroughs in instrumentation of femoral replacements
were carried out by Taylor et al. [15,72–77]. First, they modified
proximal femoral replacements (Stanmore bone tumor replace-
ment prostheses): the main shaft and intramedullary stem were
hollowed; a large cavity was machined into the proximal part
of the main shaft; a smaller cavity was machined into the distal
end of the stem; a stem tip assembly was designed to connect
electrically to an encapsulated coil (located outside the
implant’s body), through a metal-in-glass feedthrough. The sec-
ond generation was based on modifications to distal femoral
replacements (Stanmore bone tumor replacement prostheses):
the main shaft and intramedullary stem were hollowed; the
proximal shaft encloses a cavity in order to embed electronic
systems, as well as four flats to house sensors for force, torque
and moment measurements; a cavity at the end of the intrame-
dullary stem was also designed to house a force measurement
system. Both generations are based on HI architectures.
According to literature, the reliability of implants was achieved
by performing fatigue, sealing, calibration and signal attenua-
tion tests before implantation in human patients. They have
applied the ‘MATRIX’ method, proposed by Bergmann
et al. [67], in the design of both generations. The number and
location of transducers, as well as the location of coils/antennas,
differ among architectures. Their main goal has been the
in vivo measurement of forces and moments throughout
femoral replacements, and to assess progressive loosening of
intramedullary stems postoperatively [74,77]. They were the
first authors to implant instrumented femoral replacements
and acquired in vivo data from such implants. They also devel-
oped the instrumented implant with the largest number of
transducers.
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Measurement features
Measurement features of instrumented femoral replacements
and instrumented femoral fracture stabilizers are presented
in TABLE 4. Stain gauges were used in all implants and, apart
from the instrumented implant designed by Brown et al. [44,78],
they were housed in several regions of implants. Loads and
moments on implants were the main quantities under tracking.
Rectified supply voltage was monitored by the implant designed
by Schneider et al. [79–81], although no feedback control of
external oscillator frequency was reported. The second architec-
ture designed by Taylor et al. [15,73,76,77] housed 24 transducers
inside instrumented implants. Schneider et al. [79–81] achieved
accuracy errors lower than 0.1% and linearity errors up to
2.5%. Data acquisition was sampled up to 200 Hz.
Instrumented femoral replacements and instrumented femoral
fixation implants have been designed to measure biomechanical
quantities in vivo. The implants’ physiological environment has
not been monitored. Data storage inside implants has not been
reported. Data monitored in vivo was not post-processed in order
to model characteristics of implants’ failures.
Communication features
TABLE 5 introduces a comparative analysis between the communi-
cation features of implants. All instrumented implants comprise
RF transmitters. Both circuitry and antennas were housed in
several regions of implants. The induction coils for both gener-
ations proposed by Taylor et al. [15,72–75] were housed outside
the implants, supported by the tip of the modified stem (first
generation) and by the main shaft (second generation). All
measured quantities have been transmitted to instrumentation
located outside the patients’ body: the main goal has been to
use these in vivo data to optimize the design and testing of
femoral replacements and total knee replacements [82]. Data
acquisition was only conducted in research laboratories, follow-
ing the same communication method implemented for instru-
mented hip joint replacements.
Table 4. Instrumented femoral replacements and instrumented fracture stabilizers – measurement
features†.
Features Brown et al. [44,78] Schneider et al. [79–81] Taylor et al. [15,72–77]
Implant type Nail plate implant (model: N/D) Intramedullary femoral nail (AO/ASIF
universal nail)
(1) Proximal femoral replacement
(Stanmore bone tumor
replacement prosthesis); (2) Distal
femoral replacement (Stanmore
bone tumor replacement
prosthesis)
Measuring
method
Resistive (wheatstone bridges) Resistive (wheatstone bridges) (1, 2) Resistive (wheatstone
bridges)
Components of
measurement
systems
Strain gauges (quantity: N/D) 5 strain gauges; temperature transducer
(model: N/D); data conversion circuitry
(1) 8 strain gauges (2 full bridges);
(2) 24 strain gauges (5 full bridges)
Locations of
components
Inside the nail, close to junction
of the plate
Strain gauges: in the mid-diaphyseal
cross-section and 15 mm apart from the
mid-diaphyseal cross-section; temperature
transducer: N/D; circuitry: in a cavity at
intermediate location between the
proximal end and the mid-diaphyseal
cross-section, and in a cavity at the
intermediate location between the distal
end and the mid-diaphyseal cross-section
(1) Cavities in the main shaft and
above the tip of the intramedullary
stem; (2) 20 strain gauges in the
shaft cavity and 4 strain gauges in
the stem tip cavity
Measured
quantities
Two orthogonal bending
moments in nail plate junction
Three orthogonal forces and three
moments acting in mid-diaphyseal
cross-section; temperature and rectified
supply voltage
(1) Axial force over the prosthesis
shaft and stem tip; (2) axial force,
axial torque and orthogonal
bending moments over the shaft,
and axial force over the stem tip
Sampling
period
N/D 0.375 Hz (1) 200 Hz; (2) 100 Hz
Errors N/D Maximum accuracy error (load): 0.1%;
maximum linearity error: 2.5% for axial
loads, 0.25% for bending loads and 0.6%
for torsion loads
(1,2) Maximum accuracy error
(load): 10 N; Maximum accuracy
error (torque): 0.1 Nm
†Terminology: (n) – implant of the nth generation.
N/D: Information not reported.
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Therapeutic features
No instrumentation for femoral replacements and femoral fixa-
tion implants was designed in order to implement therapeutic
actuation. Research on the optimization of femoral implants is
being carried out [82], but no actuation mechanisms were
embedded in the structure of these instrumented implants, in
order to prevent failures in real-time. Their current operations
do not take into account previous data monitored in vivo
as well.
Supply features
TABLE 6 presents a comparative basis between the supply features
designed for instrumented femoral implants and instrumented
femoral fracture stabilizers. These implants only require electric
energy to operate: they were not designed to use other resources,
such as chemicals. The authors used induction-based and
battery-based supply systems to power implants. Induction-based
supply systems comprise circuitry outside the patients’ body: pri-
mary coils and/or antennas and power oscillators were required
by all architectures. Schneider et al. [79–81] and Taylor et al. [15,72–77]
housed secondary power coils and conditioning systems inside
the implants, but both generations proposed by
Taylor et al. [15,72–75] positioned the secondary coils outside
(beneath the stem tip and around the main shaft). Power regula-
tion circuitries were housed in several regions of implants. The
battery-based power system, designed by Brown et al. [44,78],
requires a switch operation to enable power (a magnet, outside
the patients’ body, must enable/disable the activation circuitry,
inside the patients’ body). No circuitry to maximize the energy
available inside the implants’ structure was reported. The mini-
mization of power consumption was not reported.
These power supply systems were customized to power mea-
surement and communication systems and were selected
according to desired autonomy and available space. The draw-
backs of using inductive-based power supply or battery-based
power supply are the same as those reported for instrumented
hip joint replacements. These power supply methods can be
used also in research focused on monitoring of biomechanical
or biochemical quantities possible to be acquired in vivo by
instrumented implants.
In vivo operation details
Instrumented nail plate implants proposed by Brown et al. [44,78]
operate if batteries have sufficient energy and the activation
Table 5. Instrumented femoral replacements and instrumented fracture stabilizers – communication
features†.
Features Brown et al. [44,78] Schneider et al. [79–81] Taylor et al. [15,72–77]
Implant type Nail plate implant
(model: N/D)
Intramedullary femoral nail (AO/ASIF
universal nail)
(1) Proximal femoral replacement
(Stanmore bone tumor replacement
prosthesis); (2) Distal femoral
replacement (Stanmore bone tumor
replacement prosthesis)
Method of
communication
Telemetric: radio transmission
of data from the implant to a
receiver
Telemetric (radio transmission of
inductive link): radio transmission of
data from the implant to a receiver
(1, 2) Telemetric (impedance
modulation of inductive link): radio
transmission of data from subject to
base station
Components of
communication
system
2-channel 88–108 MHz AM/
FM transmitter; antenna
8-channel 100 kHz Pulse code
modulation transmission system;
antenna
(1, 2) Single channel 418 MHz UHF
transceiver
Locations of
components
Inside the plate In a cavity at intermediate location
between the proximal end and the
mid-diaphyseal cross-section, near data
conversion circuitries
(1, 2) Circuitry: cavity in the main
shaft; induction coil: outside the
implant (beneath the intramedullary
stem), encapsulated to the end-cap by
silicone rubber
Transmitted
quantities
Two orthogonal bending
moments in nail plate
junction
Three orthogonal forces and three
moments acting in mid-diaphyseal
cross-section; temperature and rectified
supply voltage.
(1) Axial force over the prosthesis
shaft and stem tip; (2) axial force,
axial torque and orthogonal bending
moments over the shaft, and axial
force over the stem tip
Period During tests‡ During tests‡,§ (1, 2) During tests‡
Resolution N/D 14 bits (1, 2) Analog PWM
†Terminology: (n) – implant of the nth generation.
‡Communication with implants was only performed in the research laboratory.
§Only 10 ms in every 333 ms were used for transmission of data.
AM: Amplitude modulation; FM: Frequency modulation; N/D: Information not reported; PWM: Pulse width modulation; UHF: Ultra high frequency.
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system is switched on. They performed in vivo data acquisition
throughout postoperative and convalescent recovery of three
human patients.
The architecture for instrumented intramedullary nails, pro-
posed by Schneider et al. [79–81], operates when it is powered
by an inductive power link. They implanted this instrumented
implant into a patient and performed data acquisition in vivo
throughout 6 months postoperatively.
All architectures developed by Taylor et al. [15,72–77] require
inductive powering in order to operate. Instrumented proximal
femoral replacements, based on the first architecture, were
implanted into two patients, which allowed the acquisition of
in vivo data up to 3 years postoperatively [15]. Instrumented dis-
tal femoral replacements, based on the second architecture,
were implanted into two patients and data from each patient
was recorded over 2 years before revision was required [76,77].
No side effects on patients were reported in literature about
the operation of instrumented femoral implants and instru-
mented fracture stabilizers.
Expert commentary
The newest architecture for instrumented hip joint implants
was proposed by Bergmann et al. [83,84]. It is able to measure
implant temperatures in vivo required to study the risk of ther-
mally induced bone necrosis (FIGURE 1). The newest instrumented
intramedullary nail was developed by Faroug et al. [85].
By modifying a TriGen META Nail (Smith & Nephew),
they embedded a strain measurement system into each of eight
cavities that they machined onto the surface of the nail. They
demonstrated in vitro that such instrumented nail is able to
predict fracture healing. Currently, they are working toward
implementation of a device for in vivo operation.
Instrumented implants analyzed in this review have been
designed mainly to measure biomechanical and thermodynamic
quantities, that is, besides their main function in the articulation
motion, these implants were designed as transducers. The first con-
cepts of instrumented hip joint replacement, instrumented femoral
replacement and instrumented femoral fracture stabilizer (FIGURE 2)
defined these implants as medical devices composed by:
Table 6. Instrumented femoral replacements and instrumented fracture stabilizers – power supply
features†.
Features Brown et al. [44,78] Schneider et al. [79–81] Taylor et al. [15,72–77]
Implant type Nail plate implant (model:
N/D)
Intramedullary femoral nail (AO/ASIF
universal nail)
(1) Proximal femoral replacement
(Stanmore bone tumour replacement
prosthesis); (2) Distal femoral
replacement (Stanmore bone tumour
replacement prosthesis)
Type of supply Electric energy Electric energy (1, 2) Electric energy
Method for
power supply
Powered by batteries Inductive powering, using a 2 kHz
modulator
(1, 2) Inductive powering, using a
modulator externally located
Components of
supply systems
inside the
patients’ body
Set of batteries (1.35 V,
mercury) (quantity: N/D);
magnetic reed switch
Power coil; regulation systems (1, 2) Coil and ferrite core; regulation
systems
Locations of
components
inside the
patients’ body
Batteries: inside the nail;
switch: inside the plate
In a cavity at the intermediate location
between the distal end and the mid-
diaphyseal cross-section
(1) Coil and ferrite: outside the
implant; (1, 2) circuitry: midshaft
cavity; (2) coil and ferrite: distal
portion in the shaft
Components of
supply systems
outside the
patients’ body
Magnet (to latch the reed
switches)
(1) 2 kHz power oscillator; (primary) coil
(around thigh)
(1, 2) (Primary) coil, power oscillator
(frequency: 1.2 MHz) and battery (coil
around thigh)
Power
regulation
circuitries
Inside the implant: N/D;
outside the implant: N/D
Inside the implant: circuitry to regulate
output voltage; outside the implant: N/D
(1, 2) Inside the implant: circuitry to
regulate output DC voltage; outside
the implant: linear regulator
Power
generation
N/D 100 mW (1) 151 mW (8 mA); (2) N/D (6 mA)
Lifespan N/D N/D (1) Over 3 years; (2) over 2 years
Efficiency N/D N/D (1) 10%; (2) 13%
†Terminology: (n) – implant of the nth generation.
N/D: Information not reported.
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• Resource acquisition systems;
• Measurement systems, to monitor the states of implants and
physiological states of tissues around implants;
• Processing systems, to model physiological states of tissues
surrounding the implants’ in situ structure, as well as to
model failures’ characteristics of implants;
• Communication systems between electronic circuitries inside
and outside human body.
Following this first concept, new tele-
metric systems were developed for in vivo
monitoring: Marschner et al. [86] designed
a new telemetric system for instrumented
hip prostheses similar to the one proposed
by Puers et al. [42]; Valdastri et al. [87] pro-
posed a ZigBee wireless technology to
design telemetric systems. Research on
novel transducers for measuring bio-
mechanical quantities has also been con-
ducted: Cristofolini et al. [88] developed a
piezoelectric transducer to measure forces
in the cement–implant interface;
Gattiker et al. [89] developed a sensing sys-
tem for measurement of loads on hip
implants, by transducing load into a vary-
ing amount of fluid in a channel housed
inside transducer. Although these achieve-
ments are quite significant, no implants
have been proposed as instruments to: vali-
date biochemical models of tissues sur-
rounding implants; identify the interaction
between biochemical properties of tissues
and biomechanical properties of implants;
characterize failures; transfer the diagnose
of failures, as well as the states of tissues surrounding implants,
to/from implants (these data can be acquired by laboratory analy-
ses, and then they can be sent to implants; or they can be
acquired by measurement systems housed inside implants,
and then they can be sent to processing units outside the
human body).
Breakthroughs in real-time characterization of aseptic loosen-
ing and infection are relevant to increase the lifetime of
implants. Alpuim et al. [90] designed a thin-film strain sensor,
based on piezoresistive doped nanocrystalline silicon, for aseptic
loosening detection on prosthetic stem and cup. They used rel-
ative motions in bone–implant interface as the characterizing
feature. However, this sensor must be optimized to ensure
accurate characterization of this type of failure along critical
regions. Hao et al. [91] proposed real-time prediction of aseptic
loosening through in vivo evaluation of the implant stability
(migration and micromotion measurement). They developed a
differential variable reluctance transducer for that purpose, but
it has the limitation of not being appropriate for accurate iden-
tification of regions where aseptic loosening occurs. Recently,
Ruther et al. [92] demonstrated the potential of acoustic sound
analyses to monitor osseointegration of different orthopedic
implant surfaces in vivo.
New methods to harvest electric energy in vivo inside instru-
mented implants have been published (FIGURE 3):
Morais et al. [93–95], Silva et al. [95,96], Morgado et al. [97] and
Soares dos Santos et al. [98–100] designed motion-driven electro-
magnetic energy harvesting systems; Silva et al. [95,96], Soares
dos Santos et al. [98–100] and Platt et al. [101] proposed piezoelec-
tric energy harvesting systems. New conditioning interface
Closing plate
Shielding tube
Head
Neck
Stem
Hip
Power and
data coil
Electronic
circuit
Thermistor
Figure 1. Cross-section of instrumented hip endoprostheses for temperature
measurements in vivo.
Reproduced with permission from Bergmann et al. [83].
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Figure 2. General architecture of instrumented non-active
implants.
Empty square means ‘no operation’.
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circuitries have also been developed:
Le et al. [102] designed CMOS circuitry to
interface with piezoelectric energy har-
vesting systems and Silva et al. [95,96]
designed power management architec-
tures for instrumented hip prostheses
powered by multiple energy harvesters.
Novel energy storage systems were
recently proposed by Silva et al. [96] to
maximize the amount of available energy
harvested in vivo: they developed a storage
circuitry based on supercapacitors to avoid
using energy reservoirs based on batteries.
New telemetric systems were already tested
by Morais et al. [94,103] and Silva et al. [96]
for instrumented hip prostheses powered
by electromagnetic energy harvesting
systems.
The most significant recent advance is
the concept of instrumented active
implant (FIGURE 4). Resource acquisition,
measurement, communication and processing systems are also
required in the design of active implants. However, they must
also provide actuation with ability to implement clinical thera-
pies in real-time. Instrumented hip joint replacements, instru-
mented femoral replacements and instrumented femoral
fracture stabilizers can be designed as active implants. They can
evolve toward the minimization of failures in real-time by
using:
• Actuators as an integral part of the implant, in order to
apply therapeutic stimuli in bone–
implant interface;
• Therapeutic command generators, in
order to control actuators embedded
into instrumented implants.
Instrumented active implants can be
configured according to non-autonomous
or autonomous architectures. In non-
autonomous architectures, an extracorpo-
ral master-based active structure must be
able to generate therapeutic commands,
and an intracorporal slave-based active
structure must be able to execute such
commands. In autonomous architec-
tures, both master-based active structure
and slave-based active structure must be
able to generate therapeutic commands,
although generation of commands by
the slave-based active structure must be
carried out under supervision of the
master-based active structure. FIGURES 5
& 6 illustrate the main structural differ-
ences among instrumented active and
non-active implants. A promising
advance would be the development of implants with ability
to prevent aseptic loosening and/or infections: if they occur,
then instrumented active implants must characterize them
and perform controlled therapeutic actuations. They must be
smart implants to ensure customization and optimization of
their performance throughout their lifetime. Reis et al. [104]
and Frias et al. [105,106] used piezoelectric-based mechanical
stimulation to control bone formation surrounding hip
implants. They support their research on previous studies
Translation-based
electromagnetic
generator
Rotation-based electromagnetic generator
Piezoelectric
generator
Figure 3. Hip prosthesis prototype, comprising three energy harvesting systems.
Reproduced with permission from Silva et al. [96].
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Figure 4. General architecture of instrumented active hip implants.
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about effects of mechanical stimulation on bone cells [107,108].
Bone cell proliferation and differentiation can also be
achieved by electrical stimulation [109,110]. These two actu-
ation methods could be applied to design instrumented active
implants comprising a network of mechanical and/or electri-
cal stimulators of bone cells along the critical regions where
aseptic loosening occurs. Soares dos Santos et al. [100,111] pro-
posed such an architecture for instrumented hip implants.
Another appropriate basis for research of new therapeutic
actuations is the study published by Prescott et al. [112]. They
designed a microchip device comprising hundreds of arrays
of discrete reservoirs, which is able to control the release of
therapeutic drug doses over several months in biological envi-
ronments. This achievement can be used to design instru-
mented active implants with ability to implement controlled
biological therapies, such as antimicrobial therapies and sup-
pressive antibiotic therapies.
Instrumented active implants require powerful and miniatur-
ized processing capability. In this scope, novel miniaturized
CMOS System-on-Chip architectures for orthopedic implants
were recently proposed by Zhao et al. [113]. Additionally, the
telemetric system, proposed by Weiss et al. [114], is also
noteworthy because it maximizes the RF
coupling, which in turn can be used to
reduce size and complexity of communi-
cation systems.
Five-year view
Instrumented implants are promising devi-
ces for advanced therapies toward minimi-
zation of revision rates. Optimality
analyses of architectures and configura-
tions of instrumented active and non-
active implants would allow to define the
ability of each implant to prevent failures
in real-time. The controllability of
implants when aseptic loosening and infec-
tion occur is expected to be analyzed. Taking into account the
breakthroughs in circuit design for miniaturized and high-
performance electronic systems, as well as the progress in intelli-
gent actuation and sensing systems, the design of active implants
may become achievable.
Additional methods for loosening detection may be explored
in the coming years, such as measurement in vivo of failure-
specific molecular markers surrounding implants (e.g., nitric
oxide synthase [115] and peroxynitrite [116]). In addition to the
need of electric energy, other resources will have to be stored
inside implants, such as chemicals for biosensing [117]. Some
research projects are predicted to be focused on the accurate
characterization of aseptic loosening and/or infection in real--
time, namely on the design of miniaturized sensors and net-
works of sensors around critical regions where these causes of
failure occur.
Energy harvesting systems are maintenance-free and harvest
electric power without the need of interaction with the
bone–implant interface. It is noteworthy that power genera-
tion naturally accompanies the active lives of patients besides
these advantages, one must emphasize their ease of
implementation and low cost. To date, translational-based
Commands for
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Control of
monitoring
operations
Physiology of
the patient
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Mechanical
structures
Outcomes
Inside the human bodyOutside the human body
Monitoring of
failures
Figure 5. Structure and functions of instrumented non-active implants.
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Figure 6. Structure and functions of instrumented active implants.
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electromagnetic harvesters (designed to power instrumented
hip implants) were only configured as mass-spring-damper
systems [94,99] and magnetic levitation systems [96]. Other con-
figurations may be studied. Further research may include the
optimization of energy harvesters according to the gait pat-
terns of patients during their routine activities. For this pur-
pose, following efforts will probably concentrate on the
development and validation of non-linear models, which can
be used to accurately predict electric power harvesting.
According to the maximum power harvested in vivo by each
configuration, a specific energy harvester can be design for
each instrumented implant, either for active or non-active
implants.
In coming years, actuation systems for stimulation of bone
growth around implants, by enhancing the proliferation and
differentiation of bone cells, may be studied. One can expect
proposals of new electrical stimulation systems, since current
electrical stimulation apparatus [109,110] are not appropriate for
in vivo actuation. Finally, further steps may be taken toward
identification of suitable stimuli for each aseptic loosening
characterization.
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Key issues
• Although considerable research efforts have been conducted to optimize the design and materials of hip implants, revision rates are
about 6% after 5 years and 12% after 10 years following THR. The number of primary THR at younger ages (less than 65 years old) is
increasing. The use of uncemented primary and revision THR is also increasing. Aseptic loosening has been the most important reason
for hip revision. An increased risk of revision due to infection after THR has been verified in the last years.
• Instrumented hip joint replacements, instrumented femoral replacements and instrumented femoral fracture stabilizers were proposed
for research purposes focused on studying the dynamics of biomechanical and thermodynamic quantities when such implants operate
in vivo. They have been designed to: collect data (mainly forces, moments and temperatures) for calibration of models defining the
implants’ biomechanical and thermal environment; optimize the mechanical design and materials’ behavior of implants; carry out preclin-
ical testing; track the healing evolution and improve the rehabilitation processes after arthroplasty.
• Twelve architectures for instrumented hip joint replacements, without percutaneous wired connections, were implanted into 24 human
patients. Two architectures for instrumented femoral replacements were implanted into four human patients. Two architectures for
instrumented femoral fixation implants were implanted into four human patients.
• More than 9 years of successful operation was achieved by instrumented hip joint replacements. Up to 9 years of data were acquired
in vivo from these implants. No side effects were reported.
• All instrumented implants were designed with measurement, communication and electric power supply systems. However, no
therapeutic actuation systems were embedded in the structure of these instrumented implants in order to maximize their ability to
overcome failures in real-time.
• Instrumented implants are being developed as medical devices for advanced therapies toward the minimization of revision rates.
• The most promising trend in this field is focused on the design of instrumented active implants to prevent aseptic loosening and/or
infection: implants comprising therapeutic actuation systems with ability to induce trajectories from each state of loosening/infection to
states of without-loosening/infection.
• Optimization of electric power supply systems must be conducted toward self-powering. Energy harvesting systems are noteworthy in
this scope.
• Measurement systems must be developed toward the characterization of the implants’ biomechanical environment, as well as the
design of a network of sensors around critical regions where loosening and infection occur.
• Design of electrical and mechanical stimulation systems for instrumented implants may effectively induce and control bone growth in
regions where aseptic loosening occurs.
Instrumented hip joint replacements, femoral replacements & femoral fracture stabilizers Review
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3.2 Electromagnetic stimulation of bone cells
Results found in section 3.1 have shown that no therapeutic actuators have been
developed so far for in vivo operation, such that instrumented THRs could control
osseointegration. Currently, it is unknown if bioactivity on the bone-implant is more
effective by delivering exogenous biophysical stimuli or by the action mechanisms of
bioactive coatings. The design of instrumented implants for controlled release of drugs
and/or other bio-agents may be quite complex, as stated in chapter 1. Alternatively, it
is worth exploring if controllable biophysical stimulation systems can be designed using
non-complex architectures. Among the biophysical stimulation methods that proved to
induce osteogenic effects, and according to the analyses reported in section 1.2, the deliver
of electric and/or magnetic fields to stimulate bone cells seems the most promising method.
Since the rational identification of parameters for optimized osteogenic stimulation of
tissues or organs firstly requires a solid background on how bone cells activity is electrically
and/or magnetically controllable, a detailed review was carried out for: identifying the
apparatuses already used to deliver electric and/or magnetic stimuli to bone cells; and
analysing the interrelationship between the established stimuli parameters and obtained
biological outcomes (including possible adverse events). This study shows how stimuli
promote osteogenicity throughout the main stages of osteoblastic maturation in culture
(cellular proliferation, matrix maturation and matrix mineralization), as well as the
osteogenic effects when key experimental factors are varied (stimulation method, frequency
and field strengths of the stimulus, cell model, cell density and maturation stages, serum
concentration and osteoinductive factors). Some relevant transduction mechanisms of
osteogenicity were subjects also broached. Finally, the main limitations of the current
state-of-the-art in this scope were identified and new perspectives for its improvement were
proposed. This review paper is entitled ”Electromagnetic stimulation of bone remodeling
in vitro: a review” and it was already submitted to a peer-reviewed international journal
(Bioelectrochemistry).
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Abstract
The natural occurrence of electromagnetic fields in bone tissues has triggered
considerable research addressing their effects on bone remodeling. Electric and/or magnetic
stimulation has been proposed as a therapeutic strategy for conditions in which active
bone remodeling is critical, namely osteoporosis, bone fracture and poor osseointegration
in bone-implant interfaces. Positive effects of electric and magnetic stimulation on bone
physiology have been reported, and the variation of specific stimuli parameters, such
as frequency, electric or magnetic field strengths, and exposure time, yields different
biological outcomes. Despite the volume of work in this field, a systematic evaluation
of the correlation between the stimuli parameters and their biological output is lacking.
In this review, we provide for the first time a unique insight into the results of the
most relevant studies using direct current coupling, capacitive coupling and inductive
coupling apparatuses to deliver electric and/or magnetic stimuli to bone cells in culture
(cell lines, stem cells and primary cells). The stimuli parameters used and their biological
outcomes, concerning the three principal stages of bone remodeling (cellular proliferation,
matrix maturation and matrix mineralization) were object of a comprehensive survey here
presented. The potential molecular mechanisms underlying the biological outcomes were
also addressed. Some major conclusions could be drawn regarding the biological and stimuli
factors applied, and the resulting osteogenic responses. This review intends to support the
identification of parameters that induce optimum osteogenic stimulation of tissues and
organs for future personalized biophysical therapies.
Keywords: Electromagnetic stimulation; bone cells; osteogenic effects; bone
remodeling; nondrug therapy.
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1. Introduction
Musculoskeletal disorders account for more than 20% of the global disability burden,
and over the last 20 years this contribution has increased in developed and developing
countries [1]. Their frequency, chronicity and resultant disability are increasing the costs
due to loss of productivity and associated health care services, placing the latter amongst
the most expensive across developed countries [1–3]. Given that the socioeconomic impact
of these disorders is expected to increase dramatically in the forthcoming years [1, 2], it
is mandatory to pursue methods that increase the efficiency of the therapies employed
against these disorders.
Bone electric properties
Exogenously delivered electric stimulation is thought to mimic endogenous electric
currents that normally occur in bone, inducing similar biological effects that ultimately
regulate bone remodeling. Bone is a dynamic and highly specialized connective tissue,
which can be macroscopically divided into two types: cortical and trabecular. Cortical
bone has densely packed collagen fibrils that form concentric lamellae, and surrounds
the central marrow cavity providing mechanical and protective functions. Trabecular
(or cancellous) bone, located at the ends of long bones, has a loosely organized porous
matrix, and provides metabolic functions. At the microscopic level, bone is composed of
osteocytes (mature bone cells), crystalline and amorphous mineral phases (hydroxyapatite),
crystalline and amorphous organic phases (collagen), and liquids [4, 5]. Bone composition
provides characteristic electro-mechanical properties that depend, to a great extent, on
mechanical loading (compression or tension). Two main hypotheses have been put forward
to explain the electrical potentials measured in loaded bone: the piezoelectric effect and
the streaming potentials. Bone piezoelectricity, a bilinear interaction between electrical
and mechanical variables, was first proposed by Fukada and Yasuda and attributed to the
crystalline micelle of collagen molecules [6,7]. The magnitude of the electrical potential is
influenced by the rate and magnitude of the deformation, while its polarity is determined
by the direction: electronegative potentials occur in areas subjected to compression,
and electropositive ones occur in areas under tension [8, 9]. Dry bone has piezoelectric
constants around≈100 mV, while the loading of moist cortical bone generates much smaller
potentials (≈100 µV) that are putatively explained by streaming potentials [7]. These
potentials arise from changes in the spatial charge density followed by ionic movement,
and can be produced by the bending of hydrated bone or the fluid movement through
bone [4, 7, 10,11].
There are many factors that affect the electrical behavior of bone tissue. Electric and
dielectric properties of bone vary according to its macrostructure (cortical vs. trabecular)
[12, 13]. Intrinsic factors, such as tissue age, moisture content (wet or dry), fluid
conductivity, mineral and organic content interact with electric current and determine
the bone dielectric properties [14–17]. Fat and collagen contents are strongly related to
relative permittivity, while water content is significantly related to conductivity. These
relationships can be used as diagnostic tools, such as to predict trabecular bone water
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or fat contents during implant surgery [16] and to assess fracture healing and new bone
formation [18].
Therapeutic applications of electromagnetic stimulation
The therapeutic value of electric and/or magnetic stimulation has been recognized
for pain relief, wound healing, neuromuscular dysfunctions, pharmaceuticals delivery
(iontophoresis), among other conditions [19–26]. Fukada’s and Yasuda’s studies on the
piezoelectric effect of bone have encouraged many researchers to explore the effects of
electric current on bone remodeling [27–29]. The Food and Drug Administration (FDA)
has approved bone growth stimulation devices based on the following three methods of
administering these biophysical stimuli to bone: Direct Current (DC), Capacitive Coupling
(CC) and Inductive Coupling (IC) [30]. The DC method is invasive whereas the CC and
IC methods are non-invasive. The effectiveness of these methods has been demonstrated
both in vivo and in vitro, and they have been proposed as therapeutic strategies for
minimizing osteoporosis, promoting bone fracture healing and improving osseointegration
in bone-implant interfaces [31–36].
Bone remodeling is a tightly orchestrated process of bone resorption and bone
formation. This turnover is essential to remove microdamage, replace dead and
hypermineralized bone, adapt the bone architecture to local stresses, and regulate
calcium homeostasis and hematopoiesis, among others. Osteoporosis, one of the major
musculoskeletal disorders, is characterized by low bone mass and structural deterioration,
due to an imbalanced bone remodeling. Importantly, several authors have reported the
efficacy of electrical and/or magnetic stimulation to prevent and even reverse osteoporosis
in animal models [31–36].
Electric and/or magnetic stimulation are also valuable in bone healing upon fracture,
including fracture repair of osteoporotic bone. The process of bone regeneration is initiated
by an acute inflammatory response, in which relevant signaling molecules are produced
and released, followed by mesenchymal stem cells recruitment and subsequent proliferation
and differentiation into osteogenic cells to generate a primary cartilaginous callus. Callus
remodeling is then necessary to fully restore normal bone structure, which may take years
to be accomplished [37, 38]. If the regulation of this complex process is compromised,
in particular under osteoporotic conditions, healing is delayed or impaired, leading to
bone nonunion or disabled union. In combination with pharmacotherapy, several methods
have been proposed to treat these conditions, including invasive therapies such as surgical
repair, allografts and autogenous bone grafts, or non-invasive therapies such as ultrasound
stimulation. Electrical and/or magnetic stimulation has proven to be an effective treatment
for both nonunions [39–41] and spinal fusions [42, 43]. Additionally, when compared to
ultrasound stimulation and drug administering treatments, therapies involving electrical
stimulation are more cost-effective for fracture nonunions due to their lower total health
care resource use and lower overall costs [44].
Bone electrical and/or magnetic stimulation may also assist osseointegration, one of
the most important phenomenon affecting long-term behavior of implantable orthopedic
implants [45]. Current bone-implant interfaces cannot ensure a timeless stable
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performance, mainly when interfacing osteoporotic bones [45]. Loss of primary stability
and early migration of the implant occurs frequently, leading to revision procedures due
to implant loosening [46–49]. Instrumented active implants, with the ability to apply
personalized electrical and/or magnetic stimuli in the bone implant interface, may be a
future innovative method to optimize osseointegration. Further, their application can be
quite significant when revision procedures endanger the patients’ life or deeply deprive
their life quality, especially when suffering from osteoporosis and with less than 65 years
old [48]. Inductive coupling stimulation has been the delivery method more intensively
studied as a therapy to enhance osseointegration (as reviewed in [50]).
Characteristics and optimization of osteogenic electromagnetic
stimulation
The application of electric and/or magnetic stimulation to promote bone healing has
many advantages over pharmacological or chemical therapeutics. Firstly, most of them can
be designed as non-invasive, avoiding the production of toxic chemicals and the induction
of immunogenic responses [51, 52]. Further, these stimulators can apply painless stimuli,
employing non-complex apparatuses that are less expensive than growth factors and drug
interventions [51]. Incorporated electrodes can be used in operations where both constant
monitoring and application of therapeutic stimuli to the same specific volume co-exist [51].
Nonetheless, the application of electrical and/or magnetic stimuli as a nondrug intervention
requires a deep understanding of the correlation between specific stimulation parameters
and resulting osteogenic effects, and this is still far from an optimized level that ensures
effective bone turnover.
Osteogenic parameters to be used with DC, CC and IC stimuli-delivery devices
are usually first tested in vitro in bone cells cultures. Osteoblasts are the main cells
used, as these are responsible for bone matrix production [5]. In vitro studies using
the DC, CC and IC stimulators have explored particular features of bone remodeling,
particularly osteoblasts proliferation, differentiation (matrix maturation), and matrix
mineralization, the main stages of osteoblastic maturation in culture [53–55]. However, the
studies use quite different stimuli and biological setups in their experimental designs, and
evaluate different biological outcomes. Consequently, it is difficult to infer on potential
correlations between electric and/or magnetic stimuli and osteogenic outcomes. The
rational identification of parameters for optimized osteogenic stimulation of tissues or
organs requires a solid background on how osteoblast and osteoclast activities are influenced
by electric and/or magnetic fields. Therefore, this paper provides for the first time a unique
insight into the main results of studies using DC, CC and IC apparatuses to stimulate
osteoblast-like cell lines, stem cells and primary bone cells in culture. Critical analyses
on the influence of the experimental design factors on the biological outcome are also
presented. This added knowledge will hopefully help future designs of studies on cultured
cells stimulated electrically and/or electromagnetically, and support its translation to tissue
or organ levels. The ultimate goal is to aid in the development of innovative medical devices,
such as implantable orthopedic implants comprising intelligent stimulators [46,48].
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2. Electromagnetic stimulation of bone remodeling in
vitro
In order to identify electrical and/or magnetic stimulation conditions effective in
bone remodeling, many in vitro studies have been performed in which different stimulus
parameters were applied to cultured bone cells. Variables encompassed quite different
cell culture and stimuli conditions, and quite distinct biological outcomes were observed.
To more easily extract comparative conclusions from these studies, the most relevant
characteristics were systematized (supplementary Tables S1-S9). This analysis was
conducted considering various cell culture features, including the cellular model used and
confluence state at the time of the stimulus onset. Several stimuli characteristics were also
considered for each stimulation method, namely waveform, frequency, periodicity, electric
field (EF) strength and/or magnetic field (MF) strength, current density, time of stimuli
exposure and total assay duration.
Biological outcome evaluation was categorized based on the three specific stages of
osteoblasts in vitro maturation: proliferation, differentiation and matrix mineralization [53,
54]. In these studies, proliferation was assessed by: direct cell counting (’Cell Nr.’), trypan
blue exclusion assay (’EA’), metabolic cell viability assays (’MetB’), quantification of the
DNA content (’DNA’), quantification of incorporated exogenously added labeled-DNA
(incorporation assay, ’IA’), or by quantifying protein synthesis (’PS’).
Cellular differentiation, which takes place after cell confluence or upon osteogenic
factors medium addition, is characterized by the formation of an organic matrix. Most
surveyed studies evaluated this stage by analyzing the expression or localization of
matrix-associated proteins. Collagen type I comprises around 90% of the organic matrix
and thus its expression and medium secretion are well-recognized differentiation markers
[56, 57]. The organic matrix is also composed of other collagen proteins (type III, V and
X), proteoglycans, and numerous noncollagenous proteins such as osteonectin, osteocalcin,
bone sialoprotein, and osteopontin, which can be used to assess differentiation. Osteonectin
and osteopontin, for example, mediate signal cascades for the full expression of the mature
osteoblast phenotype and mineralization of the extracellular matrix (ECM). The expression
and activity of alkaline phosphatase (ALP) are other widely used early biomarkers of
osteoblast differentiation. This enzyme hydrolyzes organic phosphates to increase the local
phosphate concentration to a level required for the generation of hydroxyapatite crystals
[58,59].
Mineralization of the mature matrix is the end phase of osteoblastic differentiation.
In the analyzed studies, mineralization was inferred by measuring osteocalcin expression
and/or the amount of extracellularly deposited calcium. Osteocalcin, a type-1
noncollagenous protein secreted by osteoblasts, actively participates in this stage. In
the presence of calcium, osteocalcin combines with hydroxyapatite, modulating the
hydroxyapatite growth and crystal morphology [59, 60]. Matrix mineralization was also
assessed using Alizarin red and von Kossa staining for calcium deposits in the matrix. In
a few studies, electron microscopy was employed to visualize the morphology of mineral
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spherules [61]. Of note, cell migration and related intracellular calcium levels were also
measured and extracted from studies using DC stimulation.
A summary of some of the major features found are described below, but for a detail
and complete analysis of the content presented in this review paper please refer to Tables
S1-S9, which can be found in the on-line version.
2.1. Direct current coupling
2.1.1. Design of DC stimulation systems
The direct current coupling systems refer to all stimulators composed of electrodes
which are all in direct ohmic contact with the cell culture medium, such that electrical
currents are transferred to ionic currents through an electrode-electrolyte interface.
Usually, this current flow is achieved by using agar salt bridges to isolate cells from harmful
electrochemical by-products generated by the direct exposure of the electrode(s) to the
culture (Fig. 1) [51, 62–64]. However, biocompatible and highly conductive materials
immersed into the culture, mostly arranged in parallel configuration, have also been used
to carry out the electrodes-culture contact. This method ensures that bone cells are
stimulated by (constant or time-dependent) ionic currents and DC electric fields (dcEFs).
Fig. 1: Experimental setup for direct current stimulation systems. A power source provides
the required current for bone cell stimulation. To avoid cytotoxicity, salt bridges are used to ensure the
delivery of electric current without direct contact with the electrodes. PDMS - polydimethylsiloxane.
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2.1.2. Cellular responses to DC stimulation
From the surveyed data, specific DC experimental setups were able to induce positive
responses in the three cell models, particularly in terms of proliferation and Ca2+ content
(Fig. 2, supplementary Tables S1-S3).
Cell alignment and migration
Most studies using DC stimulation evaluate cell alignment and cell migration, as well as
the potential involvement of calcium in these processes. The application of short-duration
(few seconds) dcEFs is enough to promote cell alignment and elongation perpendicularly to
the EF lines (Tables S1 and S2) [65,66]. This effect is suggested to occur before migration
and to result from the alteration of cell tensions, in a pattern related to both the direction
of the stimulus and the direction of the future movement [65].
Endogenous EFs generated at wounds are known to act as migratory stimuli for
fibroblasts and macrophages [67]. Similarly, externally applied dcEFs also induce osteoblast
and osteoclast electrotaxis in culture. However, there are differences in the direction of the
migration between cell types and between species. The application of EF strengths similar
to those found in wounds (≈1 V/cm) resulted in opposite directions of migration for rat
(RCJ 1.20 and RCB 2.2A) and human (SaOS-2) osteoblast like cell-lines (Table S1). Rat
osteoblasts migrate towards the cathode [68], while human osteoblasts migrate anodally
[69].
Human bone marrow-derived mesenchymal stem cells (hBM-MSCs) (Table S2) also
presented anodal galvanotaxis at low EFs strengths (0.25 V/cm), with a maximal migratory
response at 3 V/cm [70]. Accordingly, the application of a 0.1 V/cm EF strength for
5 days (3 h/day) promoted the expression of migration- and invasion-related genes in
hBM-MSCs [71]. As for rat osteoblast-like cells, primary osteoblasts (Table S3) from rat
calvaria migrated towards the cathode [69], while primary rabbit osteoclasts presented
anodal-directed migration [68].
Concluding, externally applied dcEFs induce bone cells migration in a cell-type specific
manner and dependent on voltage, time, and calcium levels, as already suggested elsewhere
[70]. Calcium is an important second messenger, suggested to participate in the signal
transduction of electrical signals (further discussed in section 4.1). No directed migration
is observed in calcium-free conditions; however, only EFs strengths around 14 V/cm were
able to trigger a rapid increase in intracellular calcium levels [69] (Table S1), possibly
through the activation of voltage-gated calcium channels (VGCCs) [66, 72, 73]. In this
study, O¨zkucur et al. [69] have observed that the initial intracellular calcium elevation
occurs in the cell side that does not face the electrode towards which the cell migrates; this
initial calcium rise is thus initiated at opposite sides in rat calvarial and human SaOS-2
cells, resulting in their differential directionality.
Proliferation
Positive effects of dcEFs on the proliferation of osteoblast-like cells lines were observed
in few studies. The application of low EF strengths (0.015-0.02 V/cm) for 34 h to rat
osteosarcoma cells enhanced DNA synthesis by +10-40% above control levels [63] (Table
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S1). dcEFs also induced proliferative effects on hBM-MSCs, either in the presence (up
to 200%) or absence (up to 78%) of osteoinductive media (OM). Increased cell number
[74] and metabolic activity [71] of hBM-MSCs grown in OM were observed when using
EF strengths of 0.1 and 2 V/cm, respectively. The increase under normal growth media is
usually lower, but 24 h/day exposure to a current density of either 1.5 or 15 µA/cm2 at 100
Hz increased cell number after 6 days of stimulation [75]. However, these cells presented
no alterations in their metabolic activity when exposed 40 min/day (for 28 days) at a
high frequency (60 kHz) [52] (Table S2). For primary osteoblasts (Table S3), positive
proliferative effects were achieved by delivering quite different stimuli: low (10 Hz) or high
frequencies (3 kHz) during short (1 h/day) or long (24 h/day) time exposures increased
the cell number up to 46% [73,76].
Matrix maturation and mineralization
Increases in ALP activity were observed in human bone marrow-derived and mouse
adipose-derived MSCs incubated with OM and daily exposed to dcEFs (Table S2) [66,74].
Increases in the expression of ALP and collagen type I were observed for a EF exposure
of 0.02 V/cm/60 kHz (40 min/day) and 6 V/cm/50 Hz (6 h/day) [52] (Table S2). When
primary osteoblasts were stimulated 6 h/day at 10 Hz, the expression of collagen type I
increased either at day 2 or day 21 [77]. A much higher frequency (3 kHz) failed to increase
collagen and ALP expression after 4 days of 6 h or 24 h/day exposures [78] (Table S3). Of
note, cellular differentiation has not been evaluated in osteoblast-like cell lines.
Regarding hBM-MSCs matrix mineralization, only five studies analyzed matrix
mineralization, and all used osteoinductive media (Table S2). Of those, none detected
up-regulations in osteocalcin levels, and only two observed increased mineralization,
although with quite different stimuli (100 Hz, 24 h/day [75] and 1 Hz/1 V/cm, 30 min/day
[74]). However, either cells exposure 40 min/day for 28 days to a lower 0.02 V/cm EF
strength at a high 60 kHz frequency [52] or to a single-day EF exposure of 2 h followed
by 28 days of incubation in OM, failed to increase matrix mineralization [70]. Matrix
mineralization was never evaluated in osteoblast-like cell lines; in primary osteoblasts it
was only evaluated for one stimulus – a EF of 10 Hz, 6 h/day during 21 days – that induced
osteocalcin levels and calcium deposition in the extracellular matrix [77] (Table S3).
In synthesis, DC stimuli of EF strengths between 1-14 V/cm can induce proliferative
effects (+38 to 200%) and increases in differentiation markers or intracellular Ca2+, mainly
when applied to stem and primary cell cultures (Fig. 2; Tables S1-S3) [66,69,72,74]. These
studies have used either constant DC stimuli or sinusoidal and square stimuli waveforms.
However, other studies using EF strengths of 1-12 V/cm observed no effects (or even
detrimental ones) on Ca2+ content [51,62–66,69,74], differentiation [78], and mineralization
outcomes [65, 66, 69, 74]. Further, it is difficult to infer on other stimuli characteristics,
since very few studies using DC stimulation had information on both the EF strength and
frequency, and a broad spectrum of osteogenic frequencies was tested (from 1 to 60 kHz)
but in a small number of studies. The exposure time may also be an important factor
to test in future experiments, since an increase of the stimulus duration may result in
augmented cellular proliferation [78].
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2.2. Capacitive coupling
2.2.1. Design of CC stimulation systems
The capacitive coupling systems refer to all stimulators composed of electrodes such
that either they are not in ohmic contact with the cell culture medium or just one of the
electrodes is immersed into the culture to establish an electrode-culture contact. The
electrodes are plates usually arranged in parallel, and cells are placed between these
electrodes (Fig. 3) such that homogeneous distributions of charges and stimuli are provided
[51, 52, 78]. Cell stimulation is performed either by capacitive coupling EFs (ccEFs) or
electromagnetic fields (ccEMFs), and displacement currents (when time-dependent EFs
are applied), although ion translocation can also take part in this process.
2.2.2. Cellular responses to CC stimulation
Sinusoidal, square and sawtooth CC waveforms were applied successfully in osteogenesis
in various experimental setups using the three cell models (Fig. 4, supplementary Tables
S4-S6).
Fig. 3: Experimental setup for capacitive coupled stimulation systems. A power generator
provides the voltage (sine wave, square, sawtooth, etc.) required to generate the electric field to stimulate
the cells placed between two parallel plates. The plates can be on opposite sides of the culture dish or at
the top and bottom.
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Proliferation
Most of the studies using capacitive coupling systems to stimulate osteoblast-like cell
lines reported increases in DNA synthesis, even though with different stimuli (Table S4).
Besides other characteristics, such as biological ones, the conjugation of the stimulus’
frequency and EF strength seems very important. Using a frequency of 10 Hz, Ozawa et
al. [79] observed a two-fold increase in MC3T3-E1 cells’ DNA synthesis, whereas the same
frequency was not sufficient to promote DNA synthesis in TE-85 cells [80]. Differences
between the applied EF strengths may explain this discrepancy: 31.9 V/cm of the former,
contrasting to the extremely low strength of 1×10−7 V/cm of the latter [79, 80]. At equal
EF strengths (0.02 V/cm) and duration of field exposure (24 h), an increase in the stimulus
frequency from low (60 Hz) to high (60 kHz) led to a decrease in the positive effects on
MC3T3 cells DNA synthesis: from +49% to +18.7% [81]. The exposure time is also
important: when using the low 60 Hz frequency, increases in the stimulus duration (from
30 min to 2, 6 and 24 h) led to gradual increases in DNA incorporation, from +17% to
+49% [82].
Very few studies used stem cells to analyze the osteogenic effects of CC stimulation
(Table S5), but one of these reported increased metabolic activity for hBM-MSCs after 5
days (3 h/day) of exposure to an EF strength of 0.1 V/cm using degenerate waves [71].
Studies on primary cell cultures were also conducted using distinct stimuli
characteristics (Table S6). The application of two EFs with quite different strengths,
1×10−7 V/cm and 60 V/cm, at the same frequency (16 Hz), resulted in similar increases
in DNA synthesis (+30%) and cell number (+10 to 30%) after 18 h and 7 days of field
exposure, respectively [55,83]. Frequency and EF strength may induce nonlinear behaviors
on cellular proliferation. On one hand, using very low EF strength (1×10−7 V/cm),
Fitzsimmons et al. [83] observed no increase in DNA synthesis at frequencies immediately
below (8, 12 Hz) or above (20, 24 Hz) the proliferative 16 Hz value (+30% in this value)
in primary cells; these authors observed a similar behavior in osteoblast-like cells (around
the 14 Hz proliferative frequency). On the other hand, using a low frequency (3 Hz),
Binderman et al. [79, 84, 85] reported increases in DNA synthesis (+40 and +240%) for
EF strengths below (13 V/cm) and above (54 V/cm) an intermediate non-proliferative EF
strength (22-24 V/cm).
In synthesis, proliferative effects (+17 to 240% of proliferation) were observed
throughout a wide range of EF strengths (from 1×10−7 to 210 V/cm), with an incidence in
values in the tens of V/cm (Fig. 4). For setups with EFs in this range, a few trends could
be inferred: 1) more EF strength generally resulted in increased proliferative outcome,
although this behavior may not be linear [79, 84, 85]; 2) at a given EF strength and
frequency, more exposure time to the stimulus might induce more cellular proliferation
[78,79,82]. Noteworthy, when using extremely low EF strengths (1×10−7 V/cm; sinusoidal
wave), very narrow and cell-type specific intervals of successful proliferative frequencies
occurred [80, 83]. Regarding frequency, proliferative effects were observed at low (tens to
hundreds) and high (in the thousands) frequencies. High frequencies were usually used with
lower EF strengths (and exposure periods) and vice-versa. Since the number of studies
using ccEF stimulation is relatively low (13) to infer more general trends on the effects
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of these parameters on cells proliferation, more systematic approaches that independently
vary each of the stimuli parameters (such as the waveform, frequency and EF strength)
are needed.
Matrix maturation and mineralization
Regarding cell lines and stem cells, only two studies using CC stimulators (one for each
cell model) evaluated osteoblastic differentiation and matrix mineralization. Increases in
various osteogenic differentiation markers, and a 480% increase in matrix mineralization,
were observed in human SaOS-2 immortalized cells after 28 h of field exposure (0.1 V/cm,
16 Hz, 4 h/day) (Table S4) [58]. Osteocalcin expression increased in hBM-MSCs after 14
days of culture on a hydrogel when these cells underwent 6 h/day exposure to a ccEMF at
10 Hz (Table S5) [86]. In primary cultures, only three studies evaluated matrix maturation
and mineralization. ALP activity, several differentiation markers and osteocalcin levels
increased in bovine primary cells exposed for 18 days to a EF strength of 60 V/cm at 16
Hz (Table S6) [55]. The same researchers have later reported that this stimulus settings
(or altering the EF strength to 210 V/cm) also increased the matrix calcium content and
the number of nodules and mineral spherules, typical of the in vivo onset of mineralization
[61].
In summary, very few studies have monitored and reported positive effects of CC
stimulation on bone cells differentiation or mineralization (Fig. 4). These studies generally
exhibited a wide disparity of settings, and sometimes not all the information was available.
In these, frequency varied from 10 to 100 Hz, and EF strength from 0.1 to 210 V/cm.
Time of daily exposure also varied, although cells were usually stimulated over two or three
weeks in culture. Therefore, a very small amount of information is available, and it urges
to perform more systematic studies on CC stimulation effects on osteogenic differentiation
and mineralization.
2.3. Inductive coupling
2.3.1. Design of IC stimulation systems
The inductive coupling systems refer to all stimulators designed either as coil(s), formed
by winding conductive wire, or as permanent magnet(s). Usually, they are not in ohmic
contact with the cell culture medium (Fig. 5). While only magnetostatic interactions
stimulate cells when using permanent magnet(s), coil(s) can promote cell stimulation either
by magnetic or electromagnetic fields (icEMFs), because time-dependent magnetic fields
induce nonconservative EFs in the coils. Besides, ion translocations can also take part in
this process. The main stimuli waveforms applied to bone cells in the studies here presented
were pulsed electromagnetic fields (PEMF) [87, 88] and combined electromagnetic fields
(CMF) [89].
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2.3.2. Cellular responses to IC stimulation
Osteogenic effects were observed when applying sinusoidal, square, triangular and
sawtooth IC stimuli waveforms, mostly PEMF but also CMF, to the three cell model
types (Fig. 6, supplementary Tables S7-S9).
Proliferation
The IC stimulation has been the mostly used method to stimulate bone cells,
and increased DNA synthesis is reported in approximately half of the studies using
osteoblast-like cell lines (Table S7). Using CMF stimuli, some authors observed 58-71%
increases in DNA synthesis in TE-85 cells [89, 90]. Increasing PEMF field exposure
duration, from 30 min to 9 h and 24 h, promoted larger increases in DNA synthesis:
+276%, 284% and 355%, respectively [91]. As usual, some authors also reported decreased
cell number (up to -48%) and protein synthesis (up to -17%) in rat and human osteosarcoma
cell lines exposed to PEMFs [87,92–94].
Regarding stem cells (Table S8), increases in DNA synthesis, cell number and metabolic
activity were observed in hBM-MSCs exposed to PEMFs for different stimuli parameters.
Various studies using 4.4 kHz and 1.6 or 1.8 mT are included [71, 95, 96], but one other
study using a very similar PEMF stimulus presented a decrease in cell number [88,97]. The
confluent state of the cells in this later, in opposition to the pre-confluent state in most of
the former studies, may be a key factor promoting on these differences (see section 3.5).
Fig. 5: Experimental setup for inductive coupled stimulation systems. Magnetic fields are
generated by electric currents flowing through one or more wire coils. Electric fields also stimulate the
cultures placed aligned with the axis of the coil(s) when time-varying magnetic fields are generated.
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Proliferative results in stem cells were quite diverse, with 50% of the icEMFs studies in
stem cells resulting in positive effects (using low and high frequencies and EF strengths),
33% in no alteration, and around 16% in negative effects.
Most studies involving primary cultures reported increases in proliferation (Table S9).
For example, osteoblasts from rat calvaria increased their metabolic activity and cell
number when exposed for 3 days to icEMFs of lower MF strengths (and generally low
frequencies) [59, 98–100]. Using very low MF strengths, increased DNA synthesis (+26%)
was observed in human bone cells after 30 min of CMF stimulation and a subsequent 18 h
rest period [90], and an increase in their cell number (+29%) was reported upon 7 days of
exposure to PEMFs [101].
With respect to the EF/MF field strengths, frequency and time of exposure to the
stimulus, some major conclusions can be drawn (Fig. 6). Proliferative effects (up to
+355% [91]) were mainly observed for MF strengths lower than 4 mT, using frequencies
either low (up to 222 Hz) or high (4-7 kHz). Both short (30 min/day) and long (24 h/day)
exposure time increased cell proliferation [53,89,90,101,102], but for some icEMFs settings,
proliferation may increase as the exposure time increases [91]. Importantly, variations in
the PEMF proliferative effects may derive not only from the PEMF characteristics but
also from biological factors, such as the percentage of serum in the medium, cell density,
cell type and differentiation stage [103]. Further, the time when the biological outcome is
measured is also important, since decreased proliferation at later stages seems necessary
for PEMF-induced osteodifferentiation of primary and stem cells [103,104].
Matrix maturation
Most studies using IC stimulation reported increases in ALP activity and/or expression
for all cell types tested. For example, PEMFs enhanced ALP activity of human and rat
osteosarcoma cell lines by 21% to 108% (Table S7) [87,92–94,105,106]. 108% increase was
observed in the rat osteosarcoma cell line ROS 17/2.8 after 3 days of 24 h/day icEMF
exposure (30 Hz, 1.8 mT, 6 µV/cm) [94]. ALP activity of the osteocyte-like cell line
MYLO-Y4 also increased (200%) after 1 day of 8 h exposure to PEMF of 1.6 mT at
4.4 kHz [107]. A 1.6 fold increase was reported for collagen type I expression in human
osteosarcoma MG63 cells exposed to PEMFs for 4 days (8 h/day, 4.4 kHz, 1.8 mT) [92].
An increase in ALP activity was observed in hBM-MSCs exposed to different MFs (0.13
to 1000 mT) (Table S8) [88,96,97,103]. Importantly, data from Jansen et al. [104] suggest
that the strongest effect of PEMF on hBM-MSCs differentiation is exerted in the period
prior to mineralization. Using very similar experimental setups, Sun et al. [95] (MF of
1.8 mT at 4.4 kHz; 8 h/day) did not observe increased hBM-MSCs differentiation upon 24
days, but Schwartz et al. [97] (1.6 mT, 4.4 kHz; 8 h/day) did (increased ALP and OC).
The fact that in the former study cells were only exposed to the stimulus in the first 3 days
(contrasting to the all 24 days in the later) might explain this difference, together with
the addition of the growth factor BMP-2 to the media in this later (discussed in section
4.2). In hASCs, osteogenesis-related genes and ALP were up-regulated by a 1.0 mT MF
strength at both 30 and 45 Hz [104]. Noteworthy, some genes were more up-regulated at 30
Hz (Col-I, RUNX2), whereas the 45 Hz frequency was more effective for others (OSX and
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OC) [103]. Most interestingly, systematic approaches testing for intervals of frequencies
or strength values revealed ’pyramid-like’ responses of osteogenic markers. By exposing
hBM-MSCs cells to a MF strength of 1.1 mT at frequencies ranging from 5 to 150 Hz,
Luo et al. (2012) [108] unraveled a symmetric behavior in the cells’ osteogenic response
(ALP activity, OC levels). In this, the 50 Hz value corresponded to the symmetry axis,
presenting the maximum osteogenic response, and frequencies above or below it induced
lower osteogenic effects. Kang et al. [103] observed this same behavior when assessing
ALP expression and activity in hASCs, upon application of a MF strength of 1.0 mT at
frequencies in the 7.5-75 Hz range. This group also observed that ALP expression also
followed a pyramid-like curve in response to a narrow interval of MF strengths (from 0.1
to 3.0 mT). Although significantly increased over control levels from 0.8 to 3.0 mT, ALP
expression levels increased until 1.0/2.0 mT [when using supplemented e non-suplemented
medium (NSM), respectively], the MF strengths with the highest/optimal ALP responses,
and decreased thereafter [103]. Later on (2014) it has also demonstrated that osteoclast
formation, differentiation, and activity are regulated by frequency in an opposite manner
to osteoblasts [109]. While stimulation at 7.5 Hz decreased osteoblastic differentiation, it
induced osteoclastic differentiation and activity; the 45 Hz frequency, previously reported
as positive for osteoblastic differentiation, was observed to inhibit osteoclast formation
[103,109].
Regarding primary cultures, ALP activity also increased in primary human osteoblasts
after 10 days of exposure to PEMF (14.9 Hz, 0.4 mT; Table S9) [101]. Collagen type I
expression was found considerably increased (+370%) in other primary human osteoblasts
exposed to PEMF for 21 days to similar frequency conditions (20 Hz, 6 mT, 0.113 mV/cm;
Table S9) [110]. Up to date, the previously reported ’pyramid-response’ was observed on
stem cell and primary cultures, and was found along the MF strength and frequency axes.
Zhou et al. [111] observed that ALP activity behaved like a wave in response to increasing
MF strengths, presenting two maximum values at 1.8 and 3.6 mT.
Summarizing, positive differentiation effects (up to 540% [110]) were mainly achieved
with MFs higher than 0.13 mT, at frequencies either low (up to 200 Hz) or high (1-6.7 kHz)
(Fig. 6). Noticeably, most studies used more than 8 h/day of stimulus and, for a given MF
strength and frequency, exposure times higher than 4 h/day and throughout several days
may induce more cell differentiation [106]. Higher differentiation levels were found with
1.3-7 mT MF strengths [53,87] at frequencies lower than 75 Hz [93,105] (or 4-6.7 kHz for cell
lines). Primary cells presented enhanced differentiation with MF strengths belonging to a
wider interval (0.4-160 mT) and again at low and high frequencies [98, 100, 101, 110, 112].
For stem cells, differentiating effects were found at very different conditions in terms of MF
strengths and frequencies [88,96,97,113]. Importantly, in these and in primary bone cells,
the amplitude of the osteogenic effects may vary in pyramid- or even wave-like manners (as
consecutive pyramid-like behaviours) around key MF strengths or frequency values that
render high responses [103, 108]. In this way, as the MF strength or frequency linerary
increases, the maturation response is not linear, but behaves like a wave, with periodic
maximum responses occurring at key MF strengths or frequency values. These type of
characteristics should be further explored using systematic approaches even in other cell
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models. Also and related, there are various gaps in the range of stimuli setups tested so
far, namely in the 7-150 mT and 200-990 mT ranges, and in the 250-950 Hz and 1.05-3.5
kHz ranges.
Matrix mineralization
The effects on matrix mineralization may depend on the stage of maturation at which
the icEMF is applied, as suggested by Diniz et al. [53]. An increase in matrix mineralization
(51%) was observed in MC3T3-E1 cells when a PEMF stimulus (6.67 kHz, 7 mT) was
applied to early culture stages (1-15 days) (Table S7) [53]. Up regulation of osteocalcin
expression (up to 260%) was found for low MF strengths (<2.3 mT) at low and high
frequencies (75 Hz; 4.4 kHz) when the stimuli was also applied in the early culture stages
(Table S7) [92, 105]. Matrix mineralization also increased in a hBM-MSC culture at the
28th day, after a period of 15 days of PEMF stimulation (2 h/day, 7.5 Hz, 0.13 mT,
2 mV/cm) (Table S8) [88]. These cells showed increased osteocalcin expression and/or
matrix mineralization in response to icEMFs of a wide range of strengths (0.13 mT to
1 T) and at a wide frequency spectrum (5 to 4.4 kHz) [88, 96, 97, 103, 114] (Table S8).
Stimulating hASCs with a MF of 1.0 mT/30-45 Hz, Kang et al. [103] observed increased
mineralization and calcium content, either in normal growth media or in OM, although
always at higher amplitudes in OM conditions.
Likewise, rat calvarial osteoblastic cells presented increased matrix mineralization (c.a.
+50%) either upon magnetostatic (160 mT) or PEMF stimuli (1.8 mT; Table S9) [112,115].
icEMFs of low MF strengths (up to 4.5 mT), at a wide frequency spectrum (from 50 to 4444
Hz), were able to enhance osteocalcin expression and/or matrix mineralization in these cells
[100, 111, 115] (Table S9). A ’wave-like’ effect was also found for matrix mineralization in
response to a MF strength 0.9-4.8 mT interval and, as before for matrix maturation, the
maximum values occurred at 1.8 and 3.6 mT [111].
From the surveyed studies, the most significant mineralization effects were found for MF
strengths in the 1.8-7.0 mT and frequencies in the 4.4-6.7 kHz ranges [53,92,115]. Higher
mineralization levels in primary cells were found within a wider MF strength range (1.8-160
mT) at low (up to 20 Hz [110,112]) or high (3.8-4.4 kHz [100,115]) frequencies. Stem cells
enhanced mineralization at two very different MF strengths (1 T or lower than 1.8 mT),
and at frequencies of various orders of magnitude [88,96,97,113]. Importantly, osteoblastic
mineralization may also occur in a wave-like manner in response to MFs [111], what should
be further experimentally explored. Also, at a given MF strength and frequency, a period
of exposure higher than 4 h/day (for at least 3 days) may induce more cell mineralization
[53, 92, 100, 105, 106, 110, 113]. Finally, to apply the stimulus at an early stage of culture
appears to be a positive factor, but not sufficient, since other IC-related studies did not
report matrix mineralization effects, though the stimuli were also applied in the early stages
[59,95].
As general conclusions from the studies using IC stimulation, Fig. 6 shows that
frequencies up to 6.7 kHz and MF strengths up to 1 T can induce cell proliferation,
matrix differentiation and/or mineralization in osteoblast-like cell lines and stem cells,
respectively. However, most stimulations with positive osteogenic effects were carried out
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for MF strengths lower than 7 mT. Further, much higher frequencies (up 1 GHz) can
also promote positive effects on specific maturation stages, but are less explored. Also
to highlight that no effects (or even negative ones) may also occur with similar stimuli if
some of the stimulation parameters are altered [53, 88, 99]. Particular interesting is the
data from stem and primary cells differentiation studies where nonlinear responses also
occur. In these, particular frequencies and MF strengths can be highly osteogenic, while
frequencies and MF strengths close to these maximum values loose part of the osteogenic
effect, according to a pyramid-like, or even wave-like behaviors [103, 108, 111]. Therefore,
all the experimental design must be carefully stipulated, and the stimulus settings subject
to optimization, specially in what concerns these type of behaviors.
3. Factors that influence the electrical stimulation
outcome
As observed above, there is great variation regarding the biological outcomes obtained
when applying different electric and/or magnetic stimuli to bone cells, and several factors
must be considered to compare the findings and define effective stimulation parameters.
The stimulus’s characteristics can strongly influence the biological outcome, including the
stimulation method, the stimulus’s frequency, the EF/MF strengths, and the duration
of field exposure. The biological setup must also be considered, with main factors
including: the cell model, the cellular density, the serum concentration, and the presence
of osteoinductive factors in the cell culture media.
3.1. Stimulation method
The stimulation method (DC, CC, IC) may induce different osteogenic responses for
similar frequency, EF strength, exposure time, etc. due to their dissimilar apparatuses,
which result in distinct field strength distributions. Besides, these methods have specific
advantages and disadvantages that must be taken into account. Due to their effects
on cell migration, dcEFs have been proposed as an effective mechanism to recruit bone
marrow MSCs to the sites of injury, encouraging the use of dcEFs in vivo to guide MSCs
migration in bone regeneration therapies [70]. Nevertheless, there are some proposed
drawbacks of applying EFs directly to cells, including the generation of electro-chemical
products that contribute to increase both the number of reactive oxygen species (hydrogen
peroxide, hydroxyl and oxygen ions, free radicals, etc. [116]) and the pH, which can
raise the resistance to the current flow at the electrodes’ surfaces [78]. Conversely,
other authors proposed that these products – often referred to as faradic products –
contribute to the dcEF-induced bone remodeling effects. It was hypothesized that hydrogen
peroxide-stimulated osteoclastic resorption releases calcium into the medium, potentially
priming the surface for increased pH-stimulated osteoblasts to lay down new bone [64].
Capacitive coupled stimulation is suitable for delivering EFs to cultured cells, and
promote osteoblastic maturation in vitro. Nevertheless, as the distance between electrodes
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increases, the electrodes must be supplied with higher voltages, what can result in an
unsafe in vivo stimulus. This can be problematic since in the existing CC stimulators
for extracorporeal therapies the electrodes must be accommodated to the human bodys
limbs. However, this may be circumvented by housing electrodes inside implants, such that
they can be used to deliver intracorporeal therapies [117, 118]. New solutions for the in
vivo use of CC systems will certainly boost the scarce research on its effects on osteogenic
differentiation.
IC stimulation has been used in clinical practice since 1979 [119]. Nevertheless it
may also endanger the patients’ tissues in extracorporeal therapies, since the EMF is
dependent on the distance between the coil(s) and the cells/tissues. Furthermore, potential
uncontrolled cell proliferation on target and adjacent tissues may occur when inappropriate
stimuli are applied in vivo [96]. This method is being proposed in new electroinduction
systems that operate inside orthopedic implants and require much lower EMFs [117].
3.2. Frequency of the stimulus
It has been postulated that the most effective PEMF frequency should be similar
to that associated with normal body action frequencies. Bone physiological frequencies
range between 1-2 Hz during locomotion and 15-20 Hz during the maintenance of posture
[120]; upon injury, generated extracellular currents are in the range of mHz [93]. In vitro,
osteogenic effects can be obtained by using electric and/or magnetic fields at either low
frequencies (most up to 60-75 Hz), that simulate in vivo frequencies, or at much higher,
namely up to 60 kHz. Moreover, the frequency at which the most significant effects are
achieved varies between cell types, stimulation method and EF and/or MF strengths.
Up to date, studies using DC stimulation induced proliferation, matrix maturation and
mineralization for frequencies up to 100 Hz (Fig. 2). Nevertheless, the higher frequencies
already evaluated (3 and 60 kHz) also enhanced proliferation and matrix maturation.
Most studies using CC stimulation reported osteogenic effects for frequencies lower than
100 Hz, mostly bellow 20 Hz, with the exception of a tested 60 kHz frequency that induced
proliferation. Some CC studies proposed a frequency-dependent effect on osteoblast-like
cells proliferation. However, the frequency at which the most significant osteogenic effects
are achieved varies in a cell-dependent manner [80, 83] (Fig. 4). Importantly, the small
amount of studies available does not allow to infer trends for the frequencies used in DC
and CC stimulation (Tables S1-S6 and Fig. 2 and 4), and systematic approaches on stimuli
parameters, such as frequency, are mandatory.
Using the IC method, osteogenic effects can be found with frequencies from 7.5 Hz
to 1 GHz. Nevertheless, most IC stimuli enhancing proliferation, differentiation and
mineralization used low frequencies in the 7.5-75 Hz range, or high frequencies around
5 kHz. It was proposed that low-frequency PEMF stimulation (30-75 Hz) acts as
an external regulatory signal, inducing both osteoblast-like cells proliferation [94] and
the overexpression of proliferation markers, such as c-myc and c-fos [121]. Regarding
osteoblastic maturation, some authors suggest that low frequency stimuli are only able to
induce differentiation when using osteoinductive factors [97, 115]. Nevertheless, there are
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reports on increased differentiation in the absence of osteoinductive cofactors [87, 92–94,
105,106], although in the absence of OM the frequency values may need to increase (shift
right) in order for the same osteogenic effect to be obtained [103]. On the other hand,
high-frequency PEMF stimulation (≈1 kHz) can increase osteoblastic differentiation (ALP
activity; osteocalcin and osteopontin expression; matrix mineralization) without the aid
of additional co-stimulants or osteogenic media [113]. In two studies that systematically
evaluated the effects of PEMF stimulation varying frequencies on stem cells’ osteogenic
differentiation, low frequency intervals from 5 to 150 Hz [108] and 7.5 to 75 Hz [103] were
tested. In both, as the frequency initially increased, the inductive effect on differentiation
also increased (from 5 to 50 Hz using hBM-MSCs [108], and from 7.5 to 30/45 Hz using
ASCs [103]). However, from 50 to 150 Hz [108] and from 30/45 to 75 Hz [103], as the
frequency increased, the inductive differentiation effect decreased. In the later study, the
7.5 Hz frequency was even inhibitory to hASCs osteogenic differentiation [103]. Due to
this ’pyramid-like’ behavior, optimal frequencies for in vitro induction of human MSCs
bone differentiation must be carefully selected, as slight variations might greatly affect
the osteodifferentiation outcome. Moreover, optimal frequency values also depend on the
stipulated MF strengths [103], and repeated ’pyramid-like’ behaviors, resulting in wave-like
osteogenic response curves, may also exist as for the MF strength axis [111].
3.3. Electric and magnetic field strength of the stimulus
From the cellular level, weak EFs are preferred over strong ones as they more closely
resemble the endogenously produced EFs in bone tissues (1-10 µV/cm during normal
activity [94, 122]), and are able to induce beneficial responses without damaging the cells.
Noteworthy, none of the studies here included, using EF strengths from 1×10−7 to hundreds
of V/cm, reported any damage for the cells or cell death.
The EFs strengths with reported osteogenic effects ranged from 1×10−7 to 210 V/cm.
Both these lowest and highest EF strengths were found using the CC method. However,
the very low 1×10−7 V/cm EF strengths were only proliferative at specific (and cell-type
dependent) frequency values, corresponding to intermediate frequencies around which no
other frequency was osteogenic. Further, half of the CC studies applied EF strengths
ranging from 13 to 60 V/cm, more similar to the DC stimuli values applied in these studies,
which ranged from 0.015 to 14 V/cm (Tables S4-S6, Fig. 2 and 4). The proliferative output
generally increased, although sometimes nonlinearly, with the EF strength when using
ccEFs ranging from 0.02 to 60 V/cm. This increase is more consistent if no other stimulus
characteristics are altered. Additionally, at a given EF strength and frequency, increasing
the stimulus duration may result in an augmented cellular proliferation. Nevertheless,
more systematic studies are needed to confirm any of these trends, and no trend could be
depicted for osteoblastic differentiation, with differentiating EFs strengths varying from
low (0.02, 0.1 V/cm) to high (60, 210 V/cm).
Most of the MF strengths delivered by IC stimulation were lower than 3 mT. Although
no explanation was found in the literature, it may involve protection of cells from damage
when using stronger MFs. The icMF strengths that induced proliferative effects were
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mainly lower than 2.3 mT, and in the 0.1-1.8 mT range for stem and 0.05-1.5 mT for
primary cells. Similarly, positive differentiation and mineralization responses were obtained
with MF strengths within the 0.13-7.0 mT range. However, it is important to highlight
that no studies were found using MF strengths in the 7-150 mT and the 200-990 mT
intervals. Various studies using IC stimulation observed that not only the time of exposure
to the stimulus could influence the outcome, but also the period at which the stimulus
was delivered [53, 87, 88, 91, 94, 98, 100, 123]. Further, two systematic studies, one on
adipose-derived MSCs and other in primary osteoblasts, revealed that at a given frequency
the osteogenic response to a linear variation of the EF strength may be non-linear, as above
for the frequency variation. The osteogenic response may in fact occur in a symmetric
’pyramid-like’ curve, alone or repeated along the EF strength axis, as in a wave-like curve,
what again demonstrates the need for systematic approaches of this parameter in each
experimental setup [103,111].
3.4. Cell model
A number of factors, such as developmental stage, species, skeletal site of origin, state
of differentiation, and phenotype (as non-transformed versus transformed), may contribute
to variations in the osteogenic response to the electric and/or magnetic stimulation. These
factors are suggested to influence the cell membrane composition or surface charge density,
altering the interaction between the biological system and the applied EFs and/or MFs
[80]. The selection of the appropriate and most relevant in vitro osteoblast model for
studying the effect of electrical and/or magnetic stimulation in bone is thus of utmost
importance. Various cell culture models have been employed, including primary cells from
different species, mesenchymal and other stem cells, and immortalized cell lines. Each cell
model presents advantages and disadvantages that need to be considered before performing
the biological assays and upon evaluation of the stimulation outcome.
Human osteosarcoma cell lines (SaOS-2, MG63, TE-85) are easily available, do not
require time consuming isolation or ethical approval, and provide reliable reproducibility
[124]. However, these transformed cell lines present unrepressed replicative activity and
fail to display the normal coupling of growth arrest and differentiation [125]. Several
studies have been performed using these cell lines to study migration [65, 69], as well as
the three stages of osteoblast maturation [58,80,87,89–92,105,106,121,126]. Even though
they are not considered good models to study osteoblast differentiation, there are also
reports of increased ALP activity and matrix mineralization upon CC and IC stimulation
of SaOS-2 and MG63 cell lines [58,87,92,105,106]. MC3T3-E1 is a non-transformed cell line
derived from newborn murine calvariae, which has been reported to display osteoblast-like
characteristics after repeated culturing passages. It therefore provides an useful model to
study the transition between proliferation and differentiation, the molecular mechanism of
osteoblastic maturation, and the formation of bone-like extracellular matrix [125]. These
cells are frequently used as models to study proliferation upon CC stimulation [79,81,82],
and proliferation and differentiation upon IC stimulation [53,98,102].
Human mesenchymal stromal/stem cells have stem cell-like characteristics, including
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self- renewal, and are able to differentiate into bone, cartilage, fat and skeletal tissues [52].
MSCs can be derived from a variety of different sources, including bone marrow (BM),
adipose tissue and peripheral blood. hBM-MSCs are found in the stromal compartment of
bone marrow and play a vital role in the process of bone regeneration [71]. Since these cells
are recruited to the fracture site to proliferate and differentiate into osteoblasts, they are
good models to study the effectiveness of electrical and/or magnetic stimulation in bone
regeneration. While DC stimulation experiments have studied hMSCs migratory responses
[70, 71], CC and IC stimulation have focused on their proliferation and osteoblastic
differentiation under osteogenic media [52, 71, 75, 86, 88, 95–97, 103, 104, 108, 123]. It has
been suggested that hMSCs migratory responses are more pronounced than in primary
osteoblasts, as they present stiff actin fibers that are more susceptible to external EFs [62].
The magnitude of the osteogenic response of human MSCs to an EF/MF stimulus
also depends on the origin of the cells. Following an IC stimulus of 2 mT and 75 Hz
for 21 days (in OM), bone-marrow derived MSCs responded significantly better than
adipose-derived MSCs (ASCs) in terms of proliferation, osteogenic differentiation and
matrix mineralization. These were analyzed using an extensive battery of osteogenic
markers [123]. The authors proposed that, although ASCs and BM-MSCs share many
biological characteristics, there are some differences in their differentiation potential,
transcriptome, proteome, and immunomodulatory activity that result in differential
efficiency in the PEMF to induce MSCs commitment into osteoblasts, higher for BM-MSCs
[123]. Nevertheless, ASCs and BM-MSCs osteodifferentiation, follow similar patterns, such
as the pyramid-like responses, in which the highest observed osteogenic responses were
observed at frequencies in the 30-45 Hz range for hASCs [103] and 50 Hz for hB-MSCs
[108].
Primary cells reflect the in vivo niche and have therefore more preclinical applicability
[124]. As with the other cell types, significant osteogenic responses were achieved by
stimulating primary bone cells with DC, CC and IC stimulation (Tables S3, S6, S9).
However, some drawbacks exist regarding the use of primary osteoblast cultures. Firstly,
differences between species complicate the extrapolation to human clinical disease and
treatment outcomes [124]. Secondly, the presence of various cell populations (fibroblasts,
chondroblasts, and osteoblasts) in isolated calvarial and primary cell cultures, limits the
interpretation of the results [125]. Finally, subcultivation of primary cultures may result
in loss of osteoblast specific characteristics [125].
3.5. Cell density and maturation stages
The state of cell confluence (density) upon stimulation influences cell-environment and
cell-cell communication and, consequently, the cellular response to the stimuli [94]. The
growth of adherent cultured cells, such as osteoblast-like cells and stem cells, comprises
various stages, including: a ’lag’ phase of cell adaptation to the culture conditions; a
’logarithmic (log) growth’ phase of active proliferation and exponential increase in cell
density; and a ’plateau’ phase, when cellular proliferation slows down due to the occupation
of all the available space (’confluent cells’). The duration of both ’lag’ and ’log’ phases
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greatly depends on the initial cell seeding density. Enhanced proliferation is expected to
occur when cells are stimulated in the ’log growth’ phase, i.e., when the stimuli is applied
in non-confluent cultures [53, 55, 59, 63, 76, 79, 80, 89–91]. This general rule may not apply
to some osteoblastic cell lines, which partially lose the contact-contact inhibition feature
that impedes growth when confluence is reached. Consequently, increases in these cells’
proliferation can be observed in two days post-confluent cultures [81, 82]. Additionally,
decreased proliferation rates were observed even when electrical stimulation was applied
to non-confluent cultures [87, 88,93].
McLeod and colleagues [94] have reported that bone cell function is modulated by EFs in
a cell density-dependent manner: no effect on cell activity was observed for sparse cultures
(lower than 50×103 cells.cm−2), whereas denser cultures (in the 50-350×103 cells.cm−2
range) had decreased proliferation (25%) and doubled ALP activity. Nevertheless,
up-regulation of ALP activity disappeared in more highly confluent cultures. Alterations
in the internal biological and physical states were advanced as two possible interpretations
for this cell density-dependency [94]. As regards the cells physical state, gap junctional
coupling between cells (i.e. increased cell-cell communication with increasing cell density)
alters the magnitude of the cellular responses to extracellular EFs [93,107]. Gap junctional
coupling provides electrical continuity within networks of cells, allowing ions to pass from
cell to cell via their channels [93]. Another possible justification is the influence of shape and
size of individual cells in the overall population, as they may affect the EFs distribution
around the cells, as well as the amount of the charged cell surface exposed to the field
[75, 94]. In low-density cultures, cells are only sparsely distributed over the bottom of the
culture dish, and leave some areas in direct contact with the highly conductive culture
medium. As cell density increases towards maximum confluence, the cellular population
generates a compact layer of high electrical resistance, stimulating the growth of the organic
extracellular matrix; this matrix further enhances resistivity, and hence the osteogenic
efficiency of the electric stimulation [55]. Another study, conducted by Kaivosoja and
colleagues [126], points to the importance of low density cultures to induce differentiation,
as spreading of adherent cells exerts tension in actin cytoskeleton, which might induce
osteogenesis.
The differentiation stage at which cells are stimulated is also important on the effect
of PEMF stimulation on gene expression and mineralization [114]. Following an initial
up-regulation period, Jansen et al. [104] observed a down-regulation of osteogenic gene
markers in BMSCs exposed to PEMF stimulation, suggesting that the strongest effect on
differentiation is exerted in the period prior to mineralization. Due to the lack of studies in
this scope, it would be very interesting to perform studies aiming to identify correlation(s)
between the period at which the stimulus is applied and its osteodifferentiating abilities.
3.6. Serum concentration and osteoinductive factors
Together with cell density, the presence of serum and osteoinductive factors in the cell
culture media can also greatly affect the osteogenic response. Serum consists of a mixture
of hundreds of proteins, including several factors needed for the proliferation of various
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cells in culture [127]. Its inclusion in the culture media can hence influence the effects
of electrical and/or magnetic stimulation. The presence of serum in the culture media is
suggested to reverse cell migration and actin distribution in response to a DC stimulus of
2 V/cm EF strength [62]. The enhancement of bone cell proliferation in response to EF
stimulation is often associated with low concentrations (lower than 0.2%) or serum-free
culture media, since low serum concentration decreases the cells’ basal growth rate [63,83,
128]. Accordingly, high serum concentrations may inhibit EF effects after longer exposures
to this type of stimulus [94]. However, short periods (30 min) of PEMF exposure are able
to stimulate the proliferation of human osteosarcoma cell lines (TE-85 and MG63) grown
in normal 10% serum-containing media [91]. Hence, the influence of serum concentration
in the outcome of electrical and magnetic stimulation depends on the duration of the
experiment and on the ability of each cell type to grow under serum-free conditions.
Several biochemical compounds, such as ascorbic acid, β-gylcerophosphate,
dexamethasone and bone morphogenetic protein 2 (BMP-2) can be added to the culture
medium and act as pro-osteogenic cofactors to stimulate bone cell function [52, 66,
77]. Consequently, when cultures are maintained in differentiation (or osteoinductive)
media, containing osteogenic factors, better differentiation outputs are obtained though
proliferation might be impaired or delayed [52]. For example, either IC stimulation or
OM alone are able to induce hASCs matrix maturation and mineralization, but the
simultaneously treatment of cells with both results in a synergistic effect [103]. The
presence of OM can greatly increase the regulatory effect of IC stimulation on osteogenic
genes (COL-I, RUNX2, OSX and OC), an effect reproduced by adding growth factors such
as BMP-2 [97,103]. Further, in this study the presence of OM decreased the MF strength
and frequency that induced the highest osteogenic responses, from around 2.0 mT at 45
Hz (NSM conditions) to 1.0 mT at 30 Hz (OM conditions) [103].
4. Transduction of electrical signals inside bone cells
The identification of the mechanisms that mediate EF- and/or MF-induced cellular
responses would greatly facilitate the selection of the appropriate stimulation parameters,
such as strength, frequency and exposure duration [62]. Several molecular mechanisms
have been proposed, but there is still much uncertainty. DC stimulation delivering EFs at
low frequency are likely to initiate molecular signaling pathways at the cell surface, as these
are unable to penetrate into the cell due to the high resistivity of the cell membrane, with
a conductivity ≈1×106-1×108 times smaller to the cytoplasm one [62]. Some authors have
thus explored the effects of EFs in primary messengers, such as growth factors’ metabolism,
while others have focused on studying second messengers and effectors. The regulation of
intracellular calcium levels is possibly a key cellular event involved in the transduction of
electric and/or magnetic stimuli, but heat shock proteins are also emerging as potential
key factors mediating stimulatory cellular effects.
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4.1. Calcium as a second messenger of osteogenic effects induced
by electromagnetic fields
Calcium acts as a second messenger in many biochemical signal-transduction pathways,
and appears to mediate cell responses to EFs and/or MFs. Strong dcEFs (higher than 10
V/cm) may cause membrane depolarization in osteoblasts and activate voltage-gated Ca2+
channels (VGCCs), which in turn induce rapid Ca2+ influxes across the membrane [69,72].
However, the application of smaller EFs is not expected to cause VGCC activation in the
plasma membrane. Accordingly, VGCCs inhibition with Verapamil or CdCl2 blocks the
immediate increase of intracellular calcium levels that follows the application of a strong
EF strengths (10 V/cm), but fails to prevent the induction of intracellular calcium levels
by an EF strength of 2 V/cm [69,72].
Other mechanisms have been put forward to explain the changes in calcium levels upon
stimulation with weaker EFs, including stimulation of stretch-activated cation channels
(SACCs) and cell surface receptors coupled to phospholipase C (PLC) [72]. SACCs are
non-specific channels that can detect and transduce mechanical forces into biochemical
signals (influx of extracellular calcium) and therefore modulate cell locomotion [72, 129].
Electric stimuli may activate SACC by altering cellular mechanisms that induce SACC
redistribution and clustering (i.e., electroosmosis) [72]. However, the treatment of human
osteoblasts with a SACC’s blocker (Gd3+) partially inhibited EF-induced intracellular
calcium concentration ([Ca2+]i), suggesting the involvement of other mechanisms [72].
PLC selective inhibition prevents [Ca2+]i induction by applying a 2 V/cm EF, suggesting
that an electric stimulation induces conformational transitions on specific PLC-coupled
receptors [72, 74]. PLC consequent activation leads to the formation of membrane
diacylglycerol (DAG), which stimulates PKC and soluble inositol trisphosphate IP3. The
latter diffuses rapidly in the cytosol and binds to its receptors (e.g. in the endoplasmic
reticulum), stimulating Ca2+ release from internal stores [72, 130]. Therefore, Khatib et
al. [72] proposed a model in which dcEF-induced intracellular calcium are mediated by
extracellular Ca2+ influx via mechanically operated SACCs, and by PLC-dependent Ca2+
release from internal stores.
Less is discussed regarding the involvement of calcium in the effects of CC and IC
stimulation. However, Brighton and colleagues [82] suggest that the initial transduction of
CC and IC stimuli is different. While the signal transduction of CC stimuli occurs at the
bone cell membrane through VGCCs, the EMFs applied by IC stimulation pass through
the bone cell membrane and generate an EF within the cytosol, which in turn induces the
release of Ca2+ from internal stores [82].
Effects of Ca2+ on cytoskeleton dynamics and migration
As described before, EFs generated by DC stimulation induce cell orientation and
migration in a calcium-dependent manner (Tables S1-S3). Alterations in cytoskeleton and
membrane dynamics, resultant from increased [Ca2+ ]i and decreased ATP levels, are put
forward to explain the regulation of cell mechanics in response to electric stimulation [62].
After cells exposure to a 2 V/cm dcEF for 60 min in serum-free HBSS, disassembly
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of actin scaffolds was visible in both primary osteoblasts and hMSCs, similarly to what
occurred upon cell treatment with ionomycin [62]. The application of the same stimulus
also caused ATP depletion, possibly due to ATP consumption or ATP release to the
extracellular medium, which inhibits actin-linker proteins (such as Ezrin/radixin/moesin
(ERM) proteins), causing membrane separation from the cytoskeleton and further
decreases in membrane tension [62]. Additional activation of myosin light chain kinase
(MLCK), by increased [Ca2+]i, triggers actin-activated myosin ATPase that regulates cell
contraction and migration [69]. The cellular migration direction, which is species- and cell
type-specific (section 2.1.2), is thought to be determined by differential polarization of the
zone of the cell membrane that faces the anode and the cathode [69, 76]. Nevertheless,
it remains unclear how and why [Ca2+]i rises on opposite sides of the membrane. One
possible explanation involves local activation of various charged receptors or ion channels
acting as voltage sensors [69].
Ca2+ effects on proliferation
Elevated intracellular calcium levels may also transduce electric signals into bone
cell proliferation. Increased [Ca2+]i induces an increase in phospholipase A2 [82]. The
products generated by this enzyme activate the prostaglandin E2 synthesis, which acts as
an autocrine and/or paracrine factor to stimulate bone cell proliferation [82]. Additionally,
an increase in cytosolic calcium also leads to calmodulin activation, an effector known to
promote nucleotide synthesis [82, 99].
Ca2+ effects on differentiation
Concomitant changes in Ca2+ dynamics and in MAP kinases activation state have been
suggested to induce hMSC differentiation in response to dcEF exposure. A prolonged
exposure to a 0.1 V/cm dcEF might induce enzymatic activity of assembled proteins
involved in cellular adhesion, such as focal adhesion kinase (FAK), paxillin, vinculin and
src, which in turn induce MAP kinase activation [74]. Additionally, calcium might influence
osteogenesis by playing a structural role of extracellular matrix formation [131].
4.2. Growth factors in electromagnetic signal transduction
Human bone matrix is known to contain many polypeptide growth factors, which bind
to their high affinity receptors and elicit multiple effects besides stimulation or inhibition
of growth [132]. These molecules may also initiate apoptosis, differentiation and gene
expression not only in a specific target cell, but also in the neighboring cells [133]. Several
investigators have already studied the synthesis and secretion of insulin growth factor
(IGF)-II, transforming growth factor β1 (TGF-β1), and bone morphogenetic proteins
(BMPs) on electrically- and/or magnetically-stimulated bone cells.
Insulin growth factor II
IGF-II plays a key role in mammalian growth, influencing fetal cell division and
differentiation, and possibly metabolic regulation [134]. As the predominant bone-derived
mitogen, it is most probably involved in mediating EF effects on bone cell proliferation
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[80, 89, 90]. Fitzsimmons et al. [80, 89] proposed that EFs induce the release of IGF-II
into the medium, through a calcium-dependent mechanism, in sufficient concentrations to
promote cell proliferation. Upon ccEF exposure at 14 Hz for 30 minutes, IGF-II levels
were observed to increase in the cell culture medium, reaching a plateau (1.10 ng.ml−1)
approximately 1 h after CC exposure. Additionally, an accumulation of IGF-II transcripts
was also observed within a few hours of exposure [80]. In a TE-85 cell culture exposed to
CMF at 15.3 Hz for 10 min, the IGF-II medium levels increased up to 3.5 ng.ml−1 [89].
Subsequent studies also revealed the increased number of IGF-II receptors in TE-85 cell’s
membrane subjected to CMF stimuli at low frequencies [128].
Transforming growth factor β
TGF-β superfamily is composed of extracellular signaling molecules that play
widespread roles in development regulation [135]. Additionally, TGF-β is an important
growth factor involved in tissue remodeling and wound healing, as it induces fibronectin
and collagen production, thus regulating cell matrix deposition [136]. TGF-β can be
released from cells as a latent complex of dimers attached to their propeptides and
to TGF-β-associated proteins. Proteolytic activity or interaction with integrin proteins
releases and activates the TGF-β ligand [137]. The levels of TGF-β1 mRNA and activity
significantly increase after 1 day of CC exposure (60 kHz, 20 mV/cm) or 8 h of PEMF
stimulation (4.4 kHz, 1.8 mT) [81, 92]. Two observations suggest that this signaling
molecule mediates electrically- and/or magnetically-induced osteoblast differentiation
effects rather than proliferative ones. Zhuang et al. [81] failed to demonstrate a connection
between proliferation and increased TGF-β1 activity in CC-stimulated MC3T3 cells.
Lohmann et al. [92] suggested a correlation between collagen deposition and the levels
of latent TGF-β1, as they both peak simultaneously in cells stimulated with an IC
apparatus. PEMF induces TGF-β1 levels during the maturation period until the beginning
of mineralization, upon which the levels drop and cannot be up-regulated by IC stimulation
[104].
Bone morphogenetic proteins
BMP is another member of the TGF-β superfamily with the ability to induce bone
formation in cultured cells [135]. Some authors support that PEMF’s positive in
vivo osteogenic effects may be secondary to an endogenous stimulation of these BMP
osteoinductive cytokines [104]. Approximately 20 isoforms of BMP have been identified
with varying osteoinductive potentials. The most osteogenic BMPs are BMP-2, BMP-6,
BMP-9, BMP-4 and BMP-7. BMP-2 induces bone formation and promotes osteoblastic
proliferation, and their expression levels are up-regulated upon CC and IC stimulation
of rat-derived primary osteoblasts [100, 115, 138]. PEMF was reported to strongly induce
BMP-2 until the day 9, at the onset of the mineralization process [104]. Other study, using
icEMFs at high frequency to promote osteogenic differentiation of C3H10T1/2 mouse stem
cells, also observed BMPs up-regulation at specific differentiation phases. While BMP-6,
BMP-7 and BMP-9 expression levels increased during the early and late differentiation
phases (days 3 and 10), BMP-2 and BMP-4 levels increased only in the later differentiation
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stages (days 7, 10 and 14) [113]. In addition, BMP-2 and BMP-4 may also mediate the
osteoinductive effects of magnetic fields at low frequencies [139].
4.3. A role for Heat Shock proteins in electrical signal
transduction
Heat shock proteins react to stress conditions in order to maintain cellular homeostasis,
regulate protein folding, degradation and secretion, and are involved in differentiation
responses. Two heat shock proteins – hsp27 and hsp70 – have been studied as
potential mediators of electrical stimuli-induced proliferation and osteodifferentiation
effects. Hronik-Tupaj et al. [52] observed up-regulation of hsp27 mRNA levels on days 10,
15 and 20 in hMSCs stimulated with dcEFs. Both in control and stimulation groups, hsp27
peaked at the 10th day; however, in the stimulated group hsp27 levels were maintained
high, while in the control group a significant drop occurred from day 10 on. Hsp70 mRNA
levels were only significantly up-regulated in comparison to the control group at day 20.
These authors proposed the increased hsp27 to explain the morphological and biochemical
changes in osteoblasts upon electrical stimulation, as this protein affects gene expression,
differentiation, growth, and actin cytoskeleton reorganization [52,140].
5. Conclusions and future perspectives
The translational value of electric and magnetic stimulation for osteoporosis, fracture
repair, and osseointegration therapies is currently unknown but of high potential. An
extensive understanding of the cellular responses to electrical and magnetic fields is
essential for optimizing stimuli parameters for therapeutic stimulation of the bone tissue.
This requires improving the state-of-the-art by researching the influence of a broad range of
values for each parameter and stimulation method. The ability of electrical and magnetic
stimulation to promote bone remodeling in vitro was here explored. A wide variety of
stimuli setups were osteogenic (increased proliferation, matrix maturation and/or matrix
mineralization) for various cell model systems (immortalized lines, stem cells, and primary
cultures), using DC, CC or IC stimulation methods. Only isolated trends could be
observed regarding the stimuli characteristics and the osteogenic responses. However, a
few systematic studies suggest that EF strengths and frequencies may induce ’pyramidal’
osteogenic responses, or ’wave-like’ ones resulting from repeats of these pyramid-like
behaviors over the EF strength-axis and frequency-axis. Indeed, these response curves may
explain why linear increases or decreases in these parameters are not linearly permissive
or inhibitive. More systematic studies of the stimulus’ parameters, including the stimulus
exposure time, are thus crucial, along with studies of a wide range of EF/MF strengths
and frequencies not yet explored. The osteogenic response of a successful EF/MF
strength/frequency pair should also be screen at nearby values of strength and frequency,
for therapeutic optimization purposes. Further, since the aim is to translate the work to
in vivo assays and some stimuli parameters may deliver the desired opposite effects to
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osteoclast and osteoblast activities [110], the effects of electrical and magnetic stimulation
on osteoclasts should be studied more thoroughly. Methodology standardization will
facilitate the development and clinical application of electrical and/or magnetic stimulation
devices, such as medical devices with ability to control the bone remodeling unbalances,
and active orthopaedic implants. This later could be able to promote personalized
osseointegration in a safe, reproducible and automated manner using these biophysical
stimulations. Research on permanent magnets is also pertinent, since various implantable
medical devices have been proposed to stimulate osteoregeneration by using these methods
[141, 142]. However, we must highlight that CC and IC stimulators can deliver more
controllable stimuli to bone. IC stimulation has been the most used method to study the
ability of electromagnetic fields to promote osteogenesis; however, no feasible solutions
have yet been found for their use in highly controllable stimuli delivery systems, as for
the use of biophysical stimulators inside implantable devices to control osteointegration
and combat osteoporosis [36, 143]. In a nearby future, innovative electrical stimulation
systems currently under design might fulfil such purposes [144]. Currently, we are designing
and testing new CC stimulators to be used in intracorporeal systems able to administer
personalized stimulation therapies.
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3.3 Electric powering of instrumented implants
Besides the need of innovative biophysical stimulation systems, other systems must be
developed to support their operation. The osseointegration process must be monitored to
ensure that optimal therapeutic actuations can be driven, as proved in chapter 2. However,
a significant funding support is required to conduct research in this scope, which was not
possible to get during this PhD program. Sophisticated communication systems were
already developed, as shown in section 3.1, and major problems are not expected in their
optimization for ensuring the operation of the new concept model of orthopaedic implant
here proposed. Electric powering of instrumented active implants is also a subject of great
importance, as their actuation, monitoring, processing and communication systems must
be supplied to operate. But, as one has realized from section 3.1, finding a method to
power such implants remains an unsolved problem. Therefore, a detailed analysis of the
electric supply systems already developed to power instrumented THRs was also carried
out. A review paper focusing on this scope was then written. It is entitled ”Instrumented
Hip Implants: Electric Supply Systems” and is published in the Journal of Biomechanics
(volume 46, issue 15, pp. 2561-2571)3.
3As the content of this study is already published, the formatting rules established by the Journal of
Biomechanics are used.
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a b s t r a c t
Instrumented hip implants were proposed as a method to monitor and predict the biomechanical and
thermal environment surrounding such implants. Nowadays, they are being developed as active
implants with the ability to prevent failures by loosening. The generation of electric energy to power
active mechanisms of instrumented hip implants remains a question. Instrumented implants cannot be
implemented without effective electric power systems. This paper surveys the power supply systems of
seventeen implant architectures already implanted in-vivo, namely from instrumented hip joint
replacements and instrumented fracture stabilizers. Only inductive power links and batteries were
used in-vivo to power the implants. The energy harvesting systems, which were already designed to
power instrumented hip implants, were also analyzed focusing their potential to overcome the
disadvantages of both inductive-based and battery-based power supply systems. From comparative
and critical analyses of the methods to power instrumented implants, one can conclude that: inductive
powering and batteries constrain the full operation of instrumented implants; motion-driven electro-
magnetic energy harvesting is a promising method to power instrumented passive and active hip
implants.
& 2013 Elsevier Ltd. All rights reserved.
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1. Introduction
1.1. Need of instrumented hip implants
The number of total hip joint replacements (THR) has increased
and it is predicted to increase even more in the coming years
(Kurtz et al., 2007). Currently, the need of hip revision procedures
is rated about 6% after 5 years and 12% after 10 years following
arthroplasty (Labek et al., 2011). In the last 10 years, an increase
about 13.6% in the number of revisions was reported by the
Swedish Orthopedic Register (Kärrholm, 2010). In addition, the
probability to undergo re-revision is five to six times higher after
the first revision (Ong et al., 2010).
Some Arthroplasty Registers are reporting the increasing use of
uncemented and hybrid (cemented acetabulum) hip implants in
primary replacements (Bergen, 2010; Garellick et al., 2011). They
are also highlighting that most patients, undergoing the implanta-
tion of uncemented implants, are patients less than 60 years old.
This trend is also verified in projections for the future profile of
patients: 50% of the primary THR and 35% of the revision THR will
be performed in patients less than 65 years old between 2010 and
2030 (Kurtz et al., 2009).
The optimization of the design and material properties of hip
joint implants, as well as the surgical procedures to implant them,
has been a subject of paramount importance for the research
community. The current revision rates suggest the use of different
methodologies to optimize the performance of hip joint implants.
Considering the advances in the electronic systems, as well as
in the monitoring and actuation methods, the instrumented
implant may become an effective methodology to maximize the
outcomes following THR. If uncemented implants are developed to
adjust, by themselves, to the biochemical environment sur-
rounding them, then the maximization of their performance will
be achieved.
Aseptic loosening is the main reason for revision in hip
replacements (Havelin et al., 2009), being currently reported
around 70% of all revisions (although it is probably more critical
if it is associated to deep infection) (Bergen, 2010). Then, instru-
mented implants must be primarily addressed to patients who are
at risk of early implant loosening. However, it is difficult to predict
the long-term behavior of the bone-implant interface, in order to
identify previously the group of patients that will likely undergo
aseptic loosening. Considering the requirement of long-term
implant survival and the idiosyncrasies of patients, uncemented
hip replacements can be instrumented in order to operate perso-
nalized failure prevention in real-time. The main goal is to
minimize the need of revision procedures.
1.2. Potential of instrumented hip implants
The concept of Instrumented Hip Implant was proposed as an
accurate method to model the biomechanical and thermal environ-
ment surrounding hip implants and to optimize the rehabilitation
processes following arthroplasty (Bergmann et al., 2012; Damm et al.,
2010; Graichen et al., 1999; Heller et al., 2005). Rydell (1966) was the
first researcher who designed and implanted the first two instru-
mented hip implants in two patients, in order to measure orthogonal
compressive forces and moments over the neck of the implants. The
newest architecture for instrumented hip implants was proposed by
Bergmann et al. (2012). In order to study the risk of thermally
induced bone necrosis, they developed instrumented hip endo-
prostheses to measure the implant temperatures in-vivo. So far, only
passive implants have been instrumented. This class of implants
comprises architectures without active mechanisms, namely actua-
tion systems and command structures. Currently, research is being
conducted towards the development of instrumented active implants
(Frias et al., 2010; Reis et al., 2012). This approach aims the
development of instrumentation for implants with the ability to
apply stimuli in the bone-implant interface, in order to control the
bone remodeling. The architectures of instrumented active solutions
are defined according to Fig. 1, but no prototype was already fully
designed. A full active hip implant must comprise (Soares dos Santos
et al., 2012): (1) measurement systems to monitor the physiological
states of the tissues surrounding the implant; (2) processing systems
to model the physiological states of the tissues surrounding the
implant, as well as to model the failures′ characteristics, namely the
state and regions of failures by aseptic loosening; (3) actuation
systems to perform therapeutic prescriptions against states of failures
by loosening; (4) communication systems between the implant and
external systems; and (5) electrical supply systems to power sensors,
actuators, transmitters and processing systems. If aseptic loosening
occurs in the interface, then the instrumented active implant must
characterize it (in real-time) and perform a therapeutic actuation
Fig. 1. Architecture of the instrumented hip implants to overcome failures. The
Master-based Active Structure is housed outside the human body; the Slave-
based Active Structure is housed inside the implants. ‘Physiological States’ refers
to the processing operations that use biochemical and biomechanical measures
of the patient′s body in order to model the physiological states of the tissues
surrounding the instrumented implants. ‘Implant Failures’ refers to the proces-
sing operations that use the effects due to failures (such as the modulation of
biochemical and biomechanical changes in the tissues surrounding the
implants; and changes in the mechanical, electrical, chemical and communica-
tion subsystems of the instrumented implant) to model the failures′ character-
istics (such as the type, state and regions of failures). ‘Therapeutic Commands’
uses data about the state of the implants, physiological state of tissues
surrounding the implants and therapy results of previous therapeutic com-
mands, in order to generate medical prescriptions to be carried out by the
‘Therapeutic Operations’. These therapeutic commands must be conducted
primarily by medical specialists, although instrumented implants can be
designed with the ability to “learn” throughout time, by using artificial learning
algorithms. The module ‘Mechanical Features’ evaluates the operation state of
the actuators, sensors, communication systems and power supply systems
(Alpuim et al., 2008; Pan et al., 2012; Yoshida et al., 2006).
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(also in real-time) to minimize the state of failure, according to a
closed-loop control methodology. The actuators, inside the instru-
mented implants, must operate suitable (then controlled) therapeutic
actuations, in order to minimize the state of loosening throughout
time. Bone cell proliferation and differentiation can be carried out by
electrical or mechanical stimulation of bone cells (Balint et al., 2013;
Hronik-Tupaj and Kaplan, 2012; Ignatius et al., 2005; Reis et al.,
2012). Instrumented active implants could be developed to comprise
a network of electrical and/or mechanical stimulators of bone cells
along the critical regions where loosening occurs. Because they
comprise communication systems that allow the data transfer
between the implant and the external systems, medical specialists
can program therapeutic actuations, in order to be performed by the
actuators inside the implant. Because these implants comprise
measurement systems, medical specialists can monitor the evolution
of the loosening characteristics without the need of other diagnosis
methods or invasive procedures.
According to this concept of Instrumented Active Implant, one
can conclude that instrumented passive hip implants can also be
optimized to model the biochemical behavior of the tissues
surrounding the implant; to model in-vivo the interaction between
the biochemical properties of the tissues and the biomechanical
properties of the implant; to model in-vivo the failures′ character-
istics; and to communicate in-vivo the failure diagnoses during the
routine activities of the patients.
Non-instrumented active implants are also able to exhibit con-
trolled therapeutic actuation in the bone-implant interface throughout
time. Their architectures do not comprise electronics, sensors, actua-
tors and power supply systems based on mechanical structures. Smart
surface coating modifications can be used to implement non-
instrumented active implants (Lehn, 2002; Lendlein and Langer,
2002; Parvizi et al., 2007). The main drawback of this class of implants
is the difficulty to implement accurate therapeutic actuations
in response to particular biochemical properties of the bone-implant
interface when loosening occurs.
Whatever the class of the instrumented hip implants, they
require electric powering in order to operate: instrumented passive
implants have to power monitoring, processing and communication
systems; instrumented active implants have to power monitoring,
processing, communication and actuation systems. The goal of this
survey is to analyze the electric power systems which were already
designed for the particular application of powering instrumented
hip replacements and instrumented fracture stabilizers; and to
analyze which methods are most feasible for future designs of
instrumented implants.
2. Methods
2.1. Literature search strategy
Relevant publications were selected in order to compare all the power supply
methods and mechanisms already implemented and validated in instrumented hip
joint replacements and instrumented fracture stabilizers, as well as to identify the new
trends towards their optimization. The search was also carried out reviewing the
reference section of all papers eligible from the selection criteria. The collection was
completed in June 2013.
2.2. Selection criteria
Studies, focusing on the following three criteria, were selected:
(1) instrumented hip joint replacements and instrumented fracture stabilizers, which
were experimentally validated in-vivo. In-vitro studies were considered if later
in-vivo studies, using the same instrumented implants, were published.
(2) instrumented implants without percutaneous wired connections. The use of
percutaneous wiring is not acceptable for clinical applications.
(3) recent advances on power supply systems for instrumented hip joint replace-
ments and instrumented fracture stabilizers.
2.3. Assessment of other literature reviews
To our knowledge, only Ledet et al. (2012) briefly reported how telemetric
systems of instrumented passive implants were powered. Neither comparative nor
critical analyses were conducted so far to the electric power supply systems of the
instrumented hip joint replacements or instrumented fracture stabilizers. No authors
carried out a survey about all the methods, for electric power generation, that were
already applied to both instrumented passive and active hip implants. Moreover, no
viability analysis of the methods to power instrumented hip implants was already
accomplished.
3. Results
3.1. Instrumentation of hip joint replacements
Twelve architectures of instrumented hip joint replacements,
comprising electric power supply systems, were designed by five
research groups. They were arranged according to generations of
technological breakthroughs, as follows:
(a) three architectures for instrumented endoprostheses were pro-
posed by: Carlson et al. (1974), and Mann and Burgess (1990) for
the 1st generation; Carlson (1993), Hodge et al. (1989), and Mann
and Burgess (1990) for the 2nd generation; Carlson (1993) and
McGibbon et al. (1999) for the 3rd generation.
(b) Kilvington and Goodman (1981) and Puers et al. (2000)
developed, respectively, only one architecture for hip
prostheses.
(c) four architectures for total hip prostheses were designed by:
Davy et al. (1988) for the 1st generation; Davy et al. (1988) for
the 2nd generation; Davy et al. (1990) for the 3rd generation;
Davy et al. (1988) for the 4th generation.
(d) Friedmar Graichen, and associated research group, contributed
with three new designs for total hip prostheses and endoprosth-
eses: Bergmann et al. (1988) and Graichen and Bergmann (1991)
for the 1st generation; Graichen et al. (1999) for the 2nd
generation; Damm et al. (2010) and Graichen et al. (2007) for
the 3rd generation.
A comparative analysis of these electric power supply features
can be carried out using Table 1.
From the comparative analysis, one can find the following
considerations:
(1) All architectures have been powered by inductive power
links or batteries. Although the choice of the method to
power instrumented orthopedic implants has been under
discussion, only these two methods were used in in-
vivo tests;
(2) The electric supply systems were used to power instrumen-
tation housed both inside and outside the implants;
(3) Up to 9 years of continuous operation of the electric supply
systems were already reported;
(4) The electric supply systems were used only to power mea-
suring implants, i.e., passive architectures which were only
designed to collect in-vivo data (no actuation systems for
therapeutic purposes were implemented);
(5) These power supply systems were customized only to power
measurement (which were composed mainly by strain gauges
and temperature sensors), communication and processing
systems;
(6) These power supply systems are suitable for research purposes
related to the modulation of biomechanical quantities, namely
forces and temperatures, and, in general, for all research requir-
ing data monitoring that can be conducted only in laboratory or
limitedly during the daily life of patients;
(7) Processing units were only designed for power regulation;
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Table 1
Electric supply features of the instrumented hip joint replacementsa.
Features Mann et al. Kilvington and
Goodman
Graichen et al. Davy et al. Puers et al.
Implant type (1,2,3) Austin-Moore
endoprosthesis (model: ND)
English prosthesis
(model: ND)
(1) Total hip prosthesis (Uni-hip,
Mecron); (2) CENOS endoprosthesis
(ARTOS, Berlin); ceramic head
(CERASIV GmbH, Plochingen,
Germany); (3) ‘Cementless Tapered
Wedge’ (CTW) total hip prosthesis
(Merete Medical GmbH, Berlin);
ceramic head
(1) T-28 total hip prosthesis;
(2) total hip prosthesis
(model: ND); (3,4) DF-80
(Zimmer) total hip prosthesis
Hip prosthesis
(model and type:
ND)
Method for
power
supply
(1,2,3) Inductive powering,
using a 100 kHz modulation
externally located
Powered by
batteries
(1,2,3) Inductive powering, using a 3–
5 kHz modulator externally located
(1,2,3,4) Powered by a battery Inductive
powering, using
a 750 kHz
modulation
externally
located
Components
of the
supply
system
inside the
patient’s
body
(1,2,3) (secondary) coil
wound on a ferrite core;
regulation systems
3 Batteries (1.35 V
mercury); 2 reed
switches
(1,2,3) (secondary) power coil;
regulation systems
(1,2) Battery; (3,4)
pacemaker-type battery
(3.6 V lithium); (2,3) magnetic
reed switch; (4) momentary
reed switch; (1,2,3,4) regulation
systems; power coil
(Secondary)
power coil;
regulation
systems
Locations of
the
components
inside the
patients’
body
(1,2,3) Power induction link:
end of the stem; circuitry:
inside the hemisphere
Outside the implant
(inside the
transmitter system
housing)
(1) Power coil: in the top of the stem,
inside a metallic cylinder; circuitry:
in the neck, inside a metallic
cylinder; (2) in the shaft, inside a
metallic cylinder; (3) power coil: in
the neck; circuitry: inside a metallic
cylinder in the neck
(1,2) Battery, circuitry:
inside the head, in the upper
neck region; (3,4) battery:
inside the neck; (1,2) power
coil: ND; (3,4) power coil:
in the base of the prosthesis
ball; (1,2,3,4) circuitry: inside the
head, in the upper neck
region; (2,3,4) switch: inside the
head, in the upper neck region
Power coil:
inside the neck;
circuitry: inside
the titanium can,
in the head.
Components
of the
supply
system
outside the
patients’
body
(1,2,3) 100 kHz power
oscillator; (primary or
driver) coil (around the thigh)
Magnet (to latch the
reed switches)
(1) 4 kHz power oscillator; (primary)
coil (around the thigh); (2) 3.5–
4.5 kHz power oscillator; (3) 3–5 kHz
power oscillator; (2,3) (primary) coil
(around the thigh); antenna, RF
receiver and microcontroller (to
control the current supply voltage of
the electronics)
(1,2,3,4) Magnet (to latch the reed
switches)
750 kHz power
oscillator;
(primary) coil
(around the
thigh)
Systems of the
instrumen-
ted implant
requiring
power
supply
(1,2) 14 pressure
transducersi; (3)13 pressure
transducersi; temperature
transducer (thermistor); (1,2,3)
16-channel 100 MHz PAM/FM
transmitter and antenna
4 Sets of strain
gauges; single
channel 102.3 MHz
FM transmitter;
antenna; antenna
cable
(1) 3 strain gauges, temperature
transducer (thermistor NTC);
4-channel 150 MHz RF transmitter;
antenna; (2) 3 strain gauges, 9 NTC
transducers; 28 channel 130–
150 MHz PIM Coder transmitter;
2 antennas; (3) 6 strain gauges; NTC
transducer; 9-channel 150 MHz PIM
transmitter; antenna
(1,2,3,4) 3 sets of strain gauges; (3,4)
temperature transducer (model:
ND); (1,2,4) 76–90 MHz FM
transmitter (number of channels:
ND); (3) 4-channel 76–90 MHz FM
transmitter; (1,2,3,4) antenna
Accelerometer;
10–11.5 MHz RF
transmitter
(number of
channels: ND);
antenna
Electric power
needsb
(1,2) 500 mW; (3) 30 mW ND (1) 7 mW; (2) 10 mW; (3) ND (5 mW
for communication operations)
(1,2,3,4) ND 22.5 mW
Power
regulation
circuitries
(1,2,3) Inside the implant:
circuitry to regulate the output
voltage; outside the implant:
NP
Inside the implant:
ND; outside the
implant: NP
(1,2,3) Inside the implant: circuitry to
regulate the output voltage; (2,3)
Outside the implant: feedback
control of the oscillator frequency to
compensate the displacements of the
coils
(1,2,3,4) Inside the implant: circuitry
to regulate the output voltage;
outside the implant: NP
Inside the
implant: circuitry
to regulate the
output voltage;
outside the
implant: NP
Life span (1,2,3) ND 70 h (1,2,3) ND (1,2,3,4) ND ND
Tests over the
implantsl
(1,2,3) Fatigue ND (1) Fatigue; sealing; corrosion;
temperature resistance; acceleration;
burn-in; biocompatibility;
implantation in 3 sheep over 3 years;
(2) temperature resistance; burn-in;
sealing; mechanical shocks;
(3) sealing; endurance; fatigue
ND ND
Implantations (1) NA (6 human acetabular
components were usedk);
(2) 1 patient; (3) 1 patient
1 Patient (1) 4 Sheep; 3 patients; (2) 4
patients; (3) 10 patients
(1) ND; (2) 1 patient; (3) 1 patient;
(4) 1 patient
1 Patient
Operation
period
in-vivo
(1) ND; (2) over 5 yearsd
PO; (3) up to 3 yearse PO.
40 Days PO. (1) Up to 9 yearsf PO; (2) over
6 yearsg PO; (3) up to 12 monthsh PO
(1) ND; (2) up to 3 days PO; (3) up to
31 days PO; (4) up to 58 days PO
ND
Period of
power
acquisitionc
(1,2,3) NA NA (1,2,3) NA (1,2,3,4) NA NA
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(8) Lower levels of power were demanded because predicting
algorithms, database storage and therapeutic actuation
systems were not implemented;
(9) No side effects, concerning the operation of the power generators
in-vivo, were reported in the 24 patients who undergone the
implantation of these instrumented hip implants;
(10) High power consumption is demanded by the inductive
powering systems due to their poor efficiency;
(11) The life span of the battery-based power supply systems is
related with the number of systems requiring electric power;
(12) The design of these power supply systems is not suitable to
perform data acquisition throughout the daily living of the
patients.
3.2. Instrumentation of fracture stabilizers
Three architectures for distal and proximal femoral replace-
ments were proposed by: Taylor (1996) for the 1st generation;
Bassey et al. (1997) for the 2nd generation; Taylor et al. (1998), and
Taylor and Walker (2001) for the 3rd generation. Two research
groups have conducted the instrumentation of other fracture
stabilizers: Brown et al (1982) proposed an architecture for
instrumented nail plate implants; Schneider et al. (2001) proposed
an architecture for instrumented intramedullary nails. Their elec-
tric power supply features can be compared using Table 2.
Considerations 1–6, 8–12 from the previous section, which
details a critical analysis of the power supply systems for hip joint
replacements, are also true for instrumented fracture stabilizers.
No processing capability was reported.
3.3. Energy harvesting systems to power instrumented hip implants
Recently, the suitability of the energy harvesting methods to
power instrumented implants started out being studied. Instru-
mented hip joint replacements were already instrumented with
energy harvesting systems, although without in-vivo results. Four
motion-driven electromagnetic and piezoelectric harvesters were
already designed and tested in-vitro (Fig. 2):
(a) A multi-source energy harvesting system, composed by two
electromagnetic harvesters (a translational and a rotational)
and a piezoelectric harvester, was proposed by Soares dos
Santos et al. (2013). The translational-based electromagnetic
harvester was configured as a mass-spring-damper system.
(b) An electromagnetic harvester, based on a mass-spring-damper
configuration but with a braking magnet, was proposed by
Morais et al. (2009, 2010, 2011). Inductive powering was used
for activation and deactivation of the data acquisition and
processing systems.
(c) An electromagnetic harvester, based on a magnetic levita-
tion configuration, was proposed by Silva et al. (2012, 2013)
and Morgado et al. (2012). Inductive powering was also
used for activation and deactivation of the data acquisition
and processing systems.
Their electric power generation features can be compared using
Table 3.
One can state the following considerations about the ability of
the motion-driven electromagnetic harvesting systems to power
instrumented hip implants:
(1) The amount of energy harvested is based on the acceleration
profile that excites the generators;
(2) None of these energy harvesters has been optimized according
to the gait patterns of patients who undergone THR;
(3) These powering methods avoid the constraints related with the
operation period of the instrumentation embedded into the
implants;
(4) These harvesting systems ensure long-term energy generation:
they are maintenance-free; the energy source is (theoretically)
everlasting; the energy is generated inside the implants, which
ensures autonomy and safety, and avoids biological changes in
the bone-implant interface; they are not expensive; and, finally,
they are easy to implement (Morais et al., 2011);
(5) Motion-driven energy harvesters can be designed according to
different dimensions, up to nanoscale;
(6) The performance of the electromagnetic harvesters, based
on mass-spring-damper configurations, will probably
decrease throughout time, due to the mechanical fatigue
characteristics of the springs. The magnetic levitation
configuration overcomes this problem, because neody-
mium magnets keep their magnetism practically indefi-
nitely and because of the non-contact nature of this
configuration (the only mechanical contact is between the
free magnet(s) and the cylindrical tube);
(7) The major drawback of these powering methods is to require
hip movements of the patients, according to nonzero
Table 1 (continued )
Features Mann et al. Kilvington and
Goodman
Graichen et al. Davy et al. Puers et al.
Efficiency (1,2,3) 10%. ND (1,2,3) ND (1,2,3,4) ND 0,25%
Availability of
power
(1,2,3) During the testsj While batteries are
able to powerj
(1,2,3) During the testsj (1,2,3,4) While batteries are able to
powerj
During the testsj
Other
functions
(1,2,3) Antenna, for data
communication.
NA (1,2,3) NA (1,2,3,4) NA NA
Side effects (1) ND (2,3) non-existent ND (1) ND; (2,3) non-existent (1,2,3,4) ND ND
a Terminology: (n)—nth architecture; NA—not applicable; ND—information not reported; NP—operation not projected; PO—postoperatively.
b Average power consumption.
c Time required to the acquisition of enough energy to power all the circuitry.
d Five years (Givens-Heiss et al., 1992).
e McGibbon et al. (1999).
f Bergmann et al. (2004).
g Bergmann et al. (2004).
h Damm et al. (2012).
i They were designed as cantilever beams with strain gauges.
j The communication with the implant was only carried out in the research laboratory.
k Taken directly from the autopsy room to a hip simulator.
l Concerning the electric power systems of the implants.
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acceleration profiles. Consequently, only very low levels of
energy will be generated if patients are not able to perform
their routine activities. This problem arises mainly in the
recovery period following THR and it becomes critical with the
aging of patients;
(8) Currently, no conclusions can be reported about the amount of
energy possible to be generated by these powering methods,
because no accurate nonlinear models have been developed
and validated in order to conduct optimization studies.
Considerations 1–5, 7 and 8, which were stated for the electro-
magnetic harvesting systems, are also true for piezoelectric harvesting.
The progressive degradation rate of the piezoelectric materials, to
repeated mechanical and electrical cycling, cannot be disregarded, as
proved by Platt et al. (2005). No fracture stabilizers were instrumented
with energy harvesting systems.
4. Discussion
4.1. Methods already used to power instrumented hip implants
The use of inductive powering or batteries constrains the full
operation of instrumented implants. Although Bock et al. (2012)
recently highlighted the importance of the battery systems for medical
Table 2
Electric supply features of the instrumented fracture stabilizersa.
Features Brown, Burstein and Frankel. Schneider et al. Taylor et al.
Implant type Nail plate implant (model: ND) Intramedullary Femoral Nail (AO/ASIF universal nail) (1) Proximal Femoral Replacement (Stanmore prosthesis);
(2) Distal Femoral Replacement (Stanmore prosthesis).
(3) Distal Femoral Replacement (model: ND)
Method for power
supply
Powered by batteries Inductive powering, using a 2 kHz modulator
externally located
(1,2,3) Inductive powering, using a modulator externally
located
Components of the
supply system
inside the patient’s
body
Set of batteries (1.35 V
mercury) (quantity: ND);
magnetic reed switch
(Secondary) power coil; regulation systems (1,2,3) (Secondary) coil and ferrite core; regulation systems
Locations of the
components inside
the patients’ body
Batteries: inside the nail;
switch: inside the plate
In a cavity at the intermediate location between the
distal end and the mid-diaphyseal cross-section
(1,2) Coil and ferrite: outside the implant; (1) circuitry: cavity
above the tip of the smaller diameter stem; (2) circuitry:
midshaft cavity; (3) circuitry: in the distal shaft cavity; coil and
ferrite: distal portion in the shaft
Components of the
supply system
outside the
patients’ body
Magnet (to latch the reed
switches)
(1) 2 kHz power oscillator; (primary) coil (around the
thigh)
(1,2,3) (Primary) coil, power oscillator (frequency: ND) and
battery (all around the thigh)
Systems of the
instrumented
implant requiring
power supply
Strain gauges (quantity: ND);
2-channel 88–108 MHz AM/FM
transmitter and antenna
5 Strain gauges; temperature transducer; data
conversion circuitry; 8-channel 100 kHz transmission
system (pulse code modulation) and antenna
(1) 4 Strain gauges; (2,3) 24 strain gauges; (1) single channel
418 MHz UHF transmitter and antenna; (2) multi-channel
418 MHz UHF transmitter (number of channels: ND); antenna;
(3) multi-channel UHF transmitter (frequency: ND) and
antenna
Electric power
needsg
ND 100 mW (1) 151 mW (8 mA); (2) ND (6 mA); (3) ND
Power regulation
circuitries
Inside the implant: ND; outside
the implant: NP
Inside the implant: circuitry to regulate the output
voltage; outside the implant: ND
(1,2,3) Inside the implant: circuitry to regulate the output
voltage; outside the implant: ND
Life span ND ND (1,2,3) ND
Tests over the
implanth
Fatigue; biocompatibility Fatigue (1) ND; (2) Fatigue; sealing; (3) Fatigue
Implantations 3 Patients 1 Patient (1) 2 Patients; (2) 2 patients; (3) 2 patients.
Operation period in-
vivo
During the PO and
convalescent recovery process
6 Months PO. (1) 9 Yearsc PO; (2) 30 monthsd PO; (3) 30 monthse PO.
Period of power
acquisitionb
NA NA (1,2,3) NA
Efficiency ND ND (1) 10%; (2) 13%; (3) ND
Availability of power While batteries are able to
power
During the testsf (1,2,3) During the testsf
Other functions NA NA (1,2,3) Antenna, for data communication
Side effects ND ND (1,2,3) ND
a Terminology: (n)—nth architecture; NA—not applicable; ND—information not reported; NP—operation not projected; PO—postoperatively.
b Time required to the acquisition of enough energy to power all the circuitry.
c Shah et al. (2006).
d Bassey et al. (1997).
e Taylor and Walker (2001).
f The communication with the implant was only carried out in the research laboratory.
g Average power consumption.
h Concerning the electric power systems of the implants.
Fig. 2. The four motion-driven electromagnetic and piezoelectric harvesters
already designed to power instrumented hip prostheses (Silva et al., 2013).
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devices requiring high reliability, their use does not ensure long-term
operation of the instrumented implants. Batteries cannot be charged
and discharged often without damage and reduction in capacity,
which makes them unsuitable for everlasting operation. Besides,
specialized circuitry is required to charge batteries. The use of
inductive power supply strongly reduces the periodicity of operation
of the instrumented implants, because it is uncomfortable for patients
(Almouahed et al., 2011b) and it troubles their routine activities, as
shown in Fig. 3. However, one must emphasize the suitability of the
induction-based and battery-based supply systems for research pur-
poses requiring data that can be monitored in laboratory or limitedly
during the daily life of patients. Following this methodology, the
newest instrumented hip endoprostheses, developed by Bergmann
et al. (2012), uses an inductive power link to supply temperature
sensors inside the implants.
The supply problem becomes critical if one consider that the
concept of Instrumented Hip Implant allows the design of
architectures with the ability to monitor the biochemical beha-
vior of the tissues surrounding the implants. The same problem
also arises if one design instrumentation for implants with the
ability to perform therapeutic actuations, in order to overcome
detected failures (Reis et al., 2012; Soares dos Santos et al., 2012,
2013). The power consumption increases as the number of
sensors, transducers and actuators increase. Moreover, the
greater the number of operations of the instrumented hip
implants, the larger the consumption and required availability
of the power supply systems to operate. Besides, the everlasting
life span of orthopedic implants must be considered a validation
criterion. One can conclude that induction-based and battery-
based supply systems are not able to promote the optimization
of both instrumented passive and instrumented active implants,
because the monitoring and therapeutic actuation systems must
be ready to perform when command orders are prescribed. Of
course the maximum prescription rate of therapeutic com-
mands can be decreased to the maximum operation rate of
the therapeutic actuators. However, the maximum operation
rate of the therapeutic actuators must be higher than the
maximum prescription rate of therapeutic commands if optimal
performances are required. Finally, the use of inductive power
links can be dangerous for patients if their tissues are exposed
to high levels of RF electromagnetic fields for a long time. The
low efficiency of this method, as well as the higher levels of
energy required by active implants when compared to passive
implants, may impair the bone-implant interface.
Table 3
Features of the energy harvesters for instrumented hip joint replacementsa.
Features Soares dos Santos et al. Morais et al. Silva et al. and Morgado et al.
Implant type Metabloc™ hip prosthesis (Zimmer Corporate, EUA) Freeman hip prosthesis Freeman hip prosthesis
Method for
power supply
Motion-driven electromagnetic and piezoelectric
harvesting
Motion-driven electromagnetic harvesting and
inductive powering
Motion-driven electromagnetic
harvesting and inductive powering
Components of
the supply
system inside
the patient’s
body
Translational generator: 1 coil spring, 2 neodymium
magnets, 1 winding; rotational generator:
1 winding, 24 neodymium magnets; piezoelectric
generator: piezoelectric diaphragm
Harvester: 1 coil spring, 2 neodymium magnets,
2 windings, power management circuitry, (Li-ion
rechargeable) battery and 2 Aluminum Electrolytic
capacitors; inductive generator: (control link)
receiver antenna
Harvester: 3 neodymium magnets,
2 windings, power management
circuitry, 2 supercapacitors; inductive
generator: (control link) receiver
antenna
Locations of the
components
inside the
patients’ body
Translational generator: in the stem; rotational
generator: upper half of the head and acetabular
component; piezoelectric generator: lower half of
the ball head
In the stem In the stem
Components of
the supply
system outside
the patients’
body
NA Emitter antenna; 125 kHz power oscillator; ASK
receiver, microprocessors
Emitter antenna; 125 kHz power
oscillator; ASK receiver,
microprocessors
Systems of the
instrumented
implant
requiring
power supply
ND (the prototype was only designed with these
power generators)
RF transmitter, data processing circuitry, activation
circuitry
RF transmitter, data processing
circuitry, activation circuitry
Average power
generation
Up to 53.7 μW Up to 108.9 μW Up to 200 μW
Power regulation
circuitries
NA Inside the implant: circuitry to regulate the output
voltage; outside the implant: NP
Inside the implant: circuitry to regulate
the output voltage; outside the implant:
NP
Life span ND (theoretically everlasting) ND (theoretically everlasting) ND (theoretically everlasting)
Implantations NA NA NA
Tests over the
implants
ND ND ND
Operation period
in-vivo
NA NA NA
Period of power
generationb
ND (no circuitry was included) 5,5 s in every 294,44 s (considering only the
generation of power for starting-up, signal
conditioning, conversion, processing and RF
transmission)
ND
Efficiency ND (no circuitry for signal conditioning was
included)
NA NA
Availability of
power
During the movements of the patients’ body During the movements of the patients’ body, or
while batteries and storage capacitors are able to
power
During the movements of the patients’
body, or while storage capacitors are
able to power
Other functions NA NA NA
Side effects NA NA NA
a Terminology: NA—not applicable; ND—information not reported; NP—operation not projected.
b Time required to harvest enough energy to power all the circuitry.
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Although there are no conclusive proofs of the effectiveness of the
motion-driven energy harvesting systems to power instrumented
passive or active hip implants, they are being studied for these
particular applications because they can generate energy without
any of the disadvantages of both inductive supply and batteries.
However, their performances are strongly reduced in the recovery
period following THR and when patients are not able to perform their
routine activities. Therefore, motion-driven energy harvesting systems
are best suitable for patients less than 60 years old with good mobility.
More efforts must be conducted to validate them as an effective
method (within their limitations) to power instrument implants.
Firstly, the energy needs for a measurement system (in order to detect
the aseptic loosening), a processing system (in order to characterize
the loosening) and an actuation system (in order to perform ther-
apeutic actuations to prevent loosening) must be estimated. Then,
each configuration must be optimized taken into account the hip
movements during routine activities of patients. The validation of
accurate nonlinear models to predict their power generation is
mandatory. According to the maximum power harvested by each
configuration and the energy needs for each design of instrumented
passive or active implant, a particular energy harvester can be selected
to supply a particular instrumented hip implant. Moreover, models
will clarify if it is advantageous to implement only few macroscale
harvesters or many micro/nanoscale harvesters.
4.2. New conditioning systems
New conditioning systems are being developed to interface
with the energy generators operating in-vivo. The main break-
throughs about this subject are listed below:
(a) Le et al. (2006) proposed a CMOS circuitry to interface the
piezoelectric energy harvesting;
(b) Silva et al. (2012, 2013) proposed power management systems
to interface multiple energy harvesters;
(c) Telemetry systems for instrumented hip prostheses, powered
by in-vivo energy sources, were also proposed by Morais et al.
(2009, 2011) and Silva et al. (2013);
(d) Silva et al. (2013) have proposed storage systems based on
supercapacitors, in order to overcome the problems related to
the use of batteries as energy reservoirs. The storage of the
energy harvested is also a requirement for the maximization of
the amount of available energy. Otherwise, energy is lost if it is
not used thereupon the generation, or the system will not be
reliable if harvesters do not generate enough energy to meet
the power needs.
(e) Zhao et al. (2012) developed a miniaturized System-on-Chip
(SoC) that can be customized to operate in instrumented hip
implants. They embedded a processor, ADC, RF transceiver,
EEPROM and SRAM memories, and SPI peripheral interfaces
within a 9 mm3 SoC.
4.3. Methods already used to power other instrumented implants
Prior the optimization of the power supply systems for instru-
mented hip implants, one must take into account the power
systems already developed for other orthopaedic implants. To
our knowledge, only inductive power links (comprising compo-
nents inside and outside the patients′ body) were designed to
power instrumented knee implants in-vivo. The main contribu-
tions were provided by Heinlein et al. (2009, 2007), Kutzner et al.
(2010), D′Lima et al. (2008), D′Lima et al. (2005) and Kirking et al.
(2006). Although without in-vivo results, three piezoelectric har-
vesting systems were already designed to power instrumented
knee implants:
(a) Almouahed et al. (2011a, 2011b) embedded four piezoelectric
elements within the anteromedial, posteromedial, anterolat-
eral, and posterolateral compartments of the tibial baseplate.
Their main purpose was to instrument knee implants with the
ability to measure in-vivo the anteroposterior and mediolateral
distributions of tibiofemoral force on the tibial baseplate, using
self-powered methods. They conducted the optimization of
this piezoceramic generator, but only using the axial force
applied by the tibial component during the gait cycle: they
harvested about 11 mW of maximum average raw power. Such
piezoelectric generators can be customized to power instru-
mented fracture stabilizers. Their application to power instru-
mented hip joint implants will result in lower power
generation, because of the volume restrictions on the hip joint
implant. Their performance degradation is a serious drawback
for long-term applications. The major potential of this study is
the use of piezoelectric materials both for monitoring and
power generation operations.
(b) Platt et al. (2005a, 2005b) designed a force-based piezo-
electric harvesting system similar to the power generation
system proposed by Almouahed et al. (2011a, 2011b). They
embedded three PZT elements inside an instrumented knee
implant, but with larger dimensions than those used by
Almouahed et al. (2011a, 2011b). They reported power
generation levels up to 4.8 mW of raw electric power under
axial loading conditions.
(c) Luciano et al. (2012) proposed a motion-driven electromag-
netic harvesting system which uses the relative motion
between the femur and tibia to generate electric power. In
the tibial plate, they embedded two cylindrical coils between
two condyles; near the outer surface of each condyle, pris-
matic magnets were embedded. No generated power levels
were reported. The main advantage of this method is to avoid
the movement of the coils and magnets during power gen-
eration, which in turn minimizes the maintenance needs. It is
a preliminary study which may became an important break-
through for instrumented knee replacements. However, it is
not feasible for instrumented hip joint implants, because there
is no relative motion inside them or is quite difficult to create
relative motion inside them.
Fig. 3. The primary power coil around a patient’s hip (Bergmann et al., 2012). Having a
coil around the hip is uncomfortable and troubles the activities of the patients.
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Only inductive power supply systems were implemented to
power instrumented shoulder implants (Westerhoff et al., 2009a,
2009b) and instrumented vertebral body replacements (Rohlmann
et al., 2012; Rohlmann et al., 2007). No other breakthroughs were
found about electric supply methods to power these implants.
4.4. Viability analysis of other methods to power instrumented hip
implants
Rasouli and Phee (2010) reported the main energy sources to
power medical devices. Morais et al. (2011) enumerated the
methods that can be used to supply smart prostheses. The
feasibility of these methods must be analyzed in order to power
instrumented hip implants:
(a) Biofuel cells require organic components to generate electric
power. Long-term storage of enzymatic biofuel cells inside the
implants is quite hard to accomplish. The use of organic
components outside the implants requires power generation
outside the implants, as well as energy transfer into the
implants, which may conduct to biocompatibility and safety
problems. No biofuel system was already developed using
organic components of bone. Sakai et al. (2009) proposed a
biofuel cell system from activated human macrophages. Bone
marrow-derived macrophages could be used for energy gen-
eration (Weischenfeldt and Porse, 2008). However, such bio-
logical systems are quite difficult to implement and they will
cause biochemical changes in the bone-implant interface.
(b) The use of radioisotope (such as the plutonium 238) energy
conversion raises many toxicity problems (Rasouli and Phee,
2010) and it is expensive (Wei and Liu, 2008), although its
safety and reliability were already reported (Wei and Liu,
2008). Research efforts have been conducted to harness its
high energy density (Wacharasindhu et al., 2009), but no
generation system was designed to ensure more than 30 years
of power generation.
(c) Thermoelectric generation systems could be designed by
harnessing the temperature increase inside the implants
during the routine activities of patients (Bergmann et al.,
2001). Several drawbacks hinder the development of feasible
thermoelectric generators inside the implants: the tempera-
ture gradients and rates of temperature change are small; it is
quite hard to implement and to keep a cold junction inside the
implants; hip motion is required; thermoelectric generation
exhibits low conversion efficiencies, mainly at low tempera-
ture differences (Rasouli and Phee, 2010). Another approach is
to install the warm junction outside the implant, but safety
problems and biochemical changes in the bone-implant inter-
face will arise.
(d) Power generation based on magnetic coupling (Rasouli and
Phee, 2010; Wei and Liu, 2008) presents similar problems as
described for the inductive powering.
4.5. Future research
Many electromechanical harvesters have been proposed in the last
years, but most were designed for vibration-based powering. Sue and
Tsai (2012) reviewed those powered by human body motion. They
showed that electromagnetic and electrostatic energy harvesters have
been designed to operate at frequencies much higher than the
frequencies of the hip joint. Saha et al. (2008) also proposed a
magnetic levitation harvester, similar with the generators designed
by Silva et al. (2012, 2013) and Morgado et al. (2012), to generate
energy from human motion, but they optimized it to generate energy
inside backpacks. The mechanical deformation of piezoelectric
cantilever beams is being quite studied for mechanical to electrical
energy conversion. However, the literature has shown that they
maximize the power generation within vibration spectrums not
matching with the frequencies of the hip joint (Gu and Livermore,
2011; Ly et al., 2011; Morris et al., 2008; Moss et al., 2011; Sue and Tsai,
2012; Zhu et al., 2010). Considering all constraints presented in this
Section 4, one can conclude that customized harvesters must be
studied specifically for orthopaedic implants. Power generation sys-
tems, comprising motion-driven electromagnetic energy harvesters,
secondary batteries and/or supercapacitors, are potential solutions to
power instrumented hip implants for long-term requirements. Mag-
netic levitation configurations are particularly interesting because they
keep their performance throughout time (their performance changes
are insignificant) and they are maintenance-free. We propose the
development and optimization of the following three configurations of
motion-driven electromagnetic harvesters: (i) magnetic levitation
systems using several free permanent magnets, in order to optimize
the characteristics of each magnet according to the hip motions
(Fig. 4a); (ii) magnetic levitation systems using several independent
windings, so that the optimization of the characteristics of each
winding, as well as their operation mode, can be conducted
(Fig. 4b); (iii) magnetic levitation systems using hollow permanent
magnets around independent windings (Fig. 4c). The research for a
match between the use of several free magnets and several indepen-
dent windings is encouraged. It must also be optimized the relation
between the minimization of the generators′ dimensions and the
maximization of their power generations. The implementation of
electrostatic energy harvesters is an alternative approach to power
passive or active implants. However, due to their limited ability to
power medical devices by human body motion (Mitcheson et al.,
2004; Sue and Tsai, 2012), they are best suitable as secondary power
generators. So, the study of the motion-driven magnetic levitation
generators must be conducted firstly.
Fig. 4. Promising motion-driven electromagnetic harvesters to power instrumen-
ted hip joint replacements and instrumented fracture stabilizers (in section view):
(a) magnetic levitation system comprising four permanent magnets, two of which
are free magnets; (b) magnetic levitation system comprising four independent
windings and one free permanent magnet; (c) magnetic levitation system com-
posed by three hollowed permanent magnets and three independent windings
around one free magnet.
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Chapter 4
Cosurface-based capacitive
stimulation of bone remodeling
Previous chapters highlight that instrumented implants and biophysical stimulators
already developed are not suitable for designing instrumented active implants capable of
administrating therapeutic trajectories from uncontrolled to controlled osseointegration.
Up to date, only instrumented passive implants have been implemented and no effective
biophysical stimulation systems (including those based on electrical and/or magnetic field
stimulation) were engineered with potential to ensure a high controllability over the
peri-implant bone structures and bone-implant integration. Hence, a new concept model for
instrumented active implants must be developed: instrumented active implant with ability
to deliver controlled and personalized biophysical stimuli to target tissue areas. Such aim
will be only achieved if electrical and/or magnetic stimulation systems meets the following
demands:
1. to deliver non-cytotoxic and non-genotoxic stimuli;
2. to be able to deliver controlled and personalized stimuli, such that time-dependent
stimuli (varying waveform, strength, frequency, periodicity, stimulation exposure,
etc.) can be applied to various regions of target tissue;
3. to ensure everlasting operation throughout the lifetime of patients, such that revision
procedures can be avoided;
4. to be able to apply therapeutic stimuli according to the osseointegration states;
5. to allow miniaturized, stretchable and exible integration inside the implant system;
6. to require low electric power consumption.
From the three different methods of administering electromagnetic fields to bone
(direct current, inductive coupling and capacitive coupling), the capacitive-based electrical
stimulation emerge as the most feasible to fulfil these demands. Noteworthy, the use
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of electrodes in parallel configurations require stepped implants’ surfaces, which are not
the most appropriated to optimize the bone-implant fixation. Therefore, non-parallel
configurations, which can be embedded in active implantable devices, have to be designed
and their osteogenic effects start to be evaluated. Promising results on the potential
of therapeutic actuation driven by cosurface-based capacitive stimulation were achieved.
They are reported in a study entitled ”New cosurface capacitive stimulators for the
development of active osseointegrative implantable devices” , which was already submitted
to a peer-reviewed international journal (Scientific Reports - Nature Publishing Group).
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Abstract
Non-drug strategies based on biophysical stimulation have been emphasized for the
treatment and prevention of musculoskeletal conditions. However, to date, no effective
stimulation system was ever proposed for intracorporeal therapies. This is particularly
true for active intramedullary implants aiming to optimize osseointegration. The increasing
demand of these implants, particularly for hip and knee replacements, drives the design of
innovative stimulation systems truly effective in bone-implant integration. A new concept
of a cosurface-based capacitive system is here proposed for the design of implantable
devices that deliver controllable and personalized electric field stimuli to target tissues.
The concept of cosurface-based delivery system was studied, a prototype architecture was
constructed for in vitro tests, and its ability to deliver controllable stimuli was numerically
analysed. Successful results on osteoblastic proliferation and differentiation were obtained
in the in vitro tests. This work provides for the first time a design of a stimulation
system that can be embedded in active implantable devices for controllable bone-implant
integration and regeneration. This unique insight, in the form of a cosurface design,
proposes a truly new line for implementing future personalized stimulatory therapies based
on the delivery of electric fields to bone cells.
Keywords: Regenerative medicine; personalized therapy; electrical stimulation;
instrumented active implant; capacitive coupling.
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Musculoskeletal (MSK) conditions are the second cause of global disability, affecting
more than 20% of the world population [1,2]. Increasing incidences of MSK disorders have
been observed in developed and developing countries over the last 20 years [2]. Included
is osteoarthritis, a major health problem with a global prevalence around 4%, and the
most common indication for both total hip and knee replacements [2–4]. Although both
of these are already among the most worldwide performed surgical procedures, upsurges
in their incidences are predicted in the forthcoming decades [3–6]. Sustained increases in
the incidences of knee and hip replacements are mainly due to the observed significant
increases in the aged, sedentary and obese population. Current and prospectively, these
surgeries represent a burden for individuals, for health systems and for social care systems
[3,4,6]. Worsening this scenario, surgical revisions of hip and knee replacements are usually
more complex and more invasive than primary replacements, and their revision rates may
exceed 10% [7–9]. Hence, implants must be projected to minimize disability and avoid
failures throughout the patients’ lifetime, which may represent implant lifetimes higher
than 50 years. The requirement of such improved duration implants is also emphasized by
the higher deterioration risks of the mid and long term fixed cemented implants and by a
significant increasing number of more active and younger patients[10].
Asymptomatic long-term fixation of orthopaedic implants requires their
osseointegration [10, 11]. Interlocking between bone and implant surfaces should be
accomplished at the micrometer and nanometer scale levels [11, 12]. However, bone loss
is a frequent phenomenon that turns the bone-implant fixation unstable [10, 13]. This is
mainly caused by adverse bone remodeling in response to wear debris and stress-shielding
and can result in aseptic loosening [10, 13]. To avoid this cause of implant failure [3, 4],
effective regeneration of the peri-prosthetic bone stock is required to ensure a correct
biologic interplay at nano- to macro-scale levels. The bone-implant topography and
the presence of osseointegrative stimuli have a significant influence over this outcome,
given their known influence on the biointegration mechanisms [11, 13]. For optimum
osseointegration to be achieved, these positive osseointegrative cues should be optimized
and according to personalized interventions, due to the inherent complexity of this process
and to the patients’ idiosyncrasies.
Pre-optimization of the implants’ design is a current methodology used to improve their
performance. Micro and nanometer-scale texture design of the implants’ surfaces, and
custom-made geometries, are sophisticated methods aiming to maximize the host-implant
responses [12, 14]. Advanced biomaterials, inert and nearly-inert, have been sintered to
improve the mechanical properties of the bone-implant interface, including bioceramics
and biocompatible metals and alloys [15]. These approaches are nevertheless used to
optimize passive implants, i.e., implants without resources to promote bioactivity. However
and regardless of their materials, design, rehabilitation protocols, or surgical procedures
used, these passive implants were recently demonstrated to be unable to minimize failures
throughout the implants’ lifetime [16]. For optimal performances to be achieved, novel
implants should also be able to perform trajectories from failure states to without-failure
states [16]. By consequence, they must be biologically active throughout their lifetime [16].
Actuation systems based on biomaterials and drug-delivery systems are being explored
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to produce clinically-useful active implant systems. Innovative bioactive biomaterials
for coating uncemented implants have been exhaustively researched [17–19]. Another
promising approach to enhance osseointegration and prevent peri-operative infections is
to impregnate coatings with drugs (gentamicin, tobramycin and vancomycin, etc.) and/or
biomolecules (growth factors, collagen and proteins, etc.) [17, 20–22]. These solutions
can however present important drawbacks for bone-implant optimal bonding, namely: (i)
extremely complex designs may be required, mainly for multifunctional coatings [17]; (ii)
their controllability is reduced, as their behavior can not be changed after implant insertion;
(iii) their delivery dynamics do not consider current biochemical and biomechanical states
of the target bone tissues; (iv) their ability to perform personalized delivery is quite limited;
(v) long-term release of bioactive substances by these implants is currently unfeasible
and will most likely be quite difficult to implement in the forthcoming years; (vi) the
simultaneous delivery of different stimuli to different and nearby tissue areas is hard to
achieve; (vii) these solutions are unable to perform controlled time-dependent trajectories
of the bone formation process.
To date, only instrumented passive systems were implanted in human patients [8, 9].
Their operations have been restricted to measure biomechanical and thermodynamic
quantities (forces, moments, deformations and temperatures) in vivo [23–25]. Instrumented
implants that can ultimately control bone regrowth are highly desirable, particularly when
designed to comprise inner monitoring and delivery systems. In this scope, efforts have been
focused on the development of biophysical stimulation systems, to exploit the potential of
organic adaptation to exogenous excitations. Encouraging results were found in vivo by
mechanical stimulation driven by piezoelectric actuators [26], but there is an increased
risk of weakening the bone-implant interface bonding if the stimulators are located in
the implants’ surface. However, no technological solutions to stimulate target tissues
were found that used stimulators housed inside implants. Ultrasound stimulation is hard
to accomplish by instrumented implants: besides the high complexity of the required
implant’s designs, they may demand a hollowed structure that increases the implant
fracture risks. When intramedullary implants were modified to deliver magnetic field (MF)
stimuli induced by permanent magnets, a notable bone formation was observed around the
implant [27]. Since these are static stimuli, not suitable for controllable and personalized
tissue responses, their substitution by electromagnetic-stimulating hip systems has been
proposed; these would permit to deliver a controllable electric field (EF) stimulation
[28]. This solution is still not able to deliver different stimuli to very close targets
and, consequently, unable to geographically control the evolution of the bone formation
process. This results from the following: (i) the stimulators’ electrodes are attached to the
implant’s surface; and (ii) the electrical fields are obtained using extracorporeally-induced
magnetic fields. Indeed, the current clinical practice that uses biophysical stimulation
for bone remodeling is focused on delivering extracorporeal stimuli. This method does not
concentrate the stimuli density over the bone-implant interface, as desirable, but mainly on
the tissues surrounding the skin. Another method of delivering EF/electromagnetic (EMF)
stimulation, with proved in vitro osteogenic responses [29, 30] is the capacitive coupling
(CC) stimulation. Up-regulatory effects on various cellular mechanisms that underlie bone
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formation can be obtained when using CC stimulators to deliver stimuli to osteoblasts
in vitro (cell lines, stem cells and primary cells) [31–34]. Extracorporeally-induced CC
stimulation has also been used in clinical trials; its ability to improve the treatment of
nonunions and osteoarthritis, as well as to minimize post-treatment complications, have
been reported [29]. Nevertheless, the CC most common architecture uses electrodes in
parallel (Fig. 1) and cannot be integrated into instrumented implants, since the resulting
stepped implant’s surface would most likely hinder bone-implant integration.
Significant advances in the scope of active implants will be achieved if solutions for
long-term, highly controllable and personalized bone-implant bonding are developed. In
this paper, we propose a novel therapeutic delivery system with potential to meet these
demands.
Fig. 1: CC stimulation apparatus using electrodes in parallel configuration: a. in vitro
stimulation of bone cells. b. In vitro stimulation of bone tissues. c. Clinical usage of CC stimulation.
The concept of cosurface-based capacitive delivery
system
Optimized osteogenic responses can be achieved if the stimulation systems fulfil the
following requirements:
(a) to deliver non-cytotoxic and non-genotoxic stimuli;
(b) to be able to deliver controllable stimuli, such that different stimuli (varying
waveform, strength, frequency, periodicity, stimulation exposure, etc.) can be applied
to various regions of target tissue;
(c) to allow defining time-dependent stimulation for personalized medicine;
(d) to ensure everlasting operation throughout the lifetime of patients, such that revision
procedures can be avoided;
(e) to be able to apply therapeutic stimuli according to the osseointegration states;
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(f) to allow miniaturized, stretchable and/or flexible integration inside the implant
system.
To our best knowledge, the methodologies proposed so far are unfeasible for effective
bone remodeling. We here propose a new concept for delivering EF stimuli that complies
with the six requirements above described: the cosurface-based CC delivery system. This
is a non-complex and cost-effective system, with a non-parallel architecture, capable of
delivering EF stimuli using electrodes in the same surface, regardless its topology. It can
comprise as many electrodes as required, which may function independently, allowing the
delivery of EF stimuli to tissue areas in both a quasi-homogeneous and a heterogeneous
manner. Further, the electrodes can be shaped with arbitrary geometries and separated
from the adjacent electrodes by variable gaps. The solution here presented is in the form of
a stimulator composed by a set of identical stripe-shaped electrodes, separated from each
other by identical gaps (Fig. 2).
The strategy to fulfil the above describe requirement is as follows. EFs and EMFs
do not introduce toxic chemicals and do not induce immunogenic responses to foreign
bodies [35], although autophagy is significantly induced by very high EFs. Further, most
of studies analyzing potential EFs/EMFs genotoxic effects have not reported damage of
the genetic material [36]. Hence, requirement (a) will be most likely fulfilled if the field
strength-dependent toxicity of the delivered stimulus is taken in consideration.
Arbitrary and time-dependent excitations can be applied to each pair of electrodes,
including different waveforms (sinusoidal, square, triangular or sawtooth, as well
as arbitrary periodic or even non-periodic arbitrary ones), amplitudes, frequencies,
periodicities, daily stimulation exposures, resting time and total therapy duration. Various
regions of a target tissue can be differentially stimulated by defining the most appropriated
locations to embed the stimulators inside implants, by choosing optimized stimuli
parameters for each region, as well as by optimizing the cosurface architecture. Numerical
field analysis can be used to predict EFs/EMFs that are delivered to the peri-implant
bone volume, as a function of imposed excitations to electrodes, as well as to optimize the
stimulators’ design previously to the implant’s body insertion. Besides, homogeneity of the
delivered EF can be controlled by choosing which sets of electrodes pairs will be delivering
stimuli to an area(s) of the tissue. All these degrees of freedom provide the ability to
produce customized stimuli for personalizing the administration of either prophylactic or
corrective therapies. The stimuli controllability can be even increased since its delivery
can be made controlled by clinicians through the use of wireless communication between
the implant and extracorporeal systems [16]. Using these approaches, this new therapeutic
design is able to comply with requirements (b) and (c).
An everlasting operation, as required in (d), can be accomplished by designing
self-powered instrumented implants. Osseointegration states must be monitored for
optimal performance of implants [16]. Measurement operations can be performed by
the instrumented active implants (via monitoring systems housed inside implants) and/or
extracorporeally (through imaging techniques) [16]. These monitoring systems will allow
obeying requirement (e), and will establish a feedback control over the stimuli delivery.
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Stimulators must be positioned inside the implant, close to the implant’s surface,
and a biocompatible coating must be used to ensure an absolutely safe encapsulation, as
highlighted in Fig. 2a. The conformal integration of these stimulators with instrumented
implants, in a way that it withstands mechanical deformations and as stated by requirement
(f), is already feasible due to the current advances on materials, mechanics, and
manufacturing engineering [37].
An example of application of this concept is to embed stimulators in the proximomedial
region of instrumented active hip prosthesis, as illustrated by Fig. 2b. In this type of
prosthesis, stress distribution is usually reduced following arthroplasty, which can result
in bone loss and consequent implant failure [13]. This concept can also be used on other
intracorporeal implants and to stimulate many other tissues.
Results
This study provides a novel cosurface architecture for CC stimulators, a numerical
model for prediction of EFs/EMFs delivered to cell cultures, and the first osteogenic
in vitro responses obtained with such an apparatus. The less complex stimulation
apparatus that highlights the potential of this new approach was established by positioning
cell culture-containing petri dishes over the stimulators, which in turn are glued a
polycarbonate substrate (Fig. 2c,d). In this way, the petri dishes thickness (0.5 mm) avoids
cell-electrode contacts and allows a macro-scale mimicking of the stimulators embedded
into active implants (close to the implant’s surface). Stimulators are composed by 12
stripe-shaped copper electrodes of 2 mm wide, 1 mm thick and different lengths (2× 12
mm, 2× 20 mm, 2× 25 mm, 2× 28 mm, 2× 30 mm, 2× 31 mm). A 0.5 mm gap between
electrodes was set. This geometry was specified for stimulating cell cultures on petri dishes
of 35 mm of diameter. Two equally charged electrodes were never laid one after the other
(anodes are always surrounded by cathodes) such that EF homogeneity can be maximized.
Biological in vitro experiments were carried out to analyse the three principal stages
of bone remodeling (cellular proliferation, matrix maturation and matrix mineralization)
[38]. MC3T3 cells were chosen due to their inherent capability to reproduce osteoblastic
proliferation and differentiation, similar to in vivo bone formation [39]. Stimulators were
powered by excitations that were chosen on the following bases: the parameters chosen
have proved osteogenic effects in studies in vitro using parallel CC stimulators; data from
our pilot experiments was taken into consideration, as this capacitive stimulation method
was never tested before; likewise, constraints imposed by instrumented active implants to
electrically power the cosurface stimulators were also considered. To our best knowledge,
the osteogenic effects of only three different stimuli, delivered in vitro to MC3T3 cells,
are reported in the literature [31, 40, 41]. These stimulation assays were nevertheless not
designed to assess the three stages of osteogenesis, and are only reported to enhance the
proliferation rates of these cells [31, 40]. Generally, among the EFs already used to in
vitro stimulate bone cells, many of them have used strengths lower than 1 V/mm and
electrodes’ excitations up to 10 V, and at least one osteogenic stage of bone remodeling was
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Fig. 2: Cosurface-based CC stimulators according to a striped pattern: a. Embedded for
operating inside implant systems. b. Example of instrumented hip prosthesis with ability to control
osteoregeneration using these stimulators. c. Apparatus for analysing the osteogenic results in vitro in
the pre-confluent cell culture (MED2). d. Apparatus for analysing the osteogenic results in vitro in the
confluent cell culture (MED3).
up-regulated in each study [31,34,38,41–43]. Much higher EF strengths (up to 21 V/mm)
also enhance osteogenic effects, but very high voltages (hardly achievable by instrumented
implants) are required to electrically supply the stimulators [33, 44]. Hence, appropriated
voltages that generate EFs capable of enhancing osteogenesis were tested in MC3T3 cells
with our cosurface CC apparatus. Frequency is among the main parameters that influence
the osteogenic outcome [29,35]. Since increased osteogenesis has been reported mainly for
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low frequencies (lower than 16 Hz) [33,40,45], but also for high frequencies (60 kHz) [41,46],
two frequencies within these ranges were also analysed using the cosurface CC stimulator.
Given that a large number of studies on EF/EMF-induced bone cells stimulation have
powered electrodes with sinusoidal excitations [30,31,41,42], this tested stimulus’ waveform
was also elected. The daily exposures were defined from other in vitro studies, where these
parameters revealed to be osteogenic [38, 43, 47, 48]. Cosurface CC stimulators were thus
supplied by two excitations, according to the following parameters:
• LF EX: 5− 5cos(28pit) V (sinusoidal waveform, 10 V amplitude, 14 Hz frequency),
4 h/day exposure, 21 days of exposure;
• HF EX: 5− 5cos(120× 103pit) V (sinusoidal waveform, 10 V amplitude, 60× 103 Hz
frequency), 0.5 h/day exposure, 21 days of exposure.
The Marxell’s equations governing the dynamics of EF and MF fields were solved by
numerical analysis. The spatially distributed EF and MF strengths were identified when
delivered to:
(a) An empty plate, only filled with air (MED1);
(b) A plate with a pre-confluent cell culture (MED2) (Fig. 2c), considering this as an
approximation of two homogeneous phases, one above the other: 1) a cellular layer
(of 10 µm thickness) adherent to the bottom surface of petri dishes, because of the
high percentage of adhesion of MC3T3 cells to polystyrene surfaces [49]; covered by
2) the cell culture medium (a liquid solution of 1 mm thickness);
(c) A confluent cell culture (MED3) similar to MED2 (Fig. 2d), but now assuming the
adherent organic layer as resembling an organized cellular tissue of 20 µm thickness,
composed by MC3T3 cells and collagen type-I (since this protein corresponds to
≈90% of the bone organic matrix).
Such analyses were carried out to characterize how cell cultures are stimulated
throughout proliferation (pre-confluent and confluent cultures) and differentiation (fully
confluent culture) stages, as well as to study the influence of the dielectric properties of
each phase (air, organic, liquid) on the stimuli delivery. Noteworthy, a model to predict
EFs and MFs that stimulate cells during the matrix mineralization stage was not conducted
in this study.
As illustrated in Figs. 3a,b, EFs ranging between 0.027-9 V/mm are found 0.5 mm
above electrodes on MED1 at pi rad of LF EX and HF EX. Higher EFs are concentrated
above the gaps (fields in the range between 5-7 V/mm in z =0.5 mm), and according to
sinusoidal dynamics 100% cross-correlated with the excitations’ dynamics (CC = 100%), as
shown in Figs. 4a,b. Negligible H-fields (lower than 1.6×10−11 A/m, resulting in B-fields
lower than 2×10−17 T) through the air are registered (Figs. 3c,d). Supplementary Fig.
S1 provide a selected set of simulation results that highlight the ability of the cosurface
stimulator to deliver controllable stimuli to target regions on MED1. As shown, arbitrary
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(sinusoidal, squared, triangular, sawtooth, etc) EFs can be generated by this stimulator at
a required frequency. The EF dynamics is quite similar to the excitation dynamics, as it
can be also observed by cross-correlations near 100% between the generated EF waveforms
and the excitation waveforms. Besides, required EF strengths can be obtained by defining
proper excitation amplitudes, as fields’ strengths are directly related to the excitation
amplitudes (Supplementary Fig. S2a).
Throughout the proliferation stage (MED2), MC3T3 cells will be approximately
stimulated with EFs lower than 0.6 V/mm (Figs. 3e,f and Supplementary Fig. S3a,b,i,j).
In contrast to EFs distributions through MED1, the highest EFs on the cellular layer of
MED2 are situated above the electrodes, due to the high electrical conductivity of the
cell culture medium. Quite similar stimuli are then delivered to most cells located in z
∈ [0.5 0.51] mm (Figs. 3e,f, 4c,d) according to a frequency-dependent behavior (CC =
100%). Most cells are stimulated with maximum EFs around 0.16 V/mm for LF EX, and
around 0.36 V/mm for HF EX. The cellular layers are stimulated with different EFs when
electrodes are excited with HF EX, although small differences are noticed [lower than 0.025
V/mm on the midpoint located at (x, y) = (1.25, 0) mm above an electrode (Fig. 4d)].
Noteworthy, the highest EF strengths are found in the midplane (z=0.505 mm) of a cellular
layer. The B-fields (Figs. 3g,h) are more than 10×1010 fold lower than the lowest observed
osteogenic magnetic fields reported in literature (either at low or high frequency)[50] and
will most likely induce neglecting osteogenic effects. Hence, the following two stimuli were
approximately delivered to cells in the pre-confluency stage:
• LF ST: 0.08 − 0.08cos(28pit) V/mm (sinusoidal waveform, 0.16 V/mm amplitude,
14 Hz frequency), 4 h/day exposure, unto 21 days of exposure;
• HF ST: 0.18 − 0.18cos(120 × 103pit) V/mm (sinusoidal waveform, 0.36 V/mm
amplitude, 60 kHz frequency), 0.5 h/day exposure, unto 21 days of exposure.
The biological effects of these stimuli on the viability and proliferation of the
pre-osteoblastic MC3T3 cells were then analysed. The non-toxic resazurin method was
used to monitor cell viability with time in culture. 1.8 × 104 cells.cm−2 cells were plated
and followed by various days in vitro (DIV) (Fig. 5a). Since no significant differences
were observed at this initial cell density, and major alterations in cell proliferation usually
occur at the pre-confluent period, lower initial cell densities were tested afterwards (1×103,
5× 103 and 10× 103 cells.cm−2). In this test, cells were directly scored after 1 DIV (24 h)
using an exclusion dye (Fig. 5b). Both LF ST and HF ST tended to increase cell number in
these conditions, but more consistently and significantly at the lowest cell density (1× 103
cells.cm−2) (Fig. 5b).
During MC3T3 cells differentiation (MED3), which occurs following culture confluency
and cell division arrest, quite similar EFs are approximately delivered to the cells (z ∈
[0.5 0.52] mm), as shown in Figs. 3i,j, 4e,f and Supplementary Fig. S3e,f,m,n. Small
differences between the EF strengths stimulating the first layer of cells and the other layers
are envisaged in the responses to HF EX [approximately 0.06 V/mm on the midpoint
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Fig. 3: Simulation results of EF and MF distributions and strengths. a. 2D EFs stimulating
cells at pi rad: LF ST, MED1. b. 2D EFs stimulating cells at pi rad: HF ST, MED1. c. 2D MFs
stimulating cells at pi rad: LF ST, MED1. d. 2D MFs stimulating cells at pi rad: HF ST, MED1. e. 2D
EFs stimulating cells at pi rad: LF ST, MED2. f. 2D EFs stimulating cells at pi rad: HF ST, MED2. g.
2D MFs stimulating cells at pi rad: LF ST, MED2. h. 2D MFs stimulating cells at pi rad: HF ST, MED2.
i. 2D EFs stimulating cells at pi rad: LF ST, MED3. j. 2D EFs stimulating cells at pi rad: HF ST, MED3.
k. 2D MFs stimulating cells at pi rad: LF ST, MED3. l. 2D MFs stimulating cells at pi rad: HF ST,
MED3. 2D EFs and MFs reported for MED1, MED2 and MED3 refer respectively to the strengths on
z=0.5 mm, z=0.505 mm and z=0.51 mm above electrodes.
located at (x, y) = (1.25, 0) mm above an electrode (Fig. 4f)]. B-fields stimulating cells
also present similar strengths as the ones observed for MED2. Consequently, these MFs are
most likely not a driving factor enhancing osteogenesis. It should also be noted that the
stimuli delivered to MC3T3 cells throughout matrix formation and maturation are similar
to those delivered during cell proliferation. Hence, hereafter LF ST and HF ST will be
referred as the biophysical stimuli enhancing osteogenic effects during these two first stages
of bone remodeling.
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Fig. 4: Simulation results of EF strengths on the midpoint (x, y)=(1.25, 0) mm above a
gap. a. EFs in [0 2pi] rad: LF ST, MED1, z=0.5 mm (CC =100%). b. EFs in [0 2pi] rad: HF ST, MED1,
z=0.5 mm (CC =100%). c. EFs in [0 2pi] rad: LF ST, MED2 (CC =100% for z=0.5 mm, z=0.505 mm
and z=0.51 mm). d. EFs in [0 2pi] rad: HF ST, MED2 (CC =100% for z=0.5 mm, z=0.505 mm and
z=0.51 mm). e. EFs in [0 2pi] rad: LF ST, MED3 (CC =100% for z=0.5 mm, z=0.51 mm and z=0.52
mm). f. EFs in [0 2pi] rad: HF ST, MED3 (CC =100% for z=0.5 mm, z=0.51 mm and z=0.52 mm).
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Fig. 5: Influence of the LF ST and HF ST on the number of viable pre-osteoblastic cells.
MC3T3 cells were seeded at 1.8 × 104 cells.cm−2 and daily exposed to: a. NO ST and LF ST or b. NO
ST and HF ST. The number of viable cells was indirectly accessed by the metabolic reversible resazurin
assays at the indicated days in vitro (DIV) (n=6). c. The number of viable cells was directly scored 24 h
upon seeding the MC3T3 cells at increasing cell densities: 1× 103, 5× 103 and 10× 103 cells.cm−2. Cell
number was scored using Trypan blue, a membrane exclusion dye (n=7-15). All data are presented as fold
increases (FI) over control (NO ST) levels at 1 DIV.
The biological outcomes resulting from delivering the LF and HF stimuli during the
differentiation stage were evaluated. The production and secretion of collagen type-I
(’collagen-I’) and of a noncollagenous protein (osteonectin) were monitored. These are
widely used early biomarkers of osteoblastic differentiation, together with the activity
of the alkaline phosphatase (ALP) enzyme. When analysing the cellular (Fig. 6a) and
secreted (Supplementar Fig. S4) levels of osteonectin, no differences were detected between
the control cells (NO ST) and under LF/HF stimuli at various DIV. When assaying for
cellular ALP activity at 15 DIV, a time period of matrix maturation, again no significant
differences were detected (Fig. 6b). However, when collagen type-I levels were evaluated
and quantified in WB assays, a major increase (1.8-2.7 times) was observed at 7 DIV, and
particularly at 14 DIV, for cells daily exposed to the LF and HF stimuli (Fig. 6c,d). All
procollagen forms, from α monomers, β dimers, γ trimers, to collagen fibers were elevated.
The levels of secreted procollagen were also monitored, where at 14 DIV the LF and HF
stimuli also tended to increase the procollagen secretion (Supplementar Fig. S4).
Distribution of the cells and their collagen in the osteoblastic population was analysed
by confocal microscopy at 21 DIV. This is a period usually associated with matrix
maturation and the onset of matrix mineralization. Intracellular and matrix collagen-I
was immunostained (in green); filamentous actin (F-actin, in red) was detected to evidence
the cellular contours and cell-to-cell contacts (Fig. 7). Stimulation of cells by cosurface
stimulators appeared to present a more organized cellular tissue, with better-defined
cell-to-cell contacts (Fig. 7), F-actin staining). When daily stimulated with the LF and
HF stimuli for 21 DIV, cells presented a higher content of collagen-I than control cells.
This is visible not only inside cells but also at the extracellular matrix (dotted staining
in Fig. 7 zoomed-in ROIs). At this period, the highest intensity of the matrix collagen
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appeared to result from LF stimulation.
Since a recently developed organic matrix needs to be mineralized to generate a
functional mature bone matrix (stage three), the status of matrix mineralization was
further assessed. Alizarin Red, a dye that stains calcified extracellular matrices, was used.
Figure 8 photographs of representative Alizarin Red-stained circular plates and zoomed-in
microphotographic insets reveal that the different frequencies had opposite effects on matrix
mineralization. While stimulus induced by LF stimulus tended to maintain or even slightly
Fig. 6: Relative expression and activity of three matrix maturation protein markers. a.
Immunoblot analysis of the osteonectin expression in MC3T3 cells exposed for 7 and 14 DIV in vitro to
NO ST, LF ST and HF ST. β-actin was used as loading control; no differences were observed in between the
experimental conditions. b. The intracellular ALP activity was quantified in 1.8× 104 cells.cm−2 MC3T3
cells daily exposed to the LF ST and HF ST for 15 DIV. ALP activity values, determined by measuring
the conversion of the ALP substrate (p-Nitrophenyl phosphate) at 405 nm by cells lysates, were divided
by the total protein concentration of each lysate. c. and d. The expression of cell-associated collagen-I
was analyzed by immunobloting the lysates of LF ST and HF ST stimulated cells (c.) and the levels of
collagen-I bands quantified for each condition (d.). NO ST, no electromagnetic stimuli. Collagen-I forms:
unprocessed and processed α1(I) and α2(I) procollagen monomeric chains (130-160 kDa); β(I), procollagen
dimeric forms (≈270 kDa); γ(I), procollagen trimeric forms (≈400 kDa); F(I), collagen fibrils.
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Fig. 7: Confocal microscopy analysis of intracellular collagen-I in MC3T3 cells exposed to
LF ST and HF ST for 21 DIV. Fixed cells were subjected to immunocytochemistry procedures in order
to detect type-I collagen distribution (green fluorescence). The cytoskeleton constituent filamentous actin
(F-actin; labeled with red fluorescing phalloidin) and nucleic acids (labeled with blue fluorescing DAPI)
were used as cellular counterstaining. NO ST, no electromagnetic stimuli. Bar, 10 µm. ROI is the region
of interest of the green (collagen-I) channel (zoomed 2×).
increase matrix mineralization, daily stimulation with the high frequency stimulus led to
a decrease in cellular mineralization (Fig. 8).
Although only the LF ST and HF ST were biologically tested in this work, the ability
of the cosurface stimulator to deliver other required stimuli to target regions during the
first two stages of bone remodeling is also demonstrated. As shown in Supplementary Fig.
S5, EFs with required arbitrary waveform, field strength and frequency can be delivered
to the cellular layers. Further, different and nearby tissue areas can be simultaneously and
differently stimulated by supplying electrodes with different excitations, as illustrated by
Supplementary Fig. S6.
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Fig. 8: Visual analyses of the levels of matrix mineralization in MC3T3 cells exposed to
EMFs generated by LF and HF stimuli for 21 DIV. Fixed cells in 35 mm culture plates were
subjected to cytochemistry procedures with Alizarin Red, which marks calcified extracellular matrices.
Photographs of representative Alizarin Red-stained circular plates are shown, together with zoomed in
insets taken with a light microscope under a 10× objective (right rectangles). NO ST, no electromagnetic
stimuli. Bar, 50 µm.
Discussion
Stimulation of osseointegration is an essential capability of implants [10]. Although
the primary stability following implantation is obtained by mechanical press-fit, secondary
stability requires optimized bone remodeling, both on host bone and implant surfaces
(distance and contact osteogenesis) [10]. Control of the peri-prosthetic bone stock is
mandatory to avoid surgical revisions caused by adverse bone remodeling, due to alterations
on bone stress distribution that can occur after implant insertion [10, 13]. We here
started to analyse the potential of delivering EMF stimuli via cosurface CC stimulators to
control osseointegration, and began to monitor their effectiveness in delivering desirable
EF stimuli to target regions and in enhancing bone (re)growth. By only testing two
stimuli, promising results were achieved on the capability of the cosurface stimulators to
induce positive osteogenic responses to different stages of bone remodeling. The cosurface
stimulation apparatus was effective in inducing cellular proliferation at early time points
and when the culture was at low cell densities. Subsequently, both LF and HF stimuli
highly induced cellular collagen-I at the matrix maturation period (7-21 DIV), including
its incorporation at the extracellular matrix (21 DIV). Regarding the third stage of
osteogenesis, this CC architecture was observed to maintain or even slightly increase matrix
mineralization (delivering the LF stimuli) or to postpone it (delivering the LF stimuli).
The success obtained in terms of osteoblastic proliferation and differentiation supports the
future application of cosurface stimulators in personalized biophysical-based therapies for
bone-implant integration. Such purpose requires further research to identify the interplays
between the stimuli parameters and their osteogenic outcomes. More systematic studies
must be conducted, analysing how bone cell model systems (as immortalized lines, stem
cells, and primary cultures) respond to the various stimuli generated by the cosurface
architectures. Biological readouts should include cell proliferation, production of structural
and regulatory matrix proteins (collagen type-I, fibronectin, alkaline phosphatase, etc.),
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and matrix maturation and mineralization markers (as osteopontin, osteocalcin, bone
sialoprotein, hydroxyapatite mineral crystals, etc.). An extensive understanding of these
cellular responses to electrical and magnetic fields is essential for optimizing stimuli
parameters to be used in therapeutic stimulation of the bone tissue.
Since this study portrays the first analysis of cosurface CC stimulation when delivering
EFs and MFs to bony cells, and due to their inherent more complex dynamics when
compared to parallel CC stimulation, we have considered the less complex models that
could make an approximate prediction of how MC3T3 cells were stimulated by EFs and
MFs. Three assumptions were then taken into account: (1) during the proliferation stage,
the cellular phase is approximately homogeneous and mainly composed by MC3T3 cells; (2)
the achieved cellular tissue formed after cell confluency and before matrix mineralization
is also nearly homogeneous and mainly composed by MC3T3 cells and collagen-I; (3)
the dielectric properties of MC3T3 cells and hydrated collagen are similar. Undoubtedly,
further research efforts must be conducted to develop more complex models. Nevertheless,
under the conditions here established to carry out the stimulation tests, minor influences on
EFs and MFs are expected as a result of the low concentrations of the physiological culture
medium around cells, the time-dependent dielectric properties of the cellular medium due to
dynamics associated to the proliferation and differentiation stages, and the heterogeneity of
the different phases, among others. However, more complex dielectric structures will most
likely be observed as higher concentrations of inorganic components of the bone matrix
are deposited extracellularly, which will require the development of more complex models.
The use of numerical models is also envisaged in future research aiming to investigate
the capability of the cosurface stimulator to deliver desirable EFs to target regions of the
cancellous bone tissue, namely by designing accurate models defining the inhomogeneity
of trabecular structures resulting from their liquid content and crystalline and amorphous
mineral and organic phases. Finally, numerical analysis can also enable the geometric
optimization of cosurface architectures, such that required surface shapes can be designed
to optimize stimuli parameters such as EF strengths, directions, homogeneity, etc. The final
aim is to embed these novel cosurface CC stimulators into self-powered instrumented active
implants for controlling the peri-implant bone volume. Such methodology may achieve a
superior implant performance due to its potential for tracking optimized spatio-temporal
trajectories of osteoblasts proliferation, matrix maturation and mineralization [16]. These
future implants will be ultimately controlled by a clinician. Besides the innovations carried
out to design an efficient therapeutic delivery system, which is the subject of this paper,
other significant technological advances have been achieved that optimize other systems
required to the full operation of instrumented active implants, namely their communication,
monitoring and powering systems. Telemetric systems have been developed for establishing
communication between instrumented implants and extracorporeal systems [8,23–25]. This
communication can be optimized for monitoring the osseointegration status and establish
a therapeutic stimulation based on the decisions of the clinician. Instrumented implants
can thus be designed as slave systems commanded by master systems located outside the
patients’ body, allowing to define and modify time-dependent therapeutic commands [16].
Hence, the stimuli parameters, such as field strength, frequency, periodicity, activation
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time, resting time, supply duration, field homogeneity, among others, can be changed after
implanted and according to the patients’ idiosyncrasies.
Research has been also conducted to develop self-powered instrumented implants for
everlasting stimuli delivery [44, 51]. Electromagnetic and piezoelectric energy harvesting
systems and power management architectures have been optimized for such purpose [52].
Such capability can enable a superior implant performance as the stimuli delivery can be
performed autonomously throughout the routine activities of patients [16]. In parallel,
some breakthroughs involving acoustic sound analyses and motion-driven piezoelectric
sensing [8] have appeared and will support the development of instrumented implants
capable of aseptic loosening detection. Finally, electrodes can now be projected to ensure
outstanding electric conductivity properties under large mechanical deformations, which is
highly desirable for designing stretchable and flexible cosurface stimulators [37].
Materials and Methods
Construction of the co-surface CC stimulator and numerical
modulation
Electrodes were fabricated in copper due to their very high electrical conductivity.
Stripes were machined by conventional technology. The polystyrene dishes and
polycarbonate substrates were chosen due to their very high electrical resistivity.
Thicknesses of 0.4 mm and 0.5 mm for polycarbonate substrates and polystyrene dishes
were respectively used.
The finite element method was used to solve the constituent Marxell’s equations
governing the dynamics of EFs and MFs. The numerical model was developed using
the AC/DC module of COMSOL Multiphysics R© (v. 4.4, COMSOL). The finite elements
were assembled by creating refined 3D ’extra fine’ tetrahedral mesh (1.5×106 elements) to
tessellate the entire geometry of materials and media used to simulate the delivery of EFs
and MFs. The dielectric properties of MC3T3 cells were considered as previously reported
by Ozawa et al. [40] and Wiesmann et al. [32]. Similar dielectric properties of MC3T3
cells and hydrated collagen were assumed based on studies conducted by Tomaselli and
Shamos [53, 54]. Electric conductivity and permittivity of the physiological medium were
established respectively as reported by Pucihar et al. [55] and Ozawa et al. [40]. The full
list of dielectric and magnetic properties of materials and media are summarized in Table
I. Simulations were carried out using the Newton iterative method due to its convergence
effectiveness and efficiency.
Cell culture stimulation
The osteoblastic MC3T3-E1 cell line (ATCC, Barcelona, Spain; CRL-2593), established
from C57BL/6 mouse calvaria, is widely used as a model for studying the various stages of
osteogenesis in vitro and due to the similarity to primary calvaria osteoblasts. Cells were
146
maintained in a humidified atmosphere at 37◦C/5% CO2, in 2 mM glutamine-containing
Minimum Essential α-Medium in Eagle’s balanced salt solution, supplemented with
10% (v/v) fetal bovine serum, 1% (v/v) of a 100 U.mL−1 penicillin and 100 mg.mL−1
streptomycin solution (Gibco BRL, Invitrogen, Life Technologies, Carlsbad, CA, USA),
and 3.7 g.L−1 NaHCO3. Cellular subcultures were performed using 0.05% trypsin/EDTA
(Gibco BRL, Invitrogen). Stimulation of cells was carried out inside a CO2 incubator
(Galaxy 14S, New Brunswick Scientic) featuring a communication port that was employed
to deliver electric signals to electrodes.
Excitations to power stimulators were congured using a real-time application that was
developed using Simulink (v. 7.3, Mathworks) and the Real Time Workshop (v. 7.3,
Mathworks) and run using the Real Time Windows Target (v. 3.3, Mathworks) kernel.
Excitations were generated by an IO card (MF 624, Humusoft).
Resazurin metabolic and Trypan blue cell score assays
The resazurin colorimetric assay, which analyses the amounts of NADH/NADPH
produced by metabolic active cells, was used to determine the effect of LF ST and HF ST
on cell viability (as previously described [56]). Briefly, at 1, 3, 5, 7, 14 and 21 DIV, cells
were incubated for 4h with a 10% resazurin (Sigma-Aldrich) in MEM medium solution.
Resazurin reduction was spectrophotometrically measured at 570 and 600 nm (Infinite
M200 PRO, Tecan); the OD 570/OD 600 nm ratio was calculated for each condition [56]
and presented as fold increases over control cells (NO ST) levels at 1 DIV. The trypan
blue (Sigma-Aldrich) membrane exclusion assay was used in direct cell scoring to assess
cell proliferation. Briefly, cells (1 × 103, 5 × 103, 1 × 104) were plated into 35 mm dishes
(≈10 cm2) with 1 mL fresh media. Upon 24 h in culture at 5% CO2/37◦C (either on
the cosurface CC stimulators or not), the number of viable cells was scored (as previously
Table I: Dielectric and magnetic properties of materials and media used to simulate EF
and MF stimulations.
Relative
electric
permittivity
Electric
conductivity
(S/m)
Relative
magnetic
permeability
Electrodes 1 6× 107 1
Petri dish 2.6 6.7× 10−14 1
Substrate 3 6.7× 10−14 0.866
Air 1 0 1
Cellular medium
(MED1 and MED2)
73 1.6 1
Physiological medium
(MED1 and MED2)
73 1.2× 10−7 1
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reported [56]).
Alkaline phosphatase activity
ALP is an enzyme that hydrolyzes organic phosphates to increase phosphate
concentration and prepare the cell for matrix mineralization by hydroxyapatite crystals.
Intracellular ALP activity was measured at 15 DIV using ALP substrate (p-Nitrophenyl
phosphate, Merck Chemicals). Briefly, cells were washed with PBS, collected in Triton
X-100 1% and incubated at 4◦C, 200 rpm. After sonication on ice (30 sec), the cellular
content was homogenized and an aliquot (20 µl) transferred to a 96-well plate in triplicate.
After incubation with 200 µl of the ALP substrate (1 h at 37◦C in dark), the enzymatic
reaction was quantified in a microplate reader at 405 nm.
Western blot analyses
At 7 and 14 DIV, cells and conditioned media were harvested into SDS 1% solutions and
subjected to a 5-20% gradient (cells lysates) or 7.5% (cell media) SDS-PAGE and to western
blot (WB) analyses (as previously described [57]). Previous to WB, ponceau S reversible
staining was first used for detection of total protein content on nitrocellulose membranes
[58]. After overnight incubation at 4◦C with the primary antibodies [rabbit anti-collagen
type I (1:1000); rabbit anti-osteonectin (1:500); mouse anti-β-Actin (1:1000), all from
Novus Biologicals, Germany], horseradish peroxidase-linked (GE Healthcare, Chalfont St.
Giles, UK) antibodies for enhanced chemiluminescence (ECL) detection were incubated 2
h/RT. Protein bands were scanned and quantified (GS-800 R© Calibrated Densitometer and
Quantity One densitometry software, Bio-Rad), and WB data corrected to the respective
ponceau loading control (as previously reported [58]).
Morphological confocal microscopy analysis
MC3T3 cells grown on coverslips-containing 35 mm petri dishes and subjected for 21
DIV to LF and HF stimulation were fixed in 4% paraformaldehyde (PFA) for 20 min
and permeabilized with 0.1% Triton X-100 in PBS (15 min/RT). Immunocytochemistry
of collagen-I, F-actin staining with phalloidin, and nuclear staining with DAPI was as
previously described [59]. The anti-type-I collagen I antibody (1:250 in 3% BSA-PBS), a
FITC-conjugated secondary antibody (1:300 in 3% BSA-PBS), and red fluorescing Alexa
568-labelled Phalloidin (1:500) were used. Images were acquired with a plan-Neofluor
40×/1.30 oil objective in a LSM 510 META confocal microscope (Zeiss, Jena, Germany) (as
previously described [59]), in the iBiMED’s Imaging Facility, a node of PPBI (Portuguese
Platform of BioImaging).
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Alizarin red staining (ARS) visualization and quantification
Matrix mineralization was analysed as previously described [60]. Briefly, cells were
washed in PBS, fixed in 4% PFA/20 min, washed in dH2O and incubated with Alizarin
red solution (40 mM, pH4.1, Sigma; 20 min/RT). Non-incorporated staining was removed
and cells thoroughly washed before image acquisition.
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Chapter 5
Self-powering systems for
instrumented implants
Instrumented active implants must be suitably powered with electric energy to ensure
their control operations over the peri-implant bone volume. As noticed in the literature
review (section 3.3), these implants have been electrically supplied only by inductive
powering or battery systems. According to the requirements that must be fulfilled to ensure
a controlled and personalized osseointegration (section 4), self-powering systems must be
designed to support the everlasting operation of the actuation, monitoring, communication
and processing systems. Furthermore, their ability to readily provide electric power is a
fundamental criterion to ensure that any of the stimulatory therapies chosen by the clinician
are performed, although there are always constraints that confine the power consumption.
Nevertheless, energy harvesting and storage systems must allow the therapeutic actuation
throughout the routine activities of patients. Such requirements for powering instrumented
active implants demand further advances on the optimization of energy harvesting systems.
Promising results on the potential of motion-driven electromagnetic and piezoelectric
energy harvesters were achieved.
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5.1 Electric energy harvested from hip motions
There are important advantages using magnetic levitation to harvest electric energy:
(a) harvesters are low-cost, maintenance-free, non-complex and easy to manufacture; (b)
harvesters operate autonomously with stable performance during long time periods; (c)
intelligent control algorithms can control the position of their components according to the
excitations’ characteristics. These advantages can be explored to power instrumented hip
implants. As highlight the viability analysis reported in section 3.1, this motion-driven
method is among the most promising ones to effectively supply these implants. To start
analysing if hip motions of human patients can be used to power instrumented hip implants
during normal daily activities, an experimental test was designed to determine the amount
of energy harvested by a magnetic levitation-based electromagnetic energy harvester
during walking. Preliminary results were achieved without geometric optimization of
harvesters prior to fabrication or intelligent control algorithms to maximize the energy
harvesting. This study is entitled ”An electical power supply system for instrumented
hip joint prostheses” and is published in the Proceedings of the 7th World Congress of
Biomechanics1.
1As the content of this study is already published, the formatting rules established by the organizing
committee of the 7th World Congress of Biomechanics are used.
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AN ELECTRICAL POWER SUPPLY SYSTEM FOR INSTRUMENTED
HIP JOINT PROSTHESES
Marco P. Soares dos Santos1,2, Jorge A. F. Ferreira2 , Daniel R. Fernandes2, A.
Ramos1,2, José A. O. Simões2
1 Biomechanics Research Group, Centre for Mechanical Technology and Automation, University of
Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal.
2 Department of Mechanical Engineering, University of Aveiro, Aveiro, Portugal.
Introduction:The number of hip replacements (THR),including uncemented ones, is increasing.Revisions are increasing as well. Theincreasing number of “young” patientssubjected to THR is being reported annually.Soares dos Santos et al. (2013) reviewed thepower supply systems of the instrumentedhip implants (IHI) implanted in-vivo. Theyconcluded that: (1) only inductive powerlinks and batteries were used, whichconstrain the operation of IHI; (2) motion-driven energy harvesters (M-EHS) arepromising methods to power IHI, both todetect failures (such as loosening and/orinfections) and to apply therapeutic stimuliin the bone-implant interface.
Methods:A M-EHS, based on magnetic levitation, wasimplemented (Fig.1a). It was composed by:(i) 3 neodymium magnets: 2 N48 (A), 6 mmdiameter, 6 mm height; a N46 (B), 6 mmdiameter, 3 mm height; (ii) a coil with 9000turns, which was enamelled with copperwire (AWG 42, 0,068 mm diameter) arounda hollowed Teflon cylinder (HTC). MagnetsA were suspended inside the HTC. Magnet Bwas attached at the lower end of the HTC.This harvester was embedded into the stemof a hollowed MetablocTM hip prosthesis(Zimmer, EUA). Magnets (A) operate asmoving magnets when hip motion occurs,which harvest electric energy.This self-powered IHI was attached to theleft thigh of a human male (22 years old,814 N weight) wearing hiking boots. Theenergy harvested was monitored during 2,5gait cycles of normal walking at 1,05 m/sspeed over 4,3 s.
Results:67,3 μJ of electric energy was harvestedthroughout the walking trial (Fig.1b).
According to the study conducted by M.Morlock (Technical University Hamburg-Harburg) about the duration of everydayactivities of patients that underwent THR,patients walk 4386 s per 12 hours (meanvalues). Thus, 68,65 mJ of electric energycan be harvested each day only by walking(2.06 J each month).Authors are validating a nonlinear model topredict the energy harvested when the M-EHS moves in the three-dimensional space,in order to optimize the harvester andmaximize the energy harvested for eachpatient.
ReferenceMarco P. Soares dos Santos et al. (2013).Instrumented hip implants: Electric supplysystems. Journal of Biomechanics 46(15) 2561-2571.
Fig.1: (a) M-EHS (section view); (b) Power and energy harvested.
5.2 The new concept of Multi-source Harvesting
System
The reliability of self-powering systems certainly can be improved if multiple harvesting
systems operate in true parallel to power the instrumented implant. Such a redundant
structure for power supplying is mandatory to ensure the atemporal implant operation.
An instrumented hip prosthesis was designed with two electromagnetic harvesters (a
translational and a rotational) and a piezoelectric harvester. The validation of this
new concept is reported in a chapter entitled ”Multi-source Harvesting Systems for
Electric Energy Generation on Smart Hip Prostheses”, published in the book Biomedical
Engineering Systems and Technologies (Springer-Verlag Berlin Heidelberg 2013, pp.
80-96)2.
2As the content of this study is already published, the formatting rules established by the Editorial
Board of the Communications in Computer and Information Science are used.
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Abstract. The development of smart orthopaedic implants is being considered
as an effective solution to ensure their everlasting life span. The availability of
electric power to supply active mechanisms of smart prostheses has remained
a critical problem. This paper reports the first implementation of a new con-
cept of energy harvesting systems applied to hip prostheses: the multi-source
generation of electric energy. The reliability of the power supply mechanisms
is strongly increased with the application of this new concept. Three vibration-
based harvesters, operating in true parallel to harvest energy during human gait,
were implemented on a MetablocTM hip prosthesis to validate the concept. They
were designed to use the angular movements on the flexion-extension, abduction-
adduction and inward-outward rotation axes, over the femoral component, to gen-
erate electric power. The performance of each generator was tested for different
amplitudes and frequencies of operation. Electric power up to 55 µJ/s was har-
vested. The overall function of smart hip prostheses can remain performing even
if two of the generators get damaged. Furthermore, they are safe and autonomous
throughout the life span of the implant.
1 Introduction
1.1 Scope of the Problem and Background
Currently, there is no cure for most causes of failure of total joint replacement, ex-
cept surgical revision [1]. Although drug administration, such as through antimicrobial
therapy, suppressive antibiotic therapy, outpatient parenteral antimicrobial therapy and
antibiotic prophylaxis, are being used to hinder progressive failure following joint re-
placement [2], surgical revisions have been the only “medical prescription” for most
causes of failure [1]. However, these surgical procedures are not therapeutic methods
which are performed to cure or to prevent early failures, but only to relieve pain and to
? The authors would like to thank the Portuguese Foundation for Science and Technology (FCT)
for their financial support under the Grant PTDC/EME-PME/ 105465/2008.
J. Gabriel et al. (Eds.): BIOSTEC 2012, CCIS 357, pp. 80–96, 2013.
c© Springer-Verlag Berlin Heidelberg 2013
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improve joint function [3]. The ordinary methodology to improve prostheses’ function
has been based on the research of new designs, new materials, new fixation techniques
and new surgical techniques [4–6]. Although the everlasting life span is an essential
requirement for the next healthcare bio-systems generations, the 20-year revision rate
of current orthopaedic prostheses is still higher than 20%. Demographic changes and
scientific breakthroughs are the main reasons ascribed to the increase in the number
of primary and revision joint replacements [3], as well as the strong demand for joint
replacements and revisions predicted for the coming years [7]. After the first revision
procedure, the risk of failure increases even more [8]. Furthermore, the increase in the
number of inpatients less than 65 years due to joint disorders [9] is also being con-
sidered an important reason that supports the hypothesis of developing a new method-
ology to design prostheses with the ability to control their own life span. Current hip
prostheses are passive implants because they are not smart enough to promote maximal
bone-implant interaction. They match their design methodology with a design “not to
know” and “not to act against”.
Instrumented prostheses have been developed since the 60’s of the 20th century [10].
Their methodological basis is to perform in-vivo measurement and data storage func-
tions to optimize passive implants, surgical procedures, preclinical testing and physio-
therapy programs [11, 12]. They have been used to validate models of the physiological
environment and customize physiotherapy programs [13, 14]. Contact forces and mo-
ments in the joint, temperature distribution along the implant, articular motions, mis-
alignments and detection of hip loosening [15–22] are the main quantities which have
been collected by instrumented implants. Telemetric platforms for orthopaedic implants
are being optimized to minimize electric energy consumption [22, 23]. Also, activation
circuits to wake up deep sleep electronics have already been developed to instrument
hip prostheses [24].
Several causes of implant failures were already identified [25]. Loosening, infection,
instability, heterotopic ossification or fractures not only can conduct to pain and inabil-
ity to walk, to self-care and to perform activities of daily living, but also can cause
cardiovascular, pulmonary, renal, arterial, nerve or infectious complications, or even
malignancy. More than 80% of the non-success surgical procedures are due to loosen-
ing of the prosthetic stem and cup [26]. Methods for hip loosening detection in hip im-
plants, as well as to identify the regions impaired by this progressive failure throughout
the implant’s life span, are currently being proposed [19, 26]. Efficient power manage-
ment circuits were designed to energize telemetric system of smart hip implants [27].
Even though the number of methods and configurations to transduce energy from the
surrounding environment into electric energy is increasing [28–32], few research efforts
have been conducted to provide electric power supply for instrumented hip prosthesis.
Vibration-based energy harvesting is being considered the most appropriate method to
generate electric energy to supply the active elements of instrumented prostheses [27].
In order to enable loosening detection, an electromagnetic power transducer was re-
cently proposed by Morais et al. [27] to harvest electrical energy from the human gait
to supply smart hip prostheses. However, it was designed only with a single generator,
which decreases the reliability of the electric power generation because it is not a re-
dundant structure for power supplying. No studies have been reported about methods to
ensure high reliability of the electric energy generation on instrumented prostheses.
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1.2 Method
Three vibration-based energy harvesting systems were designed to implement a reli-
able electric power supply of a smart hip prosthesis. Linear models were developed in
order to analyse their accuracy predicting the energy generation. Each generator was
independently tested. Voltage generation was acquired from different rotational and
translational movements.
1.3 Paper Contribution
This paper’s main contribution is to validate the multi-source generation concept ap-
plied to smart hip prostheses. The main goal in the implementation of these harvesting
systems is to enable a multifunctional ability of the hip prosthesis, namely to monitor
and report failures, and carry out mechanical-based therapeutic prescriptions.
1.4 Main Conclusions
This study shows that it is possible to implement high reliability electric power supplies
for active hip prostheses. It was also concluded that linear models of the generators are
very inaccurate in this particular application. Experimental results show that they must
be optimized in order to maximize their performance during typical walking speeds
and to reduce their volume, which demands for accurate non-linear models to predict
the energy generation for multi-displacements of the hip prostheses.
1.5 Outline
The new concept of smart hip prosthesis is introduced in section 2. The design of the
three power generator prototypes is detailed in section 3. Experimental and simulation
results are presented in section 4. Discussion and conclusions are stated respectively in
sections 5 and 6.
2 The New Concept of Smart Hip Prosthesis
Passive prostheses are orthopaedic implants without active components implemented to
overcome failures that may occur over time. They are designed: (1) without information
about themselves, about the physiological environment that surrounds them and about
how to fix their own problems; (2) without resources to eliminate causes of failures;
(3) without a “true” connection with medical specialists. The ineffectiveness of this
method to overcome complications after primary joint replacement is caused by this
passivity, because a maximal interaction with the surrounding physiological environ-
ment is not taken into account. The concept of smart orthopaedic implant was proposed
to be based on a smartness-to-measure methodology [33], but is becoming obsolete as
the concept of individualized therapy evolves for accommodating patient physiologic
idiosyncrasies [34]. Several studies have contributed to identify the function of strain,
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Fig. 1. Block diagram of the new concept of smart orthopaedic implant
load and frequency of mechanical stimulus on the osteogenic responses [35–37], which
contributed to hypothesize that the implementation of mechanisms to carry out artifi-
cial stimulation programs on bone cells can be an effective and efficient solution to
overcome hip loosening. The new concept is based on the smartness-to-act methodol-
ogy in order to prevent and cure failures following primary arthroplasty, avoiding the
need of revision procedures. Smart orthopaedic devices must ensure personalized ther-
apy, through: (1) remote communication with external systems outside the human body;
(2) monitoring of physical and biological states which can be used to detect early causes
of failure; (3) decision-making ability when causes of failure are detected; (4) mechan-
ical actuation-based therapy in the physical and biological states which have a deci-
sive influence on the lifetime of the implant, depending on medical supervision. This
long-term survivability biosystem is based on the tip-of-the-spear methodology [34],
envisioning the application of Paul Ehrlich’s magic bullet concept [38] to orthopaedic
devices: implants must have enough “knowledge” and tools to administer the therapy
in the most suitable place and at the most suitable time. To validate the concept, a
prototype is being developed, according to the Fig. 1, in order to enable the early de-
tection and cure of aseptic loosening throughout the life span of the hip prosthesis.
The methodology is based on the implementation of mechanical micro-stimulation to
remodel the bone surrounding the implant in the regions where loosening is detected.
Several subsystems were already implemented by this research team toward the valida-
tion of a new concept of smart hip prostheses, namely: (1) a generator of electric energy
based on double permanent magnet vibration, as well as power management schemes
[27]; (2) a telemetric architecture [24, 27, 39]; (3) a piezoresistive-based mechanism
to detect prosthetic loosening [26]; (4) a piezoelectric-based stimulation mechanism
[35, 40, 41].
3 Material and Methods
3.1 Hip Prosthesis Prototype
A MetablocTM straight stem system (Zimmer Corporate, Warsaw, Indiana, EUA), size
10, was hollowed to design a hip prosthesis prototype comprising three vibration-based
electric power generators (Fig. 2). Fatigue tests on hollow bone implants were already
conducted [16], which have proved the safety of the approach.
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Fig. 2. Multiple Energy harvesting systems for a hip prosthesis prototype
Fig. 3. (Left) Scheme of the TEEH generator; (Right) CAD of the PEH generator
3.2 Translation-Based Electromagnetic Power Generator (TEEH)
Power Generator Prototype Design. An electromagnetic power transducer was de-
signed in the body of the hip prosthesis, as shown in Fig. 3 (left). It transduces mechan-
ical movements, from the abduction-adduction and flexion-extension axes, into electric
energy. The generator prototype comprises an extension coil spring (K = 2.45 N/m,
5 mm of diameter and 0.2 mm2 of wire section) and 2 neodymium disc magnets N35
(6 mm of diameter, 6 mm of height and 1.22 T of magnetic field). These magnets are
suspended inside a Teflon tube (cm = 0.04) where enamelled copper wire (0.1 mm of
diameter, 27 mm of length and 1.72 × 10−8 Ωm of electrical resistivity) was wound
(N = 2000 turns, 124.4 Ω of total wire resistance), which in turn was attached to the
hip prosthesis fixture. The coil and the prosthesis make up the body frame. A relative
displacement z(t) between the magnets and the frame comes up due to the hip displace-
ments y(t), which are transmitted by the body frame.
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Linear Model of the TEEH System. Linearly, vibration-based generators can be
modelled as second-order mass-spring-damper systems [29, 42, 43], as described by
equation (1). The mechanical structure can be modelled as an inertial frame where a
suspended mass is coupled to a spring, which in turn is coupled to a damping element.
The mass represents a set of magnets and the damper represents the sum of the com-
prising parasitic losses and the electrical energy extracted by the transducer [42].
mz¨(t) + cz˙(t) + kz(t) = −my¨(t) (1)
m is the mass of the magnets, k the stiffness of the spring and c is the damping co-
efficient. When this damping system is excited by an external sinusoidal vibration
y(t) = Y sin(ωt), the solution of (1) is given by (2). ωn = (k/m)1/2 = 4.98 Hz is
the natural frequency and ζ = c/2mωn = 0.256 its total damping ratio.
z(t) =
Y ω2( (
ω2n − ω2
)2
+
(
2ζωnω
)2)1/2 sin
(
ωt − arctg
(
2ζωnω
ω2n − ω2
))
(2)
3.3 Rotation-Based Electromagnetic Power Generator (REEH)
Power Generator Prototype Design. An electromagnetic transducer was designed us-
ing the modular ball head of the hip prosthesis and the acetabular component. Energy
is harvested from the rotation around the flexion-extension axis and around the inward-
outward. The ball head was hollowed to comprise a circular winding of enamelled cop-
per wire (AWG 42, 0.063 mm of diameter), which was coiled (N = 4710 turns, 682
Ω of total wire resistance, 117.1 m of total length of the coil, 7.92 mm of average di-
ameter) around a Teflon tube (5.8 mm of diameter, 12 mm of length), whose core was
designed to be a steel cylinder (4 mm of diameter, 14 mm of length, 100 of relative per-
meability). 24 neodymium disc magnets N52 (6 mm of diameter, 2 mm of height and
1.48 T of magnetic field) were placed on the structure of an acetabular component, in
order to set the magnetic field lines over the volume of the upper half of the ball head,
as presented by Fig. 4 (right). 6 groups of 2 magnets, positioned equidistantly, were
settled symmetrically in the acetabulum with 6 other groups of 2 magnets, which were
also equidistantly positioned. Figure 4 (left) illustrate a scheme of the REEH generator.
Linear Model of the REEH System. The total harvested energy is the total sum of
the energy that can be harvested from the rotation around the flexion-extension axis
and the energy acquired from the rotation around the inward-outward axis, according
to equation (3).
V xˆzˆemf = −πR2NB
dαzˆ
dt
sin(αzˆ)− πR2NBdαxˆ
dt
sin(αxˆ) (3)
3.4 Piezoelectric Power Generator (PEH)
Power Generator Prototype Design. A piezoelectric power generator was designed
to harvest energy from the axial load over the hip joint. Figure 3 (right) provides a CAD
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Fig. 4. (left) Scheme of the REEH transducer; (right) Acetabulum of high density polyethylene
modulation of the PEH generator. A piezoelectric ceramic diaphragm (ref. 7BB-12-9,
muRata Corporate, Kyoto, Japan) with 9 mm of diameter and 0.22 mm of thickness (12
mm of plate size, 0.1 mm of plate thickness and 9.0± 1.0 kHz of resonant frequency)
was placed on the lower half of ball head of the hip prosthesis.
Neural Network Model of the PEH System. Piezoelectric energy harvesters can be
modelled as mechanical damping systems [29, 43]. Because the piezoelectric element
is attached to the hip prosthesis structure, the mechanical damping ratio and proof mass
are very difficult to find due to the geometry of the prosthesis. An artificial neural net-
work (ANN) model was developed to predict the power and energy generation [44].
A multilayer “feed-forward” ANN was trained to perform the matching between a se-
ries of pairs of the frequency and amplitude of sinusoidal axial forces, and the aver-
age power and peak-to-peak voltage generation. The ANN consists of one input layer,
with two neurons, two hidden layers, with seven neurons each, and one output layer,
with two neurons, as shown in figure 5 and predicted by equation (4). The Levenberg-
Marquardt’s algorithm was used as the training algorithm and the mean square error
of 1.0× 10−20 as the convergence criteria for the network training. Sigmoid functions
(Tansig) for the hidden layers and linear function (Purelin) for the output layer were
used as the transfer functions.
yN = fL
(
LW2fS
(
LW1fS
(
IW1iN + b1
)
+ b2
)
+ b3
)
(4)
Here, yN is the output 2× 1 matrix, iN is the 2× 1 input matrix, IW1 is a input weight
7 × 2 matrix, LW1 and LW2 are respectively layer weight 7 × 7 and 2 × 7 matrices,
and b
1
, b
2
and b
3
are respectively bias 7× 1, 7× 1 and 2 × 1 matrices. f
L
and f
S
are
linear and sigmoid functions, respectively.
4 Experimental and Simulation Results
The experimental average and peak power, energy and peak-to-peak voltage genera-
tion were analysed. These experimental results were compared with the linear models
reported in sections 3.2, 3.3 and 3.4.
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Fig. 5. ANN used to model the average power and peak-to-peak voltage of the PEH generator
Fig. 6. Experimental (dotted line) and simulated (dashed line) average (in the left) and maximum
(in the right) power harvested from the TEEH transducer
4.1 TEEH Results
A load resistance of 979 Ω was used to enable the energy transfer when sinusoidal
input vibrations, with amplitudes in the range 10 mm to 40 mm and frequencies in
the range 0.5 Hz to 4 Hz, were applied to this generator. Figure 6 shows the results of
the experimental and simulated average and maximum power, whereas Fig. 7 highlights
the results of the experimental and simulated energy and peak-to-peak voltage. Tables
1 to 4 report the modulation errors. The maximum energy harvested was 53.7 μJ/s
when the sinusoidal function has an amplitude of 40 mm and a frequency of 4 Hz. This
harvester is able to provide 567.4 μW of instantaneous peak power when the input is
excited with an amplitude of 40 mm and a frequency of 3 Hz.
4.2 REEH Results
A load resistance of 8.98 kΩ was used to enable energy transfer of this generator when
sinusoidal rotations in the flexion-extension axis, with amplitudes in the range 50◦ to
70◦ and frequencies in the range 0.5 Hz to 2.5 Hz, were applied to the generator. Using
the magnetic field in the winding measured at the ends of the winding (80 mT), the
experimental and simulated results are reported in Fig. 8 and Fig. 9. Tables 5 to 8 report
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Fig. 7. Experimental (dotted line) and simulated (dashed line) energy (in the left) and peak-to-
peak voltage (in the right) harvested from the TEEH transducer
Table 1. TEEH generator — modulation error (W) of the average power
Amplitude Frequency (Hz)
(mm) 0.5 1 1.5 2 2.5 3 3.5 4
10 0.06(1) 0.009(2) 0.05(2) 0.02(3) 0.04(3) 0.08(3) 0.02(4) 0.03(4)
15 0.02(1) 0.02(2) 0.11(2) 0.04(3) 0.08(3) 0.18(3) 0.03(4) 0.05(4)
20 0.13(1) 0.04(2) 0.20(2) 0.06(3) 0.15(3) 0.31(3) 0.05(4) 0.09(4)
25 0.26(1) 0.06(2) 0.31(2) 0.10(3) 0.23(3) 0.47(3) 0.08(4) 0.12(4)
30 0.43(1) 0.09(2) 0.44(2) 0.14(3) 0.32(3) 0.62(3) 0.10(4) 0.18(4)
35 0.62(1) 0.12(2) 0.60(2) 0.19(3) 0.39(3) 0.71(3) 0.14(4) 0.26(4)
40 0.85(1) 0.15(2) 0.78(2) 0.24(3) 0.48(3) 0.85(3) 0.19(4) 0.35(4)
(1) × 10−7; (2) × 10−5; (3) × 10−4; (4) × 10−3.
Table 2. TEEH generator — modulation error (W) of the maximum power
Amplitude Frequency (Hz)
(mm) 0.5 1 1.5 2 2.5 3 3.5 4
10 0.70(1) 0.03(2) 0.01(2) 0.01(3) 0.001(4) 0.01(4) 0.01(4) 0.02(4)
15 0.30(1) 0.02(2) 0.06(2) 0.03(3) 0.003(4) 0.01(4) 0.02(4) 0.02(4)
20 0.54(1) 0.01(2) 0.15(2) 0.05(3) 0.01(4) 0.02(4) 0.0002(4) 0.08(4)
25 0.53(1) 0.0002(2) 0.27(2) 0.07(3) 0.02(4) 0.003(4) 0.06(4) 0.26(4)
30 0.48(1) 0.05(2) 0.35(2) 0.11(3) 0.004(4) 0.09(4) 0.23(4) 0.29(4)
35 0.37(1) 0.04(2) 0.39(2) 0.13(3) 0.09(4) 0.32(4) 0.25(4) 0.22(4)
40 0.69(1) 0.12(2) 0.64(2) 0.03(3) 0.17(4) 0.44(4) 0.22(4) 0.14(4)
(1) × 10−6; (2) × 10−5; (3) × 10−4; (4) × 10−3.
the modulation errors. The maximum energy harvested was 0.77 μJ/s. The “plus” sign
refers to peak-to-peak amplitudes in the range −10◦ to 60◦, −10◦ to 50◦ and −10◦
to 40◦; the “square” sign refers to peak-to-peak amplitudes in the range −20◦ to 50◦,
−20◦ to 40◦ and −20◦ to 30◦.
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Table 3. TEEH generator — modulation error (J) of the energy
Amplitude Frequency (Hz)
(mm) 0.5 1 1.5 2 2.5 3 3.5 4
10 0.17(1) 0.01(2) 0.03(2) 0.01(3) 0.003(4) 0.01(4) 0.01(4) 0.02(4)
15 0.16(1) 0.01(2) 0.10(2) 0.03(3) 0.01(4) 0.01(4) 0.02(4) 0.02(4)
20 0.14(1) 0.02(2) 0.18(2) 0.06(3) 0.01(4) 0.02(4) 0.02(4) 0.11(4)
25 0.13(1) 0.04(2) 0.29(2) 0.08(3) 0.02(4) 0.01(4) 0.08(4) 0.40(4)
30 0.11(1) 0.07(2) 0.42(2) 0.12(3) 0.01(4) 0.07(4) 0.29(4) 0.50(4)
35 0.09(1) 0.10(2) 0.53(2) 0.14(3) 0.06(4) 0.29(4) 0.44(4) 0.47(4)
40 0.06(1) 0.14(2) 0.69(2) 0.07(3) 0.13(4) 0.49(4) 0.45(4) 0.41(4)
(1) × 10−6; (2) × 10−5; (3) × 10−4; (4) × 10−3.
Table 4. TEEH generator — modulation error (V) of the peak-to-peak voltage
Amplitude Frequency (Hz)
(mm) 0.5 1 1.5 2 2.5 3 3.5 4
10 0.05 0.02 0.003 0.01 0.003 0.06 0.08 0.11
15 0.03 0.02 0.01 0.04 0.01 0.05 0.08 0.06
20 0.04 0.01 0.03 0.06 0.07 0.08 0.04 0.19
25 0.03 0.01 0.04 0.05 0.06 0.02 0.16 0.51
30 0.03 0.01 0.05 0.08 0.05 0.25 0.47 0.52
35 0.03 0.01 0.04 0.06 0.30 0.60 0.55 0.41
40 0.03 0.02 0.06 0.04 0.38 0.74 0.50 0.31
Table 5. REEH generator — modulation error (W) of the average power [error (“plus” test) |
error (“square” test)]
Amplitude Frequency (Hz)
(◦) 0.5 1 1.5 2 2.5
50 0.11(1) | 0.06(1) 0.04(2) | 0.25(1) 0.09(2) | 0.06(2) 0.18(2) | 0.10(2) 0.33(2) |
0.22(2)
60 0.16(1) | 0.11(1) 0.06(2) | 0.49(1) 0.22(2) | 0.10(2) 0.40(2) | 0.19(2) 0.54(2) |
0.29(2)
70 0.30(1) | 0.17(1) 0.11(2) | 0.78(1) 0.24(2) | 0.14(2) 0.44(2) | 0.41(2) 0.32(2) |
0.22(2)
(1) × 10−7; (2) × 10−6.
Table 6. REEH generator — modulation error (W) of the maximum power [error (“plus” test) |
error (“square” test)].
Amplitude Frequency (Hz)
(◦) 0.5 1 1.5 2 2.5
50 0.07(2) | 0.36(1) 0.24(2) | 0.09(2) 0.05(3) | 0.18(2) 0.08(3) | 0.03(3) 0.17(3) |
0.09(3)
60 0.13(2) | 0.45(1) 0.31(2) | 0.20(2) 0.11(3) | 0.32(2) 0.23(3) | 0.08(3) 0.24(3) |
0.13(3)
70 0.22(2) | 0.75(1) 0.58(2) | 0.36(2) 0.11(3) | 0.59(2) 0.22(3) | 0.18(3) 0.18(3) |
0.12(3)
(1) × 10−7; (2) × 10−6; (3) × 10−5 .
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Table 7. REEH generator — modulation error (J) of the energy [error (“plus” test) | error
(“square” test)]
Amplitude Frequency (Hz)
(◦) 0.5 1 1.5 2 2.5
50 0.16(1) | 0.09(1) 0.06(2) | 0.04(2) 0.14(2) | 0.08(2) 0.28(2) | 0.15(2) 0.49(2) |
0.33(2)
60 0.24(1) | 0.16(1) 0.09(2) | 0.07(2) 0.34(2) | 0.15(2) 0.59(2) | 0.29(2) 0.81(2) |
0.43(2)
70 0.44(1) | 0.26(1) 0.16(2) | 0.12(2) 0.35(2) | 0.21(2) 0.65(2) | 0.61(2) 0.48(2) |
0.33(2)
(1) × 10−6; (2) × 10−5.
Table 8. REEH generator — modulation error (V) of the peak-to-peak voltage [error (“plus” test)
| error (“square” test)]
Amplitude Frequency (Hz)
(◦) 0.5 1 1.5 2 2.5
50 0.03 | 0.02 0.05 | 0.03 0.08 | 0.04 0.11 | 0.05 0.14 | 0.09
60 0.04 | 0.02 0.06 | 0.04 0.12 | 0.05 0.16 | 0.07 0.15 | 0.09
70 0.05 | 0.02 0.08 | 0.06 0.11 | 0.06 0.13 | 0.11 0.09 | 0.06
Fig. 8. Experimental (dotted line) and simulated (dashed line) average (in the left) and maximum
(in the right) power harvested from the REEH generator
Fig. 9. Experimental (dotted line) and simulated (dashed line) energy (in the left) and peak-to-
peak voltage (in the right) harvested from the REEH generator
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Fig. 10. Experimental average power and peak-to-peak voltage results harvested from the PEH
Fig. 11. Validation of the average power harvested from the PEH generators (dash-dot line refers
to the network output)
4.3 PEH Results
External sinusoidal forces, with amplitudes in the range 100 N to 250 N and frequencies
in the range 0.5 Hz to 4 Hz, were applied to the generator. A load of 1 MΩ was used
to enable the energy transfer. Figure 10 reports the experimental average power and
peak-to-peak voltage results, whereas Fig. 11 introduces the validation results of the
“feed-forward” ANN, using only data not used in the training process. Tables 9 to 10
report the modulation errors. The maximum energy harvested was 0.6 μ J/s.
5 Discussion
5.1 Need for Multi-source Harvester Systems
The high reliability of the electric energy generation system is a necessary condition
to ensure high reliability of the therapy based on mechanical stimulation. It is tech-
nologically possible to implement active implants with the ability to monitor failures,
to communicate the states of its surrounding physiological environment to the medi-
cal specialist and carry out mechanical-based therapeutic prescriptions ordered by the
specialist. These operations demand a full availability of electric energy.
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Table 9. PEH generator — modulation error of the average power
Frequency (Hz) 0.5 0.5 1 1 1.5 3 3.5 4 4
Amplitude (N) 100 200 125 200 200 125 200 100 200
Absolute error (W)(1) 0.0004 0.003 0.0003 0.003 0.002 0.23 0.11 0.03 0.13
(1) × 10−6.
Table 10. PEH generator — modulation error of the peak-to-peak voltage
Frequency (Hz) 0.5 0.5 1 1 1.5 3 3.5 4 4
Amplitude (N) 100 200 125 200 200 125 200 100 200
Absolute error (W) 0.32 1.18 1.22 1.18 0.80 10.19 0.98 3.49 0.88
5.2 Choice of the Energy Harvesting Method
There are several methods to harvest electric energy from the surrounding environment.
Biofuel cells, magnetic induction, thermoelectric and vibration are some of the main
sources used to harvest energy. Vibration-based generation is being considered the most
appropriate solution to harvest electrical energy on prostheses [45]. Although there are
no studies supporting this hypothesis, their ease of implementation, their ability of being
fully autonomous and operating without maintenance, ensuring safety throughout the
life span of the implant, were relevant features taken into consideration to validate this
new concept of energy harvesting systems applied to hip prostheses.
5.3 Performance of the Linear Models
Linear models can only ensure accuracy within a narrow window of the systems’ op-
erating range. The modulation errors, presented in sections 4.1, 4.2 and 4.3, confirm
the inaccuracy of the linear models of the generators, especially those used to model
the behaviour of the TEEH generator. The real translational and rotational hip displace-
ments, the friction and gravity forces acting on these systems, the non-linearity behavior
of inductors and transduction damping coefficients were jeopardized from linear mod-
els. Because experimental results show a higher performance of the TEEH generator
in this particular application, it is mandatory the development of non-linear models for
high accuracy prediction of electric energy generation considering a broad specter of
the generators’ operation.
5.4 Optimization of the Multi-source Harvester System
Each transducer must be optimized in order to maximize electric generation during typ-
ical walking speeds, namely in the range between 0.5 Hz and 2 Hz. The optimization of
the TEEH and PEH generators demands for a “perfect” match between the frequency of
the hip kinematics and their resonant frequencies. The implementation of a continuous-
matching system is very complex [46] because the duration and frequency of every-day
human activities are unpredictable [47]. New methods must be developed to ensure
high performance tracking of the hip kinematics’ frequency. Each generator must be
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optimized to supply as much electric energy as demanded by the active mechanics of
smart prostheses, even though they may require different periods to generate the same
amount of energy.
6 Conclusions
A therapeutic methodology to cure failures of hip prostheses following primary artro-
plasty, based on a personalized approach, would be of great importance for the quality of
life of many patients. Multi-source electric energy generation systems for orthopaedic
implants contribute forward the implementation of individualized medicine approaches
in the scope of embedded smart bone implants. This new concept was validated with the
use of three vibrational energy harvesters: two electromagnetic generators and a piezo-
electric. Experimental results confirm the inaccuracy of the generators’ linear models
operating on hip prostheses fixtures, which invalidates their use in optimization rou-
tines.
There is ongoing work to:
1. Develop non-linear models of vibrational energy harvesters. The main goal is to
reduce the volume of each generator and maximize their performance;
2. Identify the most appropriate method to generate electrical energy on hip implants;
3. Design a new method to ensure an effective tracking of the frequency of the hip
kinematics. The set of generators must be synchronized with the hip dynamics in
order to ensure all energy requirements demanded by active elements of the smart
prostheses;
4. Design an energy management system for a multitude of power sources;
5. Design of energy harvesting systems which are independent of failures due to con-
tact stresses (for instance, magnetically levitated generators);
6. Design of a redundant multi-source harvester structure. Such a redundant ability,
along with the requirements introduced in the previous number and in section 5.4,
are sufficient to ensure reliability of the electric energy generation system.
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5.3 Modeling and simulation of electromagnetic
energy harvesting using magnetic levitation
Motion-driven energy harvesters for instrumented implants seem to be more easily
implemented by magnetic levitation-based harvesting than using piezoelectric transducers.
These harvesters using levitated hard-magnetic elements also seem to harvest more electric
energy. The results retrieved from the previous study have also confirmed that linear
models are not able to accurately predict the electromagnetic energy harvesting. Although
low levels of energy are harvested in the recovery period following THR and when patients
are not able to perform their routine activities (such as due to the ageing process or injury),
a conclusive demonstration of the (in)effectiveness of this method to power instrumented
implants requires to evaluate the maximum energy they are able to harvest according to
the gait patterns of patients. Such analysis must consider that energy harvesting must
be personalized. This purpose require the geometric optimization of the harvesters (prior
to implant insertion) and the ability of the instrumented implant to control the position
of their components (the fixed magnet(s) and coil(s)), according to the hip movements of
patients during their routine activities. These demands can only be fulfilled if non-linear
models are developed for accurate prediction of the energy harvesting considering 3D
motions of the harvesters. Currently, due to the inherent complexity to validate such
a model, a semi-analytical non-linear model that enables accurate and efficient analysis
of energy transduction was already validated for vertical excitations of the harvester.
This study is entitled ”Magnetic levitation-based electromagnetic energy harvesting: a
semi-analytical non-linear model for energy transduction”. It is published in the Scientific
Reports (Nature Publishing Group) (volume 6, 18579)3.
3As the content of this study is already published, the formatting rules established by the journal
Scientific Reports (Nature Publishing Group) are used.
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Magnetic levitation-based 
electromagnetic energy harvesting: 
a semi-analytical non-linear model 
for energy transduction
Marco P.  Soares dos Santos1,2, Jorge A. F. Ferreira1,2, José A. O. Simões2, Ricardo Pascoal3, 
João Torrão2, Xiaozheng Xue4 & Edward P. Furlani4,5
Magnetic levitation has been used to implement low-cost and maintenance-free electromagnetic 
energy harvesting. The ability of levitation-based harvesting systems to operate autonomously for long 
periods of time makes them well-suited for self-powering a broad range of technologies. In this paper, 
a combined theoretical and experimental study is presented of a harvester configuration that utilizes 
the motion of a levitated hard-magnetic element to generate electrical power. A semi-analytical, 
non-linear model is introduced that enables accurate and efficient analysis of energy transduction. 
The model predicts the transient and steady-state response of the harvester a function of its motion 
(amplitude and frequency) and load impedance. Very good agreement is obtained between simulation 
and experiment with energy errors lower than 14.15% (mean absolute percentage error of 6.02%) and 
cross-correlations higher than 86%. The model provides unique insight into fundamental mechanisms of 
energy transduction and enables the geometric optimization of harvesters prior to fabrication and the 
rational design of intelligent energy harvesters.
Motion-driven electromagnetic energy harvesting systems have been used to provide self-powering for a wide 
range of technologies, such as remote sensors and actuators, mobile electronics, wearable devices and biomedical 
implants1–7. When dominant excitations are known a priori in a constrained range, the harvesters’ characteristics 
can be optimized prior to fabrication using accurate models. For unknown, broadband and time-varying vibration 
spectra, new tunable mechanisms and broadband harvesting designs have been proposed8–14. However, these 
harvesters are usually complex and their use is often impractical due to dimensional constraints. Besides, the tun-
ing mechanisms must be subject to constraints and, thus, practical applications require geometric optimization. 
Moreover, broadband harvesters cannot ensure optimal performances if intelligent control is not used to optimize 
the adaptive mechanism15,16. Consequently, modelling of the energy transduction is essential for design optimi-
zation prior to fabrication, as well as to fulfil demanding adaptability requirements. However, such modeling is 
problematic because of the highly non-linear behavior of most harvesters.
Magnetic levitation has been used to implement low-cost and maintenance-free electromagnetic energy har-
vesters, with the ability to operate autonomously with stable performance for long periods of time17–19. Their 
non-complex design is effective in many applications involving severe dimensional constraints19. Besides, intelli-
gent control algorithms can be developed to control the position of their components according to the excitations’ 
characteristics (for example, amplitude and frequency). Geometric optimization prior to fabrication and adaptive 
positional control of components cannot be accomplished using linear system models because they are not sufficient 
to adequately predict levitation-based energy harvesting, as such systems exhibit highly nonlinear behavior20,21. 
The Finite Element Method (FEM) has been used to solve the differential equations that govern the dynamics of 
these systems, taking into account effects such as the magnetic levitation forces between magnets and magnetic 
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field (MF) distributions, etc.21–24. A combined approach using FEM and analytical or semi-analytical modeling 
has also been proposed22,24. However, the computational cost of FEM analysis is usually much greater than that 
of semi-analytical methods21, cumbersome and often impractical for system optimization. In contrast, analytical 
analysis readily enables complexity minimization and accuracy maximization of the computation21,25,26. Several ana-
lytical and semi-analytical non-linear models have been developed for modeling magnetic levitation-based energy 
harvesting systems20,21,24. So far, modeling of harvester architectures with mechanical friction has been conducted 
by either identifying models that are only valid for specific experimental setups (i.e. those that include mechanical 
and/or electrical damping identification) and, hence, not suitable for design optimization; or disregarding either the 
electric or the mechanical behavior; or neglecting the inductive effects of coil(s) on energy harvesting, including 
highly non-linear effects associated with multilayered coil(s)20–24. Some phenomena occurring in these harvesting 
systems have also been modeled using semi-analytical techniques for diamagnetic levitation systems27–30. Their 
inherent nonlinearities have not yet been observed in detail due to their insufficient levitation gaps. Besides, many 
applications require self-powering technology in which levitation must be stable for a broad range of orientations 
(with respect to the acceleration of gravity) and for unconstrained motion amplitudes of the moving magnet7,17, 
which is hard to accomplish by diamagnetic levitation. Moreover, no configuration has been developed to allow 
motion of the levitating magnet along most of the harvester length using this levitation method27–30. Hence, 
the potential of harvester architectures using tight-fit containers with very low friction contact must be further 
explored. To our best knowledge, no models have been demonstrated with the following functionalities: (a) use 
only analytical or semi-analytical equations to accurately predict both electrical and mechanical behavior; (b) 
take into account the main nonlinearities of forces that oppose magnet motion, including those due to mechanical 
contact between container and levitated magnet; (c) have been experimentally validated with different motional 
excitations (amplitude and frequency) and loads; and (d) are well-suited to be used in geometric optimization 
of the harvester and in intelligent harvesting for unconstrained motion amplitudes and arbitrary orientations of 
the harvester over a broad range of frequencies. In this paper, we introduce and demonstrate for the first time a 
validated semi-analytical model that addresses all these considerations.
Semi-analytical Model
We have developed a semi-analytical model for predicting the behavior of compact magnetic levitation-based 
harvesters of the form shown in Fig. 1(a). These comprise a hollow cylindrical structure that houses three disc-type 
cylindrical permanent magnets. A portion of the cylinder is wrapped in a multilayered coil. Two of the magnets are 
Figure 1. Section-views of the levitation-based harvester. 
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attached to the end extremities of the container. The third magnet moves within the container between the fixed 
magnets and experiences a repulsive (levitation) force from each magnet. The coil is formed by winding enamelled 
wire around the outer surface of the container.
The MF distribution of the cylindrical magnet can be predicted using a number of analytical and semi-analytical 
methods31–34. In this work, we used the “equivalent” surface current model31 and discretize the magnet into a finite 
set of current loop elements. We then superimpose the MFs of the constituent current loops to obtain the magnetic 
field of the magnet25,26. Equations (1–6) are used to compute the axial component of the MF, ( , ) = ( , ) ⋅ ˆB r z r zB zz m, 
as a function of radial and axial distances (r and z) to the center of the moving magnet.
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In these equations, Pz and δ are as defined below; Lm, Rm and Mm are the length, radius and saturation magneti-
zation of the moving magnet, respectively; µ0 is the free-space magnetic permeability; and ( )E k  and ( )K k  are 
complete elliptic integrals of the first and second kind. The use of analytical analysis to compute ( , )B r zz  is superior 
to the more commonly used numerical field analysis, both in terms of accuracy and computational 
efficiency25,26.
The Maxwell-Faraday equation can be used to model the electromotive force induced in the coil by the 
time-varying magnetic flux that permeates it. One can obtain an approximate solution for predicting voltage 
harvesting by considering the coil as a set of single circular turns (N r  turns of the coil in the radial direction for 
each z; N z turns of the coil in the axial direction for each r) and a 3D surface bounded by a closed contour defined 
by each of these turns. Using the Kelvin-Stokes theorem, and assuming that the spatial distribution of turns along 
the coil is uniform, one obtain the following Equation for computing the output voltage V as the magnet moves 
within the container.
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∂
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In this equation, r j is the radius r of the j’th turn; zk is the distance z of layer k; and t is the integration sample time. 
The voltage V induces a current I in each turn of the coil through a circuit loop composed of the impedances of 
the harvester and load, as expressed by Eq. (8). The load is assumed to be purely resistive ( )Rl  and only the coil 
resistance ( )Rw  and inductance ( )Lw  are considered21.
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The induced current I gives rise to a magnetic force (Lorentz force) that opposes the motion of the moving magnet, 
as given by:
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The magnetic force between two magnets as a function of their axial separation was computed by taking the 
derivative of their interaction energy with respect to the distance between them35,36. Equation (10) was used to 
compute the axial force = ( , ) ⋅ zˆF r zFmu mu mz  between the moving magnet and the fixed magnet located at the top of the harvester,
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where Ru is the radius, Mu is the saturation magnetization and Lu is the length, all pertaining to the fixed magnet 
at the top. Su is the distance between the moving magnet and the fixed magnets at the top and J1 is the 1st-order 
Bessel function. Equation (10) can also be used to compute the force = ( , ) ⋅ zˆF r zFmd md mz  between the moving 
magnet and the fixed magnet located at the bottom, but using Rd, Md, Ld and Sd. The assumption that the magnets 
are coaxially positioned is taken into account.
For any global coordinate system ( , , )x y z , the position Pm and orientation of zˆm of the moving magnet can be 
computed by establishing the forward kinematics for translations δ( , , + )P P Px y z  and rotations θ θ( , , )0x y  of the 
container about a (fixed) space system reference frame (δ is the distance between Pz and the center of mass of the 
moving magnet, as shown in Fig. 1(b)). Extrinsic Euler angles − −z y x were used to define a geometric matrix 
transformation Q that expresses Pm and the orientation of zˆm.
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where )(, ,( , ) , ( , )T T Tx P y P z Px y z  are the transformation matrices for translating Px, Py and Pz in ( , , )x y z ; and θ( , )R x x  
and )( θ,R y y  are the transformation matrices for rotating θx and θy around ( , )x y . Q was defined considering that the 
influence of rotations around ( , , )x y zm m m  and θz  is negligible. One can use Eqs (12) and (13) to find the axial 
acceleration = ⋅ zˆ
d P
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2  of the moving magnet. After simplification, and considering Px, Py, θx and θy to be 
constant, the following algebraic equation was obtained:
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The axial component of the gravitational force Fgr is:
( )θ θ= ⋅ = ( ) ( )ˆ ˆz zF mg mg cos cos 15gr m x y
where m is the mass of the moving magnet and g is the acceleration due to gravity. The friction force Ffr between 
the moving magnet and the container’s inner surface was modelled by using the Karnopp friction model37:
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This friction model takes into account the following effects: (i) different viscous friction coefficients for negative ( )kvn  
and positive ( )kv p  speeds 
δd
dt
; (ii) different break-away forces for negative ( )fbwn  and positive ( )fbwp  speeds; (iii) 
different Coulomb forces for negative ( )fcon  and positive ( )fcop  speeds; and (iv) a low speed region − ≤ ≤
δv vmin
d
dt min
 , 
where one can consider =δ 0d
dt
. These effects can emerge due to processes used to fabricate the container.
Two differential equations are required to model the interplay between the electrical and mechanical dynamics 
of the moving magnet. The electrical behavior is governed by Eq. (8); the motion of the moving magnet is given by:
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Results
A harvester was implemented with the characteristics described in Table 1 (Fig. 1(b)). Two resistive loads were 
chosen: = .R 89 3l  kΩ , for analyzing a quasi open-circuit voltage; and = .R 3 5l  kΩ , for maximizing the power 
transfer to the load. To accurately analyze the nonlinearities on energy transduction of this harvester architecture, 
open-load conditions were discarded, such that the current dynamics could be computed for consequent analysis 
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of friction on physical contact between the moving magnet and the container. Neodymium magnets were chosen 
to provide a substantial magnetic flux ∂Φ
∂t
 through the coils, where ∫Φ = ( , )B r z rdr
r
z k0
j . The coils were formed 
using enamelled copper with a very small diameter to accommodate a large number of turns. The coil was posi-
tioned so that the moving magnet is surrounded by the coil when the harvester is stationary, i.e., absent excitation. 
The cylindrical container was machined out of PTFE (Seal & Design Inc.) due to its low coefficients of friction.
The harvester was attached to a testing machine with servo-motors that can produce arbitrary vertical displace-
ments. θ pi= /9y  rad and θ = 0x  rad were then imposed to the experimental apparatus to ensure that ≠F 0fr . 
Several free fall tests (using only the moving magnet and the fixed magnet at the bottom of the container) were 
conducted to identify the friction coefficients. By performing a global search to find the minimum difference 
between experimental and simulated responses, the following coefficients were obtained: = . × −f 3 68 10co
3
p
 N, 
= . × −f 5 79 10co
4
n
 N ,  = . × −f 4 05 10bw
3
p
 N ,  = . × −f 6 37 10bw
4
n
 N ,  = . × −k 9 89 10v
5
p
 N s / m , 
= . × −k 5 51 10v
5
n
 Ns/m, = × −v 5 10min
3 m/s. The undisturbed position of the levitated magnet was determined 
using both experimental tests and simulation and found to be approximately δ = . × −38 3 10 3 m.
Our system model was validated by comparing predictions with measurements with the harvester subjected 
to sinusoidal motion. This choice of excitation was made due to the fact that a large number of applications use 
cyclic motion to harvest energy. Measurements were taken for frequencies in the 3–10 Hz range. Very low voltage 
output was obtained for frequencies lower than 3 Hz (mean absolute voltages lower than 0.3 V for Rl = 89.3 kΩ 
and 0.15 V for Rl = 3.5 kΩ ), and voltages exceeding the analog input range of the acquisition board (upper and 
lower saturation values: 10 V and − 10 V) was obtained for frequencies higher than 10 Hz. The steady-state and 
transient responses of the energy harvester were analysed. The results of the steady-state analysis are shown in 
Fig. 2 and Table 2. These results demonstrate that the model accurately predicts the highly non-linear behavior of 
the harvester. Note that very good agreement between experimental and simulation results were achieved with 
energy errors lower than 14.15% (mean absolute percentage error is 6.02%) and cross-correlations higher than 
86%. Similar results were obtained for the transient response, as shown in Fig. 3, i.e., the same energy errors and 
cross-correlations were obtained.
Discussion
One of the main goals of this study was to develop the less complex model that could ensure very good validation 
results. These were achieved by neglecting: (a) the non-concentricity between the moving magnet and the fixed 
magnets; (b) the dynamic effects of the friction force; (c) the effects of non-axiality and non-uniformity of the 
friction force along the overall length of the inner wall of the container; and (d) the several components of viscous 
fluidic damping and air compressibility. Although further research efforts may be conducted to develop more 
complex models, the model presented in this paper can be used for achieving very good predictions of the energy 
harvesting in nonlinear regimes.
The careful selection of appropriate materials, surface finish and container architecture is also required to 
maximize the harvester performance. Container materials should have friction coefficients as low as possible, 
and with negligible magnetic permeability. PTFE is among the materials that meet such requirements. Harvester 
Characteristics Value Units
lm 58 × 10−3 m
lc 20 × 10−3 m
li 23.5 × 10−3 m
dh 16 × 10−3 m
dc 8.2 × 10−3 m
dm 6.2 × 10−3 m
Rm 3 × 10−3 m
Ru 3 × 10−3 m
Rd 3 × 10−3 m
Lm 6 × 10−3 m
Lu 1 × 10−3 m
Ld 1 × 10−3 m
Mm 8 × 105 A/m
Mu 7.61 × 105 A/m
Md 7.61 × 105 A/m
m 1.24 × 10−3 kg
NrNz 15000 —
Coil wire diameter 6.8 × 10−5 m
Rw 3.63 kΩ 
Lw 1.009 H
Rl 89.3|3.5 kΩ 
Table 1.  Harvester’s characteristics.
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architectures using a tight-fit container-magnet interface are superior to other architectures, as they minimize 
the coil-magnet distance, maximizing the magnetic flux through the coils. More complex nonlinearities will most 
likely be observed if loose-fit container-magnet interfaces are used, due to the increasing effects of non-axiality of 
the moving magnet on friction force. The use of square containers and cylindrical magnets minimize the friction 
forces (due to the lower contact areas), but the magnetic flux through the coils would be lower. Manufacturing 
methods that minimize the surface roughness, ensuring similar friction coefficients along its area, also minimize 
nonlinearities of contact friction. Conventional machining will most likely produce worse surface finish than using 
chemical processes. The model proposed here can be used as a predictive tool if the requirement for harvesting 
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Figure 2. Steady-state analysis (experimental (red dots) and simulation (solid black lines)) for experiments: (a) 
T2; (b) T4; (c) T6; (d) T8; (e) T1; (f) T3; (g) T5; (h) T7. 
Exp. Pz (mm)c
Rl 
(kΩ) CC (%) EE (%)
ST 
(sec)d
T1 17 sin (7πt) 3.5 86.20 9.31 ≈ 12.5
T2 17 sin  (7πt) 89.3 88.30 4.26 ≈ 12.4
T3 12.25 sin  (10πt) 3.5 98.24 6.38 ≈ 9.3
T4 12.25 sin  (10πt) 89.3 88.03 2.46 ≈ 9.1
T5 7.75 sin  (15πt) 3.5 92.78 0.59 ≈ 5.8
T6 7.75 sin  (15πt) 89.3 90.63 14.15 ≈ 5.9
T7 6 sin  (18πt) 3.5 88.53 4.72 ≈ 5.1
T8 7 sin  (16πt) 89.3 94.79 6.27 ≈ 5.9
Table 2.  Validation resultsa,b. aAbbreviations: CC - Cross-correlation; EE - Energy error; ST - Simulation time. 
bResults are referred to a cycle in steady state responses. cPx = 0 m, Py = 0 m, θx = 0 rad, θy = π/9 rad. d2.5 GHz 
CPU, 8 GB RAM, Windows 7 operating system.
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Figure 3. Transient analysis (experimental (red dots) and simulation (solid black lines)) for experiments: (a) 
T4, CC = 93.85%, EE = 7.51%; (b) T7, CC = 88.62%, EE = 6.23%. 
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performance optimization described above are taken into account. If the same materials, architectures and man-
ufacturing methods are used, similar results will most likely be achieved.
EEs lower than 10% were achieved for most of the experiments. Only the T6 experiment exceeded this error 
range. To identify the most probable causes for this deviation, we hypothesized that very small errors in the iden-
tified model’s parameters and/or nonlinear effects of friction force not accurately modeled can result in higher 
energy errors for specific excitations. Considering the highly nonlinear behavior of Bz, the resulting effects of using 
a non-optimal Mm were analyzed. The steady-state analysis of the T6 experiment for Mm = 8.1 × 105 A/m (value 
also within bounds reported by the manufacturer) was carried out, which change the undisturbed position of the 
levitated magnet in 0.2 mm (to δ = . × −38 5 10 3 m). An energy error lower than 5% was observed, as shown in 
Fig. 4. Similar errors were also achieved for the other excitations analyzed in this study by applying these param-
eters. Hence, we can infer that non-optimal identification of the magnetization saturations can cause increasing 
energy errors for specific excitations. These results also suggest that a more accurate model for the friction force 
must be found. The proposed Karnopp friction model does not take into account the dynamic stick-slip motion 
of the moving magnet for PTFE-NdFeB contact surfaces and possible roughness differences that may be found 
along the container’s inner surface. Besides, even harvester architectures based on tight-fit container-magnet 
interfaces always require a time-dependent non-axiality degree of the moving magnet for levitation stability. All 
these effects may set differing initial conditions among experiments (the position, orientation and velocity of the 
moving magnet, the surface roughness, among others), mainly when successive experimental tests are conducted. 
We cannot also dismiss possible manifestations of chaoticity in these behaviors.
Few similarities are found between the semi-analytical model proposed here and those recently developed for 
diamagnetic levitation-based harvesting (DLH)29,30, namely: (a) the moving magnet is modeled as a finite set of 
thin current loops; (b) multilayered coil(s) are modeled as a finite set of thin circular turns; (c) the effects of the 
coil inductance on the current dynamics were also considered. Although DLHs are friction-free architectures, their 
accurate analysis requires modeling of other complex dynamics not existent in levitation systems using tight-fit 
containers, such as the damping forces between the moving magnet and the diamagnetic structure29,30. To our best 
knowledge, the proposed model that explores in more detail the fundamental transduction mechanisms of DLHs 
needs further improvement if it is to be used for harvester design optimization30. DLHs were tested only using 
very small excitations amplitudes27–30. Their insufficient levitation gaps have only allowed analyzing nonlinearities 
for very constrained motions of the moving magnet27–30. So far, stable levitation using different orientations of the 
harvester has been only achieved by different DLH designs30,38. However, the harvesting architecture studied in 
this paper and our semi-analytical model enables the analysis of energy transduction nonlinearities for wide range 
of motion amplitudes of the moving magnet, as well as for arbitrary orientations of the harvester.
The solver used in this work is considered one of the best global fixed-step solvers for physical systems, but it 
can be computationally more intensive than other solvers. Still, computing time efficiency is well demonstrated by 
results expressed in Table 2. Computational efficiency could be further improved if the algorithm was fully imple-
mented in compiled code and run in dedicated computing platforms. Better selection of the fixed-step size could 
also improve the simulation time. The increase in computational efficiency compared to FEM was not quantified 
because, to our knowledge, the time to simulate FEM-based models has not yet been reported.
For known and narrowband excitations, the harvester’s characteristics described in Table 1 can be optimized 
prior to fabrication. This model can be used to optimize the self-powering capability of a broad range of technol-
ogies, including those that impose hard dimensional constraints, unconstrained motion amplitudes and arbitrary 
orientations of the harvester. Intelligent levitation-based broadband harvesting can also be achieved using such an 
accurate model. Intelligent control algorithms can be developed to find the most suitable positions of the fixed mag-
nets and coil(s) for each narrowband of amplitude and frequency. It should be noted that the governing equations 
presented for this levitation-based harvester can also be used to model many other motion-driven electromagnetic 
energy harvesters, as well as to maximize the energy they can be harvested for narrow or broadband excitations. 
They can also be used to develop models for arbitrary tri-dimensional trajectories of harvesters.
Methods
The hollow cylindrical structure of the harvester was machined by conventional technology. The harvester output 
voltage was monitored and servo-motors were controlled by a DSP board (DS1102 from dSPACE). I/O modules 
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Figure 4. Steady-state analysis (experimental (red dots) and simulation (solid black lines)) for experiment 
T6 considering Mm = 8.1 × 105 A/m and δ = 38.5 × 10−3 m: CC = 99.24%, EE = 4.55%. 
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of DS1102 were initialized and configured in Simulink R13 (v. 5.0, Mathworks) by the Real Time Workshop (v. 
5.0, Mathworks) and Real Time Interface (v. 4.4, dSPACE). An application was developed in ControlDesk (v. 2.3, 
dSPACE) to interact with the real-time application and to control the experiments. V was computed by discretizing 
( , )B r zz  (incremental steps equal to the wire diameter) and, then, numerically integrating the resulting mesh. The 
1st-order Bessel function J1 was computed as proposed by Deun and Cools39. In order to improve the computational 
efficiency, ( , )B r zz , ( , )B r z rz k , ∫ ( , )B r z rdr
r
z k0
j , Fmuz and Fmdz were stored in 3D Look-up Tables. Equations (7) 
and (9) were compiled by using Matlab S-Functions API.
The simulations were carried out using Simulink R2014a (v. 8.3, Mathworks). Equations (8) and (18) were solved 
via numerical integration using global Simulink fixed-step solver ode14x (fixed-step size: 2.5 ms; solver jacobian 
method: ‘full perturbation’; extrapolation order: 4) so that high solution accuracy and computational efficiency 
could be achieved. A global search algorithm from Matlab R2014a (‘GlobalSearch’ solver; ‘fmincon’ to find the 
minimum of the constrained squared error function) was used to find the friction coefficients. The same algorithm 
was used to compute the saturation magnetizations of magnets: firstly, the force between the moving magnet and 
each of the fixed magnets were experimentally determined within the interval of possible distances between the 
two faces of the magnets (0.1 to 50 mm); finally, the matching of the experimental measurements to the theoret-
ical prediction given by Eq. 10 was carried out (the sets of lower and upper bounds of saturation magnetizations 
reported by the manufacturer were considered in the constrained optimization).
The energy errors and cross-correlations were computed using the following equations40:
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where ( )V tle  and ( )V tls  are respectively the experimental and simulated voltage harvested on the load Rl in the time 
domain; α( )Vle  and α( )Vls  are the discrete counterparts of ( )V tle  and ( )V tls  (length: Ω ; α≤ ≤ Ω)1 ; t1 is the end of the cycle time. The trapezoidal numerical integration was used to compute Eq. 19.
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Chapter 6
Discussion
This thesis proposes a novel approach to minimize implant failures: to use instrumented
implants capable of controlling the bone-implant integration. The architectures of these
implants fulfil the necessary and sufficient requirements to ensure performance optimality
preventing deficient bone remodelling. Cosurface-based capacitive stimulators allow to
deliver a wide range of electric fields to target tissue areas. The stimulators’ geometry
(electrodes and gaps), the amount of stimulators and their locations can also be optimized
to allow that required therapy-based stimuli delivery can be performed. Noteworthy, this
technology allows to deliver therapy actuations along the entire implants’ surface and
even control them in a network scheme. Besides, they can be controlled by clinicians
by establishing a communication link between implant and extracorporeal systems, which
provide the ability to deliver controllable stimuli after implant insertion. Personalized
therapies can then be administrated to patients of all ages and according to their
idiosyncrasies. The rational design of intelligent control algorithms can be useful to
adjust postoperatively the moving electrodes from their initial positioning, extending the
operability range of the stimulatory system. A superior controllability over osseointegration
can be even obtained if its states are monitored. Additionally, everlasting stimuli delivery
can be achieved using self-powering technologies to supply instrumented implants. It
should be noted that stimulation, monitoring, processing and communication systems
can be disabled, such that implants only operate passively. Hence, this new concept of
instrumented active implant can be explored to reach a controllability level (over osteoblast
proliferation, matrix maturation and matrix mineralization) that cannot be attained by
other approaches proposed so far.
This new approach give the opportunity to develop instrumented active implants with
a wide range of new means of therapeutic actuations. The clinicians’ expertise can be used
to administrate appropriated stimulatory therapies, taking advantage of decision-making
based on previous research studies and on outcomes obtained from other patients [1].
Further sophistication may be attained if active implants are designed with the ability
to autonomously define the stimulatory therapies. Nowadays, available technology allows
transferring the human knowledge to data storage systems located inside instrumented
implants, and artificial intelligence algorithms can learn from the inherent variability of
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the osseointegration states of each patient [1]. Included as controllable states might be
the cell adhesion on implants’ surface, the expression of extracellular matrix proteins
and mineralization proteins, the mechanical behavior and topological characterization
of the bone-implant interface, among others. Should not be dismissed that may exist
stimulation-based treatments, ensuring trajectories from failure states to without-failure
states, such that there is no need of monitoring the osseointegration states. This scenario
may most likely occur for preventive actuations. The potential of cosurface stimulators
to avoid the need of bioactive coatings must be referred when analysing the interaction
between these methodologies. When implants are not coated with bioactive materials, this
biophysical stimulator can only optimize the host bone adherence to implants’ surface.
Nevertheless, their stimuli delivery can be exploited as the main method to avoid implant
failures, although they can be programmed as an adjuvant strategy to enhance the
potentiality of bioactive coatings [2] or to deliver drugs and/or other bio-agents [3]. The
capability of osteogenic, osteoconductive and osteoinductive stimulations are thus inherent
to instrumented active implants.
This new concept model of Instrumented Active Implant also present some constraints.
Stimuli delivered by cosurface stimulators to mid-regions between electrodes and a
target region are dependent of the required stimuli that must be delivered to that
target region. Such limitation may not be however an obstacle for controlling bone
remodeling. Besides, it is unknown to what extend different stimuli can be delivery to
nearby tissue areas. As proved in chapter 2, monitoring of the osseointegration states
is required to obtain optimized trajectories of osteoblast proliferation, matrix formation
and maturation and matrix mineralization [1]. The decision-making of clinicians is not
error-free, and the probability to be administrated a non-optimized therapy increases
as the number of monitored states decreases. Other risks cannot be disregarded, such
as the cytotoxic and genotoxic risks related to implant fractures, which are significantly
higher when implant systems are biointegrated in young/active patients. Biocompatible
cosurface stimulators can be already constructed [4], but manufacturing of biocompatible
sensing, processing, energy storage, and communication systems is still a hot topic in
chemistry and material sciences [5]. A risk minimization can be carried out if some
electronic systems and energy harvesters were fully encapsulated using biocompatible
materials, as well as by miniaturizing these inner systems to minimize the hollowed
structures inside implants. As far we are aware, possible genotoxic effects resulted
from the delivery of electromagnetic fields cannot be overlooked, as shown in chapter
4. The above described geometry optimization of stimulators and energy harvesters
prior to arthroplasty may be a sophistication level hard to accomplish. The ability
of adaptive mechanisms to adjust the electrodes positioning will most likely be rather
limited after implant insertion. Therefore, the most reliable scheme seems to be the
identification of the peri-implant regions of more pronounced bone loss (such as the
proximomedial region of total hip replacements) and of the most effective architectures and
geometries for each patient’s profile. Another important issue is the inherent osteogenic
effects that can be promoted by extracorporeally-induced magnetic fields stimulating the
bone-implant interface when communication and/or powering operations are performed [6].
196
Although it seems reasonable to assume much lower exposure times to these stimuli when
comparing with those delivered for therapeutic actuation, these extracorporeally-originated
stimuli can interfere with administrated control trajectories imposed to bony proliferation,
differentiation and mineralization. Finally, instrumented active implants will be more
complex and expensive than passive implants, although they have a huge potential to
minimize the personal and societal burden of disability due to osseointegration problems,
as analysed in this thesis.
Various difficulties will arise in the development of instrumented active implants.
Promising results on the potential of cosurface-based capacitive stimulation to control
bone remodeling were achieved, but the osteogenic effects of a wide variety of stimuli
are still unknown. Per se, administrating EF delivery trajectories may not be enough to
ensure effective implant fixation to host bone, in particular if patients suffer from severe
bone remodeling disorders (e.g. osteoporosis). Moreover, the patients’ idiosyncrasies may
difficult the identification process towards optimality of therapeutic actuations. To ensure
everlasting operation of active implants, complex self-powering and monitoring systems
may have to be designed. Motion-driven electromagnetic energy harvesting seems the
most promising method to power instrumented implants [7]. However, such harvesters
must be designed considering: the geometric optimization prior to fabrication, taken into
account the tridimensional hip joint motions during the routine activities of patients and
according to their ageing processes; rational design of intelligent harvesters, in order to be
adaptable to the intrinsic variability of patients’ motions that significantly reduce their
performance [7, 8]. In this scope, the work here presented is a solid basis for future
research aiming to investigate the effectiveness of this strategy to power instrumented
implants. Indeed, the amount of energy harvested may impose limits on the EF strengths
that can be delivered to the peri-implant bone volume and, consequently, the amount of
therapeutic actuation trajectories may be more reduced than expected. Storage systems
will most likely be necessary [9], mainly for powering implants during the perioperative
period, in old ages and when demanding therapies are required (e.g., several hours of daily
stimulation). Even so, it should not be discarded that extracorporeal systems may be
needed to electrically supply implants. Regarding to the design of monitoring systems,
in addition to the complexity to track the osseointegration states, their operation may
produce adverse effects on the bone-implant fixation. Because monitoring systems must
be located as close as possible to the stimulatory systems, the design complexity increases as
increases the number of sensors and actuators. Projecting instrumented implants capable
of delivering bio-agents in the bone-implant interface without weaken the bone-implant
integration will be also challenging. As these implants always have to be constructed with
inner hollowed structures, it is imperative to research new materials with bulk properties
that can minimize fracture risks. To conclude this enumeration of difficulties that must be
handled, it must be also referred that stimulation therapies can no longer be modified if
the communication system stops working properly.
All technological breakthroughs accomplished to date in this research area are
not enough to develop instrumented active systems that can be already implanted
in human patients. In the forthcoming years, the ability of cosurface stimulators to
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promote controlled and personalized bone remodeling must be deeply explored. The
interrelationships between stimuli parameters and their osteogenic outcomes require to
perform a large number of stimulation assays in vitro and in vivo. Biological tests
must be conducted using various bone cell models and bone structures. Systematic
analyses of EF strength distributions throughout the highly inhomogeneous trabecular
structures are thus crucial. Besides, effects due to cosurface-based stimulation on cells’
homeostasis and adherence to the implant surface must be studied. The shared use of the
cosurface capacitive apparatuses to stimulate organic structures and to monitor changes
in the osseointegration state will most likely be considered. Additionally, the use of these
stimulators as a method to improve the performance of bioactive coatings will be most likely
analysed in detail. Research efforts must be also focused on developing non-linear models
for predicting energy harvesting considering 3D excitations of the harvesters caused by
hip motions of patients. The accurate and efficient analysis of other motion-based energy
transductions is also envisaged, such as the rotational electromagnetic and piezoelectric
harvesting. Nevertheless, innovative harvesting solutions not dependant on the mechanical
work expended by patients (e.g. femoral motions) are also expected. Finally, the
development of measurement systems to accurately monitor the osseointegration state must
be strongly encouraged.
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Chapter 7
Conclusions
The design of implants with advanced materials (including for bioactive coatings),
sophisticated geometries and inner instrumentation (for measurement and therapeutic
actuation) are among the most relevant approaches already proposed to optimize
osseointegration for long-term implant fixation. However, increasing incidences of primary
and revision THRs and TKRs have been observed, and recent previsions estimate even
higher increasing rates in the forthcoming years. This thesis demonstrates that a new
concept model for orthopaedic implants must be developed with ability to control the
peri-implant bone structures. The concept of self-powered instrumented active implant
with ability to deliver controlled and personalized biophysical stimuli to target tissue areas
is here proposed after:
1. Analysing the advantages and drawbacks of instrumented and non-instrumented
implants;
2. Carrying out literature reviews focusing on the major breakthroughs already
attained in several instrumented implants (namely hip joint replacements, femoral
replacements, femoral fracture stabilizers and knee joint replacements);
3. Analysing the potential of several biophysical stimulation systems to be embedded in
active implantable devices for controllable bone-implant integration and regeneration;
4. Investigating the various stimulators used to deliver electromagnetic fields to bone
cells in culture, and correlating the stimuli parameters with observed biological
outcomes;
5. Formulating the architecture and operation of both passive and active orthopaedic
implants;
6. Demonstrating the inability of non-instrumented passive implants and instrumented
passive implants to perform optimal trajectories from states of failure to states of
without-failure;
201
7. Demonstrating the ability of instrumented active implants to optimize the
bone-implant fixation;
8. Starting to investigate the potential of cosurface capacitive stimulators to control
bone remodeling. It was inferred that this stimulatory system can simultaneously
deliver different stimuli to different tissue areas, as well as to enhance osteogenic
responses in vitro throughout several bone remodeling stages;
9. Accomplishing various advances for the development of self-powering systems to
ensure everlasting operation of instrumented active implants.
This work then provides, for the first time, promising results that highlight the
ability of instrumented active orthopaedic implants to promote controlled and personalized
bone-implant integration.
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This article focuses on in vivo implementations of instrumented knee implants and recent
prototypes with highly innovative potential. An in-depth analysis of the evolution of these
systems was conducted, including three architectures developed by two research teams for
in vivo operation that were implanted in 13 patients. The specifications of their various
subsystems: sensor/transducers, power management, communication and processing/control
units are presented, and their features are compared. These systems were designed to
measure biomechanical quantities to further assist in rehabilitation and physical therapy, to
access proper implant placement and joint function and to help predicting aseptic loosening.
Five prototype systems that aim to improve their operation, as well as include new abilities,
are also featured. They include technology to assist proper ligament tensioning and ensure
self-powering. One can conclude that the concept of instrumented active knee implant seems
the most promising trend for improving the outcomes of knee replacements.
KEYWORDS: energy harvesting . instrumented orthopedic implant . knee arthroplasty . knee joint replacement
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As life expectancy is increasing over the past
decades, thanks to social and scientific advan-
ces, the human body is exposed to wear for
longer periods than in previous generations. In
terms of structure, bones and joints can be
susceptible to medical conditions that the
aging body cannot recover from without
advanced medical care.
The knee joint experiences several types of
loads, such as compressive forces, lateral forces
and moments, among others. Changes in the
body’s weight can adversely affect these loads,
which can lead to osteoarthritis (OA) and car-
tilage degeneration (CD) [1,2]. OA is, in fact,
the main cause for total knee replacement
(TKR), accounting between 94 and 97%. It
can be caused by changes in bone density and
morphology, meniscal derangement, hormones
or trauma, but the more critical factors remain
age and obesity [2,3].
The solution to severe conditions lies in
performing TKR procedures [4]. In the USA
more than 650,000 TKR procedures take
place every year [2], with similar rates being
reported by other national databases. In the
UK, during 2012, there were 90,842 knee
replacement-related procedures, 6.5% of which
were revisions, which represents an increase of
7.3% in comparison with the previous year [5].
Norway reports 11% increase in TKR surger-
ies in 2009, 8.3% of overall for revision proce-
dures [6]. Other studies have also presented
similar results, stating that standard TKR have
a survivability rate of well over 90% up to
15 years [5–9]. However, Labek et al. [10]
reported recently that 6% of all implants
require revision after 5 years, a number that
doubles up to 12% after 10 years. It was also
reported that the risk of subsequent revisions
is five- to six-times greater after the first revi-
sion procedure [11]. One must highlight that
these values are predicted to increase 673% for
primary procedures and 601% for revisions
cases by 2030 [4], This prediction is mainly
based on the rising obesity rates and the
increasing life expectancy, which means that
patients will outlive the implant lifespan but
will develop other medical conditions, such as
osteoporosis [4].
There are several factors for TKR revision
surgery. According to the US national joint
registry, infection (26.2%) and aseptic
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loosening (24.3%) are the main causes [4], while the UK regis-
try reports the aseptic loosening (32%), infection (22%),
patient pain (15%), instability (12%) and wear of the polymer
insert (10%). These statistics are also corroborated by the Nor-
wegian registry report, both also stating that the number of
revision procedures is rising [5,6].
Implant instability is a common problem after TKR. It is
due to several operative factors, such as improper fixation or
misalignment of the knee implant, but primarily due to a lack
of proper medial and lateral ligament tensioning [12,13]. While
placement and alignment are carefully planned on the preoper-
ative stage, ligament tensioning relies primarily on the surgeon’s
skill [12,13].
To improve the lifespan of implants and reduce their short-
comings, novel technological breakthroughs are necessary. In
vivo data are preferable for the optimization of implants, since
analytical and/or finite element models are inaccurate due to
their inherent simplifications, and experimental data from
cadaver joints can introduce significant errors due to the deteri-
oration and/or lack of soft tissues, such as muscles and
ligaments.
The first researcher to measure biomechanical quantities
in vivo was Rydell [14] in 1966. Although his instrumented hip
implant was a very important breakthrough, it was based on an
invasive method due to the use of percutaneous wires con-
nected to an external system. It was only in 1979 that English
and Kilvington [15] developed and deployed an enclosed instru-
mented hip implant system, battery powered and equipped
with a telemetry system capable of wireless communication,
allowing other researchers to develop and test new approaches
for the hip, knee and shoulder joints [16]. The first instru-
mented implant to measure in vivo loading quantities of the
knee joint was proposed by Taylor et al. [17,18] in 1996. It is a
massive instrumented femoral replacement combined with a
tibial tray, which is used to acquire axial forces on two different
locations along the femoral axis. Its telemetry system uses
remote powering via magnetic field coupling instead of
batteries. An instrumented implant simi-
lar to a standard TKR prosthesis would
only be intraoperatively tested in
2001 [19] and implanted in 2004 [20].
Some architectures have been devel-
oped and tested in vivo and used to
monitor data to optimize and calibrate
the mathematical models for joint
mechanics and component wear, as well
as for aiding in the development of pro-
totype systems to address the causes for
revision procedures.
Review scope & reading guide
This work focuses on analyzing the mod-
ifications that standard knee prosthesis
undergo to design them as instrumented
implants. A comparison between the
architectures implemented for in vivo operation and their sub-
systems is provided for analyzing the features of their monitor-
ing, power supply and communication systems. New
prototypes that have not been tested in vivo, but present inno-
vative features to minimize TKR-related failures, were also
analyzed.
The design features, architectures, functions, achievements
and the potential of new breakthroughs of instrumented knee
implants were identified from the collection of selected publica-
tions. No time-period restriction was introduced in the search
parameters because there is no previously published in-depth
review about this subject. The collection was completed in
February 2015.
Instrumented knee joint implants validated in vivo
Overview
Although many efforts have been conducted on this topic, to
date, only two research teams have concluded the development
and preclinical trials of instrumented TKR implants used in
human patients. These groups have produced three distinct
architectures that were implanted in 13 patients. They are
arranged chronologically as follows:
1. D’Lima et al. [20–32] designed two architectures for instru-
mented endoprostheses: [20–26]: for the first generation
and [27–32] the second generation.
2. Heinlein et al. [33–43] developed an architecture for instru-
mented knee implants.
These three architectures consist of instrumented tibial tray
designs customized for monitoring operations. They can be
classified into two different types, according to the location of
sensors: those located in the plate (‘SiP’) or those located in the
stem (‘SiS’) as seen in FIGURE 1.
SiP architectures were first considered. In 1996, Kauf-
man et al. [44] developed such an architecture for in vivo
measurement of compressive forces via percutaneous wiring,
by using four transducers, one at each quadrant of the
Load cells Electronics Strain gauges
Power coil
Antena
Figure 1. 3D representation of SiT (Sensors in Tray) and SiS (Sensors in Stem)
instrumented tibial tray architectures.
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plate of the modified tibial tray (N.K. Biotechnical
Corporation).
D’lima et al. [20–26] implemented the first SiP-based architec-
ture. A prototype was intraoperatively tested in 2001 during a
revision procedure. However, it was removed afterwards,
becoming the first system to measure compressive forces on the
knee joint wirelessly. Subsequently, this system was implanted
on a patient in 2004. The first-generation implants developed
by D’lima et al. [20–26] was based on a customization of a stan-
dard commercial titanium alloy implant (DePuy Johnson and
Johnson). The following main modifications were accom-
plished: hollowing of the stem, where the circuitry was housed;
customization of the plate to hold four load cells; and, finally,
the addition of an upper plate connected to the lower plate by
four posts. These developments have enabled the measurement
of compressive forces in vivo after conducting fatigue tests, cali-
bration procedures and in vitro testing using cadaveric materi-
als. Because it was the first implanted architecture, it presents
several novelties, such as:
1. first TKR implant using a SiP configuration;
2. first TKR implant capable of measuring compressive axial
loads on the tibia;
3. first TKR implant with a telemetry system;
4. first TKR implant remotely powered via an inductive power
link.
The second architecture by D’lima et al. [27–32] was devel-
oped shortly after to improve the first generation, namely by
adding new technology to measure other quantities than com-
pressive loads. It is SIS based and composed by two tibial trays:
a thinner standard inner tray (NKII, Zimmer) that was hol-
lowed and fitted inside a custom made outer tray such that
both are fixed together at the bottom most part of the outer
stem. Instead of load cells, this second generation uses four
rosettes of three strain gauges each. These 12 sensors are
embedded in the inner stem, 16 mm below the plate, which
enable measuring three orthogonal forces, both compression
and extension, as well as three moments about the orthogonal
axes. Before carrying out the required procedures for in vivo
operation, it was tested and calibrated on a simulator. Their
breakthroughs include development of the:
1. first instrumented TKR implant using a SiS based design;
2. first TKR implant to measure three orthogonal forces and
moments;
3. TKR implant with most sensing elements (12).
The implant developed by Heinlein et al. [33–43] is a SiS
design based on a modification of an Innex Fixuc prosthesis
(Zimmer). The inner tray was hollowed to house the circuitry.
A larger tray was hollowed as well to be used as the outer tray
(as opposed to the custom-made part in the second-generation
implant developed by D’Lima et al. [27–32]). Both trays were
electron beam welded along the base of the stem. This instru-
mented implant uses six strain gauges that allowed it to mea-
sure three orthogonal forces and moments. It also features a
temperature sensor to properly compensate errors due to tem-
perature sensitivity of the strain gauges. It underwent several
demanding fatigue and calibration tests to comply with the
safety criteria required by ISO 14879-1 and ASTM
F1800-04 standards.
These authors were the first to develop an instrumented
knee implant with the ability to monitor the operating temper-
ature of the circuit boards. One must also highlight that this
implant has been the most used one to date.
Measurement features
TABLE 1 lists the instrumentation features of the three architec-
tures experimentally validated in vivo. Loads and moments
over knee implants have been the main monitored quantities.
Resistive methods using strain gauges are used in all architec-
tures. Only the knee system developed by Heinlein et al.
[33–43] uses a thermistor to monitor the temperature inside the
tibial tray. This system also features the highest sampling rate
(250 Hz) and the maximum accuracy error (2%), while the
first-generation implant developed by D’Lima et al. [20–26]
measures loads at rates up to 70 Hz with a mean absolute
error of 1.5%.
Sensors, for both the second-generation implants developed
by D’Lima et al. [27–32] and Heinlein et al. [33–43], are embed-
ded in the inner wall of the stem. Not similarly, for the first
generation by D’Lima et al. [20–26], sensors were embedded on
the plate of the tibial tray. The second generation proposed by
D’Lima et al. [27–32] contains the highest number of sensors
(12).
No architecture reports any type of data storage and/or proc-
essing system for diagnosing failure states of the implants.
None of these instrumented knee systems are able to monitor
the physiological characteristics of tissues around the implants.
Communication features
TABLE 2 presents the comparison between the communication sys-
tems’ characteristics of the different architectures. All systems
use radiofrequency (RF) telemetric systems embedded in the
stem, whereas antennas were located inside a polyethylene cap
at the distal tip.
The first-generation system designed by D’Lima et al. [20–26]
used the Strainlink system developed by Townsend and
MicroStrain [21]. It supports up to five data channels and
transmission frequency of 916.5 MHz. The communication is
performed by pulse-code modulation (PCM), due to its lower
susceptibility to noise than pulse width modulation (PWM)
and pulse interval modulation (PIM). The second genera-
tion [27–32] uses a modified version of the Strainlink
(418 MHz PCM), to comply with the need of 12 channels for
the 12 embedded sensors.
The architecture designed by Heinlein et al. [33–43] uses the
communication system developed by Graichen et al. [45], which
was extensively tested by the Orthoload group [46]. By support-
ing nine channels and using 125 MHz PIM, six strain gauges,
the temperature sensor and the voltage supply system could be
Instrumented knee joint implants Review
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monitored. The communication module is housed inside a
metallic cylinder shell for mechanical and magnetic protection.
The in vivo data transmitted to receiver stations outside the
patient’s body were analyzed afterward for validating biomechan-
ical models and other gait-related research [22–26,28–32,34–43].
Supply features
TABLE 3 provides the comparative analysis of the power supplies
that enable the implants to operate. Because it is a more recent
technology, instrumented knee implants have profited from the
knowledge acquired in the development of other instrumented
implants extensively tested in vivo, such as those designed for
the hip joint [16]. All three architectures use remote electrical
powering via an inductive magnetic link. Batteries have not
been used to avoid autonomy faults and the presence of poten-
tial harmful substances inside the patient’s body.
D’Lima et al. [20–32] uses the same power supply of the
Strainlink system [21] for both architectures. A current is
induced in a secondary coil located inside the stem by a pri-
mary coil around the patient’s lower leg. However, since the
secondary coil is inside the implant’s titanium, which in turn is
surrounded by bone and soft tissue, the power transfer effi-
ciency of about 0.04% (only 40 mW is acquired when
1.6 kHz 100 W power oscillation is
driven by the primary coil). The induced
alternating current (AC) is then rectified
by a power regulation circuit, embedded
inside the implants, to provide the
40 mW steady DC voltage for powering
all the instrumentation.
Heinlein et al. [33–43,45] use a similar
system based on the power supply system
developed by the Orthoload Group to
power instrumented hip implants [46]. An
external 4 kHz power oscillator is used to
drive the primary coil around the
patient’s leg. A voltage sensor measures if
electronic systems inside the implant are
being powered suitably and relays that
information to the controller’s worksta-
tion (located outside the patients’ body).
One can find similar low power transfer
efficiency for the other designs (from
0.04 to 0.1%). The overall energy con-
sumption required to power the implant
is not reported, but the communication
system alone requires 5 mW of electrical
power.
Power requirements are relatively low
since instrumented TKR systems were
not designed to comprise data storage,
real-time processing of data measured
in vivo or real-time therapeutic actuation.
However, similar architectures composed
of higher number of sensors, and other
subsystems requiring electric power, may demand significant
energy amounts.
The main limitations of these inductive power systems are as
follows:
1. the period between data monitoring operations is limited, as
the remote powering system is too cumbersome, disrupting
the patient daily activities;
2. when developing such devices, safe operation must be
guaranteed, meaning that the RF fields need to be within
those acceptable to humans [47] and according to standards
in the Active Implantable Medical Device Directive
(AIMDD-EU Directive 90/385/EWG) and the Medical
Device Directive (MDD-EU Directive 93/42/EWG). The
Orthoload group reported that their implants were devel-
oped taking into account such norms [46].
In vivo operation details
TABLE 4 compares significant postoperative details about patient
characteristics, time and type of data acquisition events and
their purpose. Data were only acquired in the laboratorial
environment because all devices only operate (monitoring and
data communication) when they are powered by an inductive
Table 1. Instrumented knee joint replacements – measurement
features†.
Features D’Lima et al. [20–32] Heinlein et al. [33–43,45,46]
Measuring
method
(1,2) Resistive (Wheatstone
bridges)
Resistive
Components of
measurement
systems
(1) 4 load cells (strain
gauges);
(2) 12 gauges (4 rosettes of
3 gauges each)
6 strain gauges, 1 NTC thermistor
Locations of
components
(1) One in each quadrant of
the lower plate of the tibial
tray;
(2) on the stem of the tibial
component, 16 mm beneath
the plate
Inside the stem of the tibial
component
Measured
quantities
(1) Compressive medial and
lateral loads;
(2) 6 tibial loads
(3 orthogonal forces plus
3 moments)
Mediolateral force (FML),
anteroposterior force (FAP), axial
compressive force (Faxial), flexion–
extension moment (Mflex/ex), varus–
valgus moment (Mvar/val) and
internal–external moment (Mint/ext)
Transmitted
quantities‡
All measured quantities were
transmitted
All measured quantities were
transmitted
Sampling period (1) 70 Hz;
(2) N/D
125 Hz
Errors (1) Mean absolute error of
1.5% (2) N/D
Maximum accuracy error (load): 2%
†Terminology: (n): implant of the nth generation.
‡They were transmitted to signal acquisition systems outside the patients’ body.
N/D: Information not reported.
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power system and other transmission/
reception systems, which were only avail-
able outside the patients’ bodies. The
first patient received an instrumented
implant in 2004. By customizing a stan-
dard commercial titanium implant as the
first generation developed by D’Lima
et al. [20–26], data were acquired through-
out the first postoperative days and fol-
lowing weeks of rehabilitation.
Subsequently, data obtained up to 7 years
after implantation has been reported,
making it the longest data acquisition
period performed by the instrumented
knee architectures implanted by this
research group. To overcome the limita-
tion of the in vivo measurement of only
compressive loads, another three patients
received a second-generation architecture
between 2006 and 2008 [27–32], which
was able to measure all six orthogonal
loads (three Cartesian forces and three
moments). Data acquisition started at
the rehabilitation stage (3 weeks postop-
eratively) and was performed up to
1 year after implantation.
Even though the implant developed
by Heinlein et al. [33–43] is the
most recent architecture, it had been
implanted into nine patients between
2007 and 2010. Worthy of note is the
fact that a large amount of data from the
Orthoload group is publically available
on their database. It comprises the largest
amount of in vivo data of any of the
three architectures, which can be accessed
through their website [46]. For one of the
patients (K3R), data have been obtained
up to 85 months postoperatively, the
longest data acquisition period of all six
knee joint loads. It has benefited from
the developments in instrumented hip
and shoulder implants already used by
this group, namely by using the
‘MATRIX’ method that they proposed
to measure three orthogonal forces plus
three moments by using six sensors [48].
A common goal for most studies con-
ducted by both research teams was to
use the data acquired to validate and
adjust existing numerical models for the
knee joint [22–24,26,28–31,34–36,38–43,49].
Other research works include the study
of the influence of footwear on knee
loads [25,37,39] and assessment of
Table 2. Instrumented knee joint replacements – communication
features†.
Features D’Lima et al. [20–32] Heinlein et al. [33–43,45,46]
Method of
communication
(1,2) Telemetric (radio
transmission of inductive link):
radio transmission of data from
implants to a receiver
Telemetric (radio transmission of
inductive link): radio transmission
of data from implants to a receiver
Components of
communication
systems
(1) 5-channel 916.5 MHz PCM
transmitter; antenna; (2)
12-channel 418 MHz PCM
transmitter; antenna
9-channel 120–170 MHz PIM
transmitter; antenna
Locations of
components
(1,2) Circuitry: inside the stem,
antenna: distal tip, covered by a
polyethylene cap
Circuitry: inside the stem, antenna:
distal tip, covered by a
polyethylene cap
Acquisition
mode‡
(1,2) During tests During tests§
Resolution (1) 22 bits; (2) 12 bits 12 bits
†Terminology: (n): implant of the nth generation.
‡Period between data monitoring operations.
§Communication with implants was only carried out in the research laboratory.
PCM: Pulse-code modulation; PIM: Pulse-interval modulation.
Table 3. Instrumented knee joint replacements – supply features†.
Features D’Lima et al. [20–32] Heinlein et al. [33–42,45,46]
Type of supply (1,2) Electric energy Electric energy
Method for power
supply
(1,2) Inductive powering, using
a 1.5 kHz modulation
Inductive powering using a
4 kHz modulator
Components of
supply systems
inside the patient’s
body
(1,2) (Secondary) power coil;
regulation systems
(microcontroller)
(Secondary) power coil;
regulation systems
(microcontroller)
Locations of
components inside
the patients’ body
(1,2) All components are
located in the tibial tray; power
coil: bottom of the stem;
circuitry: middle of the stem
All components are located in
the tibial tray; power coil:
middle of the stem; circuitry:
bottom of the stem
Components of
supply systems
outside the
patients’ body
(1,2) 1.6 kHz power oscillator
plus 100 W amplifier; (primary)
coil (around shin)
4 kHz power oscillator;
(primary) coil (around shin);
antenna, RF receiver and
controllers
Power regulation
circuitries
(1,2) Inside the implant: circuitry
to regulate output voltage;
outside the implant: N/D
Inside the implant: circuitry to
regulate output voltage;
outside the implant: circuitry to
control the oscillator power/
frequency and to compensate
displacements between the
coils
Power generation (1) 40 mW (9 mW minimum for
sensors); (2) 40 mW
N/D (5 mW for communication
operations)
Life span (1,2) N/D N/D
Efficiency (1,2) Approximately 0.04% Between 0.04% and 0.1%
†Terminology: (n): implant of the nth generation.
N/D: Information not reported.
Instrumented knee joint implants Review
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physiotherapy techniques with or without braces and other
aids [24–26,29–31,34–41,43].
The TKR designed by D’Lima et al. [20–32] differ from those
designed by Heinlein et al. [33–43] not only due to their embed-
ded systems but also in the type of implant in which their
architectures are based. The first group used a cruciate
ligament-retaining system, while the second is a cruciate
sacrificing system that uses an ultracongruent tibial insert. Dif-
ferent implant types can affect the joint behavior [50,51], which
in turn can affect the magnitude and direction of forces that
are measured by instrumented TKRs.
D’lima et al. [30] reported low shear forces during operation
of their second-generation implant, which attributed to the cru-
ciate retaining system usage. Since all architectures have a gap
between the upper and lower plates of the tibial tray, connec-
tive tissue can grow within this space. Therefore, different
measurements can be obtained in comparison with tibial trays
effectively sealed. Even though both D’Lima et al. [27] and
Heinlein et al. [33] express their concern about this matter, only
the latter have reported the usage of a round plastic sealant
along the gap circumference positioned between the upper and
the lower plates.
No revision procedures for these implants have been
reported.
Novel breakthroughs in instrumented knee implants
Overview
To improve the autonomy and longevity of instrumented
TKRs, some prototypes were proposed by five research groups,
focusing on self-powering, kinematic measurement systems and
ligament tensioning assistance. These systems are still in their
development/experimental stage and none of them was already
tested on human patients.
Almouahed and Lahuec et al. [52–55] addressed the issue of
dependence on an external power supply by proposing a self-
powered architecture based on the first generation (SiT archi-
tecture) tested by D’Lima et al. [20–26]. They used piezoceramic
load cells to both measure compressive forces and harvest elec-
tric energy for powering the implant subsystems. Luciano et al.
[56,57] also presented a contribution for self-powering of the
implants. They developed a motion-driven electromagnetic har-
vesting system that uses the relative motion between a coil and
12 magnets to harvest electric energy. The power-generating
elements (coils, magnets and regulation electronics) are located
in the polyethylene insert, as well as in the femoral component
of the TKR.
Arami et al. [58–60] developed an instrumented TKR insert to
measure the internal–external and flexion–extension rotations
to allow measuring knee kinematics more accurately and with-
out the need of (quite expensive) external equipment, which in
turn allow the monitoring of data during the daily activities of
patients.
Two approaches were already proposed to ensure proper lig-
ament tensioning: Crottet et al. [61,62] developed an intraopera-
tive tool, similar to a TKR insert, to measure loads in real time
for aiding the surgeon; Collo et al. [63,64] produced two tibial
tray prototypes that are able to perform slight changes in their
geometry to ensure proper tensioning of the medial and lateral
ligaments after implantation.
Self-powering solutions
TABLE 5 lists significant features of the self-powered implant sys-
tems already proposed. Almouahed and Lahuec et al. [52–55]
proposed a SiT-based architecture capable of measuring antero-
medial, anterolateral, posteromedial and posterolateral compres-
sive loads, featuring its own telemetry radio communication
system. They used piezoceramic elements as power-generating
elements. They conclude that an average of 1.8 mW can be
harvested to power the telemetry system, at typical walking
speed. However, this approach for self-powering is highly
dependent on the loads on the tibial tray. This prototype is still
at an optimization stage to minimize its power requirements
and to maximize the power output of its harvesting compo-
nents. The authors have not reported if their prototype is a
customization of a commercially available model.
The proposal presented by Luciano et al. [56,57] relies on knee
motions to harvest electric energy, rather than on the use of
knee loads, to power an autonomous sensor unit. By placing
two sets of magnets with interchanged polarity orientation, one
along each condyle, and a wire coil in the insert pin between
them, such that its axis is perpendicular to the sagittal plane,
the motion of the knee joint drives magnetic flux variations to
induce voltage on the coil. The system was able to harvest an
overall power of about 92 mW during normal walking speeds
simulated in vitro using a robotic knee simulator, which is
capable of self-powering a 1.7 mW sensor unit for 16 ms. This
power magnitude is achieved by harvesting a peek voltage rang-
ing from 1.4 V to 2.0 V every 7.6 s. During this interval, com-
pressive loads measured by magnetoresistive elements are
transmitted via a 125 kHz telemetry radio. It is based on a
NexGen Legacy Knee LPS-Flex prosthesis (Zimmer) in
which the femoral component and the polyethylene insert were
modified to house the magnets, power coil and circuitry.
Kinematic measuring systems
Arami et al. [58–60] proposed a knee system to measure in vivo
knee kinematics, namely internal–external and flexion–exten-
sion rotations. This knee system is a customization of the F.I.
R.S.T. (Free Insert in Rotation, STabilized) knee prosthesis
from Symbios Orthopedie. It was designed comprising the fol-
lowing features:
. three magnetoresistive sensors housed in the insert;
. two permanent magnets, one located in the femoral compo-
nent and the other in the tibial tray;
. inductive power supply.
The system works by analyzing the variation of the magnetic
flux from the motion of permanent magnets. The magnet
located in the tibial tray is related to internal–external rotation,
while the one in the femoral component accounts for the
Instrumented knee joint implants Review
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flexion–extension rotation. Measured quantities are obtained by
fusing data from the various sensors to estimate angle configu-
rations from the raw data of each sensor. They achieved errors
up to 0.9 for internal–external rotations and 1.1 deg for flex-
ion–extension rotations. They have not reported the develop-
ment of novel breakthroughs for telemetric systems. A later
version of this prototype also comprises two strain gauges to
measure compressive loads beneath each condyle for identifying
polyethylene insert wear. However, it was not described how
load values evolve over the course of the insert degradation.
Ligament tensioning tools
TABLE 6 presents significant features of two prototypes that were
designed to assist in lateral ligament tensioning. Crottet et al.
[61,62] developed an intraoperative tool to measure ligament
forces and contact forces. It was designed for replacing the poly-
ethylene insert (between the femoral and tibial components) to
support surgeons during procedures related with ligament ten-
sioning, by providing load information in real time. After com-
pletion of these procedures, this mechanism is replaced by the
insert. The prototype is composed by two separate sensing plates
(one for each condyle) with 6 thick-film piezoresistive sensors
(three for each plate). Six cadaver knees were used for in vitro
tests. A mean relative error of 0.5% was achieved.
Collo et al. [63,64] proposed a knee system prototype com-
posed by an actuation system with the ability to change the
configuration of the upper plate of the
tibial tray such that the tension of the lig-
aments can be adjusted after the surgeon
has finished the procedure. They imple-
mented two actuation systems:
1. using a horizontal wedge plate with a
lead screw, whose forward motion
raises the upper plate of the tibial tray;
2. using a vertical planetary gear train
driving screw nuts to move up or down
the upper plate, such that an ‘optimal’
configuration can be achieved.
Both systems are driven by a micro-
stepper motor that is powered by an
internal battery, which in turn can be
charged via an inductive link. This actu-
ation system is manually controlled by
the surgeon since no measurement system
was designed to provide feedback. Only
3D printed plastic prototypes have been
produced to validate the concept. Authors
are planning to develop metallic proto-
types in the forthcoming years.
Expert commentary
The instrumented implant architectures
validated in vivo, presented in this review,
were designed as transducers to measure
biomechanical loads, in addition to their main function of restor-
ing articular motion. They are medical devices composed by:
. sensing systems;
. signal processing and conditioning systems to extract infor-
mation from the data acquired by the sensing systems;
. telemetry systems to transmit data between electronic circuits
inside and outside the patients’ body;
. power supply systems to provide the energy required for
operation.
In spite of the importance of these achievements, there are
no knee implants yet capable of:
1. monitoring biochemical characteristics of the tissues sur-
rounding the implants;
2. characterizing failures, such as component wear, aseptic loos-
ening or infection;
3. performing personalized therapies in the bone-implant
interface;
4. collect data autonomously during daily activities.
Currently, among the main obstacles for developing such
systems are those related to space availability for components
and their safe encapsulation. Only a limited amount of material
can be removed to avoid fractures and maintain mechanical
properties. Besides, major design modifications must be
avoided to ensure the patient’s compliance. Since most embed-
ded components are not biocompatible, they need to be safely
Table 5. New instrumented TKR systems – features of self-powering
prototypes†.
Features Almouahed et al. [52–54] Luciano et al. [56,57]
Method for
power
generation
Piezoelectric Electromagnetic
Power output 1.8 mW 92 mW
(1.4 V to 2.0 V at every 7.6 s to
power the 1.7 mW telemetry and
sensor system for 16 ms)
Components 4 piezoceramic elements,
power management unit
2 series of 6 box-shaped magnets;
wire coil; power management circuit
Location of
components
4 piezoceramic elements on
beneath the tray of the tibial
component
1 series of 6 magnets in each
condyle (femoral component);
Wire coil on the polyethylene insert
femoral pin;
Power management circuitry,
sensors and communication system
at the center of the insert
Measurement
features
4 piezoceramic elements
measure compressive loads
3 magneto resistive sensors to
measure compressive loads
Communication
features
402-405 MHz telemetry radio 125 kHz telemetry radio
Lifespan N/D N/D
Efficiency N/D 10%
†Terminology: N/D: information not reported.
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encapsulated and confined to small cavi-
ties inside implants. Considering that
permanent implants are mostly manufac-
tured using metallic alloys, such that
proper osseointegration and moisture
protection be achieved, remote powering
can only be conducted by using low fre-
quencies (in the kHz range). Data trans-
fer rate is also limited due to this
problem. To expand the communication
rate to the MHz range, the antenna was
located outside the metal encapsulation at
the distal tip covered by a plastic cap and
connected to the control unit via a lead-
through [21–43].
There is, however, a growing trend to
implement instrumented implants with
sensors capable of measuring quantities
other than biomechanical loads. Arami
et al. [58–60] reported a prototype TKR to
measure knee kinematics. The architec-
ture proposed by Heinlein et al. [33–43]
also includes a temperature sensor, a fea-
ture also shared with the hip implants
developed by Mann et al. [65–67],
Davy et al. [68,69] and Bergman et al.
[70–72]. The latter also proposed a hip
implant, which was already implanted in
five patients, comprising a network of
nine temperature sensors to measure the temperatures along the
entire implant length, to study how temperature changes
(induced by friction) deteriorate osseointegration [71,72]. More
recently, the same team proposed a study involving 100 individ-
uals using an implant with one temperature sensor in the neck
beneath the ceramic head, designed specifically to study the
risk of thermally induced bone necrosis [70].
Several innovations have been recently reported such that the
lifespan of instrumented TKR systems can be extended.
Ruther et al. [73] designed a method to use acoustic analysis of
sound waves, generated by a mechanical oscillator, to monitor
the osseointegration in the interface of cementless orthopedic
implants. Hao et al. [74] developed a differential variable reluc-
tance transducer to predict aseptic loosening by measuring the
migration and micromotion of implants in real time.
Alpuim et al. [75] proposed a piezoresistive thin film strain sensor
to monitor aseptic loosening by monitoring the relative motions
in the bone-implant interface. However, these systems still
require further optimization and testing for system validation [16].
The autonomy of the instrumented TKR systems to operate
throughout patients’ daily life requires housing energy harvest-
ers inside the implant. Energy harvesting in vivo is the key
challenge that must be addressed for developing self-powering
implants. To accomplish this purpose, Almoulahed et al. [52–55]
proposed a TKR using piezoelectric elements to measure loads,
as well as to harvest electric energy. Platt et al. [76] also
proposed a similar piezoelectric harvesting system, but it
requires further optimization to increase power output levels.
Luciano et al. [56,57] contributed with a motion-driven electro-
magnetic rotation-based energy harvester that was customized
for knee implants, while Morais et al. [77–79], Morgado et al.
[80] and Soares dos Santos et al. [81–83] proposed translation-
based electromagnetic harvesters to power instrumented hip
replacements, which could be customized for knee implants.
Soares dos Santos [81,82] also developed a multisource harvesting
system composed of electromagnetic and piezoelectric harvesters
to increase the amount of available energy harvested in vivo, as
well as to improve the reliability of the power supply.
Silva et al. [79,84] developed a power management system com-
prising supercapacitors to store the energy harvested from the
operation of the multisource energy harvesting system. A deep
discussion about the effectiveness of self-powering systems to
supply instrumented orthopedic implants was recently pub-
lished by Soares dos Santos et al. [83]. Although motion-driven
self-powering can generate energy without the disadvantages of
both inductive supply and batteries systems, their performance
is strongly dependent on the physical activities of patients.
Since most patients experience reduced mobility during rehabil-
itation and in their old age, further developments are still
required to improve efficiency of the power harvesting and
power management systems to maintain implant operation
when harvesting is insufficient [83].
Table 6. New instrumented TKR systems – features of prototypes for
ligament tensioning†.
Features Crottet et al. [61,62] Collo et al. [63,64]
Type Intra-operative tool Tibial tray with actuation system
Measurement
features
6 deformable bridges with piezo
resistive elements.
N/D
Measured
quantities
Medial and lateral collateral
ligament forces (FML, FLL), medial
and lateral contact forces (FMC,
FLC), external varus force (FEX)
N/D
Method for
power supply
Direct electrical supply Battery powered with inductive
coupling charging system
Actuation
systems
N/D 1: Lead-screw wedge
2: Screw nut gear-train
Actuation
system
components
N/D 1: Horizontal lead screw and
wedge to change height and
angle of upper plate of tibial tray
driven by microstepper motor
2: Vertical planetary gear train
driving screw nuts to change
configuration of upper plate of
tibial tray operated by micro
stepper motor
Testing/
development
stage
Numerical simulation;
Validation in cadaveric joint
simulator
Numerical simulation;
Proof-of-concept prototype system
†Terminology: N/D: information not reported.
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Although additional risks by using instrumented TKRs in
human patients must be taken into account, in vivo data meas-
urements using this method are more reliable than those
obtained by in vitro testing of cadaveric joints or by numerical
methods [21–43]. Still, all these innovations have been performed
to extend the lifespan of instrumented TKR systems in a non-
real-time mode, that is, their operation can be only used to
optimize the next generations of implants. The ordinary meth-
odology to improve knee implants has focused on the optimi-
zation of their design and materials. However, this approach
has not ensured long-term survival of implants and, as a conse-
quence, surgical procedures are still required significantly to
minimize complications following TKR. However, Soares dos
Santos et al. [85] studied recently the necessary and sufficient
conditions required for optimality of orthopedic implants, and
by using the Pontryagin Maximum Principle, they concluded
that it is impossible to ensure optimal trajectories from states
of failure to states of without-failure for implants without ther-
apeutic actuation and therapeutic programming (whatever its
nature), whatever their architectures, implants’ optimization,
rehabilitation protocols or surgical procedures. They also con-
cluded that if optimal trajectories between states of failure and
states of without-failure exist, then instrumented active
implants comprise suitable architectures to implement them.
The innovation proposed by Collo et al. [63,64] can be consid-
ered as an instrumented active knee prototype, but it was not
designed to apply therapeutic actuations in the bone implant
interface such that it can control its biochemical environment.
Considering that aseptic loosening and infection are among the
most common causes for revision TKR [4–6], research in the
design of instrumented active knee systems must be considered
as an effective methodology to minimize and/or prevent these
causes responsible for revision procedures.
Five-year view
Although instrumented implants are quite important tools to
calibrate biomechanical models and monitor patient evolution
throughout recovery, they still have much potential that can be
explored. Further optimization of the current TKR systems and
the inclusion of additional features could be performed to
implement them with the ability to detect and even prevent
failures in real time.
Solutions for when an external antenna cannot be used can
be developed in the forthcoming years, such as using the sec-
ondary coil of the power system as the communication
antenna. Bergman et al. [72] used this method in a recent pro-
posal for a temperature measuring total hip replacement by
using a combination of high pass and low pass filters to
demodulate signals less than 1 kHz while discarding the 4-kHz
power supply modulation, as well as the 50-Hz power mains.
As the miniaturization of electronics advances, low power
and high-performance circuits may enable the development of
implants embedding actuation systems, as well as the required
control architecture, in confined spaces. Furthermore, research
in material science may result in the development of materials
with appropriate mechanical properties that allows using them
in permanent implants minimizing fracture and improving
magnetic permeability. Higher frequencies could thus be used
for maximizing data transfer rates and remote powering system
efficiency. Breakthroughs for monitoring the insert wear, asep-
tic loosening and infection are expected to be conducted in the
forthcoming years, which can be further promoted by such
advances in electronics and material sciences. Novel sensing sys-
tems for TKRs may be developed such that the influence of
friction-induced knee implant temperatures on osseointegration
can be identified.
More advanced methods that analyze the implant stability
for detecting loosening may be explored and/or implemented
in the near future. However, one must also highlight that novel
methods based on monitoring molecular markers may be
researched [86,87]. The development of sensors to measure failure
specific marks in the regions surrounding the implant, such as
nitric oxide [86] or peroxynitrite [87], is likely to be considered
first. To accomplish this goal, implants will require resource
storage capabilities to house the chemicals required for biosens-
ing [88] and even medical drugs for therapeutic purposes [89].
Advancements in rapid prototyping technologies, such as
electron beam melting [90], can allow patient-specific implants
to be produced at reasonable rates and costs. Manufacturing of
instrumented implants using such technologies may facilitate
the inclusion of the embedded subsystems required for active
instrumented implants.
Power supply systems will require further developments to
power more complex implants with additional embedded fea-
tures. Power generation can be performed by using the move-
ments of patients during their daily activities. Energy
harvesting is a promising method to power instrumented knee
implants, mainly because it is inexpensive and maintenance-free
affordable solution, as well as it ensures long-term energy gen-
eration. Additional research will likely be focused on optimiza-
tion of harvesters considering the gait patterns of patients
during their daily activities to maximize their power output as
well as in the development of redundant multisource harvester
structures [79,84].
Therapeutic actuation systems that have been proposed, but
currently are not yet suitable for in vivo applications, such as
ligament tensioning [63,64] and stimulation systems to improve
osseointegration [91,92], may have been engineered and ready for
in vivo tests. Research to identify the most suitable noninvasive
therapeutic stimuli to deliver on the bone-implant interface is
likely to be conducted. Moreover, the stimulation parameters
that can induce bone tissue growth must be found, such that
the osseointegration can be improved.
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Key issues
. Even though considerable research has been conducted to improve implant design, revision rates of TKR are about 6% after 5 years
and 12% after 10 years. The number of primary TKR procedures is increasing, especially in a younger demographic.
. Instrumented knee implants are proposed as research tools to measure biomechanical quantities in vivo. Their purpose is to collect data
(forces and moments) to validate models defining the implants’ biomechanical behavior; optimize the mechanical design of standard
implants; carry out preclinical testing; and track patient healing and rehabilitation after arthroplasty.
. Three architectures of instrumented TKR, comprising RF telemetry systems and resistive load measuring sensors, powered by an
inductive power link, were implanted into 13 human patients.
. Up to 7 years of successful operation and in vivo data acquisition have been achieved. No revision procedures or side effects have been
reported.
. None of the architectures validated in vivo were designed with therapeutic actuation systems. Only one research team proposed a
prototype comprising an actuation system to control the lateral ligament tensioning, such that failures in the ligament tensioning can be
overcome postoperatively.
. Currently, data acquisition events are limited to laboratorial settings due to the need of external power supply technology and
supplementary kinematic measurement systems.
. New developments to acquire other biomechanical quantities, such as those related with kinematics, as well as to include sensors for
monitoring critical areas where component wear (polyethylene insert) and loosening (femoral and tibial fixations) may occur.
. Improvement and optimization of electric power supply systems, especially self-powering methods, is mandatory such that the
autonomy of instrumented implants can be maximized.
. Further research on patient-specific implants and ligament tensioning assistance tools may help in reducing revision risks and
postoperative pain in TKR patients.
. Development of embedded noninvasive stimulation systems (electrical and/or mechanical) for instrumented implants may effectively
induce and control bone growth in regions where aseptic loosening occurs.
. The design of instrumented active implants with therapeutic actuation systems seems to be the most promising trend to detect/prevent
failure states (aseptic loosening, infection or component wear) in real time.
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Chapter 9
Supplementary Material - Chapter
3.2
Supplementary material of article:
’Electromagnetic stimulation of bone remodeling in vitro: a review’
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1Supplementary Tables
Table S1 - Direct current stimulation characteristics and biological outcomes evaluated in different cell lines. ND – not defined; NA – not applicable; Cons. – constant electric
field; ES – electric stimulation; [Ca2+]i - intracellular calcium concentration; IA – DNA incorporation assay; EF – electric field.
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x10-3
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to 40%) - - - - [63]
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10 ND 1h to 17.2 h - - - - Cathodal galvanotaxis [68]
SaOS-2 (human
osteosarcoma cell line) ND Cons. NA
5 and
14 ND 5 min to 5 h - - -
↑[Ca2+]i (at
14 V/cm) Anodal galvanotaxis [69]
MG63 (human
osteosarcoma cell line) ND Cons. NA 7 to 12 ND secs to 80 min - - - ≈ [Ca
2+]i Alignment and elongationperpendicular to EF lines [65]
2Table S2 - Direct current stimulation characteristics and biological outcomes evaluated in stem cells. ND – not defined; NA – not applicable; Cons. – constant electric field; ES
– electric stimulation; [Ca2+]i - intracellular calcium concentration; [Ca2+]m – medium calcium concentration; EF – electric field;  OM – osteogenic media; MetB – metabolic activity
assay;  ALPa – Alkaline phosphatase activity; ALPe – Alkaline phosphatase expression; OC – osteocalcin; OPN – osteopontin; Col I – collagen type I; MM – matrix mineralization.
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hBM-MSCs (human
Bone Marrow
derived
Mesenchymal Stem
Cells)
ND Cons. NA
25x10-2
to 6 ND 2h to 10 h - - - -
Anodal
galvanotaxis
[70]
2 ND 2h
28 days [2 h ES
+ 1 day no ES
+ 28 days OM]
- - ≈ MM - -
hBM-MSCs (human
Bone Marrow
derived
Mesenchymal Stem
Cells)
ND
Cons. NA 0.1; 1;10 ND 30 min - - -
↓ [Ca2+]i
spikes -
[74]
Sinusoidal 1 1 ND 30 min/day 10 days (+OM)
↑Cell Nr.
(+200%) ↑ALPa ↑ MM - -
mASCs (mouse
Adipose Derived
Stromal Cells)
ND Square 50 6 ND
6 h/day 10 days ≈ Cell Nr. (days1, 3, 5, 7, 10) - - -
Alignment and
elongation
perpendicular to
field vector
[66]
6 h/day 7 days (+OM) -
↑ALPa
(+100%);
↑ALPe and
OPN
(+500%);
↑Col I; Runx2
(+100%)
- -
6 h/day 21 days (+OM) - - ≈ OC;≈ MM -
5 min - - - ↑ [Ca2+]i
hBM-MSCs (human
Bone Marrow
derived
Mesenchymal Stem
Cells)
ND Cons. NA 0.1 ND 3 h/day 5 days ↑ MetB (days 0,2, 3, 5) - - -
↑ rate of cell
migration;
↑expression of
migration and
invasion related
[71]
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hBM-MSCs (human
Bone Marrow
derived
Mesenchymal Stem
Cells)
ND Square
100 ND 1.5
24
h/day
6 days [1 day
no ES + 5 days
ES]
↑ Cell Nr. +78%
(day 3), +53.5%
(day 5)
- - - -
[87]
21 days (7 days
ES
+ 14 days no
ES) + OM
-
↑ALPa
(day 10)
≈ OPN, BSP,
Col I
≈ OC;
↑MM (+20%)
(day 21)
- -
100 ND 15
6 days
[1 day no ES
+ 5 days ES]
↑ Cell Nr. +40%
(day 3), +22.5%
(day 5)
- - - -
hBM-MSCs (human
Bone Marrow
derived
Mesenchymal Stem
Cells)
ND Sinusoidal 60x103 0.02 ND 40 min/day
28 days
+ OM ≈ MetB
↑ ALPe;
↑ Col I;
↑ Col I
deposition
(days 15, 20)
≈ MM - - [52]
4Table S3 - Direct current stimulation characteristics and biological outcomes evaluated in primary cells. ND – not defined; NA – not applicable; VE – Voltage between
electrodes; VC - voltage between cells; Cons. – constant electric field; ES – electric stimulation; [Ca2+]i - intracellular calcium concentration; [Ca2+]m – medium calcium concentration;
[Ca2+]ecm – extracellular matrix calcium concentration; EF – electric field;  EA – exclusion assay.
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Osteoblasts
(Rat calvaria)
Non-
confluent Cons. NA NA ND 100 1h/day
7 days
[2 days no ES
+ 5 days ES]
↑ EA
(+28,6%)
(day 5)
- - -
Parallel
orientation
of cells to
current flow
axis
[76]
Osteoblasts
(Rat calvaria) ND Cons. NA NA 5; 14 ND 5 min to  5 h - - -
↑ [Ca2+]i
(14 V/cm)
Cathodal
migration [69]
Osteoblasts
(Rat calvaria) ND Cons. NA
NA
ND
100;
300 5 min - - -
↑ [Ca2+]i
(+130%)
(10min after
ES)
-
[73]
NA 100 1h/day 5 days ↑Cell Nr.(+38%) - - - -
Osteoblasts
(Bovine) ND Cons. NA NA 7 to 12 ND 80 min - - - ≈ [Ca
2+]i
Alignment
and
elongation
perpendicul
ar to EF
lines
[65]
Mouse calvarial
organ culture ND Cons. NA NA ND 20 72 h - - - ↓ [Ca
2+]m - [64]
Osteoclasts
(Rabbit)
Pre-
confluent Cons. NA NA 1; 10 ND 1 h to17.2 h - - - -
Anodal
galvanotaxis [68]
Human fetal
osteoblasts
(hFOB 1.19)
Pre-
confluent Cons. NA NA 2 ND 30 min - - -
↑ [Ca2+]i
(+350%)
(20 min)
- [72]
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Osteoblasts (Rat
calvaria) ND Square 3x10
3 3.2x10-5 ND 1.5
6 h/day
3 days
[1 day
no ES + 2
days ES]
≈ EA - - - -
[78]
4 days
+ OM -
≈ OPN, Col I,
msx2; ↓ALP,
cbfa1; no
BSP
no OC - -
24 h/day
3 days
[1 day no
ES + 2 days
ES]
↑ EA
(+31%) - - - -
4 days
+ OM -
≈ OPN, Col I,
ALP, ↓cbfa1,
x BSP
no OC - -
Osteoblasts (Rat
calvaria)
Sub-
confluent
(on
polymers) Square 10 ND ND ND 6 h/day
2 days ↑ Cell Nr.(+46%)
≈ OPN,OPG;
↑ Col I
(day 1)
- -
[77]
Confluent
(on
polymers)
23 days [2
days no ES
+ 21 days
ES] + OM
-
≈ OPN;
↑ ON, OPG,
Col I (day 21)
-
↑[Ca2+]ecm
(+307%);
↑OC
-
6Table S4 - Capacitive coupling stimulation characteristics and biological outcomes evaluated in cell lines. ND – not defined stimuli characteristic; NA – not applicable; ES –
electric stimulation; IA – DNA incorporation assay; MetB – metabolic activity assay; DNA – DNA content; ALPa – Alkaline phosphatase activity (i – intracellular; m – media); ALPe –
Alkaline phosphatase expression; MM – matrix mineralization; OPN – osteopontin; Col I – collagen type I; BSP – Bone sialoprotein; ON – osteonectin.
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MC3T3-E1 (mouse
osteoblast-like cell
line)
Pre-
confluent
Square
(duty cycle: 2.9%) 10 ND
14.5
ND
20 h
68 h [24 h no ES
+ 20 h ES +24 h
no ES]
≈ IA - -
[79]
20.3 ≈ IA - -
31.9 ↑ IA (+100%) - -
31.9
5 min;
6 h;
20 h
72 h [24 h no
ES, 5 min, 6h,
20h ES --> 48h]
↑ IA
(+35-100%) - -
MC3T3-E1 (mouse
osteoblast-like cell
line)
2 days
Post-
confluent
Sinusoidal 60x103 ND 0.02 300 24 h 24h ↑ IA(+18.7%) - - [81]
TE-85 (human
osteosarcoma cell
line)
Pre-
confluent Sinusoidal
10
ND 1x10-7 ND 30 min
66,5 h [48 h no
ES (24 h Serum
+ 24 h Serum-
free) + 30 min
ES + 18 h]
≈ IA - -
[80]
12 ≈ IA - -
14 ↑ IA (+30%) - -
16 ≈ IA - -
MC3T3-E1 (mouse
osteoblast-like cell
line)
2 days
Post-
confluent
Sinusoidal 60 ND 0.02 300
30 min 24 h [ES 30 min+ 23,5 h no ES]
↑ DNA
(+17%) - -
[82]
2 h 24 h [ES 2h+ 22 h no ES]
↑DNA
(+23%) - -
6 h 24 h [ES 6h+ 18h no ES]
↑ DNA
(+25%) - -
24 h 24 h ↑ DNA(+49%) - -
SaOS-2 (human
osteosarcoma cell
line)
Non-
confluent Degenerate ND 62.5x10
-3 0.1 ND 4 h
28 h [4 h ES
+ 20 h no ES
+ 4 h ES]
↑MetB. A
(2h) ↓MetB.A
(28h)
↑ALPa(m) (28h),
ALPa(i) (2h, 26h, 28h),
ALPe; ↑Col I; ↑OPN; ↑
ON; ↑BSP
↑MM
(+480%)
(28h)
[58]
7Table S5 - Capacitive coupling stimulation characteristics and biological outcomes evaluated in stem cells. ND – not defined stimuli characteristic; NA – not applicable; ES –
electric stimulation; OM – osteogenic media; MetB – metabolic activity assay; ALPa – Alkaline phosphatase activity; ALPe – Alkaline phosphatase expression; OC – osteocalcin; OPN
– osteopontin; Col I – collagen type I; BSP – Bone sialoprotein; MM – matrix mineralization.
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hBM-MSCs (human Bone Marrow
derived Mesenchymal Stem Cells) ND
Degenerate ND 62.5x10-3 0.1 ND 3 h/day 5 days ↑ MetB - - [71]
hMSCs (human Bone Marrow derived
Mesenchymal Stem Cells)
(on an
hydrogel)
Sinusoidal 10 ND ND ND 6 h/day 14 days -
≈ Runx2; ≈
osterix; ≈ OPN
(days 7 and 14)
↑ OC
(day 14) [86]
8Table S6 - Capacitive coupling stimulation characteristics and biological outcomes evaluated in primary cells. ND – not defined stimuli characteristic; NA – not applicable; ES
– electric stimulation; [Ca2+]ecm - extracellular matrix calcium concentration; OM – osteogenic media; IA – DNA incorporation assay; MetB – metabolic activity assay; EA – exclusion
assay; ALPa – Alkaline phosphatase activity (i – intracellular; m – media); ALPe – Alkaline phosphatase expression; OC – osteocalcin; OPN – osteopontin; Col I – collagen type I; ON
– osteonectin; BSP – Bone sialoprotein; cbfa1 - Core-binding factor alpha(1); BMP2 - Bone morphogenetic protein; OPG – Osteoprotegerin.
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Bone cells (rat
embryo calvaria) Confluent
Square
(duty cycle:
7.5x10-3%)
3 ND
13 ND
5 min
24h
[5 min ES
--> 24 h no ES]
↑ IA
(+ 40%) - -
[85]22 ND ≈ IA - -
54 ND ↑ IA(+240%) - -
Bovine primary cells
(osteoblast migration
from periosteum
explants)
Sub-
confluent
Square 16 ND 60
ND
24 h/day
11 days
[4 days no ES
+ 7 days ES]
↑ Cell Nr.
(+ 10-30%)
(day 7)
↑ ALP (+200 -
300%) -
[55]
Confluent ND
22 days
[4 days no ES + 18 days
ES]
-
↑ FN, ON, Col
I, BSP, OPG
(days 9 to 22)
↑OC (days 13
and 18)
Bovine primary cells
(ostoblast migration
from periosteum
explants)
Pre-
confluent
(Confluent
before ES
application)
Square
16 ND
60 ND
24 h/day
21 days
[7 days no ES + 14 days
ES]
- -
↑[Ca2+]ecm;
globular
mineralized
bodies
[61]
Square 210 ND - - rod-shapedcrystals
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Bone cells (rat
embryo calvaria) Confluent
Square
(duty cycle:
7.5x10-3%)
3 ND
13
ND 5 min
24h
[5 min ES
--> 24 no ES]
↑IA
(+ 40%) - -
[84]
24 IA ≈ - -
54 ↑ IA(+240%) - -
Osteoblasts (Rat)
(on
conducting
polymers)
Sinusoidal 100 ND ND ND 1 h/day
8 days
[1 day no ES
+ 7 days ES]
↑ MetB
↑ BMP-2,
p-Smad4, Col
I, ON
- [138]
Embroynic chick
calvarial cells ND ND
8
ND 1x10-7 ND 30 min 18,5h [30 min ES+ 18 h no ES]
≈ IA - -
[83]
12 ≈ IA - -
16 ↑ IA(+30%) - -
20 ≈ IA - -
24 ≈ IA - -
10
Table S7 - Inductive coupling stimulation characteristics and biological outcomes evaluated in cell lines. ND – not defined stimuli characteristic; NA – not applicable; AC –
alternating voltage; CV - constant voltage; ES – electric stimulation; [Ca2+]ecm - extracellular matrix calcium concentration; OM – osteogenic media; IA – DNA incorporation assay;
MetB – metabolic activity assay; DNA – DNA content; EA – exclusion assay; PS – protein synthesis; ALPa – Alkaline phosphatase activity; OC – osteocalcin; OPN – osteopontin; Col I
– collagen type I; FN – fibronectin; MM – matrix mineralization.
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MG63 (human
osteosarcoma cell
line)
Non-
confluent
(on
polymers)
Square
(PEMF) 75 ND 2.3 ND 12 h /day
7 days [1 day no ES
+ 3 days ES
+ 3 days no ES]
↑MetB. (+31%)
(day 7)
↑ALP (+21%)
(day 4); ↑ 22%
Pro-Col I, TGF-β
(day 7)
↑OC (+14%)
(day 4) [105]
MG63 (human
osteosarcoma cell
line)
ND Square(PEMF) 75 ND 2.3 0.02
30 min, 1 h, 3 h,
6 h,12 h, 18 h
or 24 h
24 h no Es + 30 min,
1 h, 3 h, 6 h,12 h, 18 h
or 24 h ES
↑ IA (1 h to 24 h) - - [121]
TE-85 (human
osteosarcoma cell
line)
Non-
confluent
CV +
Sinusoidal
(CMF)
15.3 ND 4x10
-2 AC|
2x10-2 CV ND 10, 20 or 30 min
24 h No + 10, 20 or 30
min ES
+ 24 h no ES
↑ IA (+71%) - - [89]
TE-85 (human
osteosarcoma cell
line)
Non-
confluent
Square
(PEMF) 75 ND 2.3 0.02
10 min ≈ IA - -
[91]
30 min ↑ IA (+276%) - -
9h ↑ IA (+284%) - -
24 h ↑ IA (+355%) - -
MG63 (human
osteosarcoma cell
line)
10 min ≈ IA - -
30 min ↑ IA (+147%) - -
9 h ↑ IA (+174%) - -
18/36 h ↑ IA (+182%) - -
MC3T3-E1 (mouse
osteoblast-like cell
line)
ND Square(PEMF) 48 ND 1.55 ND
24 h
24 h ≈ MetB. no ALP -
[98]
48 h [24 h no ES
+ 24 h ES] ≈ MetB. no ALP -
48h [24 h ES
+ 24 h no ES] ≈ MetB. no ALP -
48h ≈ MetB. no ALP -
MC3T3-E1 (mouse
osteoblast-like cell
line)
ND Square(PEMF) 5000 66.7 4 ND 30 min/day
3 days [2 days ES
+ 1 day no ES] ↑MetB. ↑ALP -
[102]
3 days [2 days ES
+ 4 h or 24 h no ES] - ↑COX-2 (+24 h) -
11
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MC3T3-E1 (mouse
osteoblast-like cell
line)
Non-
confluent
Square
(PEMF) 6667 66.7 7 ND 24 h/day
30 days [5 days ES
+ 25 days no ES]
+ OM
↑ DNA +38.5%
(day 2); + 7.1%
(day 7)
↑ALP ↑ MM(+51%)
[53]
30 days [10 days no
ES + 5 days ES
+ 15 days no ES]
+ OM
↑ALP ↑ MM(+35%)
30 days [25 days no
ES + 5 days ES]
+ OM
- ↓ MM(-20%)
30 days [15 days ES
+ 15 days no ES]
+ OM
↑ALP ↑ MM(+ 51%)
30 days [15 days no
ES + 15 days ES]
+ OM
- ≈ MM
30 days + OM - ≈ MM
ROS 17/2.8 (rat
osteosarcoma cell
line)
Non-
confluent ND 30 ND 1.8 6x10
-3
24 h/day 3 days ≈ Cell Nr. ↑ ALP (+108%) -
[94]
12 h/day 3 days [2,5 days noES + 12 h ES] ≈/↓ Cell Nr. ↑ ALP -
ROS 17/2.8 (rat
osteosarcoma cell
line)
Non-
confluent Sinusoidal 30 ND 1.8 0.02 24 h/day 5 days ↓ Cell Nr. ↑ ALP - [93]
MG63 (human
osteosarcoma cell
line)
Confluent Triangular(PEMF) 4444 66.7 1.8 ND 8 h/day 4 days
↓ Cell Nr. (-48%
at day 4); ↓IA
(-37% at day 2)
↑ ALP; ↑ Col I
(+160% at day 1)
↑ OC (+260%
at day 2) [92]
MLO-Y4
(osteocyte-like cells)
Non-
confluent
(collagen
coated
plate)
Triangular
(PEMF) 4444 66.7 1.6 ND
8 h/day 4 days ≈ EA ↑ ALP (+200% atday 1) ≈ OC [107]
ROS 17/23
osteoblast-like cells Confluent 24 h/day 3 days ≈ EA - ≈ OC
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SaOS-2
Non-
confluent
Square
(PEMF) 5000 66.7 ND 9 4 h/day
3 days [2 days no ES
+ 4 h ES +16 h no ES]
≈ MetBA;
≈ Cell Nr. - -
[106]
Confluent
3 days [20 h no ES
+ 4 h ES] -
↑ALP (+85%
day 1; +43% day
2; +80%  day 3)
-
3 days [20 h no ES
+ 4 h ES] + OM - ↑ALP (+ 90%) ↑MM
TE-85 osteosarcoma
cells
Non-
confluent
CV
+Sinusoidal
(CMF)
15.3 ND 40x10
-3 AC|
20x10-3 CV ND 30 min
18.5h [30 min ES
+ 18h No ES] ↑ IA (+58%) - - [90]
SaOS-2 Non-confluent
Square
(PEMF) 1x10
6 66.7 0.1 ND 24 h/day 21 days ↑MetB (11days) - - [126]
SaOS-2 Non-confluent
Triangular
(PEMF) 4000 66.7 1.3 ND
8 h/day 3 days ↓ PS(-9% to 14%)
↑ ALP (+12% to
16%) -
[87]
24 h/day
3 days [1 day ES
+ 2 days no ES]
↓ PS
(- 11%)
↑ ALP (+14% to
20%) -
3 days [1day no ES
+ 1 day ES
+ 1 day no ES]
≈ PS ↑ ALP (+19% to38%) -
3 days [2 days no ES
+ 1 day ES]
↓ PS
(-17%)
↑ALP (0 to
+22%) -
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Table S8 - Inductive coupling stimulation characteristics and biological outcomes evaluated in stem cells. ND – not defined stimuli characteristic; NA – not applicable; ES –
electric stimulation; [Ca2+]ecm - extracellular matrix calcium concentration; OM – osteogenic media; IA – DNA incorporation assay; MetB – metabolic activity assay; DNA – DNA
content; EA – exclusion assay; ALPa – Alkaline phosphatase activity; OC – osteocalcin; MM – matrix mineralization.
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hBM-MSCs (human Bone
Marrow derived
Mesenchymal Stem Cells)
Non-
confluent
Sinusoidal 200 5000 1000 ND 3 min/day
5 days [1 day
no ES + 4 days
ES]
↑ IA - -
[96]
Pre-
confluent
25 days (+OM 7
to 25 days) - ↑ ALP ↑MM
25 days [7 days
ES + 18 days
no ES (+OM)]
- ↑ ALP ↑MM
hBM-MSCs (human Bone
Marrow derived
Mesenchymal Stem Cells)
Non-
confluent
Square
(PEMF) 4444 66.7 1.8 ND
8
h/day
10 days ↑ Cell Nr.(+20 to 60%) - -
[95]24 days
[3 days ES + 21
days no ES
(+OM)]
- ≈ ALP ≈MM
hBM-MSCs (human Bone
Marrow derived
Mesenchymal Stem Cells)
Non-
confluent
Square
(PEMF) 7.5 ND 0.13 2
2
h/day
7 days ≈ DNA - -
[88]15 days [1 day
no ES + 14
days ES]+OM
↓ DNA (-75%
at day 7); ↑
DNA (+62% at
day 10)
↑ALPa (+82%  day 7);
↓ALPa (-123% day 10);
↑Runx2/Cbfa1 (day 7);
↓Runx2/Cbfa1 (day 10)
↑MM
(day 28)
hBM-MSCs (human Bone
Marrow derived
Mesenchymal Stem Cells)
Confluent Triangular(PEMF) 4444 66.7 1.6 ND
8
h/day
24 days + OM
+ BMP-2 ↓Cell Nr. ↑ ALP ↑OC [97]
hBM-MSCs (human Bone
Marrow derived
Mesenchymal Stem Cells)
ND Triangular(PEMF) 4444 66.7 1.8 ND
3
h/day 5 days ↑ MetB. - - [71]
C3H10T1/2 (pluripotent
stem cells isolated from
mouse embryo
osteocarcoma)
ND Square(PEMF) 1000 0.1 ND 0.1
24
h/day 14 days ≈ MetB. ↑ ALP (at days 3, 9, 12)
↑ OC (days
7,10); ↑ MM
(day 14)
[113]
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hBM-MSCs (human Bone
Marrow derived
Mesenchymal Stem Cells)
ND Square(PEMF) 4444 66.7 1.8 ND
8
h/day 11 days
↑Cell nr
(+34.8%,
+ 29.8% (+
OM) at day 1)
↑ALP (at days 1 and 4);
↓Col I (day 4); ↑Col I (day 7);
↑cbfa-1 (day 2); ↓ cbfa-1
(day 4); ↓BMP-2 (day 2); ↑BMP-
2 (at days 4 and 7)
↑OC
(day 4);
↑MM
(day 11)
[114]
BMSCs (Human bone
marrow stromal cells) ND
Square
(PEMF)
200
x103 66.7 0.1 ND
24
h/day 14 days ↓IA (day 14)
≈ ALP, Col I and ON; ↑BMP-2
(at days 5 and 9); ↑TGF-β
(day 9); ↑OPG (at days 5
and 9); ↑OC I (day 9)
↑MM
(days 9 and
14)
[104]
hBM-MSCs (human Bone
Marrow derived
Mesenchymal Stem Cells)
Non-
confluent
Square
(PEMF) 1x10
6 66.7 0.1 ND 24h/day 21 days
↑MetB (+13%
at day 7,
+16% at day
14)
↑Col-1 (+120% at day 14,
+ OM); ↑ALP (+80% at day 21,
+OM)
- [126]
hBM-MSCs (human Bone
Marrow derived
Mesenchymal Stem Cells)
Non-
confluent
Square
(PEMF)
5
NA 1.1 ND 30min/day 21 days
- ≈ ALP (days 3, 6, 9);↑ ALP (days 12, 15)
↑OC; ↑MM
(day 21)
[108]
25 - ≈ ALP (day 3);↑ ALP (days 6, 9, 12, 15)
↑OC; ↑MM
(day 21)
50 - ↑ ALP (days 3, 6, 9, 12, 15)
↑↑OC (day
21); ↑MM
(day 21)
75 - ≈ ALP (day 3);↑ ALP (days 6, 9, 12, 15)
↑OC; ↑MM
(day 21)
100 - ≈ ALP (day 3);↑ ALP (days 6, 9, 12, 15)
↑OC; ↑MM
(day 21)
150 - ≈ ALP (days 3, 6, 9);↑ ALP (days 12, 15)
↑OC; ↑MM
(day 21)
hBM-MSCs (human Bone
Marrow derived
Mesenchymal Stem Cells)
Pre-
confluent
Square
(PEMF) 75 NA 2 ND
10min
/day
7 days + OM = MetB = ON, BSP, OPN, Runx2 -
[123]
21 days + OM = MetB↑DNA
↑ ON, BSP, OPN, Runx2,  DC,
FN, Col, aALP and ALP
↑ q[Ca2+]
(day 21)
ASCs (human Adipose-
derived mesenchymal
stem cells)
7 days + OM = MetB = ON, BSP, OPN, Runx2 -
21 days + OM = MetB;↑DNA
↑ OSN, BOSP,  aALP; =  OPN,
Runx2,  DC, FN, Col, and ALP
↑ q[Ca2+]
(day 21)
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ASCs (human Adipose-
derived mesenchyme stem
cells)
ND Sinusoidal
7.5
NA
0.1
ND 8h/day 20 days -
↓ ALP levels (day 7; NM and
OM)
-
[103]
10 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
15 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
30 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
45 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
60 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
75 ↓ ALP levels (day 7; NM andOM)
7.5
1
↓ ALP levels (day 7, NM and
OM), ALPai (day 10)
 ↓ Runx2, COL-I, OC, OSX (day
4 and 7, NM and OM),
↓ [Ca2+]
(NM and
OM)
10 ↑ ALP levels (day 7; NM andOM)
-
15 ↑ ALP levels (day 7; NM andOM)
30
↑ ALP levels (day 7, NM and
OM) and ↑ ALPai (day 10),
↑ Runx2, COL-I, OC, OSX (day
4 and 7, NM and OM)
↑ MM
(day 20)
↑ [Ca2+]
(day 20)
(NM and
OM)
45
↑ ALP levels (day 7, NM and
OM) and ↑ ALPai (day 10),
↑ Runx2, COL-I, OC, OSX (day
4 and 7, NM and OM)
↑ [Ca2+]
(day 20)
(NM and
OM)
60 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7) -
75 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7) -
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ASCs (human Adipose-
derived mesenchyme stem
cells)
ND Sinusoidal
7.5
NA
2
ND 8h/day 20 days -
↓ ALP levels (day 7; NM and
OM)
-
[103]
10 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
15 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
30 ↑ ALP levels (day 7, NM andOM)
45 ↑ ALP levels (day 7, NM andOM)
60 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
75 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
7.5
3
↑ (OM) and = or ↓ (NM) ALP
levels (day 7)
-
10 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
15 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
30 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
45 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
60 ↑ (OM) and = or ↓ (NM) ALPlevels (day 7)
75 ↓ ALP levels (day 7; NM andOM)
17
Table S9 - Inductive coupling stimulation characteristics and biological outcomes evaluated in primary cultures. ND – not defined stimuli characteristic; NA – not applicable;
AC – alternating voltage; CV - constant voltage; ES – electric stimulation; Cons. – constant magnetic field; [Ca2+]ecm - extracellular matrix calcium concentration;   OM – osteogenic
media; IA – incorporation assay; MetB – metabolic activity assay; DNA – DNA content; EA – exclusion assay; PS – protein synthesis; ALPa – Alkaline phosphatase activity; OC –
osteocalcin; OPN – osteopontin; Col I – collagen type I; MM – matrix mineralization.
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iCALs
(immortalized
calvarial cells)
ND Square(PEMF) 1000 0.1 ND 0.1 24 h/day 14 days ≈ MetB.
↑ ALP
( days 3, 7, 9)
↑ MM
(day 14) [113]
Osteoblasts (rat
calvaria) ND
Square
(PEMF) 48 ND 1.55 ND
24 h/day
24 h ≈ MetB. ↓ ALP -
[98]
48 h [24 h no ES
+ 24 h ES]
↑ MetB.
(+12.6%) ≈ ALP -
48 h [24 h ES
+ 24 h no ES]
↑ MetB.
(+19.8%) ≈ ALP -
48h ↑ MetB.(+19.1%) ↑ ALP -
HBC human
bone cells
Non-
confluent
CV +
Sinusoidal
(CMF)
15.3 NA
40x10-3
AC |
20x10-3
VC
ND 30 min 18.5 h [30 min ES+ 18 h no ES] ↑ IA (+26%) NA - [90]
Osteoblasts
(human femoral
heads)
ND ND(PEMF) 14.9 ND 0.4 ND 24 h/day 10 days
↑ Cell Nr.
(+1.8% day 3;
+29% day 7;
+55.5% day 10)
↑ ALP (+1% day 3; +
20% day 7;
+ 58% day 10)
- [101]
Osteoblasts (rat
calvaria)
Non-
confluent
Triangular
(PEMF) 3800 666.7 ND ND 4 h/day
7 days + BMP-2 ↑ Cell Nr. - -
[100]
13 days (ES at 9, 11,
13d) + 1 day no ES -
↑ALP (day 12),
≈ Pro-Col I ↑ OC (day 12)
13 days (ES 15, 17,
19d) + 1 day no ES - ≈ ALP, Pro-Col I ↑ OC (day 18)
20 days [1 day no
ES + 19 days ES]
+ BMP-2
- ↑ALP and ↑ Pro-Col I(day 12)
↑ OC;
↑ MM
(day 12)
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Osteoblats (rat
calvaria)
2 post-
confluent
Square
(PEMF) 7.5 ND ND 2 2 h/day 1 day ↑ MetB. - - [99]
Osteoblasts (rat
calvaria)
Non-
confluent
Square
(PEMF) 15 ~5 0.1 ND 8 h/day
14 days [2 days no
ES + 12 days ES]
↑ MetB. (34%
day 3; 11.5%
day 5; 13.3%
day 7);
≈ MetB.A
(day 14)
↓ ALP, RANKL;
≈ OPN, Col I
≈ OC;
≈ MM [59]
Osteoblasts
(human
trabecular bone
- healthy)
On a 3D
network Sinusoidal 20 NA 6 0.113 24 h/day 21 days
- ↑Col I (200% day 7;370% day 14) -
[110]
Osteoblasts
(Ectopic osseus
tissue -
myositis
ossificans)
-
↑Col I (240% day 3;
540% day 7; 120% day
21)
Densely
packed ECM;
intense Col I
and ALP
labelling
Osteoblasts (rat
calvaria)
Non-
confluent CV NA NA 160 ND 24 h/day 20 days
≈ Cell Nr.
(at day 10) ↑ [Ca
2+], ALP (day 20) ↑ MM (+50%),↑OC [112]
Osteoblasts (rat
calvaria)
Non-
confluent
Sawtooth
(PEMF) 4444 66.7 1.8 ND 6 h 6h ES + 21 days OM - -
↑ MM
(39% nr, 70%
larger)
[115]
SV-HFOs (fetal
pre-
osteoblasts)
Non-
confluent
Square
(PEMF)
200
x103 66.7 0.1 ND 24 h/day 14 days =IA - - [104]
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Osteoblasts (rat
calvaria) ND sinusoidal 50 NA
0.9
ND 30min/day Up to 15 days ↓MetB (3days)
= ALP (9 days); ↑BMP2
(12, 24, 96h)
= MM
(10 days)
[111]
1.2
↑  ALP (9 days); ↑BMP2
(12, 24, 96h); ↑Col-1
(96h)
↑  MM
(10 days)
1.5
↑ ALP (9 days); ↑BMP2
(12, 24h); ↑Runx-2
(12h); ↑Col-1 (12h)
↑  MM
(10 days)
1.8
↑ ALP (9 days); ↑BMP2
(12, 24, 96h); ↑Runx-2
(12, 24h); ↑Col-1 (12,
96h)
↑ MM
(10 days)
2.1
↑ ALP (9 days); ↑BMP2
(24h); ↑Runx-2 (12h);
↑Col-1 (12h)
↑  MM
(10 days)
2.4 ↑ ALP (9 days); ↑BMP2(24h); ↑Runx-2 (12h)
↑  MM
(10 days)
2.7 = ALP (9 days); ↑BMP2(24h)
↑ MM
(10 days)
3 = ALP (9 days); ↑BMP2(12, 24h)
=  MM
(10 days)
3.3 ↑ ALP (9 days); ↑BMP2(12h)
↑ MM
(10 days)
3.6
↑ ALP (9 days); ↑BMP2
(12, 24, 96h); ↑Runx-2
(12, 24h); ↑Col-1 (12,
96h)
↑ MM
(10 days)
3.9 ↑ ALP (9 days); ↑BMP2(12, 24h); ↑Col-1 (12h)
↑ MM
(10 days)
4.2 ↑ ALP (9 days); ↑BMP2(12h);
↑  MM
(10 days)
4.5 ↓ ALP (9 days); ↑BMP2(12h)
↑ MM
(10 days)
4.8 ↓ ALP (9 days); ↑Col-1(12h)
↓  MM
(10 days)
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Chapter 10
Supplementary Material - Section 4
Supplementary material of article:
’New cosurface capacitive stimulators for the development of active
osseointegrative implantable devices’
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Fig. S1: Simulation results of EF distributions and strengths on MED1 (z=0.5 mm) according to the
following periodic excitations applied to stimulator’ electrodes: a. 2D EFs: squared excitation (SQ ST) (5 V, 100
Hz). b. EFs on a gap midpoint (GM): SQ ST (CC =99.88%). c. 2D EFs: triangular excitation (TR ST) (0.5 V, 1 Hz).
d. EFs on GM: TR ST (CC =99.98%). e. 2D EFs: sawtooth excitation (SW ST) (2 V, 5 Hz). f. EFs on GM: SW ST
(CC =99.99%). g. 2D EFs: arbitrary excitation (AR ST) (3.5 V, 20 Hz). h. EFs on GM: AR ST (CC =100%). EFs were
obtained when voltages reach maximum amplitudes (at pi/2 rad in the triangular waveform). Results shown in 2nd column
refer to EFs in [0 2pi] rad. The midpoint above a gap is (x, y, z)=(0, 0, 0.5) mm from such horizontal planes.
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Fig S2: Interrelationships between EF strengths and constant excitations of the stimulator’
electrodes. a. EFs in the gap midpoint (x, y, z)=(0,0,0.5) mm and in the electrode midpoint (x, y,
z)=(1.25, 0, 0.5) mm on MED1. b. EFs in the gap midpoint (x, y, z)=(0, 0, 0.505) mm and in the
electrode midpoint (x, y, z)=(1.25, 0, 0.505) mm on MED2.
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Fig. S3: Simulation results of EF and MF distributions and strengths. a. 2D EFs stimulating
cells at pi rad: LF ST, MED2, z=0.5 mm. b. 2D EFs stimulating cells at pi rad: HF ST, MED2, z=0.5
mm. c. 2D MFs stimulating cells at pi rad: LF ST, MED2, z=0.5 mm. d. 2D MFs stimulating cells at
pi rad: HF ST, MED2, z=0.5 mm. e. 2D EFs stimulating cells at pi rad: LF ST, MED3, z=0.5 mm. f.
2D EFs stimulating cells at pi rad: HF ST, MED3, z=0.5 mm. g. 2D MFs stimulating cells at pi rad:
LF ST, MED3, z=0.5 mm. h. 2D MFs stimulating cells at pi rad: HF ST, MED3, z=0.5 mm. i. 2D
EFs stimulating cells at pi rad: LF ST, MED2, z=0.51 mm. j. 2D EFs stimulating cells at pi rad: HF
ST, MED2, z=0.51 mm. k. 2D MFs stimulating cells at pi rad: LF ST, MED2, z=0.51 mm. l. 2D MFs
stimulating cells at pi rad: HF ST, MED2, z=0.51 mm. m. 2D EFs stimulating cells at pi rad: LF ST,
MED3, z=0.52 mm. n. 2D EFs stimulating cells at pi rad: HF ST, MED3, z=0.52 mm. o. 2D MFs
stimulating cells at pi rad: LF ST, MED3, z=0.52 mm. p. 2D MFs stimulating cells at pi rad: HF ST,
MED3, z=0.52 mm
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Fig. S4: Secretion of two matrix maturation markers into the cells conditioned media upon
LF and HF stimuli Immunoblot analysis of the levels of: a. osteonectin (a 35 kDa protein); and b.
collagen-I [unprocessed and processed α1(I) and α2(I) procollagen monomeric chains of 130-160 kDa)],
secreted into the medium by MC3T3 cells exposed for various days in vitro (DIV) to NO ST, LF ST and
HF ST. Migration of molecular weight markers is indicated to the right.
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Fig. S5: Simulation results of EF distributions and strengths on MED2 (z=0.505 mm) according to the
following periodic excitations applied to stimulator’ electrodes: a. 2D EFs: squared excitation (SQ ST) (5 V, 100
Hz). b. EFs on a midpoint above a gap (GM): SQ ST (CC =99.88%). c. 2D EFs: triangular excitation (TR ST) (0.5 V, 1
Hz). d. EFs on GM: TR ST (CC =99.98%). e. 2D EFs: sawtooth excitation (SW ST) (2 V, 5 Hz). f. EFs on GM: SW ST
(CC =99.99%). g. 2D EFs: arbitrary excitation (AR ST) (3.5 V, 20 Hz). h. EFs on GM: AR ST (CC =100%). EFs were
obtained when voltages reach maximum amplitudes (at pi/2 rad in the triangular waveform). Results shown in 2nd column
refer to EFs in [0 2pi] rad. The midpoint above a gap is (x, y, z)=(0, 0, 0.5) mm from such horizontal planes.
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Fig. S6: Simulation results of EF distributions and strengths on MED3 (z=0.510 mm) when
electrodes are differently supplied by static excitation: a. 2D EFs: 10 V and 5 V excitations. b.
2D EFs: 10 V and 0.1 V excitations. The voltage supplying each pair of electrodes is illustrated.
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